{"Title": ["IBB, VRTX, BIIB, ILMN: Large Outflows Detected at ETF", "BIIB Makes Notable Cross Below Critical Moving Average", "Should You Sell Biogen Stock?", "Biogen: New Results From NURTURE Study Reveals Sustained Benefit Of SPINRAZA", "Japan's Fujifilm to spend $928 mln to double capacity of Danish drug facility", "7 of the Best Blue-Chip Stocks to Buy", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Despite Recent Speed Bumps, Biogen's Stock Will Soon Grow Again", "IBB, VRTX, BIIB, ILMN: Large Outflows Detected at ETF", "Got $3,000? Here Are 3 Great Biotech Stocks to Buy Right Now", "Better Buy: Biogen vs. Axsome Therapeutics", "Noteworthy ETF Outflows: IVE, IBM, FIS, BIIB", "7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine", "Nothing Will Stop Biogen Stock From Moving Higher", "Validea's Top Five Healthcare Stocks Based On Joel Greenblatt - 5/17/2020", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 5/17/2020", "Vir Biotechnology Is Bucking The Biotech COVID-19 Trends, And Stands To Win", "Noteworthy ETF Outflows: MTUM, AMD, BIIB, HUM", "5 Stocks Buffett Probably Bought in the First Quarter", "The All-Important Question Buffett Will Answer This Week", "BUZZ-U.S. STOCKS ON THE MOVE-GM, Axcella, Beyond Meat, SmileDirect", "Apple Sells $8.5 Billion in Bonds to Fuel Share Buybacks", "Apple borrows on the cheap to fund buybacks, dividends", "Health Care Sector Update for 05/04/2020: EGRX,VIR,RARE,TEVA,BIIB", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 5/17/2020", "Why Biogen Shares Fell 6.18% in April", "Has Biogen Found the Answer to Treating Alzheimer's?", "IBB, GILD, VRTX, BIIB: ETF Inflow Alert", "Better Buy: Cara Therapeutics vs. Sangamo Therapeutics", "At least 14 borrowers rush into US high-grade primary", "Analysts Forecast 13% Upside For The Holdings of TOK", "3 Big Stock Charts for Thursday: Snap, Biogen, and L Brands", "Health Care Sector Update for 05/04/2020: VIR,RARE,TEVA,BIIB", "Biogen Reports First-Quarter Results, Shares Plunge 9.4%", "Biogen Inc (BIIB) Q1 2020 Earnings Call Transcript", "Health Care Sector Update for 04/22/2020: BIIB,IMMU,PRTA,VBIV", "Noteworthy Wednesday Option Activity: CNNE, BIIB, SFNC", "Johnson & Johnson and AbbVie Earn a New FDA Approval for Imbruvica", "BUZZ-U.S. STOCKS ON THE MOVE-Snap, Peck Company, VBI Vaccines", "Why Biogen Stock Is Sinking Today", "Japanese shares snap 3-day losing streak as battered stocks bought back", "Nasdaq 100 Movers: BIIB, LRCX", "S&P 500 Movers: BIIB, EXPE", "Health Care Sector Update for 04/22/2020: BNTX, PFE, TMO, BIIB, XLV, IBB, VHT, IYH", "BUZZ-U.S. STOCKS ON THE MOVE-SAExploration Holdings, Unit Corp, Expedia Group", "Biogen delays Alzheimer's drug filing plans, shares fall", "Biogen Q1 Results Top Estimates - Quick Facts", "Biogen posts marginal rise in first-quarter sales", "Noteworthy ETF Inflows: IBB, VRTX, BIIB, REGN", "BUZZ-U.S. STOCKS ON THE MOVE-Co-Diagnostics, Xeris Pharma, Cyclacel Pharma", "BUZZ-U.S. STOCKS ON THE MOVE-DuPont, Occidental Petroleum, Safe-T Group", "BUZZ-U.S. STOCKS ON THE MOVE-Safe-T Group, Ford Motor, Facebook", "Validea's Top Five Healthcare Stocks Based On Martin Zweig - 4/19/2020", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 4/19/2020", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 4/19/2020", "Biogen Reaches Analyst Target Price", "Biogen Q1 20 Earnings Conference Call At 8:00 AM ET", "Biogen joins consortium for building COVID-19 'biobank'", "Biogen joins consortium for building COVID-19 'biobank'", "Better Buy: Alnylam Pharmaceuticals vs. Vir Biotechnology", "Should Investors Take a Chance on Biogen?", "BIIB May 29th Options Begin Trading", "3 Big Stock Charts for Thursday: Goldman Sachs, FedEx, and Biogen", "U.S. regulators delay decision on Roche SMA drug risdiplam to Aug. 24", "Biogen Is Building a COVID-19 Biobank With the Broad Institute", "GSK to partner with Vir for potential COVID-19 treatments, invest $250 mln", "GSK to partner with Vir for potential COVID-19 treatments, invest $250 mln", "GSK to partner with Vir for potential COVID-19 treatments, invest $250 mln", "3 Warren Buffett Stocks I Absolutely, Positively Wouldn't Buy Right Now", "Why Gilead Sciences Is the Hottest Stock to Buy Today", "Investors Are Wondering: Where\u2019s Warren Buffett?", "Better Buy: Gilead Sciences vs. Biogen", "Here Are All the Companies Working on COVID-19 Vaccines, Treatments, and Testing", "So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature", "IBB, VRTX, BIIB, ILMN: ETF Outflow Alert", "4 Reasons Drug Stocks Are a Buy Right Now", "First Week of BIIB May 15th Options Trading", "Bristol Myers Squibb's Multiple Sclerosis Drug, a Potential Blockbuster, Wins FDA Approval", "4 Reasons Biotech Stocks Are a Buy Right Now", "3 Big Stock Charts for Tuesday: Biogen, Activision Blizzard, and Plug Power", "Why Biogen Shares Rose 2.59% in March", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Are These Warren Buffett Stocks a Buy at Beaten-Down Prices?", "Berkshire\u2019s Recent Purchases Show Why Value Investing Still Works", "Why Biogen, GW Pharmaceuticals, and Vertex Pharmaceuticals Stocks Jumped Today", "7 Biotech Stocks to Buy and Hold in 2020", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 3/15/2020", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 3/15/2020", "Better Buy: AbbVie vs. Biogen", "Validea's Top Five Healthcare Stocks Based On Martin Zweig - 3/15/2020", "Better Buy: Biogen vs. Amgen", "Why These Drug Stocks Soared Today", "3 Ways Coronavirus Lockdowns Put Biotech and Big Pharma on Hold", "Biogen and Vir Biotechnology to Collaborate to Find a Treatment for the Coronavirus", "Health Care Sector Update for 03/12/2020: POAI,VIR,BIIB,CEMI,AZN", "Health Care Sector Update for 03/12/2020: VIR,BIIB,CEMI,AZN", "Validea's Top Five Healthcare Stocks Based On Joel Greenblatt - 3/15/2020", "Coronavirus Concerns Have Big Pharma Working From Home", "Is iShares Nasdaq Biotechnology Index Fund a Buy?", "Why Biogen Stock Rose 14.7% in February", "Former Biogen CEO to Become Biotech's New Coronavirus Czar", "Investors Endure Wild Ride in This Biotech Taking on COVID-19", "Here's Why Sangamo Therapeutics Jumped Higher Today", "Biogen Could Score a Major Win if Alzheimer's Drug Gets the Green Light", "IBB, GILD, VRTX, BIIB: Large Outflows Detected at ETF", "Biogen, Sangamo Sign Deal To Develop Gene Therapies For Neurological Diseases", "Ionis Pharmaceuticals' Revenues Rose 85% in 2019", "Noteworthy ETF Inflows: IBB, GILD, VRTX, BIIB", "Warren Buffett Is Buying This Stock Faster Than Any Other", "3 Top Stocks You Should Watch to Invest Like Berkshire Hathaway", "Why Did Warren Buffett Buy These 6 Stocks in Q4?", "Warren Buffett's 2 Pure-Play Pharma Picks Are Real Head-Scratchers", "Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%", "Warren Buffett's Big Biotech Bet Is 1 of His Riskiest Wagers Ever", "IBB, GILD, VRTX, BIIB: ETF Outflow Alert", "16 Stocks Warren Buffett Is Buying and Selling", "Stock Alert: Warren Buffett's Berkshire Hathaway Reveals Stake In Kroger, Biogen", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 2/16/2020", "Validea's Top Five Healthcare Stocks Based On Martin Zweig - 2/16/2020", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 2/16/2020", "Top Stocks Warren Buffett Just Bought", "Validea's Top Five Healthcare Stocks Based On Joel Greenblatt - 2/16/2020", "Better Buy: Biogen vs. Bristol-Myers Squibb", "Warren Buffett's Berkshire Hathaway Dives Into Biotechnology", "3 Biotech Stocks That Made Early Shareholders Millionaires", "Tuesday Sector Laggards: Consumer Products, Healthcare", "Will Biogen\u2019s Big Patent Victory Ease Investor Worries About Its Alzheimer\u2019s Drug?", "A Double Failure of Alzheimer's Drugs", "Validea's Top Five Healthcare Stocks Based On David Dreman - 2/16/2020", "3 Biotech Companies Analyzed", "Roche Presents Spinal Muscular Atrophy Drug Data", "Is This Under-the-Radar Stock Set to Succeed in Alzheimer's Disease?", "Why Amgen Stock Dropped 10.4% in January", "Biogen Surges After Winning Crucial Multiple Sclerosis Drug Patent", "Here's Why Alkermes Jumped Almost 11% Today", "Why Biogen Shares Soared Today", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Pfizer's Biosimilar Ruxience Gets EU Regulatory Backing", "Biogen is Now Oversold (BIIB)", "Amgen Revenue Slipped 1% in the Fourth Quarter", "Biogen Inc (BIIB) Q4 2019 Earnings Call Transcript", "Biogen's Earnings Per Share Jumped 19% in Fourth Quarter", "Is Biogen Stock a Buy?", "Look Under The Hood: IWX Has 11% Upside", "Biogen Guides FY20 In Line With Estimates - Quick Facts", "Biogen Inc. Q4 adjusted earnings Beat Estimates", "Noteworthy ETF Outflows: IBB, GILD, VRTX, BIIB", "2 of the Best Healthcare Stocks to Buy Today", "Nasdaq 100 Movers: AAL, BIIB", "Is Biogen Stock a Buy?", "Notable Friday Option Activity: BIIB, CASA, XRX", "Is Eli Lilly Stock Overvalued?", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "2 Reasons to be Optimistic About Biogen\u2019s Alzheimer\u2019s Drug", "Validea's Top Five Healthcare Stocks Based On Joel Greenblatt - 1/19/2020", "Validea's Top Five Healthcare Stocks Based On David Dreman - 1/19/2020", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 1/19/2020", "Validea's Top Five Healthcare Stocks Based On John Neff - 1/19/2020", "Noteworthy Friday Option Activity: CME, BIIB, PM", "Roche's Spinal Muscular Atrophy Drug Meets Primary Endpoint in Infants", "5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals", "3 Big Stock Charts for Wednesday: Biogen, Cooper Companies, and Maxim", "New Research Shows Probiotics Can Help Prevent Parkinson's", "Biogen Buys Azheimer's and Parkinson's Drug From Pfizer", "IBB, GILD, VRTX, BIIB: Large Inflows Detected at ETF", "Biogen To Acquire Clinical Stage PF-05251749 From Pfizer - Quick Facts", "Thursday Sector Laggards: Healthcare, Energy", "Why Biogen Stock Slumped Last Year", "5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals", "Better Buy: AbbVie vs. Biogen", "Better Buy: Gilead Sciences vs. Biogen", "IBB, GILD, VRTX, BIIB: ETF Outflow Alert", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "2 Biotech Stocks Poised to Soar in 2020", "Better Buy: Biogen vs. Gilead Sciences", "Why Longer-Term Investors Should Buy Amarin Stock on Weakness", "7 Biotech Stocks to Buy and Hold in 2020", "Validea's Top Five Healthcare Stocks Based On Joel Greenblatt - 12/15/2019", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 12/15/2019", "Validea's Top Five Healthcare Stocks Based On John Neff - 12/15/2019", "Validea's Top Five Healthcare Stocks Based On David Dreman - 12/15/2019", "Is Biogen Too Cheap to Ignore?", "Make the Shift Toward Value Stocks With These 5 Picks", "Should Investors Be Worried About Biogen's Alzheimer's Drug?", "Commit To Buy Biogen At $230, Earn 9.7% Using Options", "Why Shares of PDL BioPharma Are Soaring Today", "Better Buy: Biogen vs. Amgen", "Why Biogen\u2019s Alzheimer\u2019s Drug Presentation Left Investors Uninspired", "PJP, MDCO, LLY, BIIB: ETF Inflow Alert", "5 Top Stock Trades for Friday: RH, DG, KR, BIIB", "Biogen Stops Development Of Gosuranemab For Progressive Supranuclear Palsy", "Why Biogen's Recent Rebound May Not Last -- at Least for Now", "Biogen's Data Shows Improved Gastrointestinal Tolerability With Vumerity", "MOAT, STT, BIIB, BMY: Large Inflows Detected at ETF", "Thursday Sector Laggards: Consumer Products, Healthcare", "7 Biotech Stocks to Buy With Plenty of Power in the Pipeline", "Noteworthy Tuesday Option Activity: ROK, CPB, BIIB", "Here's Why Biogen Stock Shot Up 28% in October", "Why AbbVie Is a Dividend Growth Stock That's Too Cheap to Ignore", "2 Biotech Stocks Fighting Alzheimer\u2019s Disease to Own Now", "Biogen's Alzheimer's Drug Goes From Bust to Boon, Plus Why Walgreens Is Shuttering 200 Healthcare Clinics", "Noteworthy ETF Inflows: MOAT, STT, BIIB, BMY", "Is There Still Room to Profit From Biogen?", "Earningspalooza 2019: Round 4", "Massive News in Alzheimer's Drugs", "What Should Investors Think of Biogen's Alzheimer's Drug Candidate?", "Better Buy: Biogen vs. Celgene", "2 Biotech Stocks That Soared Last Week", "5 Top Healthcare ETFs", "First Trust NYSE Arca Biotechnology Index Fund Experiences Big Outflow", "Validea Warren Buffett Strategy Daily Upgrade Report - 10/24/2019", "Biogen CEO Confident Its Alzheimer's Drug Will Get FDA Approval", "Biogen Reaches Analyst Target Price", "Biogen's Stock Could More Than Quadruple in Value in 5 Years", "How The Aducanumab Surprise Helped Biogen Stock", "Is Biogen a Buy After the Biggest Biotech Bombshell in Years?", "2 Stocks That Flew High on Tuesday", "What Happened in the Stock Market Today", "Health Care Sector Update for 10/22/2019: OBLN,NLNK,BIIB,ARWR", "Tuesday Sector Leaders: Energy, Healthcare", "Health Care Sector Update for 10/22/2019: NLNK,BIIB,ARWR", "5 Healthcare Stocks to Buy", "Here's Why Biogen's Big Gain Won't Last Long", "Nasdaq 100 Movers: HAS, BIIB", "S&P 500 Movers: HAS, BIIB", "Health Care Sector Update for 10/22/2019: BIIB, CNC, NVS, JNJ, PFE, ABT, MRK, AMGN", "Why Biogen Stock Is on Fire Today", "Biogen Q3 Profit Tops Estimates; Revenue Up 5% - Quick Facts", "Biogen Plans To Submit BLA For Aducanumab In Alzheimer's Disease; Shares Jump", "Notable Friday Option Activity: WGO, BIIB, AXTA", "Biogen Inc (BIIB) Q3 2019 Earnings Call Transcript", "Better Buy: Biogen vs. Gilead Sciences", "Noteworthy Wednesday Option Activity: LNN, BIIB, UAA", "Insiders Buy the Holdings of VHT ETF", "Implied MOAT Analyst Target Price: $56", "Biogen Canada Reports Positive Results On Spinal Muscular Atrophy Study", "Notable Wednesday Option Activity: BIIB, CLX, MAC", "A Biotech Set to Dominate the Next 20 Years", "Why Did the Market Whack This IPO?", "2 Biotechs Tackling the Challenge of Lou Gehrig\u2019s Disease", "Better Buy: Biogen vs. Amgen", "Notable Tuesday Option Activity: ISRG, BIIB, COF", "Noteworthy Monday Option Activity: BIIB, MRO, WDAY", "3 Biotech Stocks That Show The Good, The Bad and the Ugly Side of This Sector", "Eisai, Biogen To Discontinue Elenbecestat Phase III Studies - Quick Facts", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Biogen Appoints Alfred Sandrock As EVP, Research And Development", "2 Biotechs Tackling the Challenge of Lou Gehrig\u2019s Disease", "Noteworthy Friday Option Activity: CI, ITW, BIIB", "Better Buy: Biogen vs. Celgene", "Health Care Sector Update for 08/21/2019: NVTA,BIIB,ALT,PFE,ALC", "What's Next for Sarepta Therapeutics After Its Surprising FDA Rejection", "Notable Friday Option Activity: BIIB, BMRN, EL", "Noteworthy Monday Option Activity: BIIB, CAT, MKTX", "2 Small-Cap Stocks That Could Make You Rich", "Notable Thursday Option Activity: NDAQ, BIIB, PRU", "Biogen Hedged Its Bet and Won Big", "ALKS : Diroximel Fumarate Shows Superior GI Tolerability On EVOLVE-MS-2 Endpoint", "Alkermes Bounces Back -- but Not Enough", "Biogen Raises Guidance as It Looks to the Pipeline for Growth", "Notable Tuesday Option Activity: BIIB, CWEN, GS", "5 Reasons Novartis Shareholders Aren't Shaken", "Biogen Earnings: BIIB Stock Surges on Big Q2 Earnings Beat", "Insiders Buy the Holdings of MOAT ETF", "Biogen Q2 Profit Rises; Lifts 2019 Outlook", "MS Franchise, Spinraza Likely to Be Key Catalysts for Biogen Stock", "Notable Earnings To Watch On July 23 - AN, JBLU, BIIB, CMG, KO, HOG, HAS, TXN", "8 More Big Pharma Events in 2019 You Don't Want to Miss", "The Multibillion-Dollar Race for Gene Therapy Manufacturing Is On", "Biogen Inc (BIIB) Q2 2019 Earnings Call Transcript", "Notable Monday Option Activity: MED, EPAM, BIIB", "Why Biogen Stock Has Plummeted in 2019", "Why Amicus Therapeutics' Stock Perked Up in June", "3 Top Biotech Stocks to Add to Your Watchlist", "3 Top Biotech Stocks to Buy Right Now", "Nasdaq Today: Hard to Keep Track of the Losers", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Notable Tuesday Option Activity: COST, BIIB, ULTA", "Nasdaq 100 Movers: NTES, BIIB", "3 Large-Cap Biotech Stocks to Buy for Massive Gains", "3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal", "Notable ETF Outflow Detected - IBB, GILD, BIIB, VRTX", "Insiders Buy the Holdings of JKD ETF", "Notable Thursday Option Activity: REGN, BIIB, GRMN", "Zynerba Stock Soars on Cannabidiol Patent for Autism Spectrum Disorder", "The 10 Biggest Biotech Stocks", "Pain, Pain Go Away - The Suicide Disease Drug Pipeline", "Better Buy: Biogen vs. Amgen", "Analysts Anticipate 17% Upside For The Holdings of JKD", "Can Novartis Convince Insurers a $2.1 Million Gene Therapy Is a Great Deal?", "Approval of a Game-Changing Gene Therapy for SMA Delivers a Win for Novartis and Regenxbio", "Notable ETF Outflow Detected - FXH, BRKR, MD, BIIB", "IBB, GILD, CELG, BIIB: ETF Outflow Alert", "Commit To Purchase Biogen At $180, Earn 8.7% Using Options", "Notable Thursday Option Activity: BIIB, FRO, FDX", "Stock Buybacks Surge", "IBB, BIIB, VRTX, ILMN: Large Outflows Detected at ETF", "Monday 5/6 Insider Buying Report: BIIB, UNH", "Noteworthy Thursday Option Activity: ABMD, BIIB, OXY", "Sum Up The Pieces: QQXT Could Be Worth $59", "Is This Highly-Anticipated Gene Therapy in Trouble?", "Ionis Pharmaceuticals Is 40% of the Way There", "Biogen Looks to 23 Clinical Programs for Growth", "Notable ETF Inflow Detected - IBB, CELG, GILD, BIIB", "Biogen Inc (BIIB) Q1 2019 Earnings Call Transcript", "Biogen Earnings: BIIB Stock Slips Despite Q1 Beat", "Earnings Reaction History: Biogen Idec, 36.4% Follow-Through Indicator, 2.8% Sensitive", "Biogen Inc. Q1 adjusted earnings Beat Estimates", "Notable Tuesday Option Activity: HIIQ, BIIB, EA", "Alkermes Looks Ahead to Growth", "Here's Why Ionis Pharmaceuticals Slumped Today", "2 Beaten Down Bluechips: Are They Buys?", "2 Beaten-Down Blue Chips: Are They Buys?", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Here's Why Ionis Pharmaceuticals Slumped Today", "2 Beaten-Down Blue Chips: Are They Buys?", "2 Beaten Down Bluechips: Are They Buys?", "Better Buy: Biogen vs. AbbVie", "Relative Strength Alert For Biogen", "Better Buy: Gilead Sciences vs. Biogen", "Health Care Sector Update for 04/12/2019: BHVN,VIVE,XFOR,TCON", "Notable Thursday Option Activity: SRPT, UNM, BIIB", "Risk-Tolerant Investors, Turn Your Eyes to Exelixis Stock", "Notable Thursday Option Activity: SRPT, UNM, BIIB", "Biogen (BIIB) Dips More Than Broader Markets: What You Should Know", "Relative Strength Alert For Biogen", "Should Biogen Investors Be Extra Nervous Right Now?", "1 Biotech That Biogen Should Buy ... but Probably Won't", "MGK, BIIB, CL, SCHW: Large Outflows Detected at ETF", "Why Biogen Stock Tanked in March", "1 Biotech That Biogen Should Buy ... but Probably Won't", "Why Nightstar Therapeutics Stock Skyrocketed 71% in March", "Biogen SMA drug price, Novartis estimates for its treatment far too high -U.S. group", "Should Biogen Investors Be Extra Nervous Right Now?", "Should Biogen Investors Be Extra Nervous Right Now?", "3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop", "Is Biogen a Beat-Up Bargain? And Is Bristol-Myers' Mega-Merger on the Rocks?", "Why Biogen's Alzheimer's Drug Failure May Have a Silver Lining", "Analysts Predict 12% Upside For DIVB", "Is Biogen a Beat-Up Bargain? And Is Bristol-Myers' Mega-Merger on the Rocks?", "3 Healthcare Stocks to Trade Now", "Biogen's Bad News for Everyone", "Celgene (CELG) Submits NDA for MS Drug to FDA for Review", "Market Close Report: NASDAQ Composite index closes at 7,691.52 up 53.98 points", "Why Viacom, Ferroglobe, and Biogen Jumped Today", "Nasdaq 100 Movers: TSLA, ORLY", "Weekly Market Summary: FOMC Goes From 60 to 0 in Three Months", "Novartis (NVS) Receives FDA Approval for MS Drug Mayzent", "1 Surprising Reason Alzheimer's Drugs Remain So Elusive", "Notable Monday Option Activity: NWSA, BIIB, JPM", "Is It Safe to Buy Biogen Stock Right Now?", "2 Biotech Takeout Targets Perfect for Biogen", "Sustainable Business Practices, Transparency Land Nasdaq Companies at Top of 2017\u2019s \u201c100 Best Corporate Citizens\u201d Ranking", "Biogen Stock Crashes on Termination of Alzheimer's Studies", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "3 Top Healthcare Stocks to Buy Right Now", "Company News For Mar 22, 2019", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 3/22/2019", "Mid-Afternoon Market Update: Dow Surges 250 Points; Micron Shares Gain On Upbeat Earnings", "Mid-Day Market Update: Superconductor Technologies Rises After Q4 Results; Staffing 360 Solutions Shares Slide", "Mid-Day Market Update: Superconductor Technologies Rises After Q4 Results; Staffing 360 Solutions Shares Slide", "What's Next for Biogen After Its Alzheimer's Disease Drug Flop?", "Biogen News: BIIB Stock Plummets on Alzheimer\u2019s Drug Failure", "Biogen Stock Fell Too Far on Unfortunate News", "Jobless Claims Dip, Philly Fed Swings, Biogen (BIIB) Plummets", "Stock Market News: Biogen Bombs, but Micron Moves Higher", "Why Biogen Stock Is Crashing Today", "Nasdaq 100 Movers: BIIB, MU", "Assessing Impact Of Biogen (BIIB) News", "S&P 500 Movers: BIIB, CAG", "Biogen Becomes Oversold (BIIB)", "Mid-Morning Market Update: Markets Open Higher; Conagra Earnings Top Expectations", "Mid-Morning Market Update: Markets Open Higher; Conagra Earnings Top Expectations", "Jobless Claims Dip, Philly Fed Swings, Biogen (BIIB) Plummets", "Alkermes Focuses on Pipeline, Depends on Partners for Funds", "Health Care Sector Update for 03/21/2019: BIIB, OGEN, NVCN, JNJ, PFE, ABT, MRK, AMGN", "Wall Street Tips Lower Ahead of Opening Bell on Dovish Fed, White House US-China Trade Talk", "Pre-Market Most Active for Mar 21, 2019 : BIIB, MU, SQQQ, QQQ, NOK, EQH, OPK, ERIC, CHL, LYG, CAG, ACB", "Initial Jobless Claims Decline", "Stock Market Today: Biogen Crushed After Failure of Alzheimer's Drug", "Is Biogen a Bad-News Buy Now?", "NASDAQ Composite Index closes up 5.02 points for the week, rising for the 5th straight day", "Close Update: Technology Sector Rally Sends US Stocks Higher as Nasdaq Leads Major Indexes", "Health Care Sector Update for 03/21/2019: LIFE,OGEN,NVCN,NVCN.TO,BIIB", "Mid-Afternoon Market Update: Dow Surges 250 Points; Micron Shares Gain On Upbeat Earnings", "Health Care Sector Update for 03/21/2019: OGEN,NVCN,BIIB", "US Futures Drop on Dovish Fed, White House US-China Trade Talk", "PDL BioPharma (PDLI) Q4 Earnings Top Mark, Revenues Fall Y/Y", "IBB, CELG, BIIB, GILD: Large Inflows Detected at ETF", "The Zacks Analyst Blog Highlights: Visa, Honeywell, Biogen, Humana and EOG Resources", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2019", "Celgene (CELG) Submits Application for MS Drug in Europe", "Better Buy: Amgen vs. Biogen", "Gene Therapy M&A Has Shares Skyrocketing -- Could This Company Be Next?", "US Stocks Push Higher After Dovish Federal Reserve Signals Goldilocks to Markets; Pound Slips on Brexit Chaos", "Company News For Mar 5, 2019", "Biogen to Acquire Gene-Therapy Company Nightstar for $800M", "NITE, BIIB: Nightstar Therapeutics Stock Soars on Biogen Buy", "Mid-Day Market Update: U.S. Stocks Turn Negative; Dow Down Over 350 Points", "Mid-Morning Market Update: Markets Open Higher; Childrens Place Misses Q4 Expectations", "AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab", "Why Nightstar Therapeutics Stock Is Soaring Today", "Biotech Stock Roundup: BIIB to Acquire Nightstar, Other Pipeline News & More", "US Stock Indexes Kick Off Week With Slump as Dow Leads Key Gauges Lower", "Ionis Pharmaceuticals Funds Its Pipeline of More Than 40 Drugs", "Health Care Sector Update for 03/04/2019: ASND,CSII,NTRI,TVTY,NITE,INO", "Mid-Afternoon Market Update: Nightstar Therapeutics Surges On Acquisition News; Evoke Pharma Shares Plunge", "Biogen to buy Nightstar Therapeutics in $800 mln cash deal", "Biogen to buy Nightstar Therapeutics for about $800 mln", "Health Care Sector Update for 03/04/2019: NITE, BIIB, ASND, AVXL, JNJ, PFE, MRK, ABT, AMGN", "Here's Why Ionis Pharmaceuticals Jumped Higher Today", "Alkermes' (ALKS) and Biogen's NDA for BIIB098 Accepted by FDA", "2 More Gene Therapy Stocks on Big Pharma's Buyout Radar", "Novartis In-Licenses Rights to Heart Candidate From Ionis", "Surprising Analyst 12-Month Target For OEW", "Novartis gene therapy would be cost effective up to $900,000 -U.S. group", "Novartis gene therapy is cost effective at up to $900,000 -U.S. group", "Health Care Sector Update for 03/04/2019: CSII,NTRI,TVTY,NITE,INO", "Nasdaq 100 Movers: NTES, HSIC", "AbbVie's RA Candidate Upadacitinib Gets FDA Priority Review", "Alkermes Breaks $1 Billion", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 2/17/2019", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 2/17/2019", "Alkermes (ALKS) Q4 Earnings & Revenues Surpass Estimates", "Notable ETF Outflow Detected - IBB, BIIB, ILMN, REGN", "Biogen Takes Over #114 Spot From Vulcan Materials", "Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2019", "The Zacks Analyst Blog Highlights: Visa, Charter, Biogen, BP and BB&T", "Top Research Reports for Visa, Charter Communications & Biogen", "BIIB Crosses Below Key Moving Average Level", "Market Close Report: NASDAQ Composite index closes at 7,288.35 down -86.93 points", "Thursday's ETF with Unusual Volume: QQEW", "Should You Buy Viking Therapeutics After Gilead Drug Failure?", "Despite M&A Spree, Biotech ETFs Slide on Mixed Earnings", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2019", "Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y", "Biogen beats estimates on multiple sclerosis drugs sales", "March 2020 Options Now Available For Biogen (BIIB)", "Biogen (BIIB) Beats Revenues and Earnings Estimates in Q4", "Monday 2/4 Insider Buying Report: BIIB, NRGX", "Biogen Q4 Results Top Estimates; Sees 2019 Results In Line With View", "Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?", "Drugmaker Biogen's fourth-quarter revenue rises 6.6 pct", "Earnings Reaction History: Biogen Idec, 45.5% Follow-Through Indicator, 3.1% Sensitive", "Health Care Sector Update for 01/29/2019: JNJ,CGC,WEED.TO,BIIB,AGN", "Health Care Sector Update for 01/29/2019: CGC,WEED.TO,BIIB,AGN", "Biogen Inc (BIIB) Q4 2018 Earnings Conference Call Transcript", "Biogen beats estimates on Spinraza, Tecfidera strength", "Noteworthy Monday Option Activity: DISH, ALGN, BIIB", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 1/26/2019", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "The Zacks Analyst Blog Highlights: Pfizer, Biogen, Schwab, Sysco and Philips", "Biogen (BIIB) Q4 Earnings Coming Up: What's in the Cards?", "Better Buy: Biogen vs. Gilead Sciences", "Notable Friday Option Activity: BIIB, CMI, CSU", "Pre-Market Earnings Report for January 29, 2019 : PFE, VZ, MMM, LMT, DHR, BIIB, AGN, HCA, GLW, PCAR, ROK, NUE", "Mizuho: 7 Long-Term Value Stocks to Buy Now", "7 Pharmaceutical Stocks That Just Raised Prices This Year", "Value Added: 7 Top Stocks for 2019", "Biotech Stock Roundup: LOXO, CELG Gain, J.P. Morgan Healthcare Conference in Focus", "Best Health-Care Stocks to Buy for 2019", "Biogen Inks Two Deals to Make Drugs for Neurological Diseases", "All the Pre-JPM News Healthcare Investors Need to Know", "Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report?", "Biogen Begins Improved Dosing Regimen on Tysabri in Phase III", "Perrigo Stock Up as Appeal Date for Irish Tax Bill Nears", "Perrigo Plunges on $1.9B Tax Bill From Irish Government", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Why Shares of Perrigo Are Plunging Today", "Health Care Sector Update for 12/21/2018: PRGO, PTI, RCKT, JNJ, PFE, ABT, MRK, AMGN", "Health Care Sector Update for 12/21/2018: APVO,JAZZ,RCKT,PRGO", "Biogen, Skyhawk Announce Collaboration - Quick Facts", "Health Care Sector Update for 12/21/2018: JAZZ,RCKT,PRGO", "U.S body says gene therapy may be more cost effective for spinal muscular atrophy", "Nasdaq 100 Movers: BIIB, NXPI", "S&P 500 Movers: BIIB, BA", "Alkermes, Biogen Submit NDA to FDA for Multiple Sclerosis Drug", "Surprising Analyst 12-Month Target For QUS", "Market Close Report: NASDAQ Composite index closes at 6,783.91 up 30.18 points", "AbbVie (ABBV) Seeks Approval for RA Candidate Upadacitinib", "Roche's SMA Candidate Risdiplam Gets PRIME Designation in EU", "Validea's Top Five Healthcare Stocks Based On John Neff - 12/16/2018", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 12/16/2018", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 12/16/2018", "Better Buy: Biogen vs. Amgen", "The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis", "5 Pharma Stocks That Could Cure Ailing Portfolios in 2019", "Noteworthy Tuesday Option Activity: BA, BIIB, BHF", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 13, 2018", "The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen", "4 Biotech Stocks Investors Can Add to Their Portfolio in 2019", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Biogen (BIIB) In-Licenses ALS Candidate BIIB067 From Ionis", "FDA Accepts BLA & Gives Priority Review to Novartis' AVXS-101", "AbbVie Presents Long-Term Data on Cancer Drugs at ASH 2018", "Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate", "Why Is Biogen (BIIB) Up 4.5% Since Last Earnings Report?", "BIIB January 2019 Options Begin Trading", "Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 11/18/2018", "Validea's Top Five Healthcare Stocks Based On John Neff - 11/18/2018", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 11/18/2018", "Implied MOAT Analyst Target Price: $51", "Teva's Rituxan Biosimilar Gets FDA Nod in Non-Hodgkin Lymphoma", "Ionis Pharmaceuticals Collects Royalties -- and Spends It All", "Noteworthy ETF Inflows: IYH, BIIB, DHR, ESRX", "6 Pharmaceutical Stocks to Buy After the Midterms", "PDL BioPharma (PDLI) Q3 Earnings Top, Revenues Rise, Stock Up", "5 Top Stocks to Make the Most of a Divided Congress", "Biogen Stock Rebounds After Impressive Q3 Earnings", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 15, 2018", "Noteworthy Friday Option Activity: BIIB, Z, AKS", "Biotech Stock Roundup: BIIB Tops, MACK Plunges, REGN's Asthma Drug Gets FDA Nod", "Biogen Becomes Oversold (BIIB)", "Biogen Rides the Spinraza Wave to Double-Digit Growth", "Alkermes Makes Financial Progress as Its Pipeline Moves Forward", "Biogen Earnings: 10 Highlights From BIIB\u2019s Q3", "Alkermes (ALKS) Exceeds Q3 Earnings Estimates, Raises Outlook", "What's in the Cards for AbbVie (ABBV) This Earnings Season?", "Earnings Reaction History: Biogen Idec, 45.5% Follow-Through Indicator, 3.1% Sensitive", "Health Care Sector Update for 10/23/2018: BIIB,PTI,TTPH", "Biogen Inc (BIIB) Q3 2018 Earnings Conference Call Transcript", "Biogen Breaks Below 200-Day Moving Average - Notable for BIIB", "iShares Nasdaq Biotechnology ETF Experiences Big Outflow", "BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store?", "Health Care Sector Update for 10/23/2018: PTI, TTPH, BIIB, JNJ, PFE, ABT, MRK, AMGN", "Better Buy: Biogen Inc. vs. Amgen Inc.", "Nasdaq 100 Movers: EBAY, PYPL", "Alkermes Boasts Strong Portfolio and Impressive Pipeline", "Biogen (BIIB) Q3 Earnings Coming Up: What's in the Cards?", "Corium's (CORI) Shares Surge on Merger Agreement With Gurnet", "The Implied Analyst 12-Month Target For RYH", "IBB, GILD, BIIB, CELG: Large Inflows Detected at ETF", "Pre-Market Earnings Report for October 23, 2018 : VZ, MCD, MMM, UTX, LMT, NEE, CAT, BIIB, CNC, GLW, PCAR, RF", "The Zacks Analyst Blog Highlights: Altria, U.S. Bancorp, Biogen, Ecolab and HSBC", "Roche (RHHBY) Presents Encouraging Data on MS Drug Ocrevus", "Biotech Stock Roundup: GILD, BIIB Present Data, VTGN Gains on Fast Track Status", "Commit To Buy Biogen At $250, Earn 6.3% Using Options", "Novartis' Applications for MS Drug Accepted by FDA & EMA", "Notable ETF Outflow Detected - IBB, GILD, BIIB, CELG", "Teva Gets FDA Committee Nod for Rituxan Biosimilar Filing", "Notable Tuesday Option Activity: BIIB, EPAY, TREE", "3 Biotech Stocks With Rising Estimates in the Past Month", "IBB, BIIB, GILD, CELG: ETF Inflow Alert", "3 Drug/Biotech Stocks in Focus on World Alzheimer's Day", "The Zacks Analyst Blog Highlights: Wells Fargo, Schlumberger, Biogen, American Express and Illinois Tool Works", "Is iShares Nasdaq Biotechnology ETF a Buy?", "Top Research Reports for Wells Fargo, Schlumberger & Biogen", "Roche (RHHBY) Presents Encouraging Data on SMA Drug Risdiplam", "Notable Tuesday Option Activity: BIIB, EPAY, TREE", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 9/16/2018", "IBB, BIIB, GILD, CELG: Large Outflows Detected at ETF", "Acorda (ACOR) Stock Dips, FDA Delays Decision on Inbrija", "3 Biotech Stocks Analysts Say Are Market Winners", "Better Buy: Gilead Sciences, Inc. vs. Biogen", "Better Buy: Celgene Corp. vs. Biogen", "Look Under The Hood: EQWL Has 10% Upside", "Alkermes Expands Study to Evaluate ALKS 4230-Keytruda Combo", "Acorda Gets Unfavorable Court Ruling for Ampyra, Stock Down", "Noteworthy Monday Option Activity: AKAM, JBHT, BIIB", "PBE, ILMN, BIIB, VRTX: ETF Inflow Alert", "Biogen Begins Phase III Study on Ischemic Stroke Candidate", "Biotech Fund Flows, Including ETF Activity, Remain a Driver to Watch", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 13, 2018", "Look Under The Hood: EQWL Has 10% Upside", "Alkermes Expands Study to Evaluate ALKS 4230-Keytruda Combo", "Acorda Gets Unfavorable Court Ruling for Ampyra, Stock Down", "Notable Friday Option Activity: PVH, PYPL, BIIB", "Biogen (BIIB) Down 10.1% Since Last Earnings Report: Can It Rebound?", "3 Terrible Stocks for Retirees", "Notable Friday Option Activity: GRUB, COOL, BIIB", "Is Biogen (BIIB) Outperforming Other Medical Stocks This Year?", "Has Biogen (BIIB) Outpaced Other Medical Stocks This Year?", "Pain Therapeutics' Shares Rally on Alzheimer's Study Grant", "Vertex's Cystic Fibrosis Drug Gets FDA Nod for Children", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 16, 2018", "Ionis Pharmaceuticals' Royalties Rise, but So Do Expenses", "Why Biogen's Stock Ripped Higher in July", "Lilly (LLY) Hits 52-Week High, Can the Run Continue?", "Is Biogen (BIIB) Outperforming Other Medical Stocks This Year?", "5 Stocks That Should Start Paying Dividends", "Interesting BIIB Put And Call Options For June 2020", "Zacks.com featured highlights include: Biogen, Thermo Fisher, HCA, Gilead and QUALCOMM", "Avoid Treating Biogen Like a Speculative Drug Stock", "5 Cheap PEG Stocks Suitable for GARP Investors", "PDL BioPharma (PDLI) Q2 Earnings Top, Revenues Slump Y/Y", "Biotech Stock Roundup: Celgene, Amgen, Vertex Impress in Q2, Gilead's CEO to Exit", "The Zacks Analyst Blog Highlights: Comcast, United Technologies, Biogen, Mondelez and Valero", "Wednesday Sector Leaders: Healthcare, Financial", "Better Buy: Biogen Inc. vs. Gilead Sciences, Inc.", "Collaborations Help Alkermes Flip to Profitability", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Nasdaq 100 Movers: FB, XLNX", "Is a Beat in Store for Ionis (IONS) This Earnings Season?", "Thursday's ETF with Unusual Volume: FBT", "Thursday Sector Laggards: Healthcare, Materials", "Why Every Investor Should Hold Shares of Biogen Stock", "Company News For Jul 25, 2018", "Biotech Stock Roundup: Biogen Gains on Q2 Results, Agios Gets FDA Nod For Leukemia Drug", "Bet on These 5 Biotech Stocks as Trump Raises Trade Tensions", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 7/25/2018", "Why Biogen's Stock Is Slumping Today", "Wall Street Rises After Strong Earnings From Tech, Health Care Sectors", "US Stocks Trend Higher After Strong Earnings from Tech, Health Care Sectors", "Biogen (BIIB) Q2 Earnings & Sales Beat Estimates, Shares Up", "Nasdaq 100 Movers: HAS, BIIB", "Morning Movers: Biogen, Alphabet, Verizon Soar as Earnings Lift the Dow", "Biogen (BIIB) Q2 Earnings Beat, Shares Up", "Earnings Reaction History: Biogen Idec, 45.5% Follow-Through Indicator, 3.1% Sensitive", "Biogen Posts Solid Earnings as the Biotech Waits for Clinical Trial Data", "Health Care Sector Update for 07/24/2018: BMY,BIIB,IMRN,LLY", "Health Care Sector Update for 07/24/2018: BIIB,IMRN,LLY", "BIIB, LLY Q2 Earnings on Jul 24: Here are the Key Predictions", "5 Top Stock Trades for Tuesday \u2014 Buy, Sell or Hold Tesla?", "5 Surprising Things You Probably Didn't Know About Alzheimer's Drug Pipelines", "Pre-Market Earnings Report for July 24, 2018 : VZ, MMM, UTX, LLY, LMT, BIIB, SHW, KMB, CNC, IQV, PCAR, AGR", "4 Biotech Bets to Watch as Industry Rebounds in a Month", "Market Close Report: NASDAQ Composite index closes at 7,840.77 down -1.10 points", "Biogen (BIIB) to Report Q2 Earnings: What's in the Cards?", "AbbVie Settles With Mylan to Delay Humira Biosimilar in U.S.", "New Drugs and Expected Growth Could Trigger a Recovery for Celgene Stock", "The Zacks Analyst Blog Highlights: PepsiCo, Eli Lilly, Broadcom, Biogen and Marathon", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 7/15/2018", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 7/15/2018", "Validea's Top Five Healthcare Stocks Based On John Neff - 7/15/2018", "Noteworthy ETF Outflows: IBB, BIIB, GILD, AMGN", "Top Analyst Reports for PepsiCo, Eli Lilly & Broadcom", "Better Know Biotech: Regenxbio Inc.", "Noteworthy Friday Option Activity: WYNN, FDX, BIIB", "Are We on the Cusp of a Big Alzheimer's Disease Breakthrough?", "Dopamine and the Weather, Part 2", "AbbVie's Imbruvica Fails in Phase III Blood Cancer Study", "Is Ionis Pharmaceuticals, Inc. a Buy?", "Better Buy: Biogen Inc. vs. Amgen", "Biotech Stock Roundup: BIIB's Gain on Alzheimer's Data, Regulatory Updates & More", "The Sad Truth: This Biotech Investing Strategy Almost Always Works", "Nasdaq 100 Movers: CERN, IDXX", "CTI BioPharma Falls After Failure of Pivotal Lymphoma Study", "Morning Movers: Pepsi Jumps, Celgene Climbs, Chipotle Slides", "Biogen Is the Right Alzheimer\u2019s Stock \u2026 At the Wrong Time", "Do Surprising Alzheimer's Disease Results Make Biogen Stock a Smart Buy Now?", "Noteworthy ETF Inflows: IBB, GILD, AMGN, BIIB", "Why CTI BioPharma Corp. Is Sinking Today", "Nasdaq 100 Movers: TTWO, BIDU", "Stock Market News For Jul 9, 2018", "Biogen Reaches Analyst Target Price", "5 Top Stock Trades for Monday", "3 Biotech Stocks That Soared This Week: Are They Buys?", "Why Biogen Inc. Stock Soared 15.2% Today", "Why Alphabet, Cerner, and Biogen Slumped Today", "Mid-Day Market Update: Crude Oil Up Over 1%; Black Box Shares Spike Higher", "Mid-Day Market Update: Crude Oil Up Over 1%; Black Box Shares Spike Higher", "Biogen Inc Stock Shoots Higher on Alzheimer\u2019s Drug Trial", "S&P 500 Movers: QRVO, BIIB", "Nasdaq 100 Movers: LRCX, BIIB", "Mid-Morning Market Update: Markets Mostly Higher; U.S. Adds 213,000 Jobs For June", "Mid-Morning Market Update: Markets Mostly Higher; U.S. Adds 213,000 Jobs For June", "BIIB Makes Bullish Cross Above Critical Moving Average", "Mid-Day Market Update: Crude Oil Up Over 1%; Black Box Shares Spike Higher", "Health Care Sector Update for 07/06/2018: BIIB,CELG,RGLS", "Pre-Market Most Active for Jul 6, 2018 : ANW, DB, SHV, IQ, BIIB, SNY, QQQ, SQQQ, TVIX, NOK, BABA, BP", "What Happened in the Stock Market Today", "Market Close Report: NASDAQ Composite index closes at 7,688.39 up 101.96 points", "Close Update: Wall Street Ends on High Note After Jobs Data Beats Expectations", "Health Care Sector Update for 07/06/2018: CELG,TGTX,BIIB,RGLS", "Biogen's Alzheimer Disease Candidate Succeeds in Phase II", "Friday's ETF Movers: IBB, GDX", "Mid-Day Update: US Shares Rise for Second Day, Boosted by Positive Data", "Health Care Sector Update for 07/06/2018: TGTX,BIIB,CELG,RGLS", "Notable Friday Option Activity: AMZN, BIIB, GOOGL", "IBB, GILD, AMGN, BIIB: Large Outflows Detected at ETF", "Sanofi's Blood Clotting Drug Gets Positive CHMP Opinion", "The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, General Motors, Valero and Ameriprise", "Why Biotech Stocks Rallied on Biogen's Alzheimer's Test", "IBB, GILD, BIIB, CELG: ETF Inflow Alert", "First Week of August 17th Options Trading For Biogen (BIIB)", "Don't Get Too Excited About PTC Therapeutics (Yet)", "Commit To Purchase Biogen At $195, Earn 3.4% Using Options", "PTC Therapeutics' Spinal Muscular Atrophy Study Successful", "Nasdaq 100 Movers: BIIB, JD", "Market Close Report: NASDAQ Composite index closes at 7,747.03 up .65 points", "Top Analyst Reports for Johnson & Johnson, Biogen & General Motors", "Monday Sector Laggards: Consumer Products, Healthcare", "Monday's ETF with Unusual Volume: IXJ", "Notable Monday Option Activity: FB, BIIB, GWW", "Here's Why PTC Therapeutics Is Soaring While Biogen and Ionis Struggle", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 6/17/2018", "Validea's Top Five Healthcare Stocks Based On John Neff - 6/17/2018", "Validea's Top Five Healthcare Stocks Based On Peter Lynch - 6/17/2018", "Why Biogen, Baytex Energy, and Catalyst Biosciences Slumped Today", "Zacks Value Investor Highlights: Gilead Sciences, Biogen, Celgene, Lannett and Valeant", "Roche Announces Positive Data on Gazyva and MS Drug Ocrevus", "Analysts Anticipate OEW Will Reach $37", "Biotech Stock Roundup: AXON Soars, Amgen Drugs Get FDA, EC Nod", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2018", "Drug Stocks: The Next Hot Industry or Value Traps?", "Gilead Sciences a Top Socially Responsible Dividend Stock With 3.2% Yield (GILD)", "Noteworthy ETF Outflows: IBB, BIIB, GILD, CELG", "Pfizer Boosts Venture Capital Efforts, Neuroscience in Focus", "iShares Nasdaq Biotechnology ETF Experiences Big Inflow", "Health Care Sector Update for 06/06/2018: ENTA,ITCI,CLRB,ALKS,BIIB", "Health Care Sector Update for 06/06/2018: ITCI,CLRB,ALKS,BIIB", "3 Top Biotech Stocks to Buy in June", "Biogen Inc Stock Got an Upgrade, but Should You Listen?", "Biogen Inks Deal With TMS To Acquire Phase II Stroke Asset", "Validea John Neff Strategy Daily Upgrade Report - 5/30/2018", "3 Top Biosimilars that Will Lift Pfizer Inc. Stock Even More", "3 Big Pharma Stocks with Huge Future Growth Potential", "Why is Biogen (BIIB) Up 6.7% Since Its Last Earnings Report?", "10 Top Health-Care Stocks That Never Break a Sweat", "IBB, BIIB, CELG, VRTX: ETF Outflow Alert", "Better Buy: Acadia Pharmaceuticals vs. Biogen", "Better Buy: Biogen Inc. vs. Celgene", "Sangamo Therapeutics Stock History", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 16, 2018", "Better Buy: Amgen Inc. vs. Biogen Inc.", "Novartis Multiple Sclerosis Drug Gets FDA Nod for Adolescents", "MOAT's Holdings Could Mean 14% Gain Potential", "Nasdaq 100 Movers: SYMC, REGN", "Noteworthy Friday Option Activity: ADBE, CELG, BIIB", "S&P 500 Analyst Moves: BIIB", "3 Stocks That Turned $10,000 Into $1 Million", "Ionis Pharmaceuticals Prepares for Launch", "IBB, CELG, BIIB, VRTX: ETF Outflow Alert", "What's in the Cards for Ionis (IONS) This Earnings Season?", "Better Buy: Biogen Inc. vs. Gilead Sciences Inc.", "Biogen's $1 Billion Bet on Ionis", "The Good and the Bad News With Biogen Inc Earnings Results", "IBB, CELG, BIIB, VRTX: ETF Inflow Alert", "3 Stocks That Turned $10,000 Into $1 Million", "Ionis Pharmaceuticals Prepares for Launch", "IBB, CELG, BIIB, VRTX: ETF Outflow Alert", "What's in the Cards for Ionis (IONS) This Earnings Season?", "Biotech Stock Roundup: PRTA Down, AMGN Revises View, BIIB Misses on Sales", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 4/25/2018", "Is Biogen Inc. a Buy?", "Biogen (BIIB) Q1 Earnings Beat, Sales Miss, Shares Down", "Health Care Sector Update for 04/24/2018: LLY, INCY, BIIB, CNC", "Biogen (BIIB) Q1 Earnings Beat, Sales Miss", "Earnings Reaction History: Biogen Idec, 54.5% Follow-Through Indicator, 5.0% Sensitive", "Why Ionis Pharmaceuticals Crashed Today", "Health Care Sector Update for 04/24/2018: ENZ,HOLX,BIIB,CNC,INCY", "Eli Lilly And Co Produced a Monstrous Q1 Beat, But Is It Enough?", "Biogen Posts Double-Digit Profits, Has Cash to Burn", "Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN", "Roche (RHHBY) Presents Encouraging Data on MS Drug Ocrevus", "Why Is Biogen Inc. Giving Ionis Another $1 Billion?", "Pre-Market Earnings Report for April 24, 2018 : VZ, KO, MMM, LMT, UTX, CAT, LLY, NEE, BIIB, TRV, SHW, FCX", "Novartis (NVS) Reports Encouraging Data on MS Candidate", "What's in Store for Biogen (BIIB) This Earnings Season?", "Health Care Sector Update for 04/20/2018: IONS, BIIB, RIGL, CMTA, VXRT", "Health Care Sector Update for 04/24/2018: INCY, BIIB,CNC", "Health Care Sector Update for 04/20/2018: CMIA,IONS,BIIB,RIGL", "Big Biotech ETF Can Bounce Back", "Is It Time to Give Up on Alkermes?", "Validea's Top Five Healthcare Stocks Based On John Neff - 4/15/2018", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 4/15/2018", "IBB, GILD, BIIB, VRTX: ETF Outflow Alert", "Add Up The Parts: SPYX Could Be Worth $74", "Health Care Sector Update for 04/20/2018: VXRT,CMIA,IONS,BIIB,RIGL,NABI", "Why One Drug Flop Tanked Incyte's Stock", "Mylan Fujifilm Kyowa Team Up to Market Humira Biosimilar", "Biotech Stock Roundup: Spectrum Up, Incyte Down, AveXis to Merge with Novartis", "Top Research Reports for NextEra, Danaher & Biogen", "Novartis' Acquisition of Avexis: Bad News for Biogen?", "AbbVie's RA Candidate Meets Primary Endpoints in Phase III", "Notable Tuesday Option Activity: IDCC, DAL, BIIB", "The Zacks Analyst Blog Highlights: NextEra, Danaher, Biogen, Facebook and Apple", "Why AveXis, Inc. Stock Is Soaring Today", "Novartis Inks $8.7 Billion Gene Therapy Deal to Buy AveXis", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 4/7/2018", "Biogen Cracks the Case With AbbVie for Humira Biosimilar", "Expect the Chaos to Continue With Today\u2019s Jobs Report", "Nasdaq 100 Movers: MU, FB", "Notable ETF Outflow Detected - IBB, BIIB, VRTX, ILMN", "Novartis' Acquisition of AveXis Takes Aim at Biogen", "Better Buy: Gilead Sciences, Inc. vs. Biogen Inc.", "Is Ionis Pharmaceuticals, Inc. a Buy?", "Better Buy: Celgene Corporation vs. Biogen Inc.", "Noteworthy ETF Outflows: OEF, CHTR, DHR, BIIB", "Buy the Bottom in Biogen Inc. Stock for a 100% Return", "The Zacks Analyst Blog Highlights: Biogen, AbbVie, Novartis, Teva and Celgene", "Despite Struggles Celgene Corporation Stock Is Still A Buy", "Better Buy: Biogen Inc. vs. Amgen Inc.", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 3/18/2018", "Why Multiple Sclerosis is a Promising but Risky Space?", "Biotech Stock Roundup: REGN Cuts Praluent Price, OREX to File for Bankruptcy", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 15, 2018", "Bull of the Day: Regeneron (REGN)", "Is Biogen Inc. a Buy?", "Why Biogen Stock Slumped in February", "Validea's Top Five Healthcare Stocks Based On John Neff - 3/18/2018", "Notable ETF Outflow Detected - BBH, CELG, BIIB, VRTX", "Market Close Report: NASDAQ Composite index closes at 7,511.01 down -77.31 points", "Biogen is Now Oversold (BIIB)", "Health Care Sector Update for 03/12/2018: SRPT,BIIB,PFE,SVRA,ALNY,SNY", "PDL BioPharma (PDLI) Q4 Earnings Beat, Revenues Rise Y/Y", "Are Alzheimer's-Focused Stocks Set for a Financial Windfall?", "More Commercial Revenue on Its Way for Ionis Pharmaceuticals", "Biogen to Buy Mid-Stage Neuropsychiatry Asset From Pfizer", "Notable Monday Option Activity: LGIH, BIIB, KHC", "Better Buy: Biogen Inc. vs. Celgene Corporation", "What's in the Cards for Ionis (IONS) This Earnings Season?", "Ionis Out-Licenses Second Candidate to AstraZeneca, Earns $30M", "Agree To Purchase Biogen At $270, Earn 9.1% Annualized Using Options", "IBB, BIIB, CELG, REGN: ETF Inflow Alert", "Buy Biogen Stock on the Dip?", "Biogen (BIIB) Down 17.2% Since Earnings Report: Can It Rebound?", "3 Biotech Stocks That Soared This Week: Are They Buys?", "Acorda (ACOR) Q4 Earnings Miss Estimates, Revenues Beat", "FDA Sets the Stage for Earlier-Stage Alzheimer's Treatments", "Biogen is Now Oversold", "Notable Friday Option Activity: COHU, BIIB, FDX", "Validea Warren Buffett Strategy Daily Upgrade Report - 2/15/2018", "Why Biogen May Seek A Merger In The Wake Of Alzheimer's Worries", "Validea's Top Five Healthcare Stocks Based On Warren Buffett - 2/18/2018", "Merck (MRK) Halts Another Late Stage Study on Alzheimer's", "NASDAQ Composite Index closes up 31.55 points for the week, rising for the 4th straight day", "Why Biogen, Groupon, and Omeros Slumped Today", "BIIB Makes Notable Cross Below Critical Moving Average", "Here's Why Alkermes Spiked Today", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 14, 2018", "3 Biotech Stocks That Soared This Week: Are They Buys?", "Alkermes (ALKS) Beats Q4 Earnings, Revenue Estimates", "The Zacks Analyst Blog Highlights: Novartis, BP and Biogen", "Notable Friday Option Activity: PWR, BIIB, ITW", "Biogen Halts Tysabri Development in Stroke as Study Fails", "Analysts Expect MGK To Hit $128", "3 Top Obesity-Drug Stocks to Consider Buying Now", "Could Sanofi's Ablynx Deal Spur A Biopharma Buying Spree?", "Indexes Edge Lower: Dr. Pepper Surges, Goldman Leads Dow", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 2/10/2018", "Biogen Inc. Caps Off a Solid 2017, Waits on Aducanumab", "Biogen Inc Is Beckoning to the Bulls", "Why Insurers Haven't \u2014 And Won't \u2014 Push Back On Rare Disease Drugs", "5 Biotech and Pharmaceutical Stocks Going Bonkers", "Biogen Earns Relative Strength Rating Upgrade; Hits Key Threshold", "Biogen Sees Its Composite Rating Rise To 98", "Noteworthy ETF Outflows: XLV, TMO, BIIB, ANTM", "Sanofi Will Buy Ablynx For $4.8 Billion On Heels Of $11.6 Billion Bioverativ Deal", "Health Care Sector Update for 01/25/2018: JNJ, PFE, ABT, MRK, AMGN, VAR, XLNX, KPTI, OCUL, SMMT, SN", "Biogen (BIIB) Q4 Earnings Miss, Sales Top, Stock Up", "Nasdaq Rebounds As Intel, Boeing Lift Dow; Varian Nails Breakout", "Biogen Revenue Tops As Spinraza, MS Drugs Deliver Upside", "Earnings Reaction History: Biogen Idec, 50.0% Follow-Through Indicator, 5.1% Sensitive", "Health Care Sector Update for 01/25/2018: OCUL,KPTI,BIIB,SNN,XLNX", "Health Care Sector Update for 01/25/2018: KPTI,BIIB,SNN,XLNX", "Biogen (BIIB) Q4 Earnings Miss, Sales Top, 2018 View Upbeat", "Pre-Market Earnings Report for January 25, 2018 : MMM, UNP, CAT, CELG, BIIB, RTN, NOC, PX, SHW, LUV, FCAU, AEP", "Noteworthy Wednesday Option Activity: LVS, HLF, BIIB", "Intel, Starbucks, Biotechs Lead Earnings Rush: Investing Action Plan", "3 Pharma and Biotech Stocks to Watch Out for in 2018", "First Trust Mega Cap AlphaDEX Fund -- Insider Buying Index Registering 10.9%", "Biotech M&A Off to a Strong Start in 2018: More Deals to Follow?", "Insiders Were Right: BIIB Makes New 52-Week High", "Will Sanofi's Big Hemophilia Deal Pay Off?", "Why 2017 Was a Year to Remember for Ionis Pharmaceuticals, Inc.", "Celgene Will Buy Juno Therapeutics For $9 Billion; Sanofi Acquires Bioverativ", "What's in the Cards for Biogen (BIIB) This Earnings Season?", "Sanofi to Acquire Haemophilia Focused Bioverativ, Stock Dips", "Why Bioverativ Inc. Stock Is Soaring Today", "Bioverativ Inc Stock Gets 64% Premium in Acquisition by Sanofi", "Will Biotech's Merger 'Spigot' Turn On After Juno, Bioverativ?", "Is Sanofi\u2019s Bioverative Inc Buyout Just the Start?", "Correction: Futures Reverse Early Gains As Focus Shifts to Washington", "Futures Reverse Early Gains As Focus Shifts to Washington", "Stocks With Rising Relative Strength: Biogen", "Notable Wednesday Option Activity: PSX, BIIB, JCI", "3 Pharma and Biotech Stocks to Watch Out for in 2018", "Roche MS Drug Ocrevus Gets Marketing Authorization in Europe", "Mid-Day Update: Wall Street Cautiously Optimistic With Washington Scrambling to Avert Shutdown", "Will 2018 Be Ionis Pharmaceuticals, Inc.'s Best Year Yet?", "Biogen Trying To Close In On Key Technical Measure", "Notable Tuesday Option Activity: MCK, ABBV, BIIB", "Nasdaq 100 Movers: SHPG, STX", "Pfizer to Stall R&D for Alzheimer's/Parkinson's, Cut Jobs", "Monday Sector Laggards: Healthcare, Services", "Biogen Unlikely To See Spinraza Rival In 2018 As AveXis Delayed", "Will 2018 Be Biogen Inc.'s Best Year Yet?", "Biotech Stock Roundup: GWPH Submits Epidiolex in the EU, Sangamo Inks Deal with Pfizer", "Stocks Generating Improved Relative Strength: Biogen", "Generalists On Biotech Sidelines As Tax Reform Sweeps The U.S.", "Tuesday Sector Leaders: Healthcare, Services", "Best Stocks Of 2017: Biotechs Shined, Despite Lack Of Profits", "Another Reason 2018 Might Not Be A Banner Year For Biotech Mergers", "Noteworthy ETF Outflows: XLV, GILD, LLY, BIIB", "IWF, NVDA, LOW, BIIB: ETF Outflow Alert", "The Zacks Analyst Blog Highlights: Pfizer, FedEx, Abbott, Biogen and Marathon Petroleum", "Biogen Shares Drop After Alzheimer's Drug Misses In Testing", "Nasdaq 100 Movers: PAYX, NTES", "The Top 8 Market-Moving Healthcare Stories of 2017", "Celgene Whacked After Blood-Drug Regimen Fails In Phase 3 Trial", "Stocks Inch Higher as Shutdown Threat Looms", "Biotech Stock Roundup: BIIB, CELG Hit by Pipeline News, Acquisition Deals for Ignyta, Sucampo", "Notable Thursday Option Activity: KMX, BIIB, ALGN", "3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2018", "Biogen, Ionis Ink Deal for Spinal Muscular Atrophy Therapies", "Orbimed Advisors Llc Buys Clementia Pharmaceuticals Inc, Aetna Inc, Universal Health Services ...", "Biotech Stock Roundup: Label Expansion for Exelixis's Cabometyx, FDA Nod for Spark's Gene Therapy", "Indexes Dip; Tax Reform Gets Done As Bullish Sentiment Rises", "This Stock Leads Oil Plays Up; Apple Fine; How Far Will This Bitcoin ETF Fall?", "Top Research Reports for Pfizer, FedEx & Abbott", "Biogen, Ionis Sink As Competitor Plans Rival Drug To Spinraza", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 14, 2017", "5 Biotech Buyout Candidates for 2018", "Biogen Sees RS Rating Rise To 72", "These 5 Top Stocks Are Near Buys In This Bullish Pattern: Action Plan", "Biotech Stock Roundup: FDA Nod for Amgen PCSK9 Inhibitor, Revance Up on RT002 Data", "Notable Wednesday Option Activity: BIIB, WFC, TROX", "Stocks Close Lower; Oracle Falls After Earnings", "Noteworthy ETF Outflows: IYH, TMO, BIIB, AET", "S&P 500 Analyst Moves: BIIB", "Here's What's Unusual About Regeneron Pharmaceuticals' Latest Deal", "Thursday 11/30 Insider Buying Report: BIIB, MDCO", "The Zacks Analyst Blog Highlights: Amazon, AbbVie, Biogen, McCormick and Hyatt", "No. 1-Ranked Medical Stock Tests Support In New Base", "Biotech Stock Roundup: Regeneron Down on Eylea Data, Biogen-Alkermes in MS Deal", "Looking for Top Stocks in the Strongest Performing Sectors", "Noteworthy ETF Outflows: IYH, TMO, BIIB, AET", "S&P 500 Analyst Moves: BIIB", "Sphera Funds Management Ltd. Buys Cellcom Israel, Allergan PLC, Teva Pharmaceutical Industries, ...", "Is Biogen's Multiple Sclerosis Franchise Getting A New Lease On Life?", "Zacks Value Trader Highlights: General Electric, Macy's, Biogen, Chipotle and Exxon Mobil", "Biogen Inc. Buys Its Way Out of Competition", "Noteworthy Monday Option Activity: BIIB, TSN, ILMN", "Biogen Acquires Worldwide License for Alkermes' MS Candidate (revised)", "Biotech Stock Roundup: RARE drug Gets FDA Nod, Acorda, Cytokinetics Hit by Pipeline Setbacks", "Bet on Biogen Inc for Easy Profits Into the New Year", "IBD Rating Upgrades: Biogen Shows Improved Price Strength", "Better Buy: Biogen Inc. vs. Gilead Sciences", "Why It\u2019s Time to Put Pfizer Inc. Stock on Your Watchlist", "Americafirst Capital Management, Llc Buys Sysco Corp, Exelon Corp, Thermo Fisher Scientific ...", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 16, 2017", "Should You Buy the Beaten Down Blue-Chip Stocks?", "Can Marijuana Cure Alzheimer's Disease?", "Better Buy: Acadia Pharmaceuticals vs. Biogen", "Ionis Pharmaceuticals' Earnings Results Fuel Volatility", "Sphera Funds Management Ltd. Buys Cellcom Israel, Allergan PLC, Teva Pharmaceutical Industries, ...", "Ionis Shares Dip After Third-Quarter Sales, Earnings Miss", "Biogen Shows Rising Relative Strength; Still Shy Of Key Threshold", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 11/15/2017", "WestEnd Advisors, LLC Buys Bank of America Corporation, SPDR Portfolio Short Term Corporate ...", "Biogen Sees IBD RS Rating Climb To 73", "Stoneridge Investment Partners Llc Buys Altria Group Inc, Mondelez International Inc, Merck ...", "Is a Beat in Store for Ionis (IONS) This Earnings Season?", "Acorda (ACOR) Q3 Earnings Lag Estimates, Revenues Up Y/Y", "Biogen Sees Relative Strength Rating Climb To 75", "PDL BioPharma (PDLI) Q3 Earnings Beat, Revenues Rise Y/Y", "Stocks Turn Red On Tax-Cut Report; These 2 iPhone Chip Suppliers Break Out", "Notable ETF Outflow Detected - BBH, BIIB, Q, SHPG", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 10/27/2017", "Key Predictions for Q3 Earnings Reports of ABBV, MRK", "5 Biotech Stocks That Are Getting Battered Too Hard for Comfort", "What's Biogen's Big Risk?", "Biogen Inc Content With \"Resilience\" of Its Multiple Sclerosis Franchise", "Ionis Down Big on Analyst Miss", "Biogen (BIIB) Tops Q3 Earnings & Sales, Spinraza Sales Up", "Why Ionis Pharmaceuticals Inc. Slipped This Morning", "Mid-Day Market Update: Dow Rises 175 Points; Identiv Shares Plunge", "3 Big Stock Charts for Tuesday: Biogen Inc (BIIB), Lockheed Martin Corporation (LMT) and McDonald\u2019s Corporation (MCD)", "Nasdaq 100 Movers: BIIB, HAS", "S&P 500 Movers: WHR, GLW", "Lilly (LLY) Beats on Q3 Earnings, Explores Sale of Elanco", "Industrial-Strength Rebound for the Dow", "Ionis Pharmaceuticals Tumbles on Biogen's Miss: Buy or Sell?", "Biogen (BIIB) Beats on Q3 Earnings and Revenue", "Biogen Dives Despite Topping Views; Lilly, Novartis Beat", "Validea Warren Buffett Strategy Daily Upgrade Report - 10/24/2017", "3 Gene Therapy Stocks That Could Make You Rich", "Key Predictions for Q3 Earnings Reports of LLY, BIIB, NVS", "IBD's No. 1 Group Under Pressure; These 6 Key Earnings Loom; S&P 500 Futures", "Morning Movers: More Cuts For GE\u2026and More Earnings Than You Can Shake a Stick At", "Noteworthy Monday Option Activity: BIIB, INTC, FCX", "iShares U.S. Healthcare ETF Experiences Big Inflow", "Zacks Market Edge Highlights: Gilead, Biogen, Teva, AbbVie and Aetna", "Biogen (BIIB) Q3 Earnings: Will it Deliver a Beat Again?", "Biotech Stock Roundup: Exelixis Soars on Priority Review, FDA Panel Supports Spark Drug", "Stock Indexes Up Slightly; Trump Threatens Drug Firms", "Nasdaq 100 Movers: STX, ULTA", "Pre-Market Earnings Report for October 24, 2017 : MCD, MMM, UTX, LLY, LMT, CAT, BIIB, GM, SHW, NVS, GLW, PCAR", "Where to Find Value in Healthcare Stocks", "3 Drug Stocks Hitting 52-Week Highs: Are They Buys?", "Tuesday Sector Leaders: Healthcare, Utilities", "BIIB Crosses Above Average Analyst Target", "IBD Biotech Innovator Awards", "6 Top Biotech Companies In Innovation Earn Recognition In New Awards", "Biogen Biomarkers Mark Way To Alzheimer's, Parkinson's Treatments", "Goldman, Morgan Stanley Gain on Earnings; Spirit Airlines Flies", "Noteworthy Monday Option Activity: FCX, BMY, BIIB", "Why These Biotech Players Look Poised To Crush Earnings Views", "This No. 1-Ranked Medical Stock Is Breaking Out With Q3 Earnings Due", "Better Buy: Biogen Inc. vs. Celgene", "Emergent BioSolutions Acquires Sanofi's Smallpox Vaccine Unit", "Intercept Dives Along With Ocaliva Prescriptions On FDA Warning", "No Side Effects to This Bullish Trade on Celgene Corporation (CELG) Stock", "Trump Likely To Sign Executive Order On Drug Pricing 'Any Day'", "ACADIA's Antipsychotic Drug Gets Breakthrough Therapy Status", "Catabasis' DMD Candidate Slows Disease Progression, Stock Up", "Ligand (LGND) Signs Deal to Acquire Crystal Bioscience", "Nasdaq 100 Movers: CELG, NCLH", "11.7% of OVLC Holdings Seeing Recent Insider Buys", "Morning Movers: Constellation Brands Jumps, Biogen Bounces, Celgene Slips", "5 Stocks to Buy As They Drive the Market Melt Up", "Notable Friday Option Activity: GDOT, BIIB, CRM", "Celsion's Immunotherapy Candidate Impresses, Stock Surges", "Emergent Completes Acquisition of Anthrax Drug Raxibacumab", "Notable ETF Outflow Detected - VHT, AGN, TMO, BIIB", "Nasdaq 100 Movers: JD, MYL", "Allergan's Botox Gets FDA Nod for Forehead Line Treatment", "Amgen Enters Into an Immuno-Oncology Partnership With CytomX", "Zacks.com featured highlights include article Texas Instruments, Applied Materials, Pepsico, CBRE Group and Biogen", "Stocks Hold Gains As Microsoft, Amazon.com Aid The Nasdaq", "After Intepirdine Flunked in Alzheimer\u2019s Disease, Is Axovant Sciences a Buy?", "Allergan's sNDA for Anti-Infective Avycaz Accepted by FDA", "3 Top-Ranked Big Biotech Stocks to Buy Now", "5 Top ROE Stocks to Buy as Markets Snub Geopolitical Threats", "The Zacks Analyst Blog Highlights: Procter & Gamble, PetroChina, Biogen, Accenture and Norfolk Southern", "Why PTC Therapeutics, Inc. Dropped Today", "Endocyte Inks Deal For Prostate Cancer Candidate, Shares Up", "Mallinckrodt, NeuroproteXeon Team Up for Inhalation Therapy", "Novo Nordisk's Fiasp Gets FDA Nod for Diabetes in Adults", "Lilly (LLY) Makes Leadership Changes to Executive Positions", "Top Stock Reports for Procter & Gamble, PetroChina & Biogen", "Top Stock Reports for Procter & Gamble, PetroChina & Biogen", "4 Biotech Stocks (and 1 ETF) to Buy As They Bolt Higher", "Notable Friday Option Activity: BIIB, RJF, TSN", "Biotechs Beating The Market, But Are They In Buy Range?", "AveXis Flies, But PTC Sinks On Spinal Muscular Atrophy Data", "MOAT, OILU: Big ETF Outflows", "Is Biogen Inc. (BIIB) a Great Stock for Value Investors?", "Sorry Qualcomm, Inc. (QCOM) Stock Bears, It Has Bottomed!", "Play the Support Test in VanEck Vectors Gold Miners ETF (GDX)", "Think Before You Chase Nvidia Corporation (NVDA) Stock\u2019s Momentum", "Profit From the Biogen Inc (BIIB) Stock Dip!", "Billionaire George Soros' Fund Bought These 3 Pharma Stocks: Should You?", "Why Amgen's Drug Win Sent AbbVie Stock Into The Stratosphere", "4 Biotech Stocks for the Long-Term", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2017", "BIIB January 2020 Options Begin Trading", "Why Biogen Stock Raced Higher In August", "Biogen Reaches Analyst Target Price", "AbbVie Submits NDA for Endometriosis Candidate to the FDA", "Novartis' (NVS) MS Drug Gilenya Positive in Long-Term Study", "IBB, BIIB, REGN, ALXN: ETF Inflow Alert", "4 Biotech Stocks for the Long-Term", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2017", "BIIB January 2020 Options Begin Trading", "Vanguard Russell 1000 ETF -- Insider Buying Index Registering 11.9%", "Monday Sector Leaders: Healthcare, Technology & Communications", "Consider This Before You Buy Biogen", "Thursday Sector Leaders: Healthcare, Energy", "Steven Cohen Plunges Into Opioid Replacement Maker Pacira", "Biotech Stock Roundup: EU Label Expansion for Alexion, BIIB Facing Drug Price Probe", "Here's the Simple Reason Why Multiple Sclerosis Drugs Cost So Much", "Orbimed Advisors Llc Buys Cigna Corp, Clovis Oncology Inc, Gilead Sciences Inc, Sells Centene ...", "Biogen & 6 Other Multiple Sclerosis Drug Stocks in Focus: Here's Why", "We Did The Math OEF Can Go To $119", "Orbimed Advisors Llc Buys Cigna Corp, Clovis Oncology Inc, Gilead Sciences Inc, Sells Centene ...", "Biogen's Humira Biosimilar Imraldi Gets Approval in EU", "Noteworthy ETF Inflows: TQQQ, GOOG, AMGN, BIIB", "What You See, and What You Get: The Neurology of Perception", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 15, 2017", "Ionis Pharmaceuticals Inc: Growing Royalties, an Advancing Pipeline, and Getting Back Rights to Some Drugs", "The Zacks Analyst Blog Highlights: Biogen, Activision, Cigna Kraft Heinz and Equinix", "Noteworthy ETF Inflows: VHT, TMO, BIIB, AET", "Top Analyst Reports for Biogen, Activision & Cigna", "Notable Thursday Option Activity: DE, NVDA, BIIB", "PDL BioPharma (PDLI) Q2 Earnings Beat, Revenues Rise Y/Y", "See Which Of The Latest 13F Filers Holds Biogen", "Is a Beat in Store for Ionis (IONS) This Earnings Season?", "7 Explosive Healthcare Stocks to Buy Now", "Notable ETF Inflow Detected - VHT, LLY, TMO, BIIB", "Acorda (ACOR) Q2 Earnings Miss Estimates, Revenues in Line", "Biotech Stock Roundup: Amgen, Biogen Top Q2 Estimates, Update on Incyte RA Drug", "These 3 Biotechs Just Crushed Analyst Expectations", "PDL BioPharma (PDLI) Q2 Earnings Beat, Revenues Rise Y/Y", "See Which Of The Latest 13F Filers Holds Biogen", "Is a Beat in Store for Ionis (IONS) This Earnings Season?", "Lilly (LLY) Q2 Earnings Top, Baricitinib Re-Filing Delayed", "Biogen (BIIB) Tops Q2 Earnings and Revenue", "Wal-Mart Stores Inc (WMT) Stock Is Perking Up!", "Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,422.75.", "Earnings Reaction History: Biogen Idec, 58.3% Follow-Through Indicator, 5.3% Sensitive", "Biogen (BIIB) Tops Q2 Earnings & Sales, Spinraza Sales Up", "Big Pharma Q2 Earnings Releases on Jul 25: LLY, BIIB, AMGN", "Pre-Market Earnings Report for July 25, 2017 : MMM, MCD, UTX, LLY, DD, CAT, BIIB, GM, KMB, HCA, PCAR, TROW", "These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet", "ITOT, TMO, COST, BIIB: ETF Inflow Alert", "Can Biogen (BIIB) Keep the Earnings Streak Alive in Q2?", "3 Stocks to Watch on Tuesday: Alphabet Inc (GOOGL), Biogen Inc (BIIB) and Michael Kors Holdings Ltd (KORS)", "Earnings Reaction History: Biogen Idec, 58.3% Follow-Through Indicator, 5.3% Sensitive", "Biogen (BIIB) Tops Q2 Earnings & Sales, Spinraza Sales Up", "AveXis Inc.: Buy at the High?", "Biogen Breaks Above 200-Day Moving Average - Bullish for BIIB", "Noteworthy Monday Option Activity: VHC, AGN, BIIB", "Better Buy: Biogen Inc. vs. Celgene Corporation", "Top Stock Reports for Boeing, AbbVie & U.S. Bancorp", "Biotech Stock Roundup: Vertex Boosted by CF Data, FDA Nod for Gilead, Puma Drugs", "The Math Shows BBH Can Go To $140", "Amgen, Inc. (AMGN) Stock Is the Cure for Ailing Portfolios", "BIB, BIIB, REGN, VRTX: ETF Outflow Alert", "3 Hot Biotech Stocks Ready for the Sector\u2019s Next Breakout", "Biotech Stock Roundup: Cara Plunges on Study Data, Regulatory Updates & More", "3 Reasons Sizzling-Hot Bioverativ Stock Can Go Even Higher", "3 Best-Performing Stocks in June", "How Biogen Inc. Makes Most of Its Money", "4 Reasons the AveXis Inc. Rally Could Continue", "Biotech Stock Roundup: EU Nod for Regeneron RA Drug, Portola Soars on FDA Nod", "Noteworthy ETF Outflows: JKD, MO, BIIB, ANTM", "Update: Wall Street Weighed Down By Oil Declines as Health Stocks Lift Nasdaq", "5 Biotech Stocks That Are Roaring Back to Life", "Noteworthy Wednesday Option Activity: CMG, BIIB, AAPL", "7 Healthcare Stocks to Buy Now", "3 Charts That Show Why to Buy Gilead Sciences Stock Now", "Bear of the Day: Bioverativ (BIVV)", "Nektar (NKTR) Stock Rallied Almost 50% This Year: Here's Why", "Will These Cutting-Edge Cancer Killers Reignite The Biotech Rally?", "Don\u2019t Be Scared of Biogen Inc (BIIB) Stock", "Biogen Loses Top Executive Again, CFO Clancy to Join Alexion", "Nasdaq 100 Movers: BIIB, ALXN", "3 Stocks to Watch on Wednesday: Ford Motor Company (F), Alexion Pharmaceuticals, Inc. (ALXN) and H & R Block Inc (HRB)", "Monday Sector Leaders: Healthcare, Technology & Communications", "Noteworthy Wednesday Option Activity: AAPL, BIIB, CMG", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2017", "Insiders Buy the Holdings of VONE ETF", "2 Reasons Why Biogen's Shares Slumped in May", "3 Stocks That Could Be Life-Changers", "Why Ionis Pharmaceuticals Inc. Swooned 6% in May", "Biogen Inc (BIIB) Stock Can Help You Earn Income From Thin Air", "Market Close Report: NASDAQ Composite index closes at 6,194.89 down -25.48 points", "Biogen/Ionis Spinraza Granted Marketing Authorization in EU", "Notable Friday Option Activity: LEN, BIIB, RRC", "5 Drug Stocks in Focus on World MS Day", "The Zacks Analyst Blog Highlights: UnitedHealth Group, Union Pacific, Biogen, United Technologies and Accenture", "Celgene's Stock May Be Incredibly Overvalued Right Now -- Here's Why", "Better Buy: Biogen Inc. vs. Gilead Sciences Inc.", "Are Nektar's (NKTR) Key Drugs Set to Drive Growth in 2017?", "Biotech ETF Experiences Big Outflow", "Merck (MRK) Buys Rights to Anti-tau Antibody for Alzheimer", "Stock Exchange: Time to reconsider health care?", "Biogen (BIIB) Down 9.5% Since Earnings Report: Can It Rebound?", "Biogen's Fampyra Conditional Approval Converted to Standard", "Jeff Ubben Buys 1, Sells 1 in 1st Quarter", "Notable Wednesday Option Activity: JNJ, C, BIIB", "Biotech Stock Roundup: Puma Soars on Advisory Panel Vote, Priority Review for Kite Drug", "Noteworthy ETF Outflows: VV, BIIB, PYPL, DHR", "Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer Deal", "Want to Get in on Biotech? Check Out These 3 Stocks", "Biogen (BIIB) Buys Stroke Candidate Cirara for $120M", "Notable Monday Option Activity: RTN, BIIB, MON", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 15, 2017", "Biogen Enters Oversold Territory (BIIB)", "Why Long-Term Investors Should Prefer Celgene Over Biogen", "iShares Russell 1000 Growth ETF Experiences Big Outflow", "IYH's Underlying Holdings Could Mean 10% Gain Potential", "Why Biogen Inc. Shareholders Have Something to Worry About", "The Zacks Analyst Blog Highlights: Exxon Mobil, JPMorgan, Union Pacific, Biogen and Becton Dickinson", "Friday Sector Laggards: Healthcare, Financial", "Notable Friday Option Activity: BIIB, NWL, NKE", "What's in the Cards for Ionis (IONS) this Earnings Season?", "Ionis Pharmaceuticals Inc.'s First Royalties Roll In", "Top Research Reports for May 4, 2017", "Morningstar Wide Moat ETF -- Insider Buying Index Registering 12.0%", "Notable ETF Outflow Detected - BIB, BIIB, REGN, ILMN", "Tuesday 5/2 Insider Buying Report: BIIB, WWD", "Acorda (ACOR) Q1 Loss Wider Than Expected, Revenues Miss", "Better Buy: Ionis Pharmaceuticals, Inc. vs. bluebird bio", "Pharma Stocks Q1 Earnings Roster for Apr 27: CELG, ABBV, BMY", "What's Behind Ionis Pharmaceuticals' 20% Rally In April", "Biogen Inc. Earnings: New Drug Sparks Life", "Biogen Inc (BIIB) Stock Pops on Strong Q1 Earnings", "Nasdaq 100 Movers: ESRX, BIIB", "Lilly (LLY) Tops Q1 Earnings, Misses Sales, Shares Down", "Biogen (BIIB) Q1 Earnings & Sales Top, Spinraza Sales Strong", "Biogen (BIIB) Beats on Q1 Earnings and Revenue", "Health Care Sector Update for 04/25/2017: BIIB, ESRX, JNJ, PFE, ABT, MRK, AMGN", "Better Buy: Amgen Inc. vs. Biogen", "Spinraza's Fast Start Puts Ionis on a Path to Profit", "Biogen and Alzheimer\u2019s: There\u2019s a Fundamental Problem Here", "Monday\u2019s Vital Data: Apple Inc. (AAPL), Visa Inc (V) and Micron Technology, Inc (MU)", "3 Key Factors to Look Out for in Biogen's Q1 Results", "Make Biogen Inc (BIIB) Stock Pay You, Even With No Dividend", "Drug Stocks Q1 Earnings Releases on Apr 25: LLY, BIIB, NVS", "Pre-Market Earnings Report for April 25, 2017 : KO, MMM, MCD, LLY, LMT, DD, BIIB, CAT, SPGI, VLO, GLW, BHI", "Earnings Reaction History: Biogen Idec, 58.3% Follow-Through Indicator, 5.0% Sensitive", "3 Stocks That Growth Investors Should Love", "Marijuana Stocks: A 4/20 Special", "What's in Store for Biogen (BIIB) this Earnings Season?", "Biotech Stock Roundup: FDA CRL Hits Incyte, Pipeline Setbacks Weigh on OncoMed", "Bristol-Myers and Nordic Ink Biomarker Collaboration Deal", "The 7 Most Expensive Prescription Drugs in the World", "Commit To Buy Biogen At $140, Earn 2.6% Using Options", "Noteworthy Monday Option Activity: AAPL, ISRG, BIIB", "3 Stocks That Growth Investors Should Love", "Roche Just Scored One of the Biggest Pharma Wins of 2017", "3 Big Stock Charts for Friday: Biogen Inc (BIIB), American Airlines Group Inc (AAL) and Cisco Systems, Inc. (CSCO)", "Acorda (ACOR) to Reduce Workforce, Focus on Product Pipeline", "Peek Under The Hood: BBH Has 14% Upside", "Wednesday Sector Laggards: Utilities, Healthcare", "3 Biotech Trades for the Faux Doomsday Scenario", "Biogen to License Alzheimer Candidate from Bristol-Myers", "Why Acorda Therapeutics Inc and Forward Pharma A/S Got Crushed Today", "Mid-Afternoon Market Update: Dow Drops 50 Points; TRC Companies Shares Spike Higher", "Noteworthy Friday Option Activity: PX, BIIB, EXPE", "Nasdaq 100 Movers: BIIB, VRTX", "Roche's Ocrevus Wins FDA Approval for 2 Forms of Sclerosis", "Biotech ETFs Defy Trump Tweets To Rally, But What Can Send Them Higher?", "Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results", "Acorda's (ACOR) MS Drug Patents Invalidated, Shares Plunge", "Health Care Sector Update for 03/21/2017: BIIB,PTIE,AXSM", "Billionaires' Best Healthcare Stock Picks of 2017 (So Far)", "AveXis Inc Stock Is Spiking Again Today -- Here's Why", "Stock Market News for March 17, 2017", "Alkermes Starts Phase III Study to Treat Multiple Sclerosis", "Mid-Day Market Update: U.S. Stocks Turn Negative; GoPro Shares Spike Higher", "BIIB Crosses Below Key Moving Average Level", "3 Biotech Stocks That Are Broker Favorites", "S&P 500 Movers: BIIB, ORCL", "Biogen Inc (BIIB): Profit From the BIIB Stock Bears", "Market Close Report: NASDAQ Composite index closes at 5,900.76 up .71 points", "Thursday Sector Laggards: Healthcare, Utilities", "Noteworthy Thursday Option Activity: MPC, BIIB, HUM", "Thursday's ETF Movers: ITB, BBH", "Noteworthy ETF Outflows: IBB, BIIB, REGN, INCY", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2017", "Biogen Spinoff Takes Flight With Focus On Hemophilia Drugs", "AbbVie Stock Upgraded: What You Need to Know", "Why Ionis Pharmaceuticals Rallied 12% in February", "Biotech Stock Roundup: Trump Tweet Hits Biotech Stocks, Concert Gains on Vertex Deal", "Notable ETF Inflow Detected - IYH, GILD, AGN, BIIB", "Repros (RPRX) Q4 Earnings: What's in Store for the Stock?", "Acorda's Four Ampyra Patents Upheld by PTAB, Shares Rise", "5 Things Biogen's CEO Just Said That You Don't Want to Miss", "Inovio (INO): What's in the Cards this Earnings Season?", "BioDelivery (BDSI): What's in Store this Earnings Season?", "4 Things Alkermes Wants Investors to Know", "New Features: Individual Portfolio Tracker and Value Screens Tracker", "Why Celgene's Shares Rallied Higher in February", "The Zacks Analyst Blog Highlights: AT&T, Visa, Biogen, Tesla and PG&E", "Is This the Right Time to Invest in Biotech Stocks?", "Get in Biogen Inc (BIIB) Stock Before It Breaks Out", "Perrigo to Sell Tysabri Royalties; Issues Tepid 2017 View", "QUAL, KMB, PEG, BIIB: ETF Inflow Alert", "Better Buy: Biogen Inc. vs. Gilead Sciences Inc.", "Here's Why Celgene's Latest Drug Is So Exciting", "Andreas Halvorsen Buys Maker of First-in-Class Cancer Treatments, Calithera Biosciences", "Did Biogen Inc. Shoot Itself in the Foot?", "Ionis Pharmaceuticals Inc Turns a Profit With Other Drugmakers' Money", "3 Top Drug Stocks That Can Be Purchased on the Cheap This Winter", "Could Celgene Have Another Billion-Dollar Blockbuster on Its Hands?", "Why Ionis Pharmaceuticals (IONS) Looks Worth the Risk", "Another Potential Alzheimer's Disease Treatment Bites the Dust: What's Next?", "BIB, BIIB, REGN, ILMN: Large Outflows Detected at ETF", "PRIMECAP Management Buys AstraZeneca PLC, Alkermes PLC, Whirlpool, Sells Union Pacific, ...", "A Potential $20 Billion Indication? 2 Must-Have Biotechs Taking on Alzheimer's Disease", "Ionis (IONS) Q4 Earnings: What's in the Cards for the Stock?", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 13, 2017", "How Biogen Inc (BIIB) Stock Could Gain Another 25%", "What's Behind Bioverativ's Spin-Out, and Should You Buy?", "Biotech Stock Roundup: Amgen, Gilead Report 4Q Results, ARIAD Seeks EU Nod for Brigatinib", "In an Ironic Twist, Generics Take Aim at Teva Pharmaceutical", "3 Healthcare Tickers That Will Return Profits in 3 Months", "Why Biogen Inc (BIIB) Stock Is a Solid Long-Term Bet", "Is Biogen a Risky Stock?", "QUAL, KMB, PEG, BIIB: ETF Outflow Alert", "5 Drugmakers Battle Over the $10 Billion Hemophilia Market", "Nasdaq 100 Movers: BIIB, TSCO", "Implied RYH Analyst Target Price: $172", "What Could Make Biogen Crash?", "Biotech Stock Roundup: Celgene, Biogen, ABBV Post Q4 Results, Catabasis Falls on DMD Data", "Why Forward Pharma A/S Stock Surged 107% in January", "Biogen Inc Makes Up for Lackluster Revenue Growth", "How to Trade Biogen Inc (BIIB) Stock After Its Q4 Beat", "Biogen (BIIB) Q4 Earnings Top Estimates; '17 Sales View Soft", "The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Celgene and Bristol-Myers Squibb", "Biogen (BIIB) Beats on Q4 Earnings; Misses Sales", "3 Top Biotech Stocks You Can Still Buy With the Dow at 20,000", "Earnings Reaction History: Biogen Idec, 50.0% Follow-Through Indicator, 4.5% Sensitive", "The Zacks Analyst Blog Highlights: AT&T, Biogen, Qualcomm, Facebook and Royal Caribbean", "Perrigo's (PRGO) Generic Version of Topicort Okayed by FDA", "Drug Stock Earnings to Watch on Jan 26: BIIB, CELG & BMY", "Pre-Market Earnings Report for January 26, 2017 : CMCSA, CELG, BMY, DOW, BIIB, CAT, F, RTN, NOC, PX, AEP, LUV", "Better Buy: Biogen Inc. vs. Gilead Sciences Inc.", "Biogen Inc (BIIB) Stock Enters Uncharted Waters", "5 Drugs That Are Way Cheaper in Canada", "Nektar Therapeutics: An Undervalued Biopharmaceuticals Company With Plenty In The Pipeline", "Notable Thursday Option Activity: PYPL, BIIB, MJN", "Alcobra Stock Down on Poor Late-Stage Data on ADHD Drug", "The Zacks Analyst Blog Highlights: Microsoft, Biogen, Home Depot, Bristol-Myers and Berkshire Hathaway", "Why Forward Pharma A/S Stock Gained 48.2% on Tuesday", "Biogen to Pay $1.25B to Forward Pharma in Tecfidera Lawsuit", "Midday Update: Stocks Pressured By Trump's Dollar Warning, Earnings and Inauguration Sell-0ff", "Mid-Day Market Update: Clayton Williams Energy Surges On Acquisition News; Christopher & Banks Shares Slide", "Noteworthy Thursday Option Activity: NANO, BIIB, SWKS", "Biogen (BIIB) Q4 Earnings: What's in Store for the Stock?", "Alcobra Stock Down on Poor Late-Stage Data on ADHD Drug", "3 Stocks to Watch on Tuesday: Chipotle Mexican Grill, Inc. (CMG), Noble Energy, Inc. (NBL) and Wells Fargo & Co (WFC)", "Biogen Inc (BIIB) Will Win a Battle, But Could Lose the War", "Why Clayton Williams Energy, Forward Pharma, and Luxottica Jumped Today", "Merrimack (MACK) Goes Uphill: Is a Turnaround Likely?", "Biogen's Multiple Sclerosis Franchise to Drive Growth in 2017", "Agree To Buy Biogen At $180, Earn 5.3% Using Options", "Mid-Morning Market Update: Markets Open Lower; Morgan Stanley Tops Q4 Estimates", "Is Biogen's Stock Ready to Heat Up After a Forgettable 2016?", "Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,574.12.", "Top Research Reports for Alibaba, Costco & Walgreens", "Energous Corp Shines Brightly as the Next Fortune-Building Company (WATT)", "Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again", "Close Update: Wall Street Braces For \"Sell-The-Fact\" Reaction After Inauguration", "Biotech Stock Roundup: ARIAD to be Acquired for $5.2B, Vertex Outlook Falls Short", "Biogen Inc (BIIB) Stock Should Move Higher in 2017", "Notable Wednesday Option Activity: BIIB, MRK, AMGN", "Stock Market News for January 10, 2017", "3 Big Reasons (and 8 Smaller Ones) to Buy Ionis Pharmaceuticals Stock", "Top Stocks to Buy Now That the 21st Century Cures Act Has Passed", "This Could Very Well Be the Greatest Drug Advancement in a Decade", "The 1 Biotech Stock I Want to Own in 2017", "Biotech Investing: 3 Bold Predictions for 2017", "Biogen's New CEO: Lots of Questions, Few Answers", "Noteworthy ETF Outflows: IYH, CELG, BIIB, AET", "Ionis (IONS) Stock Up on Positive Type II Diabetes Drug Data", "5 Slides Every Ionis Pharmaceuticals Inc Investor Needs to See", "Did Biogen Just Throw in the Towel to Celgene?", "Biotech Stock Roundup: Inotek Plunges on Pipeline Setback, Kite Files IND for Study Initiation", "Biogen Licenses Amunix's XTEN Technology for Factor IX Drug", "My Worst Predictions for Biotech in 2016", "AbbVie's Humira and Imbruvica Drive Performance in 2016", "iShares Edge MSCI USA Quality Factor ETF Experiences Big Outflow", "Biotech Stock Roundup: FDA Nod for Biogen/Ionis Drug, Seattle Genetics Hit by Clinical Hold", "Why Twilio, Northern Dynasty Minerals, and Ionis Pharmaceuticals Slumped Today", "Will Spinraza Supercharge Biogen's Top Line Next Year?", "Health Care Sector Update for 12/27/2016: SGEN, IONS, JNJ, PFE, ABT, MRK, AMGN", "Is Biogen Playing With Fire?", "Health Care Sector Update for 12/27/2016: IONS,BIIB,CAPN,ENGX", "3 Biggest Risks for AbbVie in 2017", "Biotech Stock Roundup: Conatus Soars on Novartis Deal, Early FDA Nod for Clovis Drug", "2016's Worst Clinical Failures", "Biogen (BIIB) Board Okays Hemophilia Business Spin-off", "Christmas Came Early for These Biotech Stocks", "Ionis/Biogen Spinraza Approved For Spinal Muscular Atrophy", "The 3 Biggest Risks for Pfizer in 2017", "Health Care Sector Update for 12/27/2016: IONS,BIIB,CAPN,ENGX", "3 Low-Volatility Biotech Stocks to Buy", "OEF, WBA, TWX, BIIB: ETF Outflow Alert", "The Zacks Analyst Blog Highlights: Barclays, Netflix, NIKE, Biogen and China Petroleum & ChemicalThe Zacks Analyst Blog Highlights: Barclays, Netflix, NIKE, Biogen and China Petroleum & Chemical", "Biotech Stock Roundup: Ophthotech Slumps on Fovista Results, Achaogen Skyrockets on Data", "Top Research Reports for Barclays, Netflix and Nike", "3 Stocks to Watch on Tuesday: Biogen Inc (BIIB), Conatus Pharmaceuticals Inc (CNAT) and General Motors Company (GM)", "3 Top Biotech Stocks to Buy on Sale", "Biogen Presents Positive Early Data from Alzheimer's Study", "Lilly/AstraZeneca Expand Alzheimer Disease Collaboration", "The 3 Most Profit-Friendly Biotech Stocks", "Better Buy: Amgen Inc. vs. Biogen", "Is Biogen's Aducanumab a Game-Changing Alzheimer's Drug?", "Does New Alzheimer's Data Make Biogen Stock a Buy Now?", "Trade Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free Profits", "Nasdaq 100 Movers: LRCX, BIIB", "Should You Buy Drug Stocks on Their Post-Election Drop?", "S&P 500 Movers: GRMN, BIIB", "Health Care Sector Update for 12/09/2016: BIIB", "Pre-Market Most Active for Dec 9, 2016 : SWC, MGM, BAC, TLK, LVS, MPEL, WYNN, VOD, VALE, SQQQ, BIIB, TVIX", "Biogen Inc (BIIB) Stock Trade Showcases the \u2018Art of the Steal\u2019", "Stock Market News for December 08, 2016", "Stock Market News for December 09, 2016", "Nasdaq 100 Movers: LRCX, BIIB", "Should You Buy Drug Stocks on Their Post-Election Drop?", "How Can Value Screener Record Trends Explain Market Valuations?", "Stock Exchange: Model Picks Teach Us To Manage Risk", "GW Pharmaceuticals (GWPH): What Awaits in Q4 Earnings?", "3 Things You Need to Know About Ionis Pharmaceuticals' Pipeline", "The 3 Best Biotech Stocks for 2017", "Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for Juno", "Charles Payne on Biotech: Biogen Inc (BIIB), Intercept Pharmaceuticals Inc (ICPT)", "Will Lilly's Solanezumab Setback Weigh on Other Alzheimer's Stocks?", "Lilly's Alzheimer Drug Fails Phase III Study, Stock Down", "Eli Lilly and Co (LLY) Drug Failure Doesn\u2019t Answer the Bigger Question", "Instant Analysis: Eli Lilly Drops Pre-holiday Alzheimer's Bomb", "Nasdaq 100 Movers: BIIB, EA", "Better Buy: Biogen Inc. vs. Amgen", "Pre-Market Most Active for Nov 23, 2016 : LLY, DE, RDY, NVO, BIIB, ERIC, MT, SNY, JUNO, QQQ, XIV, TVIX", "Eli Lilly's Alzheimer's Drug Is a Bust", "Market Close Report: NASDAQ Composite index closes at 5,380.68 down -5.67 points", "3 Potentially Huge Catalysts for Ionis Pharmaceuticals, Inc. in 2017", "Why Biogen Shareholders Lost $3 Billion Today", "Are Biogen and Gilead Sciences in Denial?", "Acorda Stops Post-Stroke Development Program on Ampyra", "Pre-Market Most Active for Nov 23, 2016 : LLY, NVO, TGT, MT, BAC, DE, JUNO, BIIB, ERIC, QQQ, XIV, TVIX", "3 Biotechs That Don't Pay Dividends -- but Could", "$13 Billion Opportunity: 5 Companies That Could Dominate the Alzheimer's Disease Market", "3 Irrefutable Reasons to Sell Johnson & Johnson Stock", "The Zacks Analyst Blog Highlights: Biogen, Honda, Intel, CSX and General Growth Properties", "3 Beaten-Down Biotech Stocks to Buy for Huge Gains", "Better Buy: Biogen Inc. vs. Celgene Corporation", "How To Invest During The Trump Presidency", "5 Biotech Stocks George Soros Is Buying", "Ionis Pharmaceuticals Inc Back in the Black (for Now)", "XLV, JNJ, GILD, BIIB: ETF Inflow Alert", "3 Biotech Stocks You MUST Buy for Donald Trump\u2019s Presidency", "Perrigo (PRGO) Beats on Q3 Earnings, Revenues; View Intact", "Peek Into Drug Stocks' Q3 Earnings on Nov 11: XBIT & REPH", "How a Donald Trump Presidency Could Affect Biotech Stocks", "Why Biogen Inc. Stock Lost 10.5% of Its Value In October", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 14, 2016", "Biogen's Growth Is Far Weaker Than You May Think", "Company News for November 08, 2016", "See Which Of The Latest 13F Filers Holds Biogen", "Spinal Muscular Atrophy in Focus as Biogen, IONS Shoot Up on Data", "Drug Stock Earnings to Watch on Nov 9: MYL, IONS & More", "Why Ionis Pharmaceuticals Inc. Skyrocketed Higher Today", "Midday Update: Wall Street's Appetite For Risk Returns After Clinton Cleared by FBI", "Why Ionis Pharma Is Rocketing 25% Higher Today", "Nasdaq 100 Movers: LVNTA, BIIB", "Mid-Morning Market Update: Markets Open Higher; LendingClub Posts Narrower-Than-Expected Loss", "3 Mid-Cap Stocks to Buy in November", "Zacks Industry Outlook Highlights: Bristol-Myers, Biogen, Merck, Celgene and ARIAD Pharmaceuticals", "Close Update: Stocks Soar As FBI Clears Potential Path For Clinton on Election Day", "BIIB Crosses Below Key Moving Average Level", "2 Bullish Biotech Trades to Take Your Mind off the Election (BIIB CELG)", "Mid-Day Market Update: Dow Gains Over 300 Points; Concordia International Shares Drop Following Disappointing Earnings", "Biogen Quietly Abandons a Key Next-Gen Multiple Sclerosis Drug", "Make Valeant Pharmaceuticals Intl Inc (VRX) Stock Pay YOU", "Noteworthy ETF Outflows: QUAL, PEG, COST, BIIB", "5 Reasons Ionis Pharmaceuticals Is a Top Stock to Buy Now", "The Zacks Analyst Blog Highlights: Biogen, Merck, Eli Lilly, AbbVie and ImmunoGen", "Acorda (ACOR) Reports Wider Q3 Loss, Revenues Down Y/Y", "Here's Why Biogen Should Buy Ionis Pharmaceuticals", "3 Top Biotech Stocks to Buy in November", "Key Takeaways from Biogen's Q3 Call: Tecfidera, Pipeline, Biosimilars", "Peek Into Drug Stocks' Earnings on Oct 28: ABBV & IMGN", "Biogen Inc. Working With What It's Got as It Looks to Diversify", "Midday Update: Stocks Trim Losses on Supply-Related Bounce in Oil", "Nasdaq 100 Movers: AAPL, AKAM", "Biotech Stock Roundup: Clinical Holds Hit Inovio & Aduro, Vertex Q3 Results Miss Estimates", "Biogen (BIIB) Beats on Q3 Earnings; Tecfidera Propels Sales", "Bioverativ Could Be Why Investors Should Buy Biogen", "Biogen Inc (BIIB) Stock Rises on Better-Than-Expected Quarter", "Drug Stock Earnings to Watch on Oct 26: BIIB, MDCO & More", "Pre-Market Earnings Report for October 26, 2016 : KO, CMCSA, BA, MDLZ, BIIB, SPG, GD, NOC, BSX, STT, WM, NSC", "Best And Worst Biotech ETFs Of 2016 Tell A Tale About This Industry", "Can Biogen (BIIB) Keep the Earnings Streak Alive in Q3?", "iShares Edge MSCI USA Quality Factor ETF Experiences Big Outflow", "Biotech Stock Roundup: ARIAD Down on Drug Pricing Tweet, Regeneron Study on Clinical Hold", "Biogen (BIIB) Beats on Q3 Earnings and Sales", "Better Buy: Biogen Inc. vs. Gilead Sciences, Inc.", "Commit To Buy Biogen At $180, Earn 5% Using Options", "Alzheimer's Remains a Top Priority for Big Pharma", "BioMarin Issues Encouraging Update on Hemophilia A Drug", "Is AveXis a Major Threat to Ionis Pharmaceuticals?", "Why This Top Columbia Fund Loads Up On Facebook, Other Stock Leaders", "Stock Market News for October 12, 2016", "3 Stocks That Will Be Bought Out Before Twitter", "3 Biotechs Most Likely to Be Acquired", "3 Top Biotech Stocks to Buy Right Now", "Better Buy: Biogen vs. Celgene", "6 Healthcare Stocks Investors Can't Miss in Q3 Earnings", "Noteworthy Friday Option Activity: NLNK, SRPT, BIIB", "The Key Reason Ionis Pharmaceuticals, Inc. Gained Another 24% in September", "Biotech Stock Roundup: Summit Soars on Sarepta Deal, Regeneron Presents Data", "Biotech Stock Roundup: Alnylam Slumps on Revusiran Update, TESARO Impresses at ESMO", "Instant Analysis: Biogen's Agreement With Anavex Life Sciences", "Will Celgene Depose Biogen to Become Top Dog In Multiple Sclerosis?", "Health Care Sector Update for 09/28/2016: ATHX, AVXL, BIIB, GALT", "Anavex Life Sciences Corp. (AVXL) Scores Big on Biogen Test", "Why Anavex Life Sciences Corp. Rocketed Higher Today", "Health Care Sector Update for 09/28/2016: VSAR,AVXL,BIIB,GALT", "Ionis/Biogen Complete Nusinersen NDA Submission in U.S.", "Better Buy: Anavex Life Sciences Corp. vs. Ionis Pharmaceuticals, Inc.", "The Implied Analyst 12-Month Target For IWL", "Stock Market News for September 21, 2016", "Biotech Stock Roundup: Tobira Soars on Acquisition Deal, FDA Says Yes to Sarepta DMD Drug", "Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB) Is Turning Things Around", "3 Ways Ionis Pharmaceuticals, Inc. Is Beating the Competition", "Could This Alzheimer\u2019s Disease Drug Really Be Worth $20 Billion?", "Marijuana Could Be the Answer to Curing Alzheimer's Disease, Study Shows", "Notable ETF Outflow Detected - MOAT, BIIB, TIF, STT", "3 Stocks to Trade Now for New Year\u2019s Profits", "SPDR S&P Biotech (ETF) (XBI): The Bears Got Nothin\u2019 on Biotech Stocks", "Stock Market News for September 15, 2016", "Biotech Stock Roundup: Horizon-Raptor Acquisition Deal, Geron Down on Pipeline News", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2016", "Perrigo Up as Starboard Reveals Stake, Changes Proposed", "Why Applied Genetic Technologies Corp. Is Tanking Today", "Is This New Market the Biggest Investment Idea of the Decade?", "Nasdaq 100 Movers: SWKS, STX", "IXJ, MDT, LLY, BIIB: Large Outflows Detected at ETF", "Better Buy: Biogen Inc. vs. Gilead Sciences", "Biotech Stock Roundup: CoLucid Soars on Migraine Data, Dynavax Drug FDA Panel Meeting Cancelled", "GW Pharmaceuticals PLC- ADR (GWPH) Boards the Buyout Rumor Mill", "SPDR Gold Trust (ETF) (GLD) Is Ready to Rally", "3 Stocks to Watch Tuesday: Monsanto Company (MON), Biogen Inc (BIIB) and Navistar International Corp (NAV)", "How the Tides Are Turning in Alzheimer's Research", "Nasdaq 100 Movers: AVGO, BIIB", "Biogen (BIIB) Aducanumab Gets Fast Track Status in the U.S.", "Health Care Sector Update for 09/02/2016: BIIB,ATEC,GMED,ELTP", "Tesla Motors Inc (TSLA) Needs More Cash for Gigafactory, Model 3", "Health Care Sector Update for 08/31/2016: BIIB,VEEV,ATOS", "Analysts Anticipate 12% Gains Ahead For RYH", "Biotech Stock Roundup: Medivation to Pfizer, Clovis Priority Review", "5 Stocks to Buy for September", "Biotech Stock Roundup: Vertex Slips on Study Halt, Aurinia Plunges on Lupus Data", "Sarah Ketterer Takes 3 Positions in 2nd Quarter", "Another Endorsement for Biotech ETFs", "Ionis Pharmaceuticals Inc Begins to Shift Focus", "Allergan to Buy ForSight VISION5, Boost Glaucoma Pipeline", "Top 3 Research Reports for August 15, 2016", "The Zacks Analyst Blog Highlights: Regeneron, BioMarin, AbbVie, Amgen and Biogen", "Notable ETF Outflow Detected - QLD, TXN, CHTR, BIIB", "Perrigo (PRGO) Misses Q2 Earnings Estimates, Cuts '16 View", "Ionis (IONS) Q2 Loss Narrower than Expected, Issues Outlook", "QUAL, PEG, BIIB, NKE: Large Outflows Detected at ETF", "The Zacks Analyst Blog Highlights: Intel, Align Technology, Qorvo and Biogen", "Intercept (ICPT) Reports Narrower-than-Expected Q2 Loss", "How Shows Like Grey's Anatomy Influence Patient Perceptions of Healthcare", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 15, 2016", "Zacks.com featured highlights: AngloGold Ashanti, Biogen, QUALCOMM, Tallgrass Energy GP and Steel Dynamics", "Allergan Plc: Will the Downtrend Continue for AGN Stock?", "Stop Dreaming: Biogen Isn't for Sale", "5 Best PEG Stocks for a Lucrative Value Investing", "Ionis Pharmaceuticals (IONS) Q2 Earnings: Stock to Beat?", "Why Sangamo Biosciences, Inc. Fell 29% Today", "Exelixis (EXEL) Posts Narrower Loss in Q2, Beats on Revenues", "Does Biogen's Latest Win Make Its Shares a Buy?", "3 Big Stock Charts for Wednesday: Regeneron Pharmaceuticals Inc (REGN), Biogen Inc (BIIB) and Dun & Bradstreet Corp (DNB)", "Rumors Swirl Around Biogen Today", "Why Biogen Inc. Soared 18% in July", "Why Avon Products, Inc. (AVP), Biogen Inc (BIIB) and Sodastream International Ltd (SODA) Are 3 of Today\u2019s Best Stocks", "Market Close Report: NASDAQ Composite index closes at 5,137.73 down -46.47 points", "Biogen Inc (BIIB) Tacks on $7B in Market Value on Buyout Talk", "Biogen (BIIB) Stock Surges 8% on Takeover Rumors", "Nasdaq 100 Movers: VRSK, CERN", "Midday Update: Stocks Return to Session Lows as Oil Tumbles Towards $40/Barrel", "Why Biogen Inc (BIIB) Stock Is Soaring Today", "Why Ionis Pharmaceuticals Inc Skyrocked Higher Today", "QQQ ETF Posts 52-Week High; Energy Stocks Sag As Oil Drops To $40", "Nasdaq 100 Movers: CTXS, BIIB", "S&P 500 Movers: RIG, BIIB", "Mid-Morning Market Update: Markets Mostly Higher; Tesla To Acquire SolarCity", "2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?", "Midday Update: Stocks Return to Session Lows as Oil Tumbles Towards $40/Barrel", "Why Biogen Inc (BIIB) Stock Is Soaring Today", "Health Care Sector Update for 08/01/2016: EYEG,IONS,KERX,BIIB", "Mid-Afternoon Market Update: Trina Solar Gains Following Go-Private Deal; Insperity Shares Drop", "Ionis Pharmaceuticals (IONS) Stock Surges 36% on Clinical Trial Success", "Health Care Sector Update for 08/01/2016: ITEK,IONS,KERX,BIIB", "Noteworthy ETF Outflows: BIB, AMGN, CELG, BIIB", "U.S. Equity Futures Slightly Higher As Mergers Provide A Boost", "The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene", "Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View", "Vertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short", "2 Large Cap Drug Stocks to Watch for Earnings: ABBV & MRK", "5 Undervalued Growth Stocks to Buy Today", "Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen", "What's in Store for these 5 Drug Stocks in Q2 Earnings?", "UCB (UCBJF) Posts 1H16 Results, Reaffirms 2016 Guidance", "The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Amgen and Celgene", "Amgen (AMGN) Tops Q2 Earnings & Revenues, Raises View", "Noteworthy ETF Outflows: BIB, BIIB, REGN, MYL", "E*Trade Financial Corp: ETFC Stock Stepping Into the Spotlight", "Biogen (BIIB) Stock Up on Q2 Earnings Beat, Raised Outlook", "The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen", "This Week Could Decide Whether Biotech ETFs' Rally Sizzles Or Fizzles", "Thursday\u2019s Vital Data: Microsoft Corporation (MSFT), Intel Corporation (INTC) and Facebook Inc (FB)", "Biogen (BIIB) Beats on Q2 Earnings by a Huge Margin", "Biogen Inc (BIIB) Stock: Q2 Earnings End a Year of Misery", "Earnings Reaction History: Biogen Idec, 33.3% Follow-Through Indicator, 3.8% Sensitive", "BIIB Stock: What to Know About Biogen Inc Before Thursday Morning", "Pre-Market Earnings Report for July 21, 2016 : SLB, UNP, BIIB, GM, BK, TRV, PPG, BBT, SHW, JCI, LUV, NUE", "Biotech Stock Roundup: Celgene in Immuno-Oncology Deal, Zafgen Drops Lead Drug", "Futures Trade Lower Amid Data, Earnings Deluge", "4 Rock-Solid, Cheap Biotech Stocks", "Agree To Buy Biogen At $135, Earn 3.5% Using Options", "Nasdaq 100 Movers: NCLH, INCY", "Biogen (BIIB) Q2 Earnings: Will the Stock Disappoint?", "Does Biogen's Lower P/E Ratio Make It a Better Buy Than Celgene?", "How Much Do Stock Prices Matter in Biotech?", "Biotech Stock Roundup: Juno In and Out of Clinical Hold, Amgen Biosimilar Gets Panel Backing", "Medical Stocks to Post Earnings This Week: ABT, BIIB, ALIOF", "How Marijuana Could Play a Role in Alzheimer's Disease Treatment", "Juno (JUNO) Suffers Setback, Pivotal Study on Clinical Hold", "Why Biogen Inc. Stock Dropped 15.7% in June", "Stock Market News for July 07, 2016", "3 Reasons To Buy Biogen", "These 3 Biotechs Are Down More Than 36% This Year, and They're Bargains", "Better Buy: NantKwest, Inc. vs. Ionis Pharmaceuticals", "Which Pipeline Has Better Potential: Celgene or Biogen?", "The iShares NASDAQ Biotechnology Index (IBB): Biotech Stocks Are Pushing for Recovery", "3 Stocks That Can and Should Start Paying Dividends", "2 Biotech Stocks That Won't Pay a Dividend Anytime Soon, and 1 That Should", "Better Buy: Biogen Inc. vs. Celgene Corporation", "3 Biotech Stocks to Buy Now: CELG, REGN and BIIB", "These 5 Biotech Stocks Are Ridiculously Cheap", "Why Biogen Inc. Is Down 22.5% In 2016", "3 Reasons Anavex Stock Could Rise", "The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology, Biogen, Alexion Pharma, BioMarin Pharma and Regeneron", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 14, 2016", "Is Biogen a Buy After its Clinical Failure?", "Biotech Buzz: ASCO Winners and Losers and Biogen's Discouraging Failure", "4 Stocks That Crushed the Biotechnology ETF (IBB) This Week", "The Zacks Analyst Blog Highlights: Biogen, Merrimack Pharmaceuticals, Retrophin, Idera Pharmaceuticals and Acorda Therapeutics", "BBH's Holdings Imply 25% Gain Potential", "Stock Market News for June 16, 2016", "Forget Biogen (BIIB), Buy These 5 Biotech Stocks Instead", "Biotech Stock Roundup: Biogen Slips on MS Results, ASCO Data in Focus", "Mid-Day Market Update: LDR Rises On Acquisition News; DryShips Shares Drop", "Instant Analysis: Biogen's Anti-Lingo-1 Flunks Game-Changing Study In MS", "IBB: The iShares NASDAQ Biotechnology Index (ETF) Is Still a Buy", "Noteworthy Tuesday Option Activity: CYTR, BIIB, Z", "Nasdaq 100 Movers: BIIB, WDC", "Better Buy: Anavex Life Sciences Corp. vs. Biogen", "Mid-Morning Market Update: Markets Mostly Higher; Valeant Earnings Miss Views", "Why Biogen, LendingClub, and Valeant Pharmaceuticals Slumped Today", "These Drug Stocks Just Disappointed Investors -- Are They Buys?", "Why Biogen Inc (BIIB), LendingClub Corp (LC) and Valeant Pharmaceuticals Intl Inc (VRX) Are Three of Today\u2019s Worst Stocks", "Why is Biogen (BIIB) Stock Plunging Today?", "Tuesday Sector Laggards: Healthcare, Utilities", "Mid-Afternoon Market Update: Navistar Climbs Following Earnings Beat; Biogen Shares Tumble", "S&P 500 Movers: BIIB, WDC", "Tuesday's ETF Movers: XOP, IBB", "Why Biogen Inc's Shares Couldn't Find SYNERGY Today", "The New $17 Billion Market You've Probably Never Heard of (and 3 Stocks Poised to Profit)", "Joel Greenblatt Bets on eBay, Intel, Biogen", "3 Reasons AbbVie's and Biogen's Latest MS Drug Might Flop", "10 Great Stocks That Will Make a Splash This Summer", "The Zacks Analyst Blog Highlights: Sarepta, Biogen, AbbVie, Intercept and Ionis", "Biogen Inc: BIIB Loses $8B on Drug Failure, But Upside Remains", "Las Vegas Sands Corp.: Ride the Bull Without the Risk (LVS)", "Biogen Inc: Run With the Bulls for Triple-Digit Profits (BIIB)", "Biotech Stock Roundup: Sarepta Shoots Up on FDA Delay, Ionis Falls on Pipeline News", "Nasdaq 100 Movers: CHTR, BIIB", "Roche's Subcutaneous Formulation of MabThera Gets EU Nod", "10 Biotech Stocks With Symptoms of Strong Growth", "Biogen & AbbVie's Multiple Sclerosis Drug Gets FDA Nod", "Kite (KITE) and Biogen's Drugs Included in PRIME Initiative", "Las Vegas Sands Corp.: Ride the Bull Without the Risk (LVS)", "Biogen Inc: Run With the Bulls for Triple-Digit Profits (BIIB)", "Noteworthy ETF Outflows: IVW, MO, PCLN, BIIB", "Noteworthy Thursday Option Activity: AHP, WDAY, BIIB", "Biogen Inc (BIIB) Spinout: A Graceful Exit for the Hemophilia Biz", "See Which Of The Latest 13F Filers Holds Biogen", "Last Week's Best Healthcare ETF", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 13, 2016", "Notable ETF Outflow Detected - IWB, LLY, TWX, BIIB", "Stock Market News for May 10, 2016", "Ionis Incurs Wider-than-Expected Loss in Q1, Stock Down", "The Zacks Analyst Blog Highlights: Amgen, Gilead, Celgene, Medivation and Biogen", "Better Buy: Gilead Sciences vs. Biogen", "Forget Bluebird Bio, Inc.: These 3 Stocks Are Better Buys", "Perrigo (PRGO) Tops Q1 Earnings, 2016 Earnings View Intact", "Biotech ETFs Sink on Mixed Q1 Results", "IBB, BIIB, CELG, REGN: ETF Inflow Alert", "Acorda (ACOR) Q1 Earnings Decline Y/Y, Ampyra in Focus", "3 Drug Stocks Reporting Early Next Week: PFE, MYL, MNK", "Alkermes (ALKS) Reports Narrower-than-Expected Q1 Loss", "Drug Stocks Q1 Earnings Preview: AEGR, AERI, MACK, PRTA", "The Zacks Analyst Blog Highlights: Biogen, Sarepta, Catalyst Pharmaceuticals, AbbVie and Gilead", "What's Up at Ionis Pharmaceuticals (IONS) in Q1 Earnings?", "Drug Stocks' Earnings Previews: KERX, BXLT, BMRN, AGEN, IMGN", "Biotech Stock Roundup: Biogen Tops on Q1 Earnings, Sarepta, Catalyst Plunge on Regulatory News", "Biogen Inc: Market Takes the Bull by the Horns Despite Sales Miss (BIIB)", "Biogen Inc Earnings Explode Higher, Revenue Not So Much", "Dow Jones Holds 18,000 Despite Weak Tech Earnings", "6 Mega-Cap Tech Stocks at the Brink of Imploding", "7 A-Rated Stocks With Rock-Solid Foundations", "The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Novartis, Baxalta Incorporated and Shire", "Energy Select Sector SPDR (ETF): Get Paid to Gas Up on XLE", "Alibaba Group Holding Ltd: BABA Goes BOOM and Bulls Take Note", "Biogen (BIIB) Tops on Q1 Earnings, Slight Revenue Miss", "Biogen Inc (BIIB): Embrace the \u201cDrug Trade\u201d", "Health Care Sector Update for 04/21/2016: NVS, BIIB", "Biogen (BIIB) Beats on 1Q Earnings by a Wide Margin", "Thursday Sector Leaders: Healthcare, Services", "Key Morning Earnings for April 21: BIIB, GM, UA, VZ", "Pre-Market Earnings Report for April 21, 2016 : VZ, UNP, DHR, BIIB, GM, BK, TRV, PPG, LUV, ERIC, SHW, BBT", "How Will Drug Stocks BIIB, ABT, NVS Perform in Q1 Earnings?", "Health Care Select Sector SPDR Fund Experiences Big Outflow", "Biogen Inc.: Bet on BIIB for Healthy Profits", "Health Care Sector Update for 04/18/2016: MDVN, BIIB, AMGN, MRK, ABT, PFE, JNJ", "Will MS Franchise Sales Boost Biogen's (BIIB) 1Q Earnings?", "Will Perrigo (PRGO) Surprise Earnings Estimates in Q1?", "Health Care Sector Update for 04/21/2016: BIIB,CBAY,TRXC", "AstraZeneca/Eli Lilly Alzheimer's Disease Drug in Phase III", "Commit To Buy Biogen At $150, Earn 5.2% Using Options", "Ionis Tanks, FDA Clinical Hold on IONIS-TTRRx Phase III Study", "Surprising Analyst 12-Month Target For SPXT", "Biotech Stock Roundup: Gilead's HIV Drug Approved, Regeneron Up on Positive Data", "iShares U.S. Healthcare ETF Experiences Big Outflow", "Better Buy: Gilead Sciences Inc. vs. Biogen Inc.", "ClubCorp Holdings, Inc.: Countering The Bulls", "9 Things You Need to Know About Biosimilar Drugs", "Gilead & Biogen's Patent Woes, Amgen Scores Win in Patent Litigation", "AVEO Gives AV-203 Ex-U.S. Rights to CANbridge Life Sciences", "Biogen Inc. vs. Amgen: Which Big Biotech Is the Smarter Buy Today?", "This Big Biotech ETF Faces a Key Technical Test", "Zacks Industry Outlook Highlights: Valeant, Pfizer, Amgen and Biogen", "iShares S&P 500 Growth ETF Experiences Big Outflow", "The Zacks Analyst Blog Highlights: Gilead, Amgen, Regeneron, Ionis and Biogen", "Eli Lilly Down, Alters Primary Endpoint of Solanezumab", "John Buckingham Trades in ETFs in 4th Quarter", "Better To Short Biotech ETF Or To Invest In Inverse Counterpart?", "How to Ride the Next Wave of Potential Alzheimer's Drugs", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for March 14, 2016", "Biogen Inc: Regenerate Profits in a Bear-Trapped BIIB", "Better Buy: Amgen Inc. vs. Biogen", "Stock Market News for March 16, 2016", "VUG, ABBV, UPS, BIIB: Large Outflows Detected at ETF", "The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Gilead Sciences, Biogen, Amgen and Regeneron Pharmaceuticals", "3 Stocks That Are Ridiculously Cheap Right Now", "What Does Trump's Healthcare Plan Mean for Investors?", "Ionis Incurs Wider-than-Expected Loss in Q4, Shares Down", "Alkermes Q4 Loss Narrower than Expected, Updates Pipeline", "How to Find Ethical Investments in the Pharmaceutical Industry", "Better Big Biotech Stock: Biogen vs. Celgene", "UPRO, BIIB, ABT, DHR: Large Outflows Detected at ETF", "Is Big Pharma Evil?", "Perrigo Lags on Q4 Earnings and Revenues, Updates View", "3 Biotechs that Could Snap Back and Soar Even Higher", "Noteworthy ETF Outflows: IYH, JNJ, BIIB, TMO", "Acorda Q4 Earnings Decline Y/Y, Ampyra & Pipeline in Focus", "Why Biogen Inc.'s Stock Sank in January", "What Awaits Ionis Pharmaceuticals (IONS) in Q4 Earnings?", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 11, 2016", "The Agony of High Returns", "Biotech ETFs Slide as Stocks Report Mixed Q4 Results", "Biogen Inc. Takes Aim at Johnson & Johnson", "Notable Friday Option Activity: BIIB, EIGI, ALLY", "FBT, TECH, QGEN, BIIB: Large Outflows Detected at ETF", "The Zacks Analyst Blog Highlights: Biogen, Gilead, AbbVie, Intrexon and NewLink", "See Which Of The Latest 13F Filers Holds Biogen", "Start the New Year off Right with 3 Best Biotech Stocks", "4 Top-Ranked Biotech Stocks on Sale", "Biogen Inc. Slows (But Let's Keep This in Perspective)", "Financial Sector Update for 02/02/2016: PDLI,BIIB,ACC,CACC", "Biotech ETF (IBB) Hits New 52-Week Low", "Biogen (BIIB) Looks Good: Stock Adds 5.2% in Session", "Biogen Tops on Q4 Earnings by a Wide Margin, Provides View", "Biotech Stock Roundup: Biogen, Amgen Top Estimates; Zika Virus Grabs Attention", "S&P 500 Movers: TSS, COF", "Biogen (BIIB) Beats on 4Q Earnings & Revenues", "US Stocks Eye Lower Open Ahead Of Fed Announcement; Oil Weighs on Commodities Stocks", "US Equities Futures Slip Amid Weaker Oil Prices, Apple Disappointment; Fed Decision on Tap", "Why Biogen, Freeport-McMoRan, and Hawaiian Holdings Jumped Today", "3 Healthcare Stocks You Don't Have to Babysit", "Celgene (CELG) to Report Q4 Earnings: What to Expect?", "Nasdaq 100 Movers: AAPL, BIIB", "Will Biogen (BIIB) Beat 4Q Earnings on MS Franchise Sales?", "Will Bristol-Myers (BMY) Beat Q4 Earnings Expectations?", "The Weekly Play: Sell Calls on This Sector (IBB)", "Biotech Stock Roundup: Sarepta Plunges on Briefing Documents, Acorda to Buy Biotie", "The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Cytokinetics and Bristol-Myers Squibb", "Biogen's (BIIB) Biosimilar of Amgen's Enbrel Gets EU Nod", "AbbVie's Management Just Made Some Pretty Bold Predictions", "Pre-Market Earnings Report for January 27, 2016 : BA, UTX, BIIB, EMC, GD, ANTM, ITW, ERIC, STT, NSC, PGR, STJ", "Biogen's CEO Sums Up Everything You Need to Know About the Company in 1 Comment", "7 Battered Biotech Stocks: Bargains or Busts?", "Was Celgene Corporation's Bad News Really That Bad?", "Agree To Buy Biogen At $160, Earn 6.1% Using Options", "Is This a Potential $7 Billion Waste for Celgene Corporation?", "Jean Hynes Finds Her Pot of Gold", "The Biggest Healthcare M&A News of 2015", "4 Biotech Stocks Looking Good this Earnings Season", "Biotech Industry Could Offer Early Profit in 2016", "Top Biotech Stocks to Buy in 2016", "Alkermes Hits 52 Week High on Pipeline Update & Aristada", "Health Care Sector Update for 12/16/2015: MRNS, BIIB, ALKS", "Biotech Stock Roundup: Amgen Hikes First Quarter Dividend, ARIAD Lowers Iclusig Outlook", "Isis/Biogen Initiate Amyotrophic Lateral Sclerosis Study", "7 Stocks to Buy in December", "Great News: This Government Agency Just Received a Big Raise", "IBB, AMGN, REGN, BIIB: Large Outflows Detected at ETF", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for December 14, 2015", "Positive Clinical Data Sends Isis Pharmaceuticals, Inc. Soaring in November", "Novartis??? Biosimilar for Pfizer???s Enbrel Accepted in the EU", "Do Eli Lilly and Biogen Have Alzheimer's All Wrong? Anavex Life Sciences Thinks So.", "The 3 Most Important Drugs in Isis Pharmaceuticals' Pipeline", "Insight Into Eli Lilly's Alzheimer's Drugs Is Coming Soon", "The Average American Spends This Much on Prescription Drugs Each Year", "PDL BioPharma Receives $133.7 Million in Cash Payments", "Is Anavex LIfe Sciences Corp. a Stock Worth Buying?", "Biotech Stock Roundup: Repros Tanks on CRL, AbbVie Multiple Myeloma Drug Approved", "The World's Largest Investing Firm Bought These 2 Biotech Stocks: Should You?", "There's a 0.0000000000028% Chance This Drug Doesn't Work", "A $26 Billion Hedge Fund Just Bought 9 Million Shares of This Stock: Should You Follow?", "Bristol-Myers' Cancer Drug Opdivo Gets CRL from the FDA", "Noteworthy ETF Outflows: IBB, REGN, BIIB, ALXN", "Biotech Stock Roundup: KaloBios Soars as Shkreli Steps In, FDA Panel Not Convinced about BioMarin Drug", "Bristol-Myers' Opdivo Gets FDA Nod for Another Indication", "BioMarin's (BMRN) Kyndrisa Fails to Impress FDA Panel", "Gilead's (GILD) Cocktail HIV Drug Genvoya Approved in EU", "Health Care Sector Update for 11/24/2015: SYN, NVS, BIIB", "Bristol-Myers' Opdivo Label Now Includes Renal Cell Cancer", "Biogen's (BIIB) Biosimilar of Pfizer's Enbrel Gets CHMP Nod", "The Zacks Analyst Blog Highlights: BioMarin, Amgen, Vertex, Gilead, Biogen and Repros", "Biotech Stock Roundup: Clovis Plunges, Label Expansion for Gilead's Harvoni", "Why Sangamo BioSciences Shares Rose 26% in October", "PRIMECAP Sells Stake in Technology Company", "These Biotech Stocks May Start Paying Dividends in 2016", "A Pro Forma Profit for ISIS Pharmaceuticals, Inc.", "VUG, MA, UPS, BIIB: Large Inflows Detected at ETF", "Nasdaq 100 Movers: GMCR, BIIB", "Amgen's Repatha Is Too Bloody Pricey for the U.K.", "Biotech Stock Roundup: Clovis Plunges, Label Expansion for Gilead's Harvoni", "Why Sangamo BioSciences Shares Rose 26% in October", "PRIMECAP Sells Stake in Technology Company", "Biotech Sees Better-than-Expected Earnings: ETFs in Focus", "Gilead and 2 Biotech Picks Value Investors Will Love", "Will Isis Pharmaceuticals (ISIS) Surprise in Q3 Earnings?", "Biotech Stock Roundup: AbbVie's Humira Remains Strong, Shire to Buy Dyax", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for November 12, 2015", "12 Companies Who Have Cut Jobs in 2015", "After Hours Most Active for Oct 30, 2015 : BAC, HPQ, MKTX, CYN, NYCB, FOXA, QQQ, HCBK, GE, PFE, MSFT, BIIB", "Biotech Stock Roundup: Biogen Tops Estimates, FDA Approves Alexion's Strensiq", "Biogen director buys 310,000 shares", "Tuesday 10/27 Insider Buying Report: BIIB, DKL", "Specialty Drug Classes That Are Costing Consumers an Arm and a Leg", "Is This Drug Going to Be a Big Threat to Biogen and Novartis Next Year?", "Battle Royale: Amgen Inc. vs. Biogen Inc.", "3 Earnings Reports That Surprised Us", "Perrigo Beats on Q3 Earnings, Misses Revenues, Cuts Jobs", "Biogen's Beat, Raise, and Yawn", "Biogen To Cut 11% of Its Workforce As Part Of Restructuring Plan", "BBH, CELG, BIIB, BXLT: Large Outflows Detected at ETF", "Commit To Buy Biogen At $180, Earn 5.3% Using Options", "Acorda Up on Q3 Earnings & Revenue Beat, Ampyra in Focus", "Battle Royale: Amgen Inc. vs. Biogen Inc.", "Biogen (BIIB) Beats on 3Q Earnings & Revenues", "Earnings Reaction History: Biogen Idec, 45.5% Follow-Through Indicator, 3.8% Sensitive", "Stock Market News for October 20, 2015", "Did Roche Unleash Biogen's Worst Nightmare?", "Isis (ISIS) Begins Extension Study SHINE on ISIS-SMNRx", "Pre-Market Earnings Report for October 21, 2015 : KO, BA, BIIB, ABT, EMC, GM, TMO, KMB, ITW, BHI, STJ, NLSN", "Biogen Tops Q3 Earnings, Announces Job Cuts, Ups View", "3 Blue-Chip Biotech Stocks Worth Buying for the Long Haul", "Can These Repurposed Antibodies Reshape the Multiple Sclerosis Market?", "Frank Sands' Undervalued Holdings With Growing EPS", "Biogen, Roche & Novartis Present Data on MS Drugs in Spain", "Stock Market News for October 08, 2015", "Sanofi Unveils New Positive Data on Lemtrada and Aubagio", "Stock Market News for October 07, 2015", "Will Tecfidera Slowdown Hit Biogen (BIIB) Earnings in Q3?", "3 Blue-Chip Biotech Stocks Worth Buying for the Long Haul", "3 Biotech Bargains to Buy", "VUG, MA, UNP, BIIB: Large Inflows Detected at ETF", "The Coming Clash of Big Biotechs: Biogen vs. Celgene", "The Zacks Analyst Blog Highlights: Regeneron, Vertex, Gilead, Biogen and Celgene", "The Best-Selling Drugs in the World By 2020", "3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical", "Health Care Sector Update for 09/25/2015: NAVB, BIIB, AMGN", "Biotech Stock Roundup: Clinton's Tweet Shakes Biotech Stocks, Amgen In Pipeline-Boosting Deals", "5 Biotech Stocks Hit Hard by Hillary Clinton's Tweet", "The Undervalued Stocks Among Richard Snow's Recent Buys", "Is Beaten-Down Biogen Stock a Bargain?", "Which Biotech Blue-Chip Stock Is the Best Buy?", "Merck KGaA Intends to File for Approval of MS Drug in EU", "Stock Market News for September 25, 2015", "4 Ways to Protect Yourself From a Biotech Meltdown", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for September 14, 2015", "Biogen's Surprising Weakness", "Health Care Sector Update for 09/11/2015: AKBA,BIIB,GILD,ARWR,NWBO", "2 Questions Investors Need to Ask About Biogen's Latest Deal", "Nasdaq 100 Movers: WYNN, LILA", "S&P 500 Movers: WYNN, FCX", "Better Buy: Biogen vs. Gilead Sciences", "Biotech Stock Roundup: Biosimilar Competition for Amgen, Tetraphase Hit By Disappointing Data", "Noteworthy ETF Outflows: IYH, ABBV, MDT, BIIB", "Roche's Hemophilia A Drug Gets Breakthrough Status in U.S.", "3 Biotech Stocks to Buy in the Middle of a Turbulent Market", "Biotech Stock Roundup: Amgen in the News, ARIAD a Takeover Target?", "Applied Genetic Meets Enrolment Milestone in XLRS Study", "We Believe Healthcare's Next Biotech Buyout Target Is\u2026", "Biogen (BIIB) in Autoimmune Disease Deal Worth Up To $544M", "Biogen (BIIB) Crumbles: Stock Falls by 5.9%", "Acorda (ACOR) Gets Favorable Outcome in Ampyra IPR Issue", "Bull Or Bear? Biotech's Post-Earnings Buys and Sells", "Using ETFs To Run Your Own Hedge Fund", "Biotech Stock Roundup: Kite Addresses Patient Death Concerns, Omeros Soars on Data", "Top-Rated Stock Picks and Most-Read Stories at Nasdaq.com: August 9 - 15", "IVW, NKE, BIIB, KMI: Large Outflows Detected at ETF", "Notable ETF Inflow Detected - VUG, ORCL, V, BIIB", "Nasdaq 100 Movers: YHOO, BIIB", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for August 13, 2015", "Nasdaq 100 Movers: TSLA, NVDA", "Emergent BioSolutions Tops on Q2 Earnings, Plans Spin-Off - Analyst Blog", "3 Crashing Healthcare Stocks That You Can Buy", "Noteworthy Thursday Option Activity: TSO, JPM, BIIB", "3 Reasons Why I Just Bought Biogen Inc. Stock", "Here's Why Biogen Lost $20 Billion in Market Value in July", "What Company Will Be Fastest Growing Big-Cap Biotech?", "Notable ETF Inflow Detected - VUG, ORCL, V, BIIB", "Mixed Biotech Earnings put These ETFs in Focus - ETF News And Commentary", "Will Isis Pharmaceuticals (ISIS) Beat Q2 Earnings Estimates? - Analyst Blog", "The Blockbuster Potential of Biogen Inc's Pipeline", "Acorda 2Q Earnings & Revenues Top, Ampyra in Focus - Analyst Blog", "Perrigo Beats on Q2 Earnings, Revenues In Line, Keeps View - Analyst Blog", "Here's Why Biogen Lost $20 Billion in Market Value in July", "What Company Will Be Fastest Growing Big-Cap Biotech?", "The Zacks Analyst Blog Highlights: Biogen, Ligand Pharmaceuticals, bluebird bio, Regeneron Pharmaceuticals and Exelixis - Press Releases", "3 Big Biotech Buybacks That Investors Should Love", "Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog", "3 Signs That the Healthcare Stock Bubble Might Have Just Popped", "S&P 500 Movers: MYL, BIIB", "Attention New Biotech Investors: Biogen Inc's Recent Weakness Is Your Opportunity", "Stock Market News for July 27, 2015 - Market News", "A Look Ahead: Biotech And Energy ETFs To Watch This Week", "5 Things Biogen's Management Wants You to Know", "A Big Day For Biotech And It's Not Going So Well", "Biogen Enters Oversold Territory (BIIB)", "BIIB Crosses Below Key Moving Average Level", "Biogen Tops Q2 Earnings, Cuts View on Tecfidera Issues - Analyst Blog", "Nasdaq 100 Movers: MYL, BIIB", "S&P 500 Movers: BIIB, AMZN", "3 Alzheimer's Drugs Investors Should Be Watching", "Health Care Sector Update for 07/24/2015: CGIX, REPH, BIIB", "Pre-Market Most Active for Jul 24, 2015 : EXEL, T, AMZN, BIIB, ITEK, FB, STM, QQQ, NOK, UN, ALU, CI", "Biogen (BIIB) Beats on 2Q Earnings, Misses on Revenues - Tale of the Tape", "Earnings Reaction History: Biogen Idec, 40.0% Follow-Through Indicator, 2.1% Sensitive", "Biogen's Terrible, Horrible, No Good, Very Bad Week", "Nasdaq 100 Movers: BIIB, AMZN", "Notable Friday Option Activity: BIIB, GT, XOM", "September 4th Options Now Available For Biogen (BIIB)", "Will Biogen (BIIB) Surprise in 2Q Despite Tecfidera Issues? - Analyst Blog", "Pre-Market Earnings Report for July 24, 2015 : ABBV, BIIB, SPG, STT, VFC, JCI, AAL, MCO, VTR, DTE, XRX, COL", "Eli Lilly, Biogen Present Data at Alzheimer's Association - Analyst Blog", "Biotech Stock Roundup: Amgen PCSK9 Inhibitor First to Gain Approval, Exelixis Up on Positive Data - Analyst Blog", "Biotech ETFs: 3 Questions For IShares Investing Expert", "Biogen (BIIB) Stock Plummets on Weak Guidance - Stocks in the News", "Isis Pharmaceuticals Begins Huntington's Disease Study - Analyst Blog", "Will AmerisourceBergen (ABC) Disappoint Earnings in Q3? - Analyst Blog", "Big Week for Biogen", "Celgene Buys Receptos. Is Arena Pharmaceuticals Next?", "Notable Friday Option Activity: MAT, SNDK, BIIB", "S&P 500 Analyst Moves: BIIB", "The Zacks Analyst Blog Highlights: Eli Lilly, Valeant Pharmaceuticals International, Biogen and Medicines Company - Press Releases", "Why Earnings Season Should Matter To ETF Investors", "Stock Market News for July 14, 2015 - Market News", "Health Care Sector Update for 07/14/2015: BIIB, CAH, CPXX", "4 Health Care Stocks to Watch Out for this Earnings Season - Earnings ESP", "Biogen (BIIB) Slips 2.8%, Lead R&D Executive Set to Leave - Analyst Blog", "$1.5 Trillion Reasons to Invest in These Companies", "S&P 500 Movers: BIIB, GCI", "Nasdaq 100 Movers: BIIB, WBA", "Isis Pharmaceuticals Up on Milestone Payment from Biogen - Analyst Blog", "Noteworthy Friday Option Activity: GOOGL, BIIB, KO", "The Zacks Analyst Blog Highlights: Vertex, Biogen, Applied Genetic, Gilead and Alexion - Press Releases", "Vanguard Growth ETF Experiences Big Outflow", "Biotech Stock Roundup: Vertex CF Drug Approved, Biogen Strikes Deal for Gene Therapy - Analyst Blog", "Are Biotechs In A Bubble?", "Biogen Sees Promise in Gene Therapy", "Forget Biogen (BIIB), Buy These 3 Biotechnology Stocks Instead - Stocks in the News", "3 Long Shots Biotech Companies Are Working On", "Why Applied Genetic Technologies Corporation Stock Jumped Today", "Mid-Day Market Update: US Stocks Down; Xoom Shares Jump On Acquisition News", "Midday Update: Stocks Surrender Opening Gains After Technical Resistances Holds", "Mid-Morning Market Update: Markets Edge Higher; Centene To Acquire Health Net For $6.3B", "Futures Build on Early Gains With June Payroll Report", "Close Update: Stocks Give Back Early Gains With Greece Uncertainty Escalating", "Health Care Sector Update for 07/02/2015: NTRA,AGTC,BIIB,IART,SPNEV", "Applied Genetic Up on Biogen Deal for Eye Disease Drugs - Analyst Blog", "Health Care Sector Update for 07/02/2015: HNT,CNC,CTSH,AGTC,BIIBIART,SPNEV", "Biotech Stock Roundup: Juno-Celgene In Immunotherapy Deal, BioMarin/Sarepta DMD Drugs Progress - Analyst Blog", "Stock Market News for July 01, 2015 - Market News", "Bayer Files Hemophilia A Drug Marketing Application in Japan - Analyst Blog", "VUG, ORCL, V, BIIB: Large Outflows Detected at ETF", "3 Stocks to Buy if Biotech Crashes", "Biogen/Sobi's Hemophilia B Drug Alprolix under EU Review - Analyst Blog", "Mid-Afternoon Market Update: International Speedway Slips On Weak Results; Applied Genetic Technologies Shares Spike Higher", "Stock Market News for June 23, 2015 - Market News", "Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog", "Stock Market News for June 19, 2015 - Market News", "3 Big Healthcare Trends Wall Street Is Overlooking", "Isis Pharmaceuticals Up on Positive Data on ISIS-SMNRx - Analyst Blog", "Gilead Sciences, Inc. (GILD) Ex-Dividend Date Scheduled for June 12, 2015", "Stock Market News for June 10, 2015 - Market News", "Transition Therapeutics Tanks on Alzheimer's Disease Data - Analyst Blog", "Is Gilead Sciences Inc.'s Moat Filling Up With Sand?", "Why Isis Pharmaceuticals, Inc. Exploded Higher By 19% in May", "Nasdaq 100 Movers: VRTX, WYNN", "Investing for Beginners: How to Start in Biotech", "OEF, ABBV, BA, BIIB: ETF Outflow Alert", "Pop! 3 To Buy If Biotech Stocks Burst", "Healthcare Investment Opportunities for the Long Term", "Stock Market News for June 08, 2015 - Market News", "Is Gilead Sciences Its Own Worst Enemy?", "Why Shares of Sangamo Biosciences Fell Today", "Biotech Stock Roundup: Alexion to Buy Synageva, FDA Panel Backs Vertex's Orkambi - Analyst Blog", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 12, 2015", "Here's Why Biotech Blue Chip Stock Biogen Inc. Lost 11% in April", "Isis Pharmaceuticals' Q1 Loss Narrower than Expected - Analyst Blog", "Mylan Q1 Earnings Meet Expectations, 2015 Guidance Upheld - Analyst Blog", "Stock Market News for May 21, 2015 - Market News", "Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?", "Frothy China Or No, World Mutual Funds Topped In April", "Zoetis Beats on Q1 Earnings, Revenue Guidance Lowered - Analyst Blog", "Incyte Posts Wider-than-Expected Q1 Loss, Jakafi Grows - Analyst Blog", "Integra LifeSciences Tops Q1 Earnings, Revenues; View Up - Analyst Blog", "Pharmacyclics Beats on Q1 Earnings, Misses Revenues - Analyst Blog", "QLT (QLTI) Reports Wider-than-Expected Loss in Q1 - Analyst Blog", "10 Most Profitable Businesses in Boston", "Biotech's Blue Chip Stocks", "Kythera's (KYTH) Double Chin Drug Kybella Gets FDA Nod - Analyst Blog", "Will Isis Pharmaceuticals (ISIS) Disappoint in Q1 Earnings? - Analyst Blog", "Alkermes' Q1 Loss Narrower than Expected, Maintains View - Analyst Blog", "Nektar Swings to Q1 Earnings, Updates 2015 Guidance - Analyst Blog", "Bayer (BAYRY) Q1 Net Income Down Y/Y, 2015 Outlook Up - Analyst Blog", "Acorda Posts 1Q Loss, Ampyra Generic Challenges in Focus - Analyst Blog", "The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Biogen, Actelion and Horizon Pharma - Press Releases", "Valeant Pharmaceuticals Reports In-Line Earnings, Ups View - Analyst Blog", "Oncolytics' Reolysin Gets Another Orphan Drug Status in EU - Analyst Blog", "Bristol-Myers' Supplemental BLA for Opdivo Accepted by FDA - Analyst Blog", "AmerisourceBergen Corp Beats on Q2 Earnings, Ups View - Analyst Blog", "Synageva Q1 Loss Narrower-than-Expected, Pipeline in Focus - Analyst Blog", "SurModics Misses on Q2 Earnings, Reaffirms 2015 Guidance - Analyst Blog", "Vertex Posts Wider 1Q Loss, Affirms Kalydeco Outlook - Analyst Blog", "Celgene Beats on Q1 Earnings, Misses Revenues, Keeps View - Analyst Blog", "The Zacks Analyst Blog Highlights: Celladon, Amgen, Biogen and Alnylam Pharmaceuticals - Press Releases", "Aeterna Zentaris to Continue Phase III Study of Cancer Drug - Analyst Blog", "BioMarin Upgraded to Strong Buy, Is It in Your Portfolio? - Analyst Blog", "Celldex 1Q Loss Narrower-Than-Expected, Pipeline in Focus - Analyst Blog", "Merck (MRK) Beats on Q1 Earnings & Revenues, Ups View - Analyst Blog", "The Zacks Analyst Blog Highlights: Amgen, Celladon, Biogen, Celgene and Gilead - Press Releases", "Hospira, Set to Be Acquired by Pfizer, Beats on Q1 Earnings - Analyst Blog", "Bristol-Myers Q1 Earnings Beat Driven by Strong Sales - Analyst Blog", "Stock Market News for April 28, 2015 - Market News", "Pfizer Beats on Q1 Earnings, Cuts View on Currency Woes - Analyst Blog", "RedHill Finishes Patient Enrollment for RHB-105 Study - Analyst Blog", "Will Teva's (TEVA) Earnings Streak Continue in Q1? - Analyst Blog", "Celgene to Buy Quanticel, Boost Pipeline Development - Analyst Blog", "3 Biotech Stocks Still Attractive After Monday's Sell-Off - Analyst Blog", "10 Most Profitable Businesses in Biotech", "Company News for April 27, 2015 - Corporate Summary", "The Zacks Analyst Blog Highlights: Biogen, NV5 Holdings, Tractor Supply, ULTA Salon, Cosmetics & Fragrance and Intuit - Press Releases", "Gilead and Bristol-Myers Reveal Positive Data on HCV Drugs - Analyst Blog", "Fidelity Contrafund: Beating the Market the Old-Fashioned Way", "Biogen Misses on 1Q Earnings, Tecfidera Falls Short - Analyst Blog", "Nasdaq 100 Movers: BIIB, AMZN", "Celladon's Advanced Heart Failure Study Fails, Shares Crash - Analyst Blog", "10 Most Profitable Businesses in Biotech", "Intercept Pharmaceuticals Releases Data on Lead Drug - Analyst Blog", "Biogen Inc Earnings: Tecfidera Turbulance", "Close Update: Record Highs on Wall Street As Tech Earnings Upstage Disappointing Durable Goods", "AbbVie Beats Earnings on Humira and HCV Sales, Ups View - Analyst Blog", "Eli Lilly Beats on 1Q Earnings by Wide Margin, Affirms View - Analyst Blog", "Alexion Misses Q1 Earnings Estimates, Keeps 2015 Outlook - Analyst Blog", "Biogen (BIIB) Misses on 1Q Earnings & Revenues - Tale of the Tape", "Emergent BioSolutions Resumes BioThrax Manufacturing - Analyst Blog", "Gilead (GILD) Announces Encouraging Data on its HCV Drugs - Analyst Blog", "Capricor's CAP-1002 Gets Orphan Drug Status in the U.S. - Analyst Blog", "Baxter International Inc.: Where a Decline Is a Win", "Will Biogen's (BIIB) Earnings Streak Continue in 1Q? - Analyst Blog", "Ultragenyx Announces Positive Data from Triheptanoin Study - Analyst Blog", "Isis Pharmaceuticals' ISIS-TTR Effective in Extension Study - Analyst Blog", "Acorda Reports Encouraging Data on MS Drug - Analyst Blog", "Emergent BioSolutions Resumes BioThrax Manufacturing - Analyst Blog", "Gilead (GILD) Announces Encouraging Data on its HCV Drugs - Analyst Blog", "Capricor's CAP-1002 Gets Orphan Drug Status in the U.S. - Analyst Blog", "Amgen Beats on Q1 Earnings & Revenues, Ups Earnings View - Analyst Blog", "Perrigo Beats on Q3 Earnings, Gives View, Rejects Mylan Bid - Analyst Blog", "Pfizer's Cancer Drug Meets First Primary Endpoint in Phase III - Analyst Blog", "Pre-Market Earnings Report for April 24, 2015 : BIIB, SPG, LYB, AAL, STT, VTR, TYC, DTE, XRX, COG, IMS, LEA", "Will Agenus (AGEN) Disappoint in Q1 Earning Season? - Analyst Blog", "Alnylam Reports Positive Patisiran Results, Shares Up - Analyst Blog", "Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog", "Will Edwards Lifesciences (EW) Top Q1 Earnings Estimates? - Analyst Blog", "Can Healthways (HWAY) Pull a Surprise this Earnings? - Analyst Blog", "Fate Therapeutics (FATE) Jumps: Stock Moves 12.4% Higher - Tale of the Tape", "Forget Gilead (GILD), Buy These Impressive Biotech Stocks Instead - Analyst Blog", "Immunomedics (IMMU) Provides Update on Lead ADC Candidate - Analyst Blog", "Pharmacyclics Announces Positive Results on Imbruvica - Analyst Blog", "C. R. Bard (BCR) Q1 Earnings: Lutonix DCB Holds the Key - Analyst Blog", "Will Alexion's (ALXN) Soliris Drive Q1 Earnings Beat? - Analyst Blog", "Actavis' Botox Upper Limb Spasticity Label Expanded by FDA - Analyst Blog", "Is AbbVie (ABBV) Set to Top 1Q Earnings on Humira & HCV? - Analyst Blog", "Will Eli Lilly (LLY) Beat Earnings in 1Q Despite Generics? - Analyst Blog", "Will Novartis' (NVS) Earnings Disappoint This Quarter? - Analyst Blog", "Bristol-Myers Announces Positive Data from Opdivo Study - Analyst Blog", "Will Mead Johnson's (MJN) Q1 Earnings Surprise Estimates? - Analyst Blog", "ResMed (RMD) Poised to Outshine Q3 Earnings Estimates - Analyst Blog", "Clovis Oncology (CLVS) Falls: Stock Goes Down 5.3% - Tale of the Tape", "Athersys Slumps as MultiStem Fails in Mid-Stage Study - Analyst Blog", "Bristol-Myers' Study on Opdivo Halted on Early Success - Analyst Blog", "Will Amgen (AMGN) Keep Earnings Streak Alive in 1Q? - Analyst Blog", "Will CONMED (CNMD) Disappoint Earnings Estimates in Q1? - Analyst Blog", "Will Baxter's (BAX) Earnings Disappoint Estimates in Q1? - Analyst Blog", "3 Biotech Stocks That Could Be Developing Billion Dollar Drugs", "Biotech Investors Shouldn't Miss These Stocks This Earnings - Earnings ESP", "Will Intuitive Surgical (ISRG) Surprise Earnings in Q1? - Analyst Blog", "Can Illumina (ILMN) Keep the Earnings Streak Alive in Q1? - Analyst Blog", "Amgen Gets FDA Nod for Chronic Heart Failure Drug Corlanor - Analyst Blog", "VIVUS Responds to Teva's Filing for Qsymia Generics - Analyst Blog", "AbbVie's HCV Treatment Granted Priority Review in Japan - Analyst Blog", "Will Abbott Labs (ABT) Disappoint on Earnings This Quarter? - Analyst Blog", "Bayer to Expand Copanlisib Program by Three New Studies - Analyst Blog", "Biotech Stock Roundup: Favorable Briefing Documents for MDCO's Kengreal, Alexion Soliris Label Update - Analyst Blog", "J&J Beats on Q1 Earnings, Cuts View on Currency Woes - Analyst Blog", "Alnylam Reports Publication of New Data on Hemophilia Drug - Analyst Blog", "Aeterna Zentaris to Advance Hormone Drug to Phase III Study - Analyst Blog", "Will Pharmaceutical Sales Drive J&J (JNJ) Earnings Again? - Analyst Blog", "Biogen, SodaStream, TASER International, Napco Security Technologies and SuperCom highlighted as Zacks Bull and Bear of the Day - Press Releases", "Biogen Reports New Data from Acute Optic Neuritis Study - Analyst Blog", "The 3 Best Stocks to Invest in Biotechnology", "10 Largest Companies by Market Cap in Biotech", "Stock Market News for April 09, 2015 - Market News", "Apple: A Top Mutual Fund Manager's Concerns", "Why Smart Money Loves This Biotech Stock", "The Truly Staggering Cost of Alzheimer's Disease", "Has the Biotech Bubble Already Popped?", "Bull of the Day: Biogen (BIIB) - Bull of the Day", "Notable ETF Outflow Detected - IWF, ACT, BIIB, CELG", "The Zacks Analyst Blog Highlights: Horizon Pharma, Hyperion Therapeutics, Conatus, Amgen and Biogen - Press Releases", "Stock Market News for April 01, 2015 - Market News", "Why Receptos, Inc. Shares Soared Higher Today", "Biotech Stock Roundup: Horizon to Buy Hyperion, Conatus Up on Liver Disease Data - Analyst Blog", "Biogen's Biosimilar Version of Remicade Under EU Review - Analyst Blog", "Stock Market News for March 30, 2015 - Market News", "The Safest Biotech Bet on the Market", "Based on This Study, an Alzheimer's Disease Cure Could Be Around the Corner", "Could These Experimental Drugs Eclipse Harvoni's Historic Launch?", "The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex, Gilead and Amgen - Press Releases", "Biotech Stock Roundup: Biogen Soars on Alzheimer's Data, Gilead HCV Drugs Label Update - Analyst Blog", "The Zacks Analyst Blog Highlights: HSBC Holdings, Goldman Sachs, Acorda Therapeutics, Biogen Idec and Ross Stores - Press Releases", "This Tiny Biotech Offers Up New Hope for Parkinson's Disease Patients", "Bubble Bursting? 3 Top Stock Biotech Stocks to Buy", "Biogen/AbbVie's MS Drug Zinbryta Under Review in the EU - Analyst Blog", "Biogen Gains on Positive Alzheimer's Drug Interim Results - Analyst Blog", "3 Biotech Stocks to Buy If the Sector Crashes", "Financial Sector Update for 03/23/2015: GNW,BIIB,OCN,BRX,BX", "1 Biotech Stock You Can Buy and Hold for the Next 20 Years", "Midday Update: First Day of Spring Brings Green on Wall Street; Nasdaq Hits 15-Yr High", "Biogen Idec Inc.'s Stock Bursts Higher On Alzheimer\u2019s News: Here's Why", "2 Stocks to Beat the Dollar's Volatile Run - Analyst Blog", "Nasdaq 100 Movers: DISH, BIIB", "S&P 500 Movers: MAC, BIIB", "U.S. Stock Futures Follow European Markets Higher on Hopes for Greece Deal", "Pre-Market Most Active for Mar 20, 2015 : MAC, BIIB, CTRP, NOK, QQQ, BAC, FB, AAPL, PRTA, NKE, KBH, HSEB", "U.S. Stock Futures Point Higher After Weak Thursday Session; Germany Sees Hope for Greece Deal", "Closing Update: Session-Long Surge Lifts, Market Gauges to Big Weekly Advance; Nasdaq Composite Index Again Tops 5,000", "Health Care Sector Update for 03/20/2015: BIIB,PRTA,THRX", "Notable ETF Inflow Detected - XLV, AMGN, BIIB, CELG", "New Biotech ETFs Highlight Evolving Growth Opportunities", "Zacks Investment Ideas feature highlights: Biogen, Amgen, SPDR S&P Biotech ETF, BioShares Biotechnology Clinical Trials Fund and ProShares Ultra Nasdaq Biotechnology ETF - Press Releases", "Should Gilead Sciences Inc.\u2019s Slowing Growth Concern Investors?", "3 Biotech ETFs Crushing the Market in 2015 - ETF News And Commentary", "S&P 500 Analyst Moves: BIIB", "Notable ETF Outflow Detected - XLV, MDT, BIIB, CELG", "Merck KGaA to Pay $3M to Opexa for Tcelna Study - Analyst Blog", "Can This Biotech Stock Go from Good to Great?", "Could This Study Help Lead to a Cure for Select Multiple Sclerosis Patients?", "2 Tiny Biotechs That Could Have Blockbuster Opportunity", "Health Care Sector Update for 03/06/2015: CALA, ISIS, HZNP", "Top Funds Buying Rackspace, Allergan, Biogen Idec, Apple", "Isis Pharmaceuticals Up on Q4 Earnings and Revenues Beat - Analyst Blog", "Biogen/Sobi Report Postive Phase III Data on Alprolix - Analyst Blog", "3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year", "Isis Pharmaceuticals Earns Milestone Payment from Biogen - Analyst Blog", "iShares S&P 500 Growth ETF Experiences Big Outflow", "5 Things Biogen Idec Inc's Management Wants You to Know", "3 Biotech Stocks I'd Love to Stash Away in My Portfolio Forever", "Stock Market News for February 18, 2015 - Market News", "Could the Solution to Treating Alzheimer's Disease Really Be This Simple?", "3 Stocks That Were Huge Winners Last Week", "3 Biotech Stocks I Love", "Why Don't These Winning Stocks Pay Dividends?", "Ironwood Pharmaceuticals Cuts Loss on Higher Revenues - Analyst Blog", "Oncolytics' Reolysin Gets Orphan Status for Ovarian Cancer - Analyst Blog", "Forget Gilead Sciences: Here Are 3 Better Biotech Stocks", "Sucampo, Par Pharmaceuticals Enter License Agreement - Analyst Blog", "Why Sangamo Biosciences Inc. Shares Rocketed Higher Today", "Charles River (CRL) Beats on Q4 Earnings and Revenues - Analyst Blog", "Isis Pharma to Get $5M from Biogen - Analyst Blog", "Acorda Beats Q4 Earnings Estimates; Ampyra Sales Grow - Analyst Blog", "Orexigen Gives Positive Updates on its Weight Loss Drug - Analyst Blog", "Alkermes Reports Positive Data on Multiple Sclerosis Drug - Analyst Blog", "Oncolytics Seeks Orphan Drug Status for Reolysin in the U.S. - Analyst Blog", "Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 10, 2015", "Will Sangamo (SGMO) Disappoint This Earnings Season? - Analyst Blog", "3 Medical Advancements You May Be Missing Out On", "3 Biotech Stocks We've Fallen For", "How to Profit from Elon Musk's \"Space Internet\"", "Orexigen Gives Positive Updates on its Weight Loss Drug - Analyst Blog", "Alkermes Reports Positive Data on Multiple Sclerosis Drug - Analyst Blog", "Gilead, Amgen Q4 Earnings & Weak Outlook Affect Biotech ETFs - ETF News And Commentary", "Perrigo Beats on Earnings, FY15 Guidance In Line - Analyst Blog", "Allergan Beats Earnings Yet Again on Strong Revenues - Analyst Blog", "bluebird bio's Thalassemia Drug Gets Breakthrough Status - Analyst Blog", "Merck (MRK) Beats on Q4 Earnings but Guidance Falls Short - Analyst Blog", "These Common Medications May Put You At a Greater Risk of Developing Dementia", "3 Blockbuster Drugs That May Be Obsolete in 5 Years", "Sanofi Misses on Q4 Earnings, Maintains Diabetes Guidance - Analyst Blog", "Gilead, Amgen Q4 Earnings & Weak Outlook Affect Biotech ETFs - ETF News And Commentary", "Perrigo Beats on Earnings, FY15 Guidance In Line - Analyst Blog", "Biogen Idec (BIIB) Shows Strength: Stock Moves Up 10.2% - Tale of the Tape", "This Could Be Game-Changing News in the Battle Against Multiple Sclerosis", "3 Biotech Giants That Shouldn't Pay a Dividend", "5 Things AbbVie Inc.'s Management Wants You to Know", "Biogen Tops Q4 Earnings, Provides Strong Outlook for 2015 - Analyst Blog", "Nasdaq 100 Movers: PCAR, AMZN", "S&P 500 Movers: PCAR, BIIB", "Why Biogen Idec's Shares Skyrocketed Higher", "Vertex Posts Wider 4Q Loss, Affirms Kalydeco Outlook - Analyst Blog", "Biogen Idec Inc Earnings: Worth the Wait", "After-Hours Earnings Report for January 29, 2015 : AMZN, V, BIIB, CB, BRCM, BXP, PFG, BCR, HBI, EMN, MCHP, N", "IUSG, VZ, BIIB, HON: ETF Outflow Alert", "Pre-Market Earnings Report for January 28, 2015 : BA, BIIB, EMC, GD, PX, AEP, TEL, IP, TROW, HES, ABC, STJ", "Commit To Purchase Biogen Idec At $240, Earn 6.7% Using Options", "How Will M&A ETFs Perform In 2015? Many Deals Lined Up", "Biotech Stock Roundup: EU Approvals for AbbVie & Celgene Drugs, CytRx Partial Clinical Hold Lifted - Analyst Blog", "State of the Union Address Investing Idea: Precision Medicine", "AbbVie Inc.'s Insights at the JP Morgan Healthcare Conference", "Isis Pharmaceuticals Earns Milestone Payment from Biogen - Analyst Blog", "Will Biogen (BIIB) Surpass Q4 Earnings Expectations? - Analyst Blog", "Biogen to Acquire Convergence, Expand Pain Pipeline - Analyst Blog", "Seattle Genetics, Bristol-Myers to Study Adcetris-Opdivo - Analyst Blog", "Which Big Biotech Will Soar in 2015?", "Better Healthcare Buy: Big or Little Biotechs", "IYH, BIIB, MDT, ACT: ETF Inflow Alert", "Isis Pharmaceuticals Improves 2014 Outlook, Shares Up - Analyst Blog", "Diving Deeper into Biogen's Lingo Results", "Health Care Sector Update for 01/14/2015: AZN, ISIS, VICL", "Nasdaq 100 Movers: BIIB, TSCO", "3 Biotech Stocks That Could Trounce Gilead Sciences, Inc. in 2015", "Why Isis Pharmaceuticals, Inc. Stock Surged 19% in December", "Nasdaq 100 Movers: NXPI, BIIB", "Why Biogen Idec Inc. Stock Catapulted 10% Higher in December", "Isis Pharmaceuticals Up on Collaboration with J&J - Analyst Blog", "VUG, CELG, BIIB, ACT: Large Inflows Detected at ETF", "Biogen Reveals Positive Data from Acute Optic Neuritis Study - Analyst Blog", "Devon Energy Achieves #107 Analyst Rank, Surpassing Biogen Idec", "Stock Market News for December 26, 2014 - Market News", "After Gilead Sciences, Is it Time to Sell Biotech Stocks? - Analyst Blog", "Vanda Gains Fanapt Rights from Novartis for the U.S. Region - Analyst Blog", "XLV, BIIB, ACT, AGN: Large Inflows Detected at ETF", "3 Drugmakers Facing a Pivotal 2015", "Vertex Pharmaceuticals' Kalydeco Label Expanded in the U.S. - Analyst Blog", "Prothena Corp. (PRTA) Looks Good: Stock Moves Up 5.7% - Tale of the Tape", "Orexigen's Obesity Drug Mysimba Gets CHMP Nod - Analyst Blog", "Genomic Health (GHDX) Shines on Prospective Cancer Tests - Analyst Blog", "Roche to Acquire Austrian Biotechnology Company Dutalys - Analyst Blog", "Celgene Gets Positive CHMP Recommendation for Revlimid - Analyst Blog", "Novo Nordisk's Tresiba Favored by CHMP for Expanded Use - Analyst Blog", "Eli Lilly-Adocia Strike Deal to Develop Ultra-Rapid Insulin - Analyst Blog", "Puma Biotechnology (PBYI) Jumps: Stock Moves 6.1% Up - Tale of the Tape", "Prothena Corp. (PRTA) Looks Good: Stock Moves Up 5.7% - Tale of the Tape", "Orexigen's Obesity Drug Mysimba Gets CHMP Nod - Analyst Blog", "Agenus Jumps on Positive Data from Shingles Candidate - Analyst Blog", "Integra Lifesciences Up on Launch of Bilayer Skin Product - Analyst Blog", "Bruker Unveils bioAFM System for High Resolution Imaging - Analyst Blog", "OvaScience Slumps: OVAS Tanks 12.3% in Session - Tale of the Tape", "Which Biotech Will Become the Next Gilead Sciences, Inc.?", "3 Large Cap Biotech Stocks That Could Surprise Investors in 2015", "Trevena (TRVN) in Focus: Stock Rallies 7.5% - Tale of the Tape", "Alkermes Starts Phase I Study on Schizophrenia Candidate - Analyst Blog", "Acorda's Ampyra in Phase III for Post-Stroke Walking Deficit - Analyst Blog", "Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog", "OPKO Up on Announcing Global Partnership with Pfizer - Analyst Blog", "Genomic Health's Breast Cancer Test Yields Positive Results - Analyst Blog", "Strength Seen in GTX Inc (GTXI): Stock Rises 10.6% - Tale of the Tape", "BioDelivery Sciences (BDSI) in Focus: Stock Tanks 11% - Tale of the Tape", "Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog", "Jazz Pharmaceuticals Starts Defibrotide Rolling NDA Filing - Analyst Blog", "Sangamo Biosciences (SGMO) Jumps: Stock Rises 7.2% - Tale of the Tape", "Alder Biopharmaceuticals Inc. (ALDR) in Focus: Stock Soars 31.9% - Tale of the Tape", "Celladon Corporation (CLDN) Falls: Stock Goes Down 8.6% - Tale of the Tape", "3 Reasons Biogen Idec Inc. Could Soar in 2015", "Teva's (TEVA) 2015 Guidance Hit By Generics - Analyst Blog", "Alder Biopharmaceuticals Slumps: ALDR Falls 5.5% in Session - Tale of the Tape", "Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog", "PDL BioPharma's Q4 Revenues to Rise Y/Y on Higher Royalties - Analyst Blog", "Genomic Health's Liquid Biopsy Tests Positive in Twin Studies - Analyst Blog", "AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH (Revised) - Analyst Blog", "3 Biotech Stocks to Buy in December", "Avalanche Biotechnologies (AAVL) Jumps: Stock Adds 6.1% in Session - Tale of the Tape", "Incyte (INCY) Gains on Positive Baricitinib Study Results - Analyst Blog", "Ophthotech Corporation (OPHT) Jumps: Stock Gains 5% - Tale of the Tape", "Biogen Idec (BIIB) Stock: Moving Average Crossover Alert - Tale of the Tape", "Rexahn Pharmaceuticals, Inc. (RNN) Rises: Stock Up 8.6% - Tale of the Tape", "Acceleron Pharma, Inc. (XLRN) in Focus: Stock Soars 13.6% - Tale of the Tape", "bluebird bio (BLUE) in Focus: Stock Surges 9.4% - Tale of the Tape", "ISIS Jumps on Positive Results for Venous Thrombosis Drug - Analyst Blog", "Dynavax & AstraZeneca Alter Agreement for Asthma Product - Analyst Blog", "Alnylam Reports Positive Initial Phase I Data on ALN-AT3 - Analyst Blog", "JAZZ Pharmaceuticals Slips After Dosing Issue on JZP-386 - Analyst Blog", "Myriad Genetics Unveils Positive Cancer Study Results - Analyst Blog", "Compugen (CGEN) Worth Watching: Stock Moves 8.8% Higher - Tale of the Tape", "Kindred Biosciences, Inc. (KIN) in Focus: Stock Soars 10.6% - Tale of the Tape", "Amgen Unveils Positive Results from Blood Cancer Studies - Analyst Blog", "Pharmacyclics (PCYC) Launches U.S.-Based CLL Registry - Analyst Blog", "Agios (AGIO) Reports Encouraging Data on Leukemia Drug - Analyst Blog", "Pharmacyclics Presents Imbruvica Data at the ASH Meeting - Analyst Blog", "AbbVie Reveals Phase II Data on Blood Cancer Drug at ASH - Analyst Blog", "3 Large Cap Biotech Stocks That Could Pay Dividends, But Won't", "Exciting News: A Game-Changing Alzheimer's Drug Could be on Its Way", "Bayer Files Hemophilia A Drug Marketing Application in EU - Analyst Blog", "Array BioPharma, Inc. (ARRY) in Focus: Stock Soars 14.3% - Tale of the Tape", "Walgreens (WAG) Up on 4.9% Y/Y Rise in November Sales - Analyst Blog", "Celldex's Glembatumumab Vedotin in Phase II for Melanoma - Analyst Blog", "Seattle Genetics-Takeda's Adcetris Shows Long-Term Effect - Analyst Blog", "Why Isis Pharmaceuticals, Inc. Stock Leaped 12% in November", "Sequenom Inc. (SQNM) in Focus: Stock Surges 23.6% - Tale of the Tape", "Amgen's Blincyto Gets FDA Nod, Carries Boxed Warning - Analyst Blog", "ADMA Biologics' RI-002 Positive in Phase III Study - Analyst Blog", "Synageva Completes BLA Submission for Sebelipase Alfa - Analyst Blog", "Array BioPharma Regains Binimetinib Rights from Novartis - Analyst Blog", "Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study - Analyst Blog", "Incyte's Jakafi Gets FDA Approval for Polycythemia Vera - Analyst Blog", "Jazz Pharmaceuticals (JAZZ) Starts Late-Stage Study on Xyrem - Analyst Blog", "Biogen Idec (BIIB) Shows Strength: Stock Moves 6.4% Up - Tale of the Tape", "Puma Biotechnology Down on Delay in Neratinib NDA Filing - Analyst Blog", "Actelion Submits Marketing Application for Uptravi in EU - Analyst Blog", "Biogen Up on Encouraging Interim Data on Alzheimer's Drug - Analyst Blog", "Myriad Genetics' Prolaris: A Pocket-Friendly Cancer Test - Analyst Blog", "Midday Update: Stocks Positive on Construction Spending, Auto Sales", "Stock Market News for December 03, 2014 - Market News", "Nasdaq 100 Movers: NXPI, BIIB", "Stocks Resume Advance, Buoyed by Construction Spending", "Noteworthy ETF Outflows: MTUM, MU, ACT, BIIB", "Intra-Cellular Therapies (ITCI) Jumps: Stock Rises 6.8% - Tale of the Tape", "MediciNova (MNOV) Looks Good: Stock Soars 19.3% - Tale of the Tape", "Pharmacyclics, J&J Seek Imbruvica Label Expansion in EU - Analyst Blog", "Regeneron/Bayer's Eylea to be Reviewed on a Priority Basis - Analyst Blog", "S&P 500 Movers: NEM, BIIB", "Nasdaq 100 Movers: NXPI, BIIB", "Momenta's Necuparanib Gets Fast Track Status in the U.S. - Analyst Blog", "Health Care Sector Update for 12/02/2014: BIIB, IMNP, QDEL, PFE, GSK", "Dynavax Regains TLR 7/9 Inhibitor DV1179 Rights from Glaxo - Analyst Blog", "Vertex Pharmaceuticals' 52-Week High Driven by Kalydeco - Analyst Blog", "Oncothyreon Inc. (ONTY) in Focus: Stock Surges 10.1% - Tale of the Tape", "Alexion's Soliris Gets Final Positive NICE Recommendation - Analyst Blog", "Closing Update: Dow Closes At Record High on Positive Data, Rebound in Energy Sector", "Strength Seen in Kythera (KYTH): Stock Moves 5.5% Higher - Tale of the Tape", "Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog", "Isis Pharmaceuticals Earns Milestone on Study Initiation - Analyst Blog", "Intra-Cellular Commences Phase III Schizophrenia Study - Analyst Blog", "Coronado Biosciences (CNDO) Jumps: Stock Rises 8.5% - Tale of the Tape", "Prosensa Soars on $680M Buyout Offer from BioMarin - Analyst Blog", "Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog", "Avanir's Migraine Drug Gets Complete Response Letter - Analyst Blog", "Ocera Therapeutics (OCRX) Worth Watching: Stock Up 9.4% - Tale of the Tape", "Enzo Biochem (ENZ) in Focus: Stock Moves 6.9% Higher - Tale of the Tape", "AbbVie's HCV Cocktail Treatment Closer to EU Approval - Analyst Blog", "Immunomedics' Veltuzumab Receives Orphan Drug Status - Analyst Blog", "XOMA Corp Worth Watching: Stock Moves 10.3% Higher - Tale of the Tape", "EPIRUS Biopharmaceuticals (EPRS) Jumps: Stock Up 15.9% - Tale of the Tape", "Compugen (CGEN) Worth Watching: Stock Adds 6% in Session - Tale of the Tape", "SPY, BA, COP, BIIB: ETF Outflow Alert", "Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog", "Epizyme Gains on Positive Phase I Data on EPZ-6438 - Analyst Blog", "Is Illumina (ILMN) Worth Adding to Your Portfolio? - Analyst Blog", "Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog", "Agios (AGIO) Shares Up on Positive AG-120 Study Data - Analyst Blog", "Mallinckrodt Q4 Earnings Boosted by Acquisitions, Sales Beat - Analyst Blog", "Argos Therapeutics (ARGS) Jumps: Stock Gains 7.4% - Tale of the Tape", "This High-Yield Dividend Stock Screams Danger", "Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog", "Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog", "Kite Pharma's Q3 Loss Narrows Y/Y, Focus on Pipeline - Analyst Blog", "Alnylam Reports Positive Initial Phase II Data on Revusiran - Analyst Blog", "Is Mallinckrodt (MNK) Poised to Beat Q4 Earnings Estimates? - Analyst Blog", "Sanofi's Lemtrada Gets U.S. Approval, Carries Boxed Warning - Analyst Blog", "Puma Biotechnology Falls on Disappointing Neratinib Data - Analyst Blog"], "Elapsed Time": ["1 DAY AGO", "1 DAY AGO", "2 DAYS AGO", "3 DAYS AGO", "3 DAYS AGO", "4 DAYS AGO", "JUN 4, 2020", "JUN 4, 2020", "1 DAY AGO", "MAY 29, 2020", "MAY 23, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 19, 2020", "MAY 17, 2020", "MAY 17, 2020", "JUN 1, 2020", "MAY 13, 2020", "MAY 12, 2020", "MAY 11, 2020", "MAY 6, 2020", "MAY 5, 2020", "MAY 4, 2020", "MAY 4, 2020", "MAY 17, 2020", "MAY 4, 2020", "MAY 1, 2020", "APR 30, 2020", "APR 29, 2020", "APR 27, 2020", "APR 24, 2020", "APR 23, 2020", "MAY 4, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 23, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 22, 2020", "APR 20, 2020", "APR 20, 2020", "APR 20, 2020", "APR 19, 2020", "APR 19, 2020", "APR 19, 2020", "APR 17, 2020", "APR 22, 2020", "APR 16, 2020", "APR 16, 2020", "APR 12, 2020", "APR 10, 2020", "APR 9, 2020", "APR 9, 2020", "APR 7, 2020", "APR 17, 2020", "APR 6, 2020", "APR 6, 2020", "APR 6, 2020", "APR 5, 2020", "APR 4, 2020", "APR 3, 2020", "APR 3, 2020", "APR 7, 2020", "APR 1, 2020", "MAR 31, 2020", "MAR 30, 2020", "MAR 27, 2020", "MAR 26, 2020", "MAR 25, 2020", "MAR 24, 2020", "APR 2, 2020", "MAR 23, 2020", "MAR 23, 2020", "MAR 20, 2020", "MAR 17, 2020", "MAR 16, 2020", "MAR 15, 2020", "MAR 15, 2020", "MAR 24, 2020", "MAR 15, 2020", "MAR 15, 2020", "MAR 13, 2020", "MAR 13, 2020", "MAR 12, 2020", "MAR 12, 2020", "MAR 12, 2020", "MAR 15, 2020", "MAR 9, 2020", "MAR 5, 2020", "MAR 3, 2020", "FEB 29, 2020", "FEB 29, 2020", "FEB 28, 2020", "FEB 28, 2020", "MAR 10, 2020", "FEB 27, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 25, 2020", "FEB 25, 2020", "FEB 24, 2020", "FEB 27, 2020", "FEB 19, 2020", "FEB 18, 2020", "FEB 18, 2020", "FEB 18, 2020", "FEB 16, 2020", "FEB 16, 2020", "FEB 16, 2020", "FEB 21, 2020", "FEB 16, 2020", "FEB 16, 2020", "FEB 15, 2020", "FEB 13, 2020", "FEB 11, 2020", "FEB 11, 2020", "FEB 10, 2020", "FEB 16, 2020", "FEB 7, 2020", "FEB 7, 2020", "FEB 7, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 5, 2020", "FEB 10, 2020", "JAN 31, 2020", "JAN 31, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 30, 2020", "FEB 4, 2020", "JAN 30, 2020", "JAN 30, 2020", "JAN 29, 2020", "JAN 29, 2020", "JAN 27, 2020", "JAN 25, 2020", "JAN 24, 2020", "JAN 30, 2020", "JAN 21, 2020", "JAN 21, 2020", "JAN 19, 2020", "JAN 19, 2020", "JAN 19, 2020", "JAN 19, 2020", "JAN 17, 2020", "JAN 23, 2020", "JAN 16, 2020", "JAN 15, 2020", "JAN 14, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 16, 2020", "JAN 16, 2020", "JAN 16, 2020", "JAN 8, 2020", "JAN 5, 2020", "JAN 3, 2020", "DEC 24, 2019", "DEC 24, 2019", "JAN 11, 2020", "DEC 19, 2019", "DEC 17, 2019", "DEC 15, 2019", "DEC 15, 2019", "DEC 15, 2019", "DEC 15, 2019", "DEC 13, 2019", "DEC 19, 2019", "DEC 12, 2019", "DEC 9, 2019", "DEC 9, 2019", "DEC 8, 2019", "DEC 7, 2019", "DEC 6, 2019", "DEC 5, 2019", "DEC 13, 2019", "NOV 27, 2019", "NOV 22, 2019", "NOV 15, 2019", "NOV 14, 2019", "NOV 12, 2019", "NOV 12, 2019", "NOV 10, 2019", "NOV 27, 2019", "NOV 9, 2019", "NOV 8, 2019", "NOV 7, 2019", "NOV 1, 2019", "NOV 1, 2019", "NOV 1, 2019", "OCT 31, 2019", "NOV 10, 2019", "OCT 28, 2019", "OCT 26, 2019", "OCT 24, 2019", "OCT 24, 2019", "OCT 23, 2019", "OCT 23, 2019", "OCT 23, 2019", "OCT 31, 2019", "OCT 23, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 23, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 22, 2019", "OCT 18, 2019", "OCT 22, 2019", "OCT 10, 2019", "OCT 9, 2019", "OCT 9, 2019", "OCT 7, 2019", "OCT 3, 2019", "OCT 2, 2019", "OCT 1, 2019", "OCT 14, 2019", "SEP 30, 2019", "SEP 27, 2019", "SEP 24, 2019", "SEP 16, 2019", "SEP 14, 2019", "SEP 13, 2019", "SEP 11, 2019", "OCT 1, 2019", "SEP 30, 2019", "AUG 30, 2019", "AUG 25, 2019", "AUG 21, 2019", "AUG 20, 2019", "AUG 16, 2019", "SEP 9, 2019", "AUG 1, 2019", "AUG 1, 2019", "JUL 30, 2019", "JUL 30, 2019", "JUL 26, 2019", "JUL 24, 2019", "JUL 23, 2019", "AUG 11, 2019", "JUL 23, 2019", "JUL 23, 2019", "JUL 23, 2019", "JUL 22, 2019", "JUL 22, 2019", "JUL 20, 2019", "JUL 17, 2019", "JUL 23, 2019", "JUL 8, 2019", "JUL 8, 2019", "JUL 4, 2019", "JUN 30, 2019", "JUN 30, 2019", "JUN 25, 2019", "JUN 25, 2019", "JUL 16, 2019", "JUN 25, 2019", "JUN 19, 2019", "JUN 18, 2019", "JUN 17, 2019", "JUN 17, 2019", "JUN 13, 2019", "JUN 11, 2019", "JUN 25, 2019", "JUN 6, 2019", "JUN 3, 2019", "JUN 3, 2019", "MAY 26, 2019", "MAY 24, 2019", "MAY 23, 2019", "MAY 15, 2019", "JUN 10, 2019", "MAY 9, 2019", "MAY 9, 2019", "MAY 7, 2019", "MAY 6, 2019", "MAY 2, 2019", "MAY 2, 2019", "APR 26, 2019", "MAY 14, 2019", "APR 25, 2019", "APR 25, 2019", "APR 24, 2019", "APR 24, 2019", "APR 24, 2019", "APR 24, 2019", "APR 23, 2019", "APR 26, 2019", "APR 17, 2019", "APR 17, 2019", "APR 17, 2019", "APR 17, 2019", "APR 17, 2019", "APR 17, 2019", "APR 17, 2019", "APR 22, 2019", "APR 16, 2019", "APR 14, 2019", "APR 12, 2019", "APR 11, 2019", "APR 11, 2019", "APR 11, 2019", "APR 9, 2019", "APR 16, 2019", "APR 6, 2019", "APR 4, 2019", "APR 4, 2019", "APR 4, 2019", "APR 4, 2019", "APR 3, 2019", "APR 3, 2019", "APR 6, 2019", "APR 6, 2019", "MAR 30, 2019", "MAR 28, 2019", "MAR 28, 2019", "MAR 28, 2019", "MAR 28, 2019", "APR 2, 2019", "MAR 26, 2019", "MAR 26, 2019", "MAR 26, 2019", "MAR 26, 2019", "MAR 25, 2019", "MAR 25, 2019", "MAR 27, 2019", "MAR 25, 2019", "MAR 25, 2019", "MAR 24, 2019", "MAR 23, 2019", "MAR 22, 2019", "MAR 22, 2019", "MAR 22, 2019", "MAR 25, 2019", "MAR 22, 2019", "MAR 22, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 22, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 21, 2019", "MAR 15, 2019", "MAR 14, 2019", "MAR 13, 2019", "MAR 13, 2019", "MAR 12, 2019", "MAR 10, 2019", "MAR 8, 2019", "MAR 21, 2019", "MAR 5, 2019", "MAR 5, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 6, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 4, 2019", "MAR 4, 2019", "FEB 27, 2019", "FEB 26, 2019", "FEB 26, 2019", "FEB 25, 2019", "FEB 25, 2019", "FEB 22, 2019", "FEB 22, 2019", "MAR 4, 2019", "FEB 21, 2019", "FEB 20, 2019", "FEB 19, 2019", "FEB 17, 2019", "FEB 17, 2019", "FEB 15, 2019", "FEB 14, 2019", "FEB 21, 2019", "FEB 14, 2019", "FEB 13, 2019", "FEB 11, 2019", "FEB 8, 2019", "FEB 7, 2019", "FEB 7, 2019", "FEB 7, 2019", "FEB 14, 2019", "FEB 14, 2019", "FEB 13, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "FEB 4, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 29, 2019", "JAN 28, 2019", "JAN 26, 2019", "JAN 24, 2019", "JAN 21, 2019", "JAN 21, 2019", "JAN 19, 2019", "JAN 18, 2019", "JAN 28, 2019", "JAN 14, 2019", "JAN 11, 2019", "JAN 9, 2019", "JAN 9, 2019", "JAN 8, 2019", "JAN 7, 2019", "JAN 6, 2019", "JAN 17, 2019", "JAN 4, 2019", "DEC 27, 2018", "DEC 24, 2018", "DEC 21, 2018", "DEC 21, 2018", "DEC 21, 2018", "DEC 21, 2018", "JAN 4, 2019", "DEC 21, 2018", "DEC 20, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 18, 2018", "DEC 21, 2018", "DEC 17, 2018", "DEC 16, 2018", "DEC 16, 2018", "DEC 16, 2018", "DEC 15, 2018", "DEC 13, 2018", "DEC 12, 2018", "DEC 18, 2018", "DEC 12, 2018", "DEC 12, 2018", "DEC 11, 2018", "DEC 10, 2018", "DEC 7, 2018", "DEC 4, 2018", "DEC 3, 2018", "DEC 12, 2018", "NOV 22, 2018", "NOV 21, 2018", "NOV 21, 2018", "NOV 18, 2018", "NOV 18, 2018", "NOV 18, 2018", "NOV 15, 2018", "NOV 29, 2018", "NOV 12, 2018", "NOV 12, 2018", "NOV 9, 2018", "NOV 8, 2018", "NOV 7, 2018", "NOV 5, 2018", "OCT 31, 2018", "NOV 14, 2018", "OCT 26, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 24, 2018", "OCT 23, 2018", "OCT 23, 2018", "OCT 30, 2018", "OCT 23, 2018", "OCT 23, 2018", "OCT 23, 2018", "OCT 23, 2018", "OCT 22, 2018", "OCT 22, 2018", "OCT 23, 2018", "OCT 21, 2018", "OCT 19, 2018", "OCT 19, 2018", "OCT 19, 2018", "OCT 15, 2018", "OCT 15, 2018", "OCT 12, 2018", "OCT 22, 2018", "OCT 11, 2018", "OCT 10, 2018", "OCT 10, 2018", "OCT 8, 2018", "OCT 8, 2018", "OCT 4, 2018", "OCT 11, 2018", "OCT 2, 2018", "SEP 28, 2018", "SEP 26, 2018", "SEP 21, 2018", "SEP 21, 2018", "SEP 21, 2018", "SEP 20, 2018", "OCT 4, 2018", "OCT 2, 2018", "SEP 16, 2018", "SEP 14, 2018", "SEP 14, 2018", "SEP 13, 2018", "SEP 13, 2018", "SEP 17, 2018", "SEP 12, 2018", "SEP 11, 2018", "SEP 11, 2018", "SEP 10, 2018", "SEP 6, 2018", "SEP 5, 2018", "AUG 31, 2018", "SEP 12, 2018", "SEP 12, 2018", "SEP 11, 2018", "SEP 11, 2018", "AUG 24, 2018", "AUG 23, 2018", "AUG 22, 2018", "AUG 31, 2018", "AUG 17, 2018", "AUG 17, 2018", "AUG 16, 2018", "AUG 16, 2018", "AUG 15, 2018", "AUG 13, 2018", "AUG 11, 2018", "AUG 17, 2018", "AUG 17, 2018", "AUG 6, 2018", "AUG 3, 2018", "AUG 3, 2018", "AUG 3, 2018", "AUG 2, 2018", "AUG 9, 2018", "AUG 1, 2018", "AUG 1, 2018", "AUG 1, 2018", "JUL 31, 2018", "JUL 27, 2018", "JUL 27, 2018", "JUL 26, 2018", "AUG 1, 2018", "JUL 26, 2018", "JUL 26, 2018", "JUL 25, 2018", "JUL 25, 2018", "JUL 25, 2018", "JUL 25, 2018", "JUL 25, 2018", "JUL 26, 2018", "JUL 24, 2018", "JUL 24, 2018", "JUL 24, 2018", "JUL 24, 2018", "JUL 24, 2018", "JUL 24, 2018", "JUL 24, 2018", "JUL 25, 2018", "JUL 24, 2018", "JUL 24, 2018", "JUL 23, 2018", "JUL 23, 2018", "JUL 23, 2018", "JUL 23, 2018", "JUL 20, 2018", "JUL 24, 2018", "JUL 19, 2018", "JUL 18, 2018", "JUL 18, 2018", "JUL 16, 2018", "JUL 15, 2018", "JUL 15, 2018", "JUL 15, 2018", "JUL 19, 2018", "JUL 13, 2018", "JUL 13, 2018", "JUL 13, 2018", "JUL 13, 2018", "JUL 12, 2018", "JUL 12, 2018", "JUL 12, 2018", "JUL 15, 2018", "JUL 11, 2018", "JUL 11, 2018", "JUL 10, 2018", "JUL 10, 2018", "JUL 10, 2018", "JUL 10, 2018", "JUL 10, 2018", "JUL 11, 2018", "JUL 9, 2018", "JUL 9, 2018", "JUL 9, 2018", "JUL 9, 2018", "JUL 8, 2018", "JUL 7, 2018", "JUL 6, 2018", "JUL 10, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 6, 2018", "JUL 3, 2018", "JUL 2, 2018", "JUN 29, 2018", "JUL 6, 2018", "JUN 25, 2018", "JUN 20, 2018", "JUN 20, 2018", "JUN 19, 2018", "JUN 19, 2018", "JUN 18, 2018", "JUN 18, 2018", "JUN 28, 2018", "JUN 18, 2018", "JUN 18, 2018", "JUN 18, 2018", "JUN 18, 2018", "JUN 17, 2018", "JUN 17, 2018", "JUN 17, 2018", "JUN 18, 2018", "JUN 15, 2018", "JUN 15, 2018", "JUN 14, 2018", "JUN 13, 2018", "JUN 13, 2018", "JUN 13, 2018", "JUN 11, 2018", "JUN 15, 2018", "JUN 7, 2018", "JUN 6, 2018", "JUN 6, 2018", "JUN 6, 2018", "JUN 4, 2018", "JUN 4, 2018", "JUN 8, 2018", "MAY 30, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 21, 2018", "MAY 18, 2018", "JUN 3, 2018", "MAY 17, 2018", "MAY 15, 2018", "MAY 15, 2018", "MAY 14, 2018", "MAY 14, 2018", "MAY 11, 2018", "MAY 11, 2018", "MAY 17, 2018", "MAY 9, 2018", "MAY 9, 2018", "MAY 2, 2018", "MAY 1, 2018", "MAY 1, 2018", "APR 30, 2018", "APR 30, 2018", "MAY 10, 2018", "MAY 9, 2018", "MAY 9, 2018", "MAY 2, 2018", "MAY 1, 2018", "APR 25, 2018", "APR 25, 2018", "APR 28, 2018", "APR 24, 2018", "APR 24, 2018", "APR 24, 2018", "APR 24, 2018", "APR 24, 2018", "APR 24, 2018", "APR 24, 2018", "APR 25, 2018", "APR 23, 2018", "APR 23, 2018", "APR 23, 2018", "APR 23, 2018", "APR 20, 2018", "APR 20, 2018", "APR 20, 2018", "APR 24, 2018", "APR 20, 2018", "APR 18, 2018", "APR 16, 2018", "APR 15, 2018", "APR 15, 2018", "APR 12, 2018", "APR 12, 2018", "APR 20, 2018", "APR 12, 2018", "APR 12, 2018", "APR 11, 2018", "APR 11, 2018", "APR 10, 2018", "APR 10, 2018", "APR 10, 2018", "APR 12, 2018", "APR 9, 2018", "APR 9, 2018", "APR 7, 2018", "APR 6, 2018", "APR 6, 2018", "APR 5, 2018", "APR 4, 2018", "APR 10, 2018", "MAR 25, 2018", "MAR 24, 2018", "MAR 22, 2018", "MAR 21, 2018", "MAR 20, 2018", "MAR 19, 2018", "MAR 19, 2018", "MAR 30, 2018", "MAR 18, 2018", "MAR 16, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 14, 2018", "MAR 13, 2018", "MAR 18, 2018", "MAR 13, 2018", "MAR 13, 2018", "MAR 12, 2018", "MAR 12, 2018", "MAR 9, 2018", "MAR 6, 2018", "MAR 1, 2018", "MAR 13, 2018", "FEB 26, 2018", "FEB 23, 2018", "FEB 22, 2018", "FEB 21, 2018", "FEB 20, 2018", "FEB 20, 2018", "FEB 19, 2018", "FEB 26, 2018", "FEB 17, 2018", "FEB 16, 2018", "FEB 16, 2018", "FEB 16, 2018", "FEB 16, 2018", "FEB 15, 2018", "FEB 15, 2018", "FEB 18, 2018", "FEB 14, 2018", "FEB 14, 2018", "FEB 14, 2018", "FEB 14, 2018", "FEB 14, 2018", "FEB 13, 2018", "FEB 10, 2018", "FEB 15, 2018", "FEB 9, 2018", "FEB 9, 2018", "FEB 8, 2018", "FEB 8, 2018", "FEB 3, 2018", "JAN 29, 2018", "JAN 29, 2018", "FEB 10, 2018", "JAN 29, 2018", "JAN 26, 2018", "JAN 26, 2018", "JAN 26, 2018", "JAN 26, 2018", "JAN 26, 2018", "JAN 25, 2018", "JAN 29, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 25, 2018", "JAN 24, 2018", "JAN 24, 2018", "JAN 24, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 24, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 22, 2018", "JAN 19, 2018", "JAN 19, 2018", "JAN 18, 2018", "JAN 17, 2018", "JAN 15, 2018", "JAN 15, 2018", "JAN 19, 2018", "JAN 13, 2018", "JAN 11, 2018", "JAN 9, 2018", "JAN 8, 2018", "JAN 8, 2018", "JAN 8, 2018", "JAN 5, 2018", "JAN 14, 2018", "JAN 4, 2018", "JAN 3, 2018", "JAN 3, 2018", "JAN 2, 2018", "DEC 29, 2017", "DEC 27, 2017", "DEC 27, 2017", "JAN 5, 2018", "DEC 22, 2017", "DEC 21, 2017", "DEC 21, 2017", "DEC 21, 2017", "DEC 21, 2017", "DEC 21, 2017", "DEC 27, 2017", "DEC 21, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 20, 2017", "DEC 21, 2017", "DEC 14, 2017", "DEC 13, 2017", "DEC 13, 2017", "DEC 12, 2017", "DEC 11, 2017", "DEC 6, 2017", "DEC 6, 2017", "DEC 14, 2017", "DEC 4, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 30, 2017", "NOV 29, 2017", "DEC 5, 2017", "DEC 4, 2017", "NOV 30, 2017", "NOV 27, 2017", "NOV 27, 2017", "NOV 27, 2017", "NOV 27, 2017", "NOV 27, 2017", "NOV 29, 2017", "NOV 22, 2017", "NOV 21, 2017", "NOV 20, 2017", "NOV 18, 2017", "NOV 17, 2017", "NOV 16, 2017", "NOV 15, 2017", "NOV 22, 2017", "NOV 13, 2017", "NOV 11, 2017", "NOV 10, 2017", "NOV 9, 2017", "NOV 7, 2017", "NOV 6, 2017", "NOV 15, 2017", "NOV 3, 2017", "NOV 2, 2017", "NOV 2, 2017", "NOV 1, 2017", "NOV 1, 2017", "OCT 31, 2017", "NOV 3, 2017", "OCT 30, 2017", "OCT 30, 2017", "OCT 27, 2017", "OCT 26, 2017", "OCT 26, 2017", "OCT 25, 2017", "OCT 25, 2017", "OCT 31, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 25, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 24, 2017", "OCT 23, 2017", "OCT 23, 2017", "OCT 23, 2017", "OCT 24, 2017", "OCT 23, 2017", "OCT 20, 2017", "OCT 19, 2017", "OCT 18, 2017", "OCT 18, 2017", "OCT 17, 2017", "OCT 17, 2017", "OCT 23, 2017", "OCT 17, 2017", "OCT 17, 2017", "OCT 17, 2017", "OCT 16, 2017", "OCT 16, 2017", "OCT 16, 2017", "OCT 16, 2017", "OCT 17, 2017", "OCT 16, 2017", "OCT 13, 2017", "OCT 12, 2017", "OCT 10, 2017", "OCT 9, 2017", "OCT 6, 2017", "OCT 6, 2017", "OCT 16, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 5, 2017", "OCT 6, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 4, 2017", "OCT 5, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 3, 2017", "OCT 2, 2017", "OCT 2, 2017", "OCT 2, 2017", "OCT 2, 2017", "OCT 2, 2017", "SEP 29, 2017", "SEP 28, 2017", "OCT 3, 2017", "SEP 26, 2017", "SEP 25, 2017", "SEP 19, 2017", "SEP 19, 2017", "SEP 19, 2017", "SEP 19, 2017", "SEP 18, 2017", "SEP 28, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 11, 2017", "SEP 11, 2017", "SEP 11, 2017", "SEP 7, 2017", "SEP 6, 2017", "SEP 15, 2017", "SEP 13, 2017", "SEP 13, 2017", "SEP 11, 2017", "AUG 28, 2017", "AUG 28, 2017", "AUG 27, 2017", "AUG 31, 2017", "AUG 24, 2017", "AUG 23, 2017", "AUG 23, 2017", "AUG 22, 2017", "AUG 21, 2017", "AUG 18, 2017", "AUG 17, 2017", "AUG 25, 2017", "AUG 16, 2017", "AUG 15, 2017", "AUG 14, 2017", "AUG 11, 2017", "AUG 9, 2017", "AUG 8, 2017", "AUG 8, 2017", "AUG 17, 2017", "AUG 7, 2017", "AUG 4, 2017", "AUG 1, 2017", "JUL 31, 2017", "JUL 28, 2017", "JUL 28, 2017", "JUL 26, 2017", "AUG 7, 2017", "AUG 7, 2017", "AUG 4, 2017", "AUG 1, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 26, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 24, 2017", "JUL 24, 2017", "JUL 23, 2017", "JUL 20, 2017", "JUL 19, 2017", "JUL 25, 2017", "JUL 25, 2017", "JUL 18, 2017", "JUL 18, 2017", "JUL 17, 2017", "JUL 17, 2017", "JUL 16, 2017", "JUL 13, 2017", "JUL 19, 2017", "JUL 12, 2017", "JUL 10, 2017", "JUL 10, 2017", "JUL 6, 2017", "JUL 5, 2017", "JUL 5, 2017", "JUL 3, 2017", "JUL 13, 2017", "JUL 1, 2017", "JUN 29, 2017", "JUN 26, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUN 21, 2017", "JUL 2, 2017", "JUN 16, 2017", "JUN 16, 2017", "JUN 15, 2017", "JUN 15, 2017", "JUN 14, 2017", "JUN 14, 2017", "JUN 14, 2017", "JUN 19, 2017", "JUN 14, 2017", "JUN 13, 2017", "JUN 12, 2017", "JUN 9, 2017", "JUN 6, 2017", "JUN 6, 2017", "JUN 5, 2017", "JUN 14, 2017", "JUN 2, 2017", "JUN 2, 2017", "MAY 31, 2017", "MAY 31, 2017", "MAY 31, 2017", "MAY 31, 2017", "MAY 30, 2017", "JUN 2, 2017", "MAY 26, 2017", "MAY 26, 2017", "MAY 26, 2017", "MAY 25, 2017", "MAY 24, 2017", "MAY 24, 2017", "MAY 30, 2017", "MAY 18, 2017", "MAY 17, 2017", "MAY 16, 2017", "MAY 16, 2017", "MAY 15, 2017", "MAY 12, 2017", "MAY 11, 2017", "MAY 21, 2017", "MAY 10, 2017", "MAY 9, 2017", "MAY 7, 2017", "MAY 5, 2017", "MAY 5, 2017", "MAY 5, 2017", "MAY 4, 2017", "MAY 11, 2017", "MAY 4, 2017", "MAY 3, 2017", "MAY 2, 2017", "MAY 2, 2017", "APR 28, 2017", "APR 27, 2017", "APR 26, 2017", "MAY 4, 2017", "APR 26, 2017", "APR 25, 2017", "APR 25, 2017", "APR 25, 2017", "APR 25, 2017", "APR 25, 2017", "APR 25, 2017", "APR 26, 2017", "APR 25, 2017", "APR 25, 2017", "APR 24, 2017", "APR 24, 2017", "APR 24, 2017", "APR 24, 2017", "APR 24, 2017", "APR 25, 2017", "APR 23, 2017", "APR 20, 2017", "APR 20, 2017", "APR 19, 2017", "APR 18, 2017", "APR 18, 2017", "APR 18, 2017", "APR 24, 2017", "APR 23, 2017", "APR 10, 2017", "APR 7, 2017", "APR 6, 2017", "APR 5, 2017", "APR 5, 2017", "APR 3, 2017", "APR 17, 2017", "MAR 31, 2017", "MAR 31, 2017", "MAR 31, 2017", "MAR 29, 2017", "MAR 29, 2017", "MAR 28, 2017", "MAR 22, 2017", "APR 3, 2017", "MAR 21, 2017", "MAR 21, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 17, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 21, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 16, 2017", "MAR 13, 2017", "MAR 10, 2017", "MAR 10, 2017", "MAR 9, 2017", "MAR 8, 2017", "MAR 7, 2017", "MAR 7, 2017", "MAR 13, 2017", "MAR 7, 2017", "MAR 6, 2017", "MAR 6, 2017", "MAR 6, 2017", "MAR 3, 2017", "MAR 2, 2017", "MAR 1, 2017", "MAR 7, 2017", "FEB 28, 2017", "FEB 28, 2017", "FEB 27, 2017", "FEB 27, 2017", "FEB 23, 2017", "FEB 22, 2017", "FEB 21, 2017", "MAR 1, 2017", "FEB 20, 2017", "FEB 19, 2017", "FEB 16, 2017", "FEB 15, 2017", "FEB 13, 2017", "FEB 13, 2017", "FEB 11, 2017", "FEB 21, 2017", "FEB 10, 2017", "FEB 8, 2017", "FEB 8, 2017", "FEB 8, 2017", "FEB 7, 2017", "FEB 6, 2017", "FEB 3, 2017", "FEB 10, 2017", "FEB 2, 2017", "FEB 2, 2017", "FEB 2, 2017", "FEB 2, 2017", "FEB 2, 2017", "FEB 2, 2017", "FEB 3, 2017", "JAN 27, 2017", "JAN 26, 2017", "JAN 26, 2017", "JAN 26, 2017", "JAN 26, 2017", "JAN 26, 2017", "JAN 26, 2017", "JAN 30, 2017", "JAN 25, 2017", "JAN 25, 2017", "JAN 25, 2017", "JAN 24, 2017", "JAN 24, 2017", "JAN 21, 2017", "JAN 20, 2017", "JAN 26, 2017", "JAN 18, 2017", "JAN 18, 2017", "JAN 18, 2017", "JAN 18, 2017", "JAN 17, 2017", "JAN 17, 2017", "JAN 19, 2017", "JAN 19, 2017", "JAN 17, 2017", "JAN 17, 2017", "JAN 17, 2017", "JAN 17, 2017", "JAN 17, 2017", "JAN 17, 2017", "JAN 17, 2017", "JAN 17, 2017", "JAN 13, 2017", "JAN 13, 2017", "JAN 13, 2017", "JAN 12, 2017", "JAN 12, 2017", "JAN 17, 2017", "JAN 11, 2017", "JAN 11, 2017", "JAN 11, 2017", "JAN 10, 2017", "JAN 10, 2017", "JAN 9, 2017", "JAN 9, 2017", "JAN 11, 2017", "JAN 6, 2017", "JAN 6, 2017", "JAN 5, 2017", "JAN 5, 2017", "JAN 5, 2017", "JAN 4, 2017", "JAN 4, 2017", "JAN 6, 2017", "JAN 3, 2017", "DEC 30, 2016", "DEC 28, 2016", "DEC 28, 2016", "DEC 28, 2016", "DEC 28, 2016", "DEC 27, 2016", "JAN 4, 2017", "DEC 27, 2016", "DEC 27, 2016", "DEC 21, 2016", "DEC 21, 2016", "DEC 21, 2016", "DEC 21, 2016", "DEC 27, 2016", "DEC 27, 2016", "DEC 27, 2016", "DEC 18, 2016", "DEC 16, 2016", "DEC 14, 2016", "DEC 14, 2016", "DEC 13, 2016", "DEC 20, 2016", "DEC 13, 2016", "DEC 12, 2016", "DEC 12, 2016", "DEC 12, 2016", "DEC 11, 2016", "DEC 10, 2016", "DEC 9, 2016", "DEC 13, 2016", "DEC 9, 2016", "DEC 9, 2016", "DEC 9, 2016", "DEC 9, 2016", "DEC 9, 2016", "DEC 8, 2016", "DEC 8, 2016", "DEC 9, 2016", "DEC 9, 2016", "DEC 9, 2016", "DEC 2, 2016", "DEC 2, 2016", "DEC 1, 2016", "DEC 1, 2016", "DEC 8, 2016", "NOV 30, 2016", "NOV 29, 2016", "NOV 25, 2016", "NOV 24, 2016", "NOV 23, 2016", "NOV 23, 2016", "NOV 23, 2016", "NOV 30, 2016", "NOV 23, 2016", "NOV 23, 2016", "NOV 23, 2016", "NOV 23, 2016", "NOV 23, 2016", "NOV 22, 2016", "NOV 22, 2016", "NOV 23, 2016", "NOV 22, 2016", "NOV 21, 2016", "NOV 21, 2016", "NOV 17, 2016", "NOV 17, 2016", "NOV 15, 2016", "NOV 14, 2016", "NOV 22, 2016", "NOV 11, 2016", "NOV 10, 2016", "NOV 10, 2016", "NOV 10, 2016", "NOV 10, 2016", "NOV 9, 2016", "NOV 9, 2016", "NOV 11, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 9, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 7, 2016", "NOV 3, 2016", "NOV 2, 2016", "NOV 7, 2016", "OCT 29, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "OCT 28, 2016", "NOV 2, 2016", "OCT 27, 2016", "OCT 27, 2016", "OCT 27, 2016", "OCT 26, 2016", "OCT 26, 2016", "OCT 26, 2016", "OCT 26, 2016", "OCT 27, 2016", "OCT 26, 2016", "OCT 25, 2016", "OCT 25, 2016", "OCT 21, 2016", "OCT 20, 2016", "OCT 19, 2016", "OCT 19, 2016", "OCT 26, 2016", "OCT 18, 2016", "OCT 18, 2016", "OCT 17, 2016", "OCT 14, 2016", "OCT 14, 2016", "OCT 13, 2016", "OCT 12, 2016", "OCT 19, 2016", "OCT 11, 2016", "OCT 11, 2016", "OCT 10, 2016", "OCT 7, 2016", "OCT 7, 2016", "OCT 7, 2016", "OCT 5, 2016", "OCT 12, 2016", "SEP 28, 2016", "SEP 28, 2016", "SEP 28, 2016", "SEP 28, 2016", "SEP 28, 2016", "SEP 28, 2016", "SEP 27, 2016", "OCT 5, 2016", "SEP 26, 2016", "SEP 21, 2016", "SEP 21, 2016", "SEP 21, 2016", "SEP 19, 2016", "SEP 19, 2016", "SEP 18, 2016", "SEP 26, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 15, 2016", "SEP 14, 2016", "SEP 13, 2016", "SEP 13, 2016", "SEP 13, 2016", "SEP 17, 2016", "SEP 9, 2016", "SEP 8, 2016", "SEP 8, 2016", "SEP 7, 2016", "SEP 7, 2016", "SEP 6, 2016", "SEP 6, 2016", "SEP 12, 2016", "SEP 2, 2016", "SEP 2, 2016", "SEP 2, 2016", "AUG 31, 2016", "AUG 31, 2016", "AUG 25, 2016", "AUG 24, 2016", "SEP 6, 2016", "AUG 17, 2016", "AUG 16, 2016", "AUG 16, 2016", "AUG 16, 2016", "AUG 15, 2016", "AUG 15, 2016", "AUG 12, 2016", "AUG 22, 2016", "AUG 10, 2016", "AUG 10, 2016", "AUG 9, 2016", "AUG 9, 2016", "AUG 8, 2016", "AUG 8, 2016", "AUG 12, 2016", "AUG 5, 2016", "AUG 4, 2016", "AUG 4, 2016", "AUG 4, 2016", "AUG 4, 2016", "AUG 4, 2016", "AUG 4, 2016", "AUG 6, 2016", "AUG 3, 2016", "AUG 2, 2016", "AUG 2, 2016", "AUG 2, 2016", "AUG 2, 2016", "AUG 2, 2016", "AUG 2, 2016", "AUG 3, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 2, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 1, 2016", "JUL 29, 2016", "AUG 1, 2016", "JUL 28, 2016", "JUL 28, 2016", "JUL 28, 2016", "JUL 28, 2016", "JUL 27, 2016", "JUL 25, 2016", "JUL 25, 2016", "JUL 29, 2016", "JUL 28, 2016", "JUL 28, 2016", "JUL 21, 2016", "JUL 21, 2016", "JUL 21, 2016", "JUL 21, 2016", "JUL 25, 2016", "JUL 21, 2016", "JUL 21, 2016", "JUL 21, 2016", "JUL 21, 2016", "JUL 20, 2016", "JUL 20, 2016", "JUL 20, 2016", "JUL 21, 2016", "JUL 16, 2016", "JUL 15, 2016", "JUL 15, 2016", "JUL 15, 2016", "JUL 15, 2016", "JUL 14, 2016", "JUL 13, 2016", "JUL 19, 2016", "JUL 9, 2016", "JUL 8, 2016", "JUL 8, 2016", "JUL 7, 2016", "JUN 30, 2016", "JUN 29, 2016", "JUN 28, 2016", "JUL 12, 2016", "JUN 24, 2016", "JUN 24, 2016", "JUN 24, 2016", "JUN 23, 2016", "JUN 21, 2016", "JUN 21, 2016", "JUN 21, 2016", "JUN 27, 2016", "JUN 13, 2016", "JUN 13, 2016", "JUN 12, 2016", "JUN 10, 2016", "JUN 10, 2016", "JUN 9, 2016", "JUN 9, 2016", "JUN 16, 2016", "JUN 8, 2016", "JUN 8, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 9, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 7, 2016", "JUN 4, 2016", "JUN 3, 2016", "JUN 3, 2016", "JUN 3, 2016", "JUN 2, 2016", "JUN 7, 2016", "JUN 1, 2016", "JUN 1, 2016", "JUN 1, 2016", "MAY 31, 2016", "MAY 31, 2016", "MAY 31, 2016", "MAY 30, 2016", "JUN 2, 2016", "JUN 1, 2016", "JUN 1, 2016", "MAY 19, 2016", "MAY 19, 2016", "MAY 16, 2016", "MAY 13, 2016", "MAY 28, 2016", "MAY 12, 2016", "MAY 10, 2016", "MAY 10, 2016", "MAY 5, 2016", "MAY 5, 2016", "MAY 4, 2016", "MAY 3, 2016", "MAY 12, 2016", "MAY 2, 2016", "APR 29, 2016", "APR 29, 2016", "APR 29, 2016", "APR 29, 2016", "APR 29, 2016", "APR 28, 2016", "MAY 2, 2016", "APR 27, 2016", "APR 27, 2016", "APR 22, 2016", "APR 22, 2016", "APR 22, 2016", "APR 22, 2016", "APR 22, 2016", "APR 28, 2016", "APR 21, 2016", "APR 21, 2016", "APR 21, 2016", "APR 21, 2016", "APR 21, 2016", "APR 21, 2016", "APR 21, 2016", "APR 21, 2016", "APR 20, 2016", "APR 19, 2016", "APR 18, 2016", "APR 18, 2016", "APR 18, 2016", "APR 18, 2016", "APR 15, 2016", "APR 21, 2016", "APR 11, 2016", "APR 8, 2016", "APR 8, 2016", "APR 7, 2016", "APR 6, 2016", "APR 4, 2016", "APR 4, 2016", "APR 12, 2016", "MAR 28, 2016", "MAR 24, 2016", "MAR 23, 2016", "MAR 21, 2016", "MAR 18, 2016", "MAR 17, 2016", "MAR 16, 2016", "MAR 28, 2016", "MAR 16, 2016", "MAR 16, 2016", "MAR 15, 2016", "MAR 13, 2016", "MAR 11, 2016", "MAR 11, 2016", "MAR 10, 2016", "MAR 16, 2016", "MAR 7, 2016", "MAR 7, 2016", "MAR 5, 2016", "MAR 4, 2016", "FEB 26, 2016", "FEB 26, 2016", "FEB 24, 2016", "MAR 8, 2016", "FEB 22, 2016", "FEB 21, 2016", "FEB 18, 2016", "FEB 15, 2016", "FEB 12, 2016", "FEB 12, 2016", "FEB 11, 2016", "FEB 23, 2016", "FEB 10, 2016", "FEB 9, 2016", "FEB 9, 2016", "FEB 7, 2016", "FEB 5, 2016", "FEB 4, 2016", "FEB 4, 2016", "FEB 11, 2016", "FEB 2, 2016", "FEB 2, 2016", "FEB 2, 2016", "FEB 2, 2016", "JAN 29, 2016", "JAN 28, 2016", "JAN 27, 2016", "FEB 3, 2016", "JAN 27, 2016", "JAN 27, 2016", "JAN 27, 2016", "JAN 27, 2016", "JAN 27, 2016", "JAN 27, 2016", "JAN 26, 2016", "JAN 27, 2016", "JAN 25, 2016", "JAN 25, 2016", "JAN 20, 2016", "JAN 20, 2016", "JAN 18, 2016", "JAN 18, 2016", "JAN 16, 2016", "JAN 26, 2016", "JAN 15, 2016", "JAN 14, 2016", "JAN 14, 2016", "JAN 8, 2016", "JAN 8, 2016", "JAN 7, 2016", "DEC 27, 2015", "JAN 15, 2016", "DEC 24, 2015", "DEC 21, 2015", "DEC 17, 2015", "DEC 16, 2015", "DEC 16, 2015", "DEC 14, 2015", "DEC 13, 2015", "DEC 26, 2015", "DEC 11, 2015", "DEC 11, 2015", "DEC 10, 2015", "DEC 9, 2015", "DEC 7, 2015", "DEC 7, 2015", "DEC 4, 2015", "DEC 12, 2015", "DEC 3, 2015", "DEC 2, 2015", "DEC 2, 2015", "DEC 1, 2015", "NOV 30, 2015", "NOV 30, 2015", "NOV 30, 2015", "DEC 3, 2015", "NOV 25, 2015", "NOV 25, 2015", "NOV 25, 2015", "NOV 24, 2015", "NOV 24, 2015", "NOV 24, 2015", "NOV 23, 2015", "NOV 27, 2015", "NOV 18, 2015", "NOV 17, 2015", "NOV 16, 2015", "NOV 16, 2015", "NOV 15, 2015", "NOV 11, 2015", "NOV 11, 2015", "NOV 19, 2015", "NOV 18, 2015", "NOV 17, 2015", "NOV 16, 2015", "NOV 6, 2015", "NOV 6, 2015", "NOV 5, 2015", "NOV 4, 2015", "NOV 11, 2015", "OCT 30, 2015", "OCT 30, 2015", "OCT 28, 2015", "OCT 28, 2015", "OCT 27, 2015", "OCT 24, 2015", "NOV 4, 2015", "OCT 23, 2015", "OCT 23, 2015", "OCT 22, 2015", "OCT 22, 2015", "OCT 21, 2015", "OCT 21, 2015", "OCT 21, 2015", "OCT 23, 2015", "OCT 23, 2015", "OCT 21, 2015", "OCT 21, 2015", "OCT 20, 2015", "OCT 20, 2015", "OCT 20, 2015", "OCT 20, 2015", "OCT 21, 2015", "OCT 17, 2015", "OCT 15, 2015", "OCT 12, 2015", "OCT 9, 2015", "OCT 8, 2015", "OCT 8, 2015", "OCT 7, 2015", "OCT 19, 2015", "OCT 17, 2015", "OCT 5, 2015", "OCT 2, 2015", "OCT 1, 2015", "OCT 1, 2015", "SEP 26, 2015", "OCT 7, 2015", "SEP 25, 2015", "SEP 23, 2015", "SEP 22, 2015", "SEP 17, 2015", "SEP 17, 2015", "SEP 14, 2015", "SEP 14, 2015", "SEP 25, 2015", "SEP 13, 2015", "SEP 11, 2015", "SEP 11, 2015", "SEP 11, 2015", "SEP 10, 2015", "SEP 10, 2015", "SEP 10, 2015", "SEP 14, 2015", "SEP 9, 2015", "SEP 4, 2015", "SEP 4, 2015", "SEP 3, 2015", "SEP 2, 2015", "AUG 31, 2015", "AUG 30, 2015", "SEP 10, 2015", "AUG 25, 2015", "AUG 25, 2015", "AUG 23, 2015", "AUG 20, 2015", "AUG 19, 2015", "AUG 18, 2015", "AUG 27, 2015", "AUG 12, 2015", "AUG 12, 2015", "AUG 12, 2015", "AUG 7, 2015", "AUG 7, 2015", "AUG 6, 2015", "AUG 6, 2015", "AUG 15, 2015", "AUG 5, 2015", "AUG 5, 2015", "AUG 4, 2015", "AUG 4, 2015", "AUG 3, 2015", "AUG 1, 2015", "JUL 31, 2015", "AUG 5, 2015", "AUG 5, 2015", "AUG 5, 2015", "JUL 28, 2015", "JUL 28, 2015", "JUL 27, 2015", "JUL 27, 2015", "JUL 27, 2015", "JUL 30, 2015", "JUL 27, 2015", "JUL 27, 2015", "JUL 27, 2015", "JUL 27, 2015", "JUL 24, 2015", "JUL 24, 2015", "JUL 24, 2015", "JUL 27, 2015", "JUL 24, 2015", "JUL 24, 2015", "JUL 24, 2015", "JUL 24, 2015", "JUL 24, 2015", "JUL 24, 2015", "JUL 24, 2015", "JUL 24, 2015", "JUL 24, 2015", "JUL 23, 2015", "JUL 23, 2015", "JUL 23, 2015", "JUL 23, 2015", "JUL 22, 2015", "JUL 22, 2015", "JUL 24, 2015", "JUL 22, 2015", "JUL 21, 2015", "JUL 21, 2015", "JUL 21, 2015", "JUL 17, 2015", "JUL 16, 2015", "JUL 15, 2015", "JUL 22, 2015", "JUL 14, 2015", "JUL 14, 2015", "JUL 14, 2015", "JUL 13, 2015", "JUL 12, 2015", "JUL 10, 2015", "JUL 10, 2015", "JUL 15, 2015", "JUL 10, 2015", "JUL 9, 2015", "JUL 8, 2015", "JUL 8, 2015", "JUL 7, 2015", "JUL 7, 2015", "JUL 6, 2015", "JUL 10, 2015", "JUL 2, 2015", "JUL 2, 2015", "JUL 2, 2015", "JUL 2, 2015", "JUL 2, 2015", "JUL 2, 2015", "JUL 2, 2015", "JUL 3, 2015", "JUL 2, 2015", "JUL 1, 2015", "JUL 1, 2015", "JUL 1, 2015", "JUN 29, 2015", "JUN 29, 2015", "JUN 29, 2015", "JUL 2, 2015", "JUN 23, 2015", "JUN 23, 2015", "JUN 19, 2015", "JUN 14, 2015", "JUN 12, 2015", "JUN 11, 2015", "JUN 10, 2015", "JUN 25, 2015", "JUN 6, 2015", "JUN 4, 2015", "JUN 2, 2015", "MAY 30, 2015", "MAY 28, 2015", "MAY 26, 2015", "MAY 23, 2015", "JUN 8, 2015", "MAY 17, 2015", "MAY 14, 2015", "MAY 13, 2015", "MAY 11, 2015", "MAY 7, 2015", "MAY 6, 2015", "MAY 6, 2015", "MAY 21, 2015", "MAY 5, 2015", "MAY 5, 2015", "MAY 5, 2015", "MAY 4, 2015", "MAY 4, 2015", "MAY 4, 2015", "MAY 4, 2015", "MAY 6, 2015", "MAY 4, 2015", "MAY 4, 2015", "MAY 4, 2015", "MAY 4, 2015", "MAY 4, 2015", "MAY 1, 2015", "MAY 4, 2015", "MAY 4, 2015", "MAY 1, 2015", "MAY 1, 2015", "MAY 1, 2015", "APR 30, 2015", "APR 30, 2015", "MAY 1, 2015", "APR 30, 2015", "APR 30, 2015", "APR 29, 2015", "APR 29, 2015", "APR 29, 2015", "APR 29, 2015", "APR 28, 2015", "APR 30, 2015", "APR 28, 2015", "APR 28, 2015", "APR 28, 2015", "APR 28, 2015", "APR 28, 2015", "APR 28, 2015", "APR 28, 2015", "APR 28, 2015", "APR 28, 2015", "APR 27, 2015", "APR 27, 2015", "APR 27, 2015", "APR 25, 2015", "APR 24, 2015", "APR 24, 2015", "APR 28, 2015", "APR 24, 2015", "APR 24, 2015", "APR 24, 2015", "APR 24, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 24, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 23, 2015", "APR 22, 2015", "APR 22, 2015", "APR 22, 2015", "APR 23, 2015", "APR 22, 2015", "APR 22, 2015", "APR 22, 2015", "APR 22, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 22, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 21, 2015", "APR 20, 2015", "APR 20, 2015", "APR 20, 2015", "APR 20, 2015", "APR 20, 2015", "APR 21, 2015", "APR 19, 2015", "APR 17, 2015", "APR 17, 2015", "APR 17, 2015", "APR 16, 2015", "APR 16, 2015", "APR 16, 2015", "APR 20, 2015", "APR 15, 2015", "APR 15, 2015", "APR 14, 2015", "APR 14, 2015", "APR 14, 2015", "APR 13, 2015", "APR 13, 2015", "APR 15, 2015", "APR 11, 2015", "APR 11, 2015", "APR 9, 2015", "APR 7, 2015", "APR 5, 2015", "APR 4, 2015", "APR 4, 2015", "APR 13, 2015", "APR 2, 2015", "APR 2, 2015", "APR 1, 2015", "APR 1, 2015", "APR 1, 2015", "MAR 31, 2015", "MAR 30, 2015", "APR 4, 2015", "MAR 29, 2015", "MAR 28, 2015", "MAR 26, 2015", "MAR 25, 2015", "MAR 25, 2015", "MAR 25, 2015", "MAR 25, 2015", "MAR 30, 2015", "MAR 23, 2015", "MAR 23, 2015", "MAR 23, 2015", "MAR 21, 2015", "MAR 20, 2015", "MAR 20, 2015", "MAR 24, 2015", "MAR 20, 2015", "MAR 20, 2015", "MAR 20, 2015", "MAR 20, 2015", "MAR 20, 2015", "MAR 20, 2015", "MAR 20, 2015", "MAR 20, 2015", "MAR 17, 2015", "MAR 16, 2015", "MAR 15, 2015", "MAR 13, 2015", "MAR 13, 2015", "MAR 10, 2015", "MAR 10, 2015", "MAR 19, 2015", "MAR 8, 2015", "MAR 7, 2015", "MAR 6, 2015", "MAR 3, 2015", "MAR 2, 2015", "MAR 2, 2015", "MAR 1, 2015", "MAR 9, 2015", "FEB 27, 2015", "FEB 25, 2015", "FEB 22, 2015", "FEB 18, 2015", "FEB 15, 2015", "FEB 14, 2015", "FEB 14, 2015", "MAR 1, 2015", "FEB 13, 2015", "FEB 12, 2015", "FEB 12, 2015", "FEB 12, 2015", "FEB 11, 2015", "FEB 11, 2015", "FEB 11, 2015", "FEB 13, 2015", "FEB 10, 2015", "FEB 10, 2015", "FEB 10, 2015", "FEB 9, 2015", "FEB 9, 2015", "FEB 8, 2015", "FEB 7, 2015", "FEB 10, 2015", "FEB 10, 2015", "FEB 6, 2015", "FEB 6, 2015", "FEB 5, 2015", "FEB 5, 2015", "FEB 5, 2015", "FEB 4, 2015", "FEB 7, 2015", "FEB 7, 2015", "FEB 6, 2015", "FEB 6, 2015", "FEB 3, 2015", "FEB 2, 2015", "FEB 1, 2015", "JAN 31, 2015", "FEB 4, 2015", "JAN 30, 2015", "JAN 30, 2015", "JAN 30, 2015", "JAN 30, 2015", "JAN 29, 2015", "JAN 29, 2015", "JAN 29, 2015", "JAN 30, 2015", "JAN 27, 2015", "JAN 26, 2015", "JAN 26, 2015", "JAN 21, 2015", "JAN 21, 2015", "JAN 15, 2015", "JAN 15, 2015", "JAN 27, 2015", "JAN 13, 2015", "JAN 13, 2015", "JAN 12, 2015", "JAN 11, 2015", "JAN 9, 2015", "JAN 9, 2015", "JAN 9, 2015", "JAN 14, 2015", "JAN 8, 2015", "JAN 7, 2015", "JAN 7, 2015", "JAN 6, 2015", "JAN 6, 2015", "JAN 6, 2015", "DEC 31, 2014", "JAN 9, 2015", "DEC 26, 2014", "DEC 26, 2014", "DEC 26, 2014", "DEC 24, 2014", "DEC 22, 2014", "DEC 22, 2014", "DEC 30, 2014", "DEC 22, 2014", "DEC 22, 2014", "DEC 22, 2014", "DEC 22, 2014", "DEC 22, 2014", "DEC 22, 2014", "DEC 22, 2014", "DEC 22, 2014", "DEC 22, 2014", "DEC 19, 2014", "DEC 19, 2014", "DEC 19, 2014", "DEC 18, 2014", "DEC 16, 2014", "DEC 16, 2014", "DEC 21, 2014", "DEC 16, 2014", "DEC 16, 2014", "DEC 16, 2014", "DEC 16, 2014", "DEC 16, 2014", "DEC 16, 2014", "DEC 15, 2014", "DEC 16, 2014", "DEC 15, 2014", "DEC 15, 2014", "DEC 12, 2014", "DEC 12, 2014", "DEC 12, 2014", "DEC 12, 2014", "DEC 12, 2014", "DEC 15, 2014", "DEC 15, 2014", "DEC 11, 2014", "DEC 11, 2014", "DEC 10, 2014", "DEC 10, 2014", "DEC 10, 2014", "DEC 10, 2014", "DEC 11, 2014", "DEC 10, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 9, 2014", "DEC 10, 2014", "DEC 10, 2014", "DEC 8, 2014", "DEC 8, 2014", "DEC 8, 2014", "DEC 8, 2014", "DEC 8, 2014", "DEC 9, 2014", "DEC 8, 2014", "DEC 7, 2014", "DEC 6, 2014", "DEC 5, 2014", "DEC 5, 2014", "DEC 5, 2014", "DEC 5, 2014", "DEC 8, 2014", "DEC 4, 2014", "DEC 4, 2014", "DEC 4, 2014", "DEC 4, 2014", "DEC 4, 2014", "DEC 4, 2014", "DEC 3, 2014", "DEC 5, 2014", "DEC 3, 2014", "DEC 3, 2014", "DEC 3, 2014", "DEC 3, 2014", "DEC 3, 2014", "DEC 3, 2014", "DEC 2, 2014", "DEC 3, 2014", "DEC 2, 2014", "DEC 2, 2014", "DEC 2, 2014", "DEC 2, 2014", "DEC 2, 2014", "DEC 2, 2014", "DEC 2, 2014", "DEC 2, 2014", "DEC 2, 2014", "DEC 2, 2014", "DEC 2, 2014", "DEC 1, 2014", "DEC 1, 2014", "NOV 28, 2014", "NOV 28, 2014", "DEC 2, 2014", "NOV 26, 2014", "NOV 26, 2014", "NOV 26, 2014", "NOV 26, 2014", "NOV 25, 2014", "NOV 25, 2014", "NOV 25, 2014", "NOV 27, 2014", "NOV 24, 2014", "NOV 24, 2014", "NOV 24, 2014", "NOV 24, 2014", "NOV 21, 2014", "NOV 21, 2014", "NOV 21, 2014", "NOV 24, 2014", "NOV 21, 2014", "NOV 21, 2014", "NOV 21, 2014", "NOV 21, 2014", "NOV 20, 2014", "NOV 19, 2014", "NOV 19, 2014", "NOV 21, 2014", "NOV 18, 2014", "NOV 18, 2014", "NOV 17, 2014", "NOV 17, 2014", "NOV 17, 2014", "NOV 17, 2014", "NOV 17, 2014"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/ibb-vrtx-biib-ilmn%3A-large-outflows-detected-at-etf-2020-06-12", "https://www.nasdaq.com/articles/biib-makes-notable-cross-below-critical-moving-average-2020-06-11", "https://www.nasdaq.com/articles/should-you-sell-biogen-stock-2020-06-10", "https://www.nasdaq.com/articles/biogen%3A-new-results-from-nurture-study-reveals-sustained-benefit-of-spinraza-2020-06-10", "https://www.nasdaq.com/articles/japans-fujifilm-to-spend-%24928-mln-to-double-capacity-of-danish-drug-facility-2020-06-09", "https://www.nasdaq.com/articles/7-of-the-best-blue-chip-stocks-to-buy-2020-06-08", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2020-06-04", "https://www.nasdaq.com/articles/despite-recent-speed-bumps-biogens-stock-will-soon-grow-again-2020-06-04", "https://www.nasdaq.com/articles/ibb-vrtx-biib-ilmn%3A-large-outflows-detected-at-etf-2020-06-12", "https://www.nasdaq.com/articles/got-%243000-here-are-3-great-biotech-stocks-to-buy-right-now-2020-05-29", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-axsome-therapeutics-2020-05-23", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-ive-ibm-fis-biib-2020-05-22", "https://www.nasdaq.com/articles/7-top-rated-biotech-stocks-to-buy-on-the-hunt-for-a-vaccine-2020-05-22", "https://www.nasdaq.com/articles/nothing-will-stop-biogen-stock-from-moving-higher-2020-05-19", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joel-greenblatt-5-17-2020-2020-05-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-peter-lynch-5-17-2020-2020-05-17", "https://www.nasdaq.com/articles/vir-biotechnology-is-bucking-the-biotech-covid-19-trends-and-stands-to-win-2020-06-01", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-mtum-amd-biib-hum-2020-05-13", "https://www.nasdaq.com/articles/5-stocks-buffett-probably-bought-in-the-first-quarter-2020-05-12", "https://www.nasdaq.com/articles/the-all-important-question-buffett-will-answer-this-week-2020-05-11", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-gm-axcella-beyond-meat-smiledirect-2020-05-06", "https://www.nasdaq.com/articles/apple-sells-%248.5-billion-in-bonds-to-fuel-share-buybacks-2020-05-05", "https://www.nasdaq.com/articles/apple-borrows-on-the-cheap-to-fund-buybacks-dividends-2020-05-04", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-04-2020%3A-egrxvirraretevabiib-2020-05-04", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-warren-buffett-5-17-2020-2020-05-17", "https://www.nasdaq.com/articles/why-biogen-shares-fell-6.18-in-april-2020-05-04", "https://www.nasdaq.com/articles/has-biogen-found-the-answer-to-treating-alzheimers-2020-05-01", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-etf-inflow-alert-2020-04-30", "https://www.nasdaq.com/articles/better-buy%3A-cara-therapeutics-vs.-sangamo-therapeutics-2020-04-29", "https://www.nasdaq.com/articles/at-least-14-borrowers-rush-into-us-high-grade-primary-2020-04-27", "https://www.nasdaq.com/articles/analysts-forecast-13-upside-for-the-holdings-of-tok-2020-04-24", "https://www.nasdaq.com/articles/3-big-stock-charts-for-thursday%3A-snap-biogen-and-l-brands-2020-04-23", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-04-2020%3A-virraretevabiib-2020-05-04", "https://www.nasdaq.com/articles/biogen-reports-first-quarter-results-shares-plunge-9.4-2020-04-22", "https://www.nasdaq.com/articles/biogen-inc-biib-q1-2020-earnings-call-transcript-2020-04-22", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-22-2020%3A-biibimmuprtavbiv-2020-04-22", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity%3A-cnne-biib-sfnc-2020-04-22", "https://www.nasdaq.com/articles/johnson-johnson-and-abbvie-earn-a-new-fda-approval-for-imbruvica-2020-04-22", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-snap-peck-company-vbi-vaccines-2020-04-22", "https://www.nasdaq.com/articles/why-biogen-stock-is-sinking-today-2020-04-22", "https://www.nasdaq.com/articles/japanese-shares-snap-3-day-losing-streak-as-battered-stocks-bought-back-2020-04-23", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-biib-lrcx-2020-04-22", "https://www.nasdaq.com/articles/sp-500-movers%3A-biib-expe-2020-04-22", "https://www.nasdaq.com/articles/health-care-sector-update-for-04-22-2020%3A-bntx-pfe-tmo-biib-xlv-ibb-vht-iyh-2020-04-22", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-saexploration-holdings-unit-corp-expedia-group-2020-04-22", "https://www.nasdaq.com/articles/biogen-delays-alzheimers-drug-filing-plans-shares-fall-2020-04-22", "https://www.nasdaq.com/articles/biogen-q1-results-top-estimates-quick-facts-2020-04-22", "https://www.nasdaq.com/articles/biogen-posts-marginal-rise-in-first-quarter-sales-2020-04-22", "https://www.nasdaq.com/articles/noteworthy-etf-inflows%3A-ibb-vrtx-biib-regn-2020-04-22", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-co-diagnostics-xeris-pharma-cyclacel-pharma-2020-04-20", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-dupont-occidental-petroleum-safe-t-group-2020-04-20", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-safe-t-group-ford-motor-facebook-2020-04-20", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-martin-zweig-4-19-2020-2020-04-19", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-peter-lynch-4-19-2020-2020-04-19", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-warren-buffett-4-19-2020-2020-04-19", "https://www.nasdaq.com/articles/biogen-reaches-analyst-target-price-2020-04-17", "https://www.nasdaq.com/articles/biogen-q1-20-earnings-conference-call-at-8%3A00-am-et-2020-04-22", "https://www.nasdaq.com/articles/biogen-joins-consortium-for-building-covid-19-biobank-2020-04-16-0", "https://www.nasdaq.com/articles/biogen-joins-consortium-for-building-covid-19-biobank-2020-04-16", "https://www.nasdaq.com/articles/better-buy%3A-alnylam-pharmaceuticals-vs.-vir-biotechnology-2020-04-12", "https://www.nasdaq.com/articles/should-investors-take-a-chance-on-biogen-2020-04-10", "https://www.nasdaq.com/articles/biib-may-29th-options-begin-trading-2020-04-09", "https://www.nasdaq.com/articles/3-big-stock-charts-for-thursday%3A-goldman-sachs-fedex-and-biogen-2020-04-09", "https://www.nasdaq.com/articles/u.s.-regulators-delay-decision-on-roche-sma-drug-risdiplam-to-aug.-24-2020-04-07", "https://www.nasdaq.com/articles/biogen-is-building-a-covid-19-biobank-with-the-broad-institute-2020-04-17", "https://www.nasdaq.com/articles/gsk-to-partner-with-vir-for-potential-covid-19-treatments-invest-%24250-mln-2020-04-06-1", "https://www.nasdaq.com/articles/gsk-to-partner-with-vir-for-potential-covid-19-treatments-invest-%24250-mln-2020-04-06-0", "https://www.nasdaq.com/articles/gsk-to-partner-with-vir-for-potential-covid-19-treatments-invest-%24250-mln-2020-04-06", "https://www.nasdaq.com/articles/3-warren-buffett-stocks-i-absolutely-positively-wouldnt-buy-right-now-2020-04-05", "https://www.nasdaq.com/articles/why-gilead-sciences-is-the-hottest-stock-to-buy-today-2020-04-04", "https://www.nasdaq.com/articles/investors-are-wondering%3A-wheres-warren-buffett-2020-04-03", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-biogen-2020-04-03", "https://www.nasdaq.com/articles/here-are-all-the-companies-working-on-covid-19-vaccines-treatments-and-testing-2020-04-07", "https://www.nasdaq.com/articles/so-your-biotech-announced-positive-phase-3-results-celebrating-could-be-premature-2020-04", "https://www.nasdaq.com/articles/ibb-vrtx-biib-ilmn%3A-etf-outflow-alert-2020-03-31", "https://www.nasdaq.com/articles/4-reasons-drug-stocks-are-a-buy-right-now-2020-03-30", "https://www.nasdaq.com/articles/first-week-of-biib-may-15th-options-trading-2020-03-27", "https://www.nasdaq.com/articles/bristol-myers-squibbs-multiple-sclerosis-drug-a-potential-blockbuster-wins-fda-approval", "https://www.nasdaq.com/articles/4-reasons-biotech-stocks-are-a-buy-right-now-2020-03-25", "https://www.nasdaq.com/articles/3-big-stock-charts-for-tuesday%3A-biogen-activision-blizzard-and-plug-power-2020-03-24", "https://www.nasdaq.com/articles/why-biogen-shares-rose-2.59-in-march-2020-04-02", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2020-03-23", "https://www.nasdaq.com/articles/are-these-warren-buffett-stocks-a-buy-at-beaten-down-prices-2020-03-23", "https://www.nasdaq.com/articles/berkshires-recent-purchases-show-why-value-investing-still-works-2020-03-20", "https://www.nasdaq.com/articles/why-biogen-gw-pharmaceuticals-and-vertex-pharmaceuticals-stocks-jumped-today-2020-03-17", "https://www.nasdaq.com/articles/7-biotech-stocks-to-buy-and-hold-in-2020-2020-03-16", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-peter-lynch-3-15-2020-2020-03-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-warren-buffett-3-15-2020-2020-03-15", "https://www.nasdaq.com/articles/better-buy%3A-abbvie-vs.-biogen-2020-03-24", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-martin-zweig-3-15-2020-2020-03-15", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2020-03-15", "https://www.nasdaq.com/articles/why-these-drug-stocks-soared-today-2020-03-13", "https://www.nasdaq.com/articles/3-ways-coronavirus-lockdowns-put-biotech-and-big-pharma-on-hold-2020-03-13", "https://www.nasdaq.com/articles/biogen-and-vir-biotechnology-to-collaborate-to-find-a-treatment-for-the-coronavirus-2020", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-12-2020%3A-poaivirbiibcemiazn-2020-03-12", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-12-2020%3A-virbiibcemiazn-2020-03-12", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joel-greenblatt-3-15-2020-2020-03-15", "https://www.nasdaq.com/articles/coronavirus-concerns-have-big-pharma-working-from-home-2020-03-09", "https://www.nasdaq.com/articles/is-ishares-nasdaq-biotechnology-index-fund-a-buy-2020-03-05", "https://www.nasdaq.com/articles/why-biogen-stock-rose-14.7-in-february-2020-03-03", "https://www.nasdaq.com/articles/former-biogen-ceo-to-become-biotechs-new-coronavirus-czar-2020-02-29", "https://www.nasdaq.com/articles/investors-endure-wild-ride-in-this-biotech-taking-on-covid-19-2020-02-29", "https://www.nasdaq.com/articles/heres-why-sangamo-therapeutics-jumped-higher-today-2020-02-28", "https://www.nasdaq.com/articles/biogen-could-score-a-major-win-if-alzheimers-drug-gets-the-green-light-2020-02-28", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-large-outflows-detected-at-etf-2020-03-10", "https://www.nasdaq.com/articles/biogen-sangamo-sign-deal-to-develop-gene-therapies-for-neurological-diseases-2020-02-27", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-revenues-rose-85-in-2019-2020-02-26", "https://www.nasdaq.com/articles/noteworthy-etf-inflows%3A-ibb-gild-vrtx-biib-2020-02-26", "https://www.nasdaq.com/articles/warren-buffett-is-buying-this-stock-faster-than-any-other-2020-02-26", "https://www.nasdaq.com/articles/3-top-stocks-you-should-watch-to-invest-like-berkshire-hathaway-2020-02-25", "https://www.nasdaq.com/articles/why-did-warren-buffett-buy-these-6-stocks-in-q4-2020-02-25", "https://www.nasdaq.com/articles/warren-buffetts-2-pure-play-pharma-picks-are-real-head-scratchers-2020-02-24", "https://www.nasdaq.com/articles/sangamo-therapeutics-and-biogen-announce-gene-therapy-deal-stock-up-39-2020-02-28", "https://www.nasdaq.com/articles/warren-buffetts-big-biotech-bet-is-1-of-his-riskiest-wagers-ever-2020-02-19", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-etf-outflow-alert-2020-02-18", "https://www.nasdaq.com/articles/16-stocks-warren-buffett-is-buying-and-selling-2020-02-18", "https://www.nasdaq.com/articles/stock-alert%3A-warren-buffetts-berkshire-hathaway-reveals-stake-in-kroger-biogen-2020-02-18", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-peter-lynch-2-16-2020-2020-02-16", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-martin-zweig-2-16-2020-2020-02-16", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-warren-buffett-2-16-2020-2020-02-16", "https://www.nasdaq.com/articles/top-stocks-warren-buffett-just-bought-2020-02-21", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joel-greenblatt-2-16-2020-2020-02-16", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-bristol-myers-squibb-2020-02-16", "https://www.nasdaq.com/articles/warren-buffetts-berkshire-hathaway-dives-into-biotechnology-2020-02-15", "https://www.nasdaq.com/articles/3-biotech-stocks-that-made-early-shareholders-millionaires-2020-02-13", "https://www.nasdaq.com/articles/tuesday-sector-laggards%3A-consumer-products-healthcare-2020-02-11", "https://www.nasdaq.com/articles/will-biogens-big-patent-victory-ease-investor-worries-about-its-alzheimers-drug-2020-02-11", "https://www.nasdaq.com/articles/a-double-failure-of-alzheimers-drugs-2020-02-10", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-david-dreman-2-16-2020-2020-02-16", "https://www.nasdaq.com/articles/3-biotech-companies-analyzed-2020-02-07", "https://www.nasdaq.com/articles/roche-presents-spinal-muscular-atrophy-drug-data-2020-02-07", "https://www.nasdaq.com/articles/is-this-under-the-radar-stock-set-to-succeed-in-alzheimers-disease-2020-02-07", "https://www.nasdaq.com/articles/why-amgen-stock-dropped-10.4-in-january-2020-02-05", "https://www.nasdaq.com/articles/biogen-surges-after-winning-crucial-multiple-sclerosis-drug-patent-2020-02-05", "https://www.nasdaq.com/articles/heres-why-alkermes-jumped-almost-11-today-2020-02-05", "https://www.nasdaq.com/articles/why-biogen-shares-soared-today-2020-02-05", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2020-02-10", "https://www.nasdaq.com/articles/pfizers-biosimilar-ruxience-gets-eu-regulatory-backing-2020-01-31-0", "https://www.nasdaq.com/articles/biogen-is-now-oversold-biib-2020-01-31", "https://www.nasdaq.com/articles/amgen-revenue-slipped-1-in-the-fourth-quarter-2020-01-31", "https://www.nasdaq.com/articles/biogen-inc-biib-q4-2019-earnings-call-transcript-2020-01-30", "https://www.nasdaq.com/articles/biogens-earnings-per-share-jumped-19-in-fourth-quarter-2020-01-30", "https://www.nasdaq.com/articles/is-biogen-stock-a-buy-2020-01-30", "https://www.nasdaq.com/articles/look-under-the-hood%3A-iwx-has-11-upside-2020-02-04", "https://www.nasdaq.com/articles/biogen-guides-fy20-in-line-with-estimates-quick-facts-2020-01-30", "https://www.nasdaq.com/articles/biogen-inc.-q4-adjusted-earnings-beat-estimates-2020-01-30", "https://www.nasdaq.com/articles/noteworthy-etf-outflows%3A-ibb-gild-vrtx-biib-2020-01-29", "https://www.nasdaq.com/articles/2-of-the-best-healthcare-stocks-to-buy-today-2020-01-29", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-aal-biib-2020-01-27", "https://www.nasdaq.com/articles/is-biogen-stock-a-buy-2020-01-25", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-biib-casa-xrx-2020-01-24", "https://www.nasdaq.com/articles/is-eli-lilly-stock-overvalued-2020-01-30", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2020-01-21", "https://www.nasdaq.com/articles/2-reasons-to-be-optimistic-about-biogens-alzheimers-drug-2020-01-21", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joel-greenblatt-1-19-2020-2020-01-19", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-david-dreman-1-19-2020-2020-01-19", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-peter-lynch-1-19-2020-2020-01-19", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-john-neff-1-19-2020-2020-01-19", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-cme-biib-pm-2020-01-17", "https://www.nasdaq.com/articles/roches-spinal-muscular-atrophy-drug-meets-primary-endpoint-in-infants-2020-01-23", "https://www.nasdaq.com/articles/5-reasons-2020-will-be-a-big-year-for-ionis-pharmaceuticals-2020-01-16", "https://www.nasdaq.com/articles/3-big-stock-charts-for-wednesday%3A-biogen-cooper-companies-and-maxim-2020-01-15", "https://www.nasdaq.com/articles/new-research-shows-probiotics-can-help-prevent-parkinsons-2020-01-14", "https://www.nasdaq.com/articles/biogen-buys-azheimers-and-parkinsons-drug-from-pfizer-2020-01-13", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-large-inflows-detected-at-etf-2020-01-13", "https://www.nasdaq.com/articles/biogen-to-acquire-clinical-stage-pf-05251749-from-pfizer-quick-facts-2020-01-13", "https://www.nasdaq.com/articles/thursday-sector-laggards%3A-healthcare-energy-2020-01-16", "https://www.nasdaq.com/articles/why-biogen-stock-slumped-last-year-2020-01-16", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-blk-whr-biib-2020-01-09", "https://www.nasdaq.com/articles/better-buy%3A-abbvie-vs.-biogen-2020-01-08", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-biogen-2020-01-05", "https://www.nasdaq.com/articles/ibb-gild-vrtx-biib%3A-etf-outflow-alert-2020-01-03", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2019-12-24", "https://www.nasdaq.com/articles/2-biotech-stocks-poised-to-soar-in-2020-2019-12-24", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-gilead-sciences-2020-01-11", "https://www.nasdaq.com/articles/why-longer-term-investors-should-buy-amarin-stock-on-weakness-2019-12-19", "https://www.nasdaq.com/articles/7-biotech-stocks-to-buy-and-hold-in-2020-2019-12-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-joel-greenblatt-12-15-2019-2019-12-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-peter-lynch-12-15-2019-2019-12-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-john-neff-12-15-2019-2019-12-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-on-david-dreman-12-15-2019-2019-12-15", "https://www.nasdaq.com/articles/is-biogen-too-cheap-to-ignore-2019-12-13", "https://www.nasdaq.com/articles/make-the-shift-toward-value-stocks-with-these-5-picks-2019-12-19", "https://www.nasdaq.com/articles/should-investors-be-worried-about-biogens-alzheimers-drug-2019-12-12", "https://www.nasdaq.com/articles/commit-to-buy-biogen-at-%24230-earn-9.7-using-options-2019-12-09", "https://www.nasdaq.com/articles/why-shares-of-pdl-biopharma-are-soaring-today-2019-12-09", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2019-12-08", "https://www.nasdaq.com/articles/why-biogens-alzheimers-drug-presentation-left-investors-uninspired-2019-12-07", "https://www.nasdaq.com/articles/pjp-mdco-lly-biib%3A-etf-inflow-alert-2019-12-06", "https://www.nasdaq.com/articles/5-top-stock-trades-for-friday%3A-rh-dg-kr-biib-2019-12-05", "https://www.nasdaq.com/articles/biogen-stops-development-of-gosuranemab-for-progressive-supranuclear-palsy-2019-12-13", "https://www.nasdaq.com/articles/why-biogens-recent-rebound-may-not-last-at-least-for-now-2019-11-27", "https://www.nasdaq.com/articles/biogens-data-shows-improved-gastrointestinal-tolerability-with-vumerity-2019-11-22", "https://www.nasdaq.com/articles/moat-stt-biib-bmy%3A-large-inflows-detected-at-etf-2019-11-15", "https://www.nasdaq.com/articles/thursday-sector-laggards%3A-consumer-products-healthcare-2019-11-14", "https://www.nasdaq.com/articles/7-biotech-stocks-to-buy-with-plenty-of-power-in-the-pipeline-2019-11-12", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity%3A-rok-cpb-biib-2019-11-12", "https://www.nasdaq.com/articles/heres-why-biogen-stock-shot-up-28-in-october-2019-11-10", "https://www.nasdaq.com/articles/why-abbvie-is-a-dividend-growth-stock-thats-too-cheap-to-ignore-2019-11-27", "https://www.nasdaq.com/articles/2-biotech-stocks-fighting-alzheimers-disease-to-own-now-2019-11-09", "https://www.nasdaq.com/articles/biogens-alzheimers-drug-goes-from-bust-to-boon-plus-why-walgreens-is-shuttering-200", "https://www.nasdaq.com/articles/noteworthy-etf-inflows%3A-moat-stt-biib-bmy-2019-11-07", "https://www.nasdaq.com/articles/is-there-still-room-to-profit-from-biogen-2019-11-01", "https://www.nasdaq.com/articles/earningspalooza-2019%3A-round-4-2019-11-01", "https://www.nasdaq.com/articles/massive-news-in-alzheimers-drugs-2019-11-01", "https://www.nasdaq.com/articles/what-should-investors-think-of-biogens-alzheimers-drug-candidate-2019-10-31", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-celgene-2019-11-10", "https://www.nasdaq.com/articles/2-biotech-stocks-that-soared-last-week-2019-10-28", "https://www.nasdaq.com/articles/5-top-healthcare-etfs-2019-10-26", "https://www.nasdaq.com/articles/first-trust-nyse-arca-biotechnology-index-fund-experiences-big-outflow-2019-10-24", "https://www.nasdaq.com/articles/validea-warren-buffett-strategy-daily-upgrade-report-10-24-2019-2019-10-24", "https://www.nasdaq.com/articles/biogen-ceo-confident-its-alzheimers-drug-will-get-fda-approval-2019-10-23", "https://www.nasdaq.com/articles/biogen-reaches-analyst-target-price-2019-10-23", "https://www.nasdaq.com/articles/biogens-stock-could-more-than-quadruple-in-value-in-5-years-2019-10-23", "https://www.nasdaq.com/articles/how-the-aducanumab-surprise-helped-biogen-stock-2019-10-31", "https://www.nasdaq.com/articles/is-biogen-a-buy-after-the-biggest-biotech-bombshell-in-years-2019-10-23", "https://www.nasdaq.com/articles/2-stocks-that-flew-high-on-tuesday-2019-10-23", "https://www.nasdaq.com/articles/what-happened-in-the-stock-market-today-2019-10-22", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-22-2019%3A-oblnnlnkbiibarwr-2019-10-22", "https://www.nasdaq.com/articles/tuesday-sector-leaders%3A-energy-healthcare-2019-10-22", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-22-2019%3A-nlnkbiibarwr-2019-10-22", "https://www.nasdaq.com/articles/5-healthcare-stocks-to-buy-2019-10-22", "https://www.nasdaq.com/articles/heres-why-biogens-big-gain-wont-last-long-2019-10-23", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-has-biib-2019-10-22", "https://www.nasdaq.com/articles/sp-500-movers%3A-has-biib-2019-10-22", "https://www.nasdaq.com/articles/health-care-sector-update-for-10-22-2019%3A-biib-cnc-nvs-jnj-pfe-abt-mrk-amgn-2019-10-22", "https://www.nasdaq.com/articles/why-biogen-stock-is-on-fire-today-2019-10-22", "https://www.nasdaq.com/articles/biogen-q3-profit-tops-estimates-revenue-up-5-quick-facts-2019-10-22", "https://www.nasdaq.com/articles/biogen-plans-to-submit-bla-for-aducanumab-in-alzheimers-disease-shares-jump-2019-10-22", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-wgo-biib-axta-2019-10-18", "https://www.nasdaq.com/articles/biogen-inc-biib-q3-2019-earnings-call-transcript-2019-10-22", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-gilead-sciences-2019-10-10", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity%3A-lnn-biib-uaa-2019-10-09", "https://www.nasdaq.com/articles/insiders-buy-the-holdings-of-vht-etf-2019-10-09", "https://www.nasdaq.com/articles/implied-moat-analyst-target-price%3A-%2456-2019-10-07", "https://www.nasdaq.com/articles/biogen-canada-reports-positive-results-on-spinal-muscular-atrophy-study-2019-10-03", "https://www.nasdaq.com/articles/notable-wednesday-option-activity%3A-biib-clx-mac-2019-10-02", "https://www.nasdaq.com/articles/a-biotech-set-to-dominate-the-next-20-years-2019-10-01", "https://www.nasdaq.com/articles/why-did-the-market-whack-this-ipo-2019-10-14", "https://www.nasdaq.com/articles/2-biotechs-tackling-the-challenge-of-lou-gehrigs-disease-2019-09-30", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2019-09-27", "https://www.nasdaq.com/articles/notable-tuesday-option-activity%3A-isrg-biib-cof-2019-09-24", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-biib-mro-wday-2019-09-16", "https://www.nasdaq.com/articles/3-biotech-stocks-that-show-the-good-the-bad-and-the-ugly-side-of-this-sector-2019-09-14", "https://www.nasdaq.com/articles/eisai-biogen-to-discontinue-elenbecestat-phase-iii-studies-quick-facts-2019-09-13", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2019-09-11", "https://www.nasdaq.com/articles/biogen-appoints-alfred-sandrock-as-evp-research-and-development-2019-10-01", "https://www.nasdaq.com/articles/2-biotechs-tackling-the-challenge-of-lou-gehrigs-disease-2019-09-30", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity%3A-ci-itw-biib-2019-08-30", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-celgene-2019-08-25", "https://www.nasdaq.com/articles/health-care-sector-update-for-08-21-2019%3A-nvtabiibaltpfealc-2019-08-21", "https://www.nasdaq.com/articles/whats-next-for-sarepta-therapeutics-after-its-surprising-fda-rejection-2019-08-21", "https://www.nasdaq.com/articles/notable-friday-option-activity%3A-biib-bmrn-el-2019-08-16", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity%3A-biib-cat-mktx-2019-09-09", "https://www.nasdaq.com/articles/2-small-cap-stocks-that-could-make-you-rich-2019-08-01", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-ndaq-biib-pru-2019-08-01", "https://www.nasdaq.com/articles/biogen-hedged-its-bet-and-won-big-2019-07-30", "https://www.nasdaq.com/articles/alks-%3A-diroximel-fumarate-shows-superior-gi-tolerability-on-evolve-ms-2-endpoint-2019-07", "https://www.nasdaq.com/articles/alkermes-bounces-back-but-not-enough-2019-07-26", "https://www.nasdaq.com/articles/biogen-raises-guidance-as-it-looks-to-the-pipeline-for-growth-2019-07-24", "https://www.nasdaq.com/articles/notable-tuesday-option-activity%3A-biib-cwen-gs-2019-07-23", "https://www.nasdaq.com/articles/5-reasons-novartis-shareholders-arent-shaken-2019-08-11", "https://www.nasdaq.com/articles/biogen-earnings%3A-biib-stock-surges-on-big-q2-earnings-beat-2019-07-23", "https://www.nasdaq.com/articles/insiders-buy-the-holdings-of-moat-etf-2019-07-23", "https://www.nasdaq.com/articles/biogen-q2-profit-rises-lifts-2019-outlook-2019-07-23", "https://www.nasdaq.com/articles/ms-franchise-spinraza-likely-to-be-key-catalysts-for-biogen-stock-2019-07-22", "https://www.nasdaq.com/articles/notable-earnings-to-watch-on-july-23-an-jblu-biib-cmg-ko-hog-has-txn-2019-07-22", "https://www.nasdaq.com/articles/8-more-big-pharma-events-in-2019-you-dont-want-to-miss-2019-07-20", "https://www.nasdaq.com/articles/the-multibillion-dollar-race-for-gene-therapy-manufacturing-is-on-2019-07-17", "https://www.nasdaq.com/articles/biogen-inc-biib-q2-2019-earnings-call-transcript-2019-07-23", "https://www.nasdaq.com/articles/notable-monday-option-activity%3A-med-epam-biib-2019-07-08", "https://www.nasdaq.com/articles/why-biogen-stock-has-plummeted-in-2019-2019-07-08", "https://www.nasdaq.com/articles/why-amicus-therapeutics-stock-perked-up-in-june-2019-07-04", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-add-to-your-watchlist-2019-06-30", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-right-now-2019-06-30", "https://www.nasdaq.com/articles/nasdaq-today%3A-hard-to-keep-track-of-the-losers-2019-06-25", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2019-06-25", "https://www.nasdaq.com/articles/notable-tuesday-option-activity%3A-cost-biib-ulta-2019-07-16", "https://www.nasdaq.com/articles/nasdaq-100-movers%3A-ntes-biib-2019-06-25", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-to-buy-for-massive-gains-2019-06-19", "https://www.nasdaq.com/articles/3-big-drugmakers-most-likely-to-make-acquisitions-after-pfizers-surprise-deal-2019-06-18", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-gild-biib-vrtx-2019-06-17", "https://www.nasdaq.com/articles/insiders-buy-the-holdings-of-jkd-etf-2019-06-17", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-regn-biib-grmn-2019-06-13", "https://www.nasdaq.com/articles/zynerba-stock-soars-cannabidiol-patent-autism-spectrum-disorder-2019-06-11", "https://www.nasdaq.com/articles/the-10-biggest-biotech-stocks-2019-06-25", "https://www.nasdaq.com/articles/pain-pain-go-away-suicide-disease-drug-pipeline-2019-06-07", "https://www.nasdaq.com/articles/better-buy%3A-biogen-vs.-amgen-2019-06-03", "https://www.nasdaq.com/articles/analysts-anticipate-17-upside-holdings-jkd-2019-06-03", "https://www.nasdaq.com/articles/can-novartis-convince-insurers-%242.1-million-gene-therapy-great-deal-2019-05-26", "https://www.nasdaq.com/articles/approval-game-changing-gene-therapy-sma-delivers-win-novartis-and-regenxbio-2019-05-24", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-fxh-brkr-md-biib-2019-05-23", "https://www.nasdaq.com/articles/ibb-gild-celg-biib%3A-etf-outflow-alert-2019-05-15", "https://www.nasdaq.com/articles/commit-purchase-biogen-%24180-earn-8.7-using-options-2019-06-10", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-biib-fro-fdx-2019-05-09", "https://www.nasdaq.com/articles/stock-buybacks-surge-2019-05-09", "https://www.nasdaq.com/articles/ibb-biib-vrtx-ilmn%3A-large-outflows-detected-etf-2019-05-07", "https://www.nasdaq.com/articles/monday-5/6-insider-buying-report%3A-biib-unh-2019-05-06", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity%3A-abmd-biib-oxy-2019-05-02", "https://www.nasdaq.com/articles/sum-pieces%3A-qqxt-could-be-worth-59-2019-05-02", "https://www.nasdaq.com/articles/highly-anticipated-gene-therapy-trouble-2019-04-26", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-40-way-there-2019-05-14", "https://www.nasdaq.com/articles/biogen-looks-23-clinical-programs-growth-2019-04-25", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-ibb-celg-gild-biib-2019-04-25", "https://www.nasdaq.com/articles/biogen-inc-biib-q1-2019-earnings-call-transcript-2019-04-24", "https://www.nasdaq.com/articles/biogen-earnings-biib-stock-slips-despite-q1-beat-2019-04-24", "https://www.nasdaq.com/articles/earnings-reaction-history%3A-biogen-idec-36.4-follow-through-indicator-2.8-sensitive-2019-04", "https://www.nasdaq.com/articles/biogen-inc.-q1-adjusted-earnings-beat-estimates-2019-04-24", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-hiiq-biib-ea-2019-04-23", "https://www.nasdaq.com/articles/alkermes-looks-ahead-growth-2019-04-26", "https://www.nasdaq.com/articles/heres-why-ionis-pharmaceuticals-slumped-today-2019-04-17", "https://www.nasdaq.com/articles/2-beaten-down-bluechips-are-they-buys-2019-04-17", "https://www.nasdaq.com/articles/2-beaten-down-blue-chips-are-they-buys-2019-04-17", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2019-04-17", "https://www.nasdaq.com/articles/heres-why-ionis-pharmaceuticals-slumped-today-2019-04-17-0", "https://www.nasdaq.com/articles/2-beaten-down-blue-chips-are-they-buys-2019-04-17-0", "https://www.nasdaq.com/articles/2-beaten-down-bluechips-are-they-buys-2019-04-17-0", "https://www.nasdaq.com/articles/better-buy-biogen-vs-abbvie-2019-04-22", "https://www.nasdaq.com/articles/relative-strength-alert-biogen-2019-04-16-0", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-vs-biogen-2019-04-14", "https://www.nasdaq.com/articles/health-care-sector-update-04122019-bhvnvivexfortcon-2019-04-12-0", "https://www.nasdaq.com/articles/notable-thursday-option-activity-srpt-unm-biib-2019-04-11", "https://www.nasdaq.com/articles/risk-tolerant-investors-turn-your-eyes-exelixis-stock-2019-04-11", "https://www.nasdaq.com/articles/notable-thursday-option-activity-srpt-unm-biib-2019-04-11-0", "https://www.nasdaq.com/articles/biogen-biib-dips-more-than-broader-markets%3A-what-you-should-know-2019-04-09-0", "https://www.nasdaq.com/articles/relative-strength-alert-biogen-2019-04-16", "https://www.nasdaq.com/articles/should-biogen-investors-be-extra-nervous-right-now-2019-04-06-0", "https://www.nasdaq.com/articles/1-biotech-biogen-should-buy-probably-wont-2019-04-04", "https://www.nasdaq.com/articles/mgk-biib-cl-schw-large-outflows-detected-etf-2019-04-04", "https://www.nasdaq.com/articles/why-biogen-stock-tanked-march-2019-04-04", "https://www.nasdaq.com/articles/1-biotech-biogen-should-buy-probably-wont-2019-04-04-0", "https://www.nasdaq.com/articles/why-nightstar-therapeutics-stock-skyrocketed-71-march-2019-04-03", "https://www.nasdaq.com/articles/biogen-sma-drug-price-novartis-estimates-its-treatment-far-too-high-us-group-2019-04-03", "https://www.nasdaq.com/articles/should-biogen-investors-be-extra-nervous-right-now-2019-04-06", "https://www.nasdaq.com/articles/should-biogen-investors-be-extra-nervous-right-now-2019-04-06-0", "https://www.nasdaq.com/articles/3-leading-alzheimers-disease-drugs-development-after-biogens-aducanumab-flop-2019-03-30", "https://www.nasdaq.com/articles/biogen-beat-bargain-and-bristol-myers-mega-merger-rocks-2019-03-28", "https://www.nasdaq.com/articles/why-biogens-alzheimers-drug-failure-may-have-silver-lining-2019-03-28", "https://www.nasdaq.com/articles/analysts-predict-12-upside-divb-2019-03-28", "https://www.nasdaq.com/articles/biogen-beat-bargain-and-bristol-myers-mega-merger-rocks-2019-03-28-0", "https://www.nasdaq.com/articles/3-healthcare-stocks-to-trade-now-2019-04-02", "https://www.nasdaq.com/articles/biogens-bad-news-everyone-2019-03-26", "https://www.nasdaq.com/articles/celgene-celg-submits-nda-for-ms-drug-to-fda-for-review-2019-03-26", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-769152-5398-points-2019-03-26", "https://www.nasdaq.com/articles/why-viacom-ferroglobe-and-biogen-jumped-today-2019-03-26", "https://www.nasdaq.com/articles/nasdaq-100-movers-tsla-orly-2019-03-25", "https://www.nasdaq.com/articles/weekly-market-summary-fomc-goes-60-0-three-months-2019-03-25", "https://www.nasdaq.com/articles/novartis-nvs-receives-fda-approval-for-ms-drug-mayzent-2019-03-27-0", "https://www.nasdaq.com/articles/1-surprising-reason-alzheimers-drugs-remain-so-elusive-2019-03-25", "https://www.nasdaq.com/articles/notable-monday-option-activity-nwsa-biib-jpm-2019-03-25", "https://www.nasdaq.com/articles/it-safe-buy-biogen-stock-right-now-2019-03-24", "https://www.nasdaq.com/articles/2-biotech-takeout-targets-perfect-biogen-2019-03-23", "https://www.nasdaq.com/articles/sustainable-business-practices-transparency-land-nasdaq-companies-top-2017s-100-best-ranking-2019-03-22", "https://www.nasdaq.com/articles/biogen-stock-crashes-on-termination-of-alzheimers-studies-2019-03-22", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2019-03-22", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-buy-right-now-2019-03-25", "https://www.nasdaq.com/articles/company-news-for-mar-22-2019-2019-03-22", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-3222019-2019-03-22", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-surges-250-points-micron-shares-gain-upbeat-earnings-2019", "https://www.nasdaq.com/articles/mid-day-market-update-superconductor-technologies-rises-after-q4-results-staffing-360", "https://www.nasdaq.com/articles/mid-day-market-update-superconductor-technologies-rises-after-q4-results-staffing-360-0", "https://www.nasdaq.com/articles/whats-next-biogen-after-its-alzheimers-disease-drug-flop-2019-03-21", "https://www.nasdaq.com/articles/biogen-news-biib-stock-plummets-alzheimers-drug-failure-2019-03-21", "https://www.nasdaq.com/articles/biogen-stock-fell-too-far-unfortunate-news-2019-03-22", "https://www.nasdaq.com/articles/jobless-claims-dip-philly-fed-swings-biogen-biib-plummets-2019-03-21-0", "https://www.nasdaq.com/articles/stock-market-news-biogen-bombs-micron-moves-higher-2019-03-21", "https://www.nasdaq.com/articles/why-biogen-stock-crashing-today-2019-03-21", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-mu-2019-03-21", "https://www.nasdaq.com/articles/assessing-impact-biogen-biib-news-2019-03-21", "https://www.nasdaq.com/articles/sp-500-movers-biib-cag-2019-03-21", "https://www.nasdaq.com/articles/biogen-becomes-oversold-biib-2019-03-21", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-conagra-earnings-top-expectations-2019-03-0", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-conagra-earnings-top-expectations-2019-03-21", "https://www.nasdaq.com/articles/jobless-claims-dip-philly-fed-swings-biogen-biib-plummets-2019-03-21", "https://www.nasdaq.com/articles/alkermes-focuses-on-pipeline-depends-on-partners-for-funds-2019-03-21", "https://www.nasdaq.com/articles/health-care-sector-update-03212019-biib-ogen-nvcn-jnj-pfe-abt-mrk-amgn-2019-03-21", "https://www.nasdaq.com/articles/wall-street-tips-lower-ahead-opening-bell-dovish-fed-white-house-us-china-trade-talk-2019", "https://www.nasdaq.com/articles/pre-market-most-active-mar-21-2019-biib-mu-sqqq-qqq-nok-eqh-opk-eric-chl-lyg-cag-acb-2019", "https://www.nasdaq.com/articles/initial-jobless-claims-decline-2019-03-21", "https://www.nasdaq.com/articles/stock-market-today-biogen-crushed-after-failure-alzheimers-drug-2019-03-21", "https://www.nasdaq.com/articles/biogen-bad-news-buy-now-2019-03-21", "https://www.nasdaq.com/articles/nasdaq-composite-index-closes-502-points-week-rising-5th-straight-day-2019-03-21", "https://www.nasdaq.com/articles/close-update-technology-sector-rally-sends-us-stocks-higher-nasdaq-leads-major-indexes", "https://www.nasdaq.com/articles/health-care-sector-update-03212019-lifeogennvcnnvcntobiib-2019-03-21", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-surges-250-points-micron-shares-gain-upbeat-earnings-0", "https://www.nasdaq.com/articles/health-care-sector-update-03212019-ogennvcnbiib-2019-03-21", "https://www.nasdaq.com/articles/us-futures-drop-dovish-fed-white-house-us-china-trade-talk-2019-03-21", "https://www.nasdaq.com/articles/pdl-biopharma-pdli-q4-earnings-top-mark-revenues-fall-y-y-2019-03-15", "https://www.nasdaq.com/articles/ibb-celg-biib-gild-large-inflows-detected-etf-2019-03-14", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-visa-honeywell-biogen-humana-and-eog-resources-2019-03", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-14-2019-2019-03-13", "https://www.nasdaq.com/articles/celgene-celg-submits-application-for-ms-drug-in-europe-2019-03-12", "https://www.nasdaq.com/articles/better-buy-amgen-vs-biogen-2019-03-10", "https://www.nasdaq.com/articles/gene-therapy-ma-has-shares-skyrocketing-could-company-be-next-2019-03-08", "https://www.nasdaq.com/articles/us-stocks-push-higher-after-dovish-federal-reserve-signals-goldilocks-markets-pound-slips", "https://www.nasdaq.com/articles/company-news-for-mar-5-2019-2019-03-05", "https://www.nasdaq.com/articles/biogen-to-acquire-gene-therapy-company-nightstar-for-%24800m-2019-03-05", "https://www.nasdaq.com/articles/nite-biib-nightstar-therapeutics-stock-soars-biogen-buy-2019-03-04", "https://www.nasdaq.com/articles/mid-day-market-update-us-stocks-turn-negative-dow-down-over-350-points-2019-03-04", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-childrens-place-misses-q4-expectations-2019", "https://www.nasdaq.com/articles/abbvie-gets-chmp-nod-for-psoriasis-candidate-risankizumab-2019-03-04", "https://www.nasdaq.com/articles/why-nightstar-therapeutics-stock-soaring-today-2019-03-04", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-biib-to-acquire-nightstar-other-pipeline-news-more-2019-03-06", "https://www.nasdaq.com/articles/us-stock-indexes-kick-week-slump-dow-leads-key-gauges-lower-2019-03-04", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-funds-its-pipeline-more-40-drugs-2019-03-04", "https://www.nasdaq.com/articles/health-care-sector-update-03042019-asndcsiintritvtyniteino-2019-03-04", "https://www.nasdaq.com/articles/mid-afternoon-market-update-nightstar-therapeutics-surges-acquisition-news-evoke-pharma", "https://www.nasdaq.com/articles/biogen-buy-nightstar-therapeutics-800-mln-cash-deal-2019-03-04", "https://www.nasdaq.com/articles/biogen-buy-nightstar-therapeutics-about-800-mln-2019-03-04", "https://www.nasdaq.com/articles/health-care-sector-update-03042019-nite-biib-asnd-avxl-jnj-pfe-mrk-abt-amgn-2019-03-04", "https://www.nasdaq.com/articles/heres-why-ionis-pharmaceuticals-jumped-higher-today-2019-02-27", "https://www.nasdaq.com/articles/alkermes-alks-and-biogens-nda-for-biib098-accepted-by-fda-2019-02-26", "https://www.nasdaq.com/articles/2-more-gene-therapy-stocks-big-pharmas-buyout-radar-2019-02-26", "https://www.nasdaq.com/articles/novartis-in-licenses-rights-to-heart-candidate-from-ionis-2019-02-25", "https://www.nasdaq.com/articles/surprising-analyst-12-month-target-oew-2019-02-25", "https://www.nasdaq.com/articles/novartis-gene-therapy-would-be-cost-effective-900000-us-group-2019-02-22", "https://www.nasdaq.com/articles/novartis-gene-therapy-cost-effective-900000-us-group-2019-02-22", "https://www.nasdaq.com/articles/health-care-sector-update-03042019-csiintritvtyniteino-2019-03-04", "https://www.nasdaq.com/articles/nasdaq-100-movers-ntes-hsic-2019-02-21", "https://www.nasdaq.com/articles/abbvies-ra-candidate-upadacitinib-gets-fda-priority-review-2019-02-20", "https://www.nasdaq.com/articles/alkermes-breaks-1-billion-2019-02-19", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-warren-buffett-2172019-2019-02-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-peter-lynch-2172019-2019-02-17", "https://www.nasdaq.com/articles/alkermes-alks-q4-earnings-revenues-surpass-estimates-2019-02-15", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-biib-ilmn-regn-2019-02-14", "https://www.nasdaq.com/articles/biogen-takes-over-114-spot-vulcan-materials-2019-02-21", "https://www.nasdaq.com/articles/despite-ma-spree-biotech-etfs-slide-mixed-earnings-2019-02-14", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-14-2019-2019-02-13", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-visa-charter-biogen-bp-and-bbt-2019-02-11", "https://www.nasdaq.com/articles/top-research-reports-visa-charter-communications-biogen-2019-02-08", "https://www.nasdaq.com/articles/biib-crosses-below-key-moving-average-level-2019-02-07", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-728835-down-8693-points-2019-02-07", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-qqew-2019-02-07", "https://www.nasdaq.com/articles/should-you-buy-viking-therapeutics-after-gilead-drug-failure-2019-02-14", "https://www.nasdaq.com/articles/despite-ma-spree-biotech-etfs-slide-mixed-earnings-2019-02-14", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-14-2019-2019-02-13", "https://www.nasdaq.com/articles/biogen-biib-q4-earnings-beat-estimates-revenues-up-y-y-2019-01-29", "https://www.nasdaq.com/articles/biogen-beats-estimates-multiple-sclerosis-drugs-sales-2019-01-29", "https://www.nasdaq.com/articles/march-2020-options-now-available-biogen-biib-2019-01-29", "https://www.nasdaq.com/articles/biogen-biib-beats-revenues-and-earnings-estimates-in-q4-2019-01-29", "https://www.nasdaq.com/articles/monday-24-insider-buying-report-biib-nrgx-2019-02-04", "https://www.nasdaq.com/articles/biogen-q4-results-top-estimates-sees-2019-results-line-view-2019-01-29", "https://www.nasdaq.com/articles/should-franklin-libertyq-u.s.-equity-etf-flql-be-on-your-investing-radar-2019-01-29", "https://www.nasdaq.com/articles/drugmaker-biogens-fourth-quarter-revenue-rises-66-pct-2019-01-29", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-455-follow-through-indicator-31-sensitive-2019-01-29", "https://www.nasdaq.com/articles/health-care-sector-update-01292019-jnjcgcweedtobiibagn-2019-01-29", "https://www.nasdaq.com/articles/health-care-sector-update-01292019-cgcweedtobiibagn-2019-01-29", "https://www.nasdaq.com/articles/biogen-inc-biib-q4-2018-earnings-conference-call-transcript-2019-01-29", "https://www.nasdaq.com/articles/biogen-beats-estimates-spinraza-tecfidera-strength-2019-01-29", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-dish-algn-biib-2019-01-28", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-1262019-2019-01-26", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2019-01-24", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-pfizer-biogen-schwab-sysco-and-philips-2019-01-21", "https://www.nasdaq.com/articles/biogen-biib-q4-earnings-coming-up%3A-whats-in-the-cards-2019-01-21", "https://www.nasdaq.com/articles/better-buy-biogen-vs-gilead-sciences-2019-01-19", "https://www.nasdaq.com/articles/notable-friday-option-activity-biib-cmi-csu-2019-01-18", "https://www.nasdaq.com/articles/pre-market-earnings-report-january-29-2019-pfe-vz-mmm-lmt-dhr-biib-agn-hca-glw-pcar-rok", "https://www.nasdaq.com/articles/mizuho%3A-7-long-term-value-stocks-to-buy-now-2019-01-14", "https://www.nasdaq.com/articles/7-pharmaceutical-stocks-that-just-raised-prices-this-year-2019-01-11", "https://www.nasdaq.com/articles/value-added-7-top-stocks-2019-2019-01-09", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-loxo-celg-gain-j.p.-morgan-healthcare-conference-in-focus-2019-01", "https://www.nasdaq.com/articles/best-health-care-stocks-buy-2019-2019-01-08", "https://www.nasdaq.com/articles/biogen-inks-two-deals-to-make-drugs-for-neurological-diseases-2019-01-07", "https://www.nasdaq.com/articles/all-pre-jpm-news-healthcare-investors-need-know-2019-01-06", "https://www.nasdaq.com/articles/will-biogen-biib-beat-estimates-again-in-its-next-earnings-report-2019-01-17", "https://www.nasdaq.com/articles/biogen-begins-improved-dosing-regimen-on-tysabri-in-phase-iii-2019-01-04", "https://www.nasdaq.com/articles/perrigo-stock-up-as-appeal-date-for-irish-tax-bill-nears-2018-12-27", "https://www.nasdaq.com/articles/perrigo-plunges-on-%241.9b-tax-bill-from-irish-government-2018-12-24", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-12-21", "https://www.nasdaq.com/articles/why-shares-perrigo-are-plunging-today-2018-12-21", "https://www.nasdaq.com/articles/health-care-sector-update-12212018-prgo-pti-rckt-jnj-pfe-abt-mrk-amgn-2018-12-21", "https://www.nasdaq.com/articles/health-care-sector-update-12212018-apvojazzrcktprgo-2018-12-21", "https://www.nasdaq.com/articles/biogen-skyhawk-announce-collaboration-quick-facts-2019-01-04", "https://www.nasdaq.com/articles/health-care-sector-update-12212018-jazzrcktprgo-2018-12-21", "https://www.nasdaq.com/articles/us-body-says-gene-therapy-may-be-more-cost-effective-spinal-muscular-atrophy-2018-12-20", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-nxpi-2018-12-18", "https://www.nasdaq.com/articles/sp-500-movers-biib-ba-2018-12-18", "https://www.nasdaq.com/articles/alkermes-biogen-submit-nda-to-fda-for-multiple-sclerosis-drug-2018-12-18", "https://www.nasdaq.com/articles/surprising-analyst-12-month-target-qus-2018-12-18", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-678391-3018-points-2018-12-18", "https://www.nasdaq.com/articles/abbvie-abbv-seeks-approval-for-ra-candidate-upadacitinib-2018-12-21", "https://www.nasdaq.com/articles/roches-sma-candidate-risdiplam-gets-prime-designation-in-eu-2018-12-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-john-neff-12162018-2018-12-16", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-warren-buffett-12162018-2018-12-16", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-peter-lynch-12162018-2018-12-16", "https://www.nasdaq.com/articles/better-buy-biogen-vs-amgen-2018-12-15", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-conatus-pharmaceuticals-biogen-ionis", "https://www.nasdaq.com/articles/5-pharma-stocks-that-could-cure-ailing-portfolios-in-2019-2018-12-12", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-ba-biib-bhf-2018-12-18", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-december-13-2018-2018-12-12", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-alexion-pharmaceuticals-regeneron", "https://www.nasdaq.com/articles/4-biotech-stocks-investors-can-add-their-portfolio-2019-2018-12-11", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2018-12-10", "https://www.nasdaq.com/articles/biogen-biib-in-licenses-als-candidate-biib067-from-ionis-2018-12-07", "https://www.nasdaq.com/articles/fda-accepts-bla-gives-priority-review-to-novartis-avxs-101-2018-12-04", "https://www.nasdaq.com/articles/abbvie-presents-long-term-data-on-cancer-drugs-at-ash-2018-2018-12-03", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gilead-to-get-new-ceo-biogen-in-licenses-candidate-2018-12-12", "https://www.nasdaq.com/articles/why-is-biogen-biib-up-4.5-since-last-earnings-report-2018-11-22", "https://www.nasdaq.com/articles/biib-january-2019-options-begin-trading-2018-11-21", "https://www.nasdaq.com/articles/should-you-invest-invesco-dynamic-biotechnology-genome-etf-pbe-2018-11-21", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-peter-lynch-11182018-2018-11-18", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-john-neff-11182018-2018-11-18", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-warren-buffett-11182018-2018-11-18", "https://www.nasdaq.com/articles/implied-moat-analyst-target-price-51-2018-11-15", "https://www.nasdaq.com/articles/tevas-rituxan-biosimilar-gets-fda-nod-in-non-hodgkin-lymphoma-2018-11-29", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-collects-royalties-and-spends-it-all-2018-11-12", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-iyh-biib-dhr-esrx-2018-11-12", "https://www.nasdaq.com/articles/6-pharmaceutical-stocks-to-buy-after-the-midterms-2018-11-09", "https://www.nasdaq.com/articles/pdl-biopharma-pdli-q3-earnings-top-revenues-rise-stock-up-2018-11-08", "https://www.nasdaq.com/articles/5-top-stocks-make-most-divided-congress-2018-11-07", "https://www.nasdaq.com/articles/biogen-stock-rebounds-after-impressive-q3-earnings-2018-11-05", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-10-31", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-15-2018-2018-11-14", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-biib-z-aks-2018-10-26", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-biib-tops-mack-plunges-regns-asthma-drug-gets-fda-nod-2018-10-24", "https://www.nasdaq.com/articles/biogen-becomes-oversold-biib-2018-10-24", "https://www.nasdaq.com/articles/biogen-rides-spinraza-wave-double-digit-growth-2018-10-24", "https://www.nasdaq.com/articles/alkermes-makes-financial-progress-its-pipeline-moves-forward-2018-10-24", "https://www.nasdaq.com/articles/biogen-earnings-10-highlights-biibs-q3-2018-10-23", "https://www.nasdaq.com/articles/alkermes-alks-exceeds-q3-earnings-estimates-raises-outlook-2018-10-23", "https://www.nasdaq.com/articles/whats-in-the-cards-for-abbvie-abbv-this-earnings-season-2018-10-30", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-455-follow-through-indicator-31-sensitive-2018-10-23", "https://www.nasdaq.com/articles/health-care-sector-update-10232018-biibptittph-2018-10-23", "https://www.nasdaq.com/articles/biogen-inc-biib-q3-2018-earnings-conference-call-transcript-2018-10-23", "https://www.nasdaq.com/articles/biogen-breaks-below-200-day-moving-average-notable-biib-2018-10-23", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-outflow-2018-10-22", "https://www.nasdaq.com/articles/biib-alks-q3-earnings-due-on-oct-23%3A-whats-in-store-2018-10-22", "https://www.nasdaq.com/articles/health-care-sector-update-10232018-pti-ttph-biib-jnj-pfe-abt-mrk-amgn-2018-10-23", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-inc-2018-10-21", "https://www.nasdaq.com/articles/nasdaq-100-movers-ebay-pypl-2018-10-19", "https://www.nasdaq.com/articles/alkermes-boasts-strong-portfolio-and-impressive-pipeline-2018-10-19", "https://www.nasdaq.com/articles/biogen-biib-q3-earnings-coming-up%3A-whats-in-the-cards-2018-10-19", "https://www.nasdaq.com/articles/coriums-cori-shares-surge-on-merger-agreement-with-gurnet-2018-10-15", "https://www.nasdaq.com/articles/implied-analyst-12-month-target-ryh-2018-10-15", "https://www.nasdaq.com/articles/ibb-gild-biib-celg-large-inflows-detected-etf-2018-10-12", "https://www.nasdaq.com/articles/pre-market-earnings-report-october-23-2018-vz-mcd-mmm-utx-lmt-nee-cat-biib-cnc-glw-pcar-rf", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-altria-u.s.-bancorp-biogen-ecolab-and-hsbc-2018-10-11", "https://www.nasdaq.com/articles/roche-rhhby-presents-encouraging-data-on-ms-drug-ocrevus-2018-10-10", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-gild-biib-present-data-vtgn-gains-on-fast-track-status-2018-10-10", "https://www.nasdaq.com/articles/commit-buy-biogen-250-earn-63-using-options-2018-10-08", "https://www.nasdaq.com/articles/novartis-applications-for-ms-drug-accepted-by-fda-ema-2018-10-08", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-gild-biib-celg-2018-10-04", "https://www.nasdaq.com/articles/teva-gets-fda-committee-nod-for-rituxan-biosimilar-filing-2018-10-11", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-biib-epay-tree-2018-10-02", "https://www.nasdaq.com/articles/3-biotech-stocks-with-rising-estimates-in-the-past-month-2018-09-28", "https://www.nasdaq.com/articles/ibb-biib-gild-celg-etf-inflow-alert-2018-09-26", "https://www.nasdaq.com/articles/3-drug-biotech-stocks-in-focus-on-world-alzheimers-day-2018-09-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-wells-fargo-schlumberger-biogen-american-express-and", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-buy-2018-09-21", "https://www.nasdaq.com/articles/top-research-reports-wells-fargo-schlumberger-biogen-2018-09-20", "https://www.nasdaq.com/articles/roche-rhhby-presents-encouraging-data-on-sma-drug-risdiplam-2018-10-04", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-biib-epay-tree-2018-10-02", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-peter-lynch-9162018-2018-09-16", "https://www.nasdaq.com/articles/ibb-biib-gild-celg-large-outflows-detected-etf-2018-09-14", "https://www.nasdaq.com/articles/acorda-acor-stock-dips-fda-delays-decision-on-inbrija-2018-09-14", "https://www.nasdaq.com/articles/3-biotech-stocks-analysts-say-are-market-winners-2018-09-13", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-biogen-2018-09-13", "https://www.nasdaq.com/articles/better-buy-celgene-corp-vs-biogen-2018-09-17", "https://www.nasdaq.com/articles/look-under-hood-eqwl-has-10-upside-2018-09-12", "https://www.nasdaq.com/articles/alkermes-expands-study-to-evaluate-alks-4230-keytruda-combo-2018-09-11", "https://www.nasdaq.com/articles/acorda-gets-unfavorable-court-ruling-for-ampyra-stock-down-2018-09-11", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-akam-jbht-biib-2018-09-10", "https://www.nasdaq.com/articles/pbe-ilmn-biib-vrtx-etf-inflow-alert-2018-09-06", "https://www.nasdaq.com/articles/biogen-begins-phase-iii-study-on-ischemic-stroke-candidate-2018-09-05", "https://www.nasdaq.com/articles/biotech-fund-flows-including-etf-activity-remain-driver-watch-2018-08-31", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-13-2018-2018-09-12", "https://www.nasdaq.com/articles/look-under-hood-eqwl-has-10-upside-2018-09-12", "https://www.nasdaq.com/articles/alkermes-expands-study-to-evaluate-alks-4230-keytruda-combo-2018-09-11", "https://www.nasdaq.com/articles/acorda-gets-unfavorable-court-ruling-for-ampyra-stock-down-2018-09-11", "https://www.nasdaq.com/articles/notable-friday-option-activity-pvh-pypl-biib-2018-08-24", "https://www.nasdaq.com/articles/biogen-biib-down-10.1-since-last-earnings-report%3A-can-it-rebound-2018-08-23", "https://www.nasdaq.com/articles/3-terrible-stocks-retirees-2018-08-22", "https://www.nasdaq.com/articles/notable-friday-option-activity-grub-cool-biib-2018-08-31", "https://www.nasdaq.com/articles/is-biogen-biib-outperforming-other-medical-stocks-this-year-2018-08-17", "https://www.nasdaq.com/articles/has-biogen-biib-outpaced-other-medical-stocks-this-year-2018-08-17", "https://www.nasdaq.com/articles/pain-therapeutics-shares-rally-on-alzheimers-study-grant-2018-08-16", "https://www.nasdaq.com/articles/vertexs-cystic-fibrosis-drug-gets-fda-nod-for-children-2018-08-16", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-16-2018-2018-08-15", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-royalties-rise-so-do-expenses-2018-08-13", "https://www.nasdaq.com/articles/why-biogens-stock-ripped-higher-july-2018-08-11", "https://www.nasdaq.com/articles/lilly-lly-hits-52-week-high-can-the-run-continue-2018-08-17", "https://www.nasdaq.com/articles/is-biogen-biib-outperforming-other-medical-stocks-this-year-2018-08-17", "https://www.nasdaq.com/articles/5-stocks-should-start-paying-dividends-2018-08-06", "https://www.nasdaq.com/articles/interesting-biib-put-and-call-options-june-2020-2018-08-03", "https://www.nasdaq.com/articles/zacks.com-featured-highlights-include%3A-biogen-thermo-fisher-hca-gilead-and-qualcomm-2018", "https://www.nasdaq.com/articles/avoid-treating-biogen-speculative-drug-stock-2018-08-03", "https://www.nasdaq.com/articles/5-cheap-peg-stocks-suitable-for-garp-investors-2018-08-02", "https://www.nasdaq.com/articles/pdl-biopharma-pdli-q2-earnings-top-revenues-slump-y-y-2018-08-09", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-celgene-amgen-vertex-impress-in-q2-gileads-ceo-to-exit-2018-08-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-comcast-united-technologies-biogen-mondelez-and-valero", "https://www.nasdaq.com/articles/wednesday-sector-leaders-healthcare-financial-2018-08-01", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-inc-2018-07-31", "https://www.nasdaq.com/articles/collaborations-help-alkermes-flip-profitability-2018-07-27", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2018-07-27", "https://www.nasdaq.com/articles/nasdaq-100-movers-fb-xlnx-2018-07-26", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-ionis-ions-this-earnings-season-2018-08-01", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-fbt-2018-07-26", "https://www.nasdaq.com/articles/thursday-sector-laggards-healthcare-materials-2018-07-26", "https://www.nasdaq.com/articles/why-every-investor-should-hold-shares-biogen-stock-2018-07-25", "https://www.nasdaq.com/articles/company-news-for-jul-25-2018-2018-07-25", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-biogen-gains-on-q2-results-agios-gets-fda-nod-for-leukemia-drug", "https://www.nasdaq.com/articles/bet-these-5-biotech-stocks-trump-raises-trade-tensions-2018-07-25", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-7252018-2018-07-25", "https://www.nasdaq.com/articles/why-biogens-stock-slumping-today-2018-07-26", "https://www.nasdaq.com/articles/wall-street-rises-after-strong-earnings-tech-health-care-sectors-2018-07-24", "https://www.nasdaq.com/articles/us-stocks-trend-higher-after-strong-earnings-tech-health-care-sectors-2018-07-24", "https://www.nasdaq.com/articles/biogen-biib-q2-earnings-sales-beat-estimates-shares-up-2018-07-24", "https://www.nasdaq.com/articles/nasdaq-100-movers-has-biib-2018-07-24", "https://www.nasdaq.com/articles/morning-movers-biogen-alphabet-verizon-soar-earnings-lift-dow-2018-07-24", "https://www.nasdaq.com/articles/biogen-biib-q2-earnings-beat-shares-up-2018-07-24", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-455-follow-through-indicator-31-sensitive-2018-07-24", "https://www.nasdaq.com/articles/biogen-posts-solid-earnings-biotech-waits-clinical-trial-data-2018-07-25", "https://www.nasdaq.com/articles/health-care-sector-update-07242018-bmybiibimrnlly-2018-07-24", "https://www.nasdaq.com/articles/health-care-sector-update-07242018-biibimrnlly-2018-07-24", "https://www.nasdaq.com/articles/biib-lly-q2-earnings-on-jul-24%3A-here-are-the-key-predictions-2018-07-23", "https://www.nasdaq.com/articles/5-top-stock-trades-for-tuesday-buy-sell-or-hold-tesla-2018-07-23", "https://www.nasdaq.com/articles/5-surprising-things-you-probably-didnt-know-about-alzheimers-drug-pipelines-2018-07-23", "https://www.nasdaq.com/articles/pre-market-earnings-report-july-24-2018-vz-mmm-utx-lly-lmt-biib-shw-kmb-cnc-iqv-pcar-agr", "https://www.nasdaq.com/articles/4-biotech-bets-watch-industry-rebounds-month-2018-07-20", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-784077-down-110-points-2018-07-24", "https://www.nasdaq.com/articles/biogen-biib-to-report-q2-earnings%3A-whats-in-the-cards-2018-07-19", "https://www.nasdaq.com/articles/abbvie-settles-with-mylan-to-delay-humira-biosimilar-in-u.s.-2018-07-18", "https://www.nasdaq.com/articles/new-drugs-and-expected-growth-could-trigger-a-recovery-for-celgene-stock-2018-07-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-pepsico-eli-lilly-broadcom-biogen-and-marathon-2018-07", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-warren-buffett-7152018-2018-07-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-peter-lynch-7152018-2018-07-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-john-neff-7152018-2018-07-15", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-ibb-biib-gild-amgn-2018-07-19", "https://www.nasdaq.com/articles/top-analyst-reports-pepsico-eli-lilly-broadcom-2018-07-13", "https://www.nasdaq.com/articles/better-know-biotech-regenxbio-inc-2018-07-13", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-wynn-fdx-biib-2018-07-13", "https://www.nasdaq.com/articles/are-we-cusp-big-alzheimers-disease-breakthrough-2018-07-13", "https://www.nasdaq.com/articles/dopamine-and-weather-part-2-2018-07-12", "https://www.nasdaq.com/articles/abbvies-imbruvica-fails-in-phase-iii-blood-cancer-study-2018-07-12", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-inc-buy-2018-07-12", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-2018-07-15", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-biibs-gain-on-alzheimers-data-regulatory-updates-more-2018-07-11", "https://www.nasdaq.com/articles/sad-truth-biotech-investing-strategy-almost-always-works-2018-07-11", "https://www.nasdaq.com/articles/nasdaq-100-movers-cern-idxx-2018-07-10", "https://www.nasdaq.com/articles/cti-biopharma-falls-after-failure-of-pivotal-lymphoma-study-2018-07-10", "https://www.nasdaq.com/articles/morning-movers-pepsi-jumps-celgene-climbs-chipotle-slides-2018-07-10", "https://www.nasdaq.com/articles/biogen-right-alzheimers-stock-wrong-time-2018-07-10", "https://www.nasdaq.com/articles/do-surprising-alzheimers-disease-results-make-biogen-stock-smart-buy-now-2018-07-10", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-ibb-gild-amgn-biib-2018-07-11", "https://www.nasdaq.com/articles/why-cti-biopharma-corp-sinking-today-2018-07-09", "https://www.nasdaq.com/articles/nasdaq-100-movers-ttwo-bidu-2018-07-09", "https://www.nasdaq.com/articles/stock-market-news-for-jul-9-2018-2018-07-09", "https://www.nasdaq.com/articles/biogen-reaches-analyst-target-price-2018-07-09", "https://www.nasdaq.com/articles/5-top-stock-trades-for-monday-2018-07-08", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2018-07-07", "https://www.nasdaq.com/articles/why-biogen-inc-stock-soared-152-today-2018-07-06", "https://www.nasdaq.com/articles/why-alphabet-cerner-and-biogen-slumped-today-2018-07-10", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-over-1-black-box-shares-spike-higher-2018-07-06-0", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-over-1-black-box-shares-spike-higher-2018-07-06", "https://www.nasdaq.com/articles/biogen-inc-stock-shoots-higher-alzheimers-drug-trial-2018-07-06", "https://www.nasdaq.com/articles/sp-500-movers-qrvo-biib-2018-07-06", "https://www.nasdaq.com/articles/nasdaq-100-movers-lrcx-biib-2018-07-06", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-higher-us-adds-213000-jobs-june-2018-07-06", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-higher-us-adds-213000-jobs-june-2018-07-06-0", "https://www.nasdaq.com/articles/biib-makes-bullish-cross-above-critical-moving-average-2018-07-06", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-over-1-black-box-shares-spike-higher-2018-07-06-0", "https://www.nasdaq.com/articles/health-care-sector-update-07062018-biibcelgrgls-2018-07-06", "https://www.nasdaq.com/articles/pre-market-most-active-jul-6-2018-anw-db-shv-iq-biib-sny-qqq-sqqq-tvix-nok-baba-bp-2018-07", "https://www.nasdaq.com/articles/what-happened-stock-market-today-2018-07-06", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-768839-10196-points-2018-07-06", "https://www.nasdaq.com/articles/close-update-wall-street-ends-high-note-after-jobs-data-beats-expectations-2018-07-06", "https://www.nasdaq.com/articles/health-care-sector-update-07062018-celgtgtxbiibrgls-2018-07-06", "https://www.nasdaq.com/articles/biogens-alzheimer-disease-candidate-succeeds-in-phase-ii-2018-07-06", "https://www.nasdaq.com/articles/fridays-etf-movers-ibb-gdx-2018-07-06", "https://www.nasdaq.com/articles/mid-day-update-us-shares-rise-second-day-boosted-positive-data-2018-07-06", "https://www.nasdaq.com/articles/health-care-sector-update-07062018-tgtxbiibcelgrgls-2018-07-06", "https://www.nasdaq.com/articles/notable-friday-option-activity-amzn-biib-googl-2018-07-06", "https://www.nasdaq.com/articles/ibb-gild-amgn-biib-large-outflows-detected-etf-2018-07-03", "https://www.nasdaq.com/articles/sanofis-blood-clotting-drug-gets-positive-chmp-opinion-2018-07-02", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-johnson-johnson-biogen-general-motors-valero-and", "https://www.nasdaq.com/articles/why-biotech-stocks-rallied-biogens-alzheimers-test-2018-07-06", "https://www.nasdaq.com/articles/ibb-gild-biib-celg-etf-inflow-alert-2018-06-25", "https://www.nasdaq.com/articles/first-week-august-17th-options-trading-biogen-biib-2018-06-20", "https://www.nasdaq.com/articles/dont-get-too-excited-about-ptc-therapeutics-yet-2018-06-20", "https://www.nasdaq.com/articles/commit-purchase-biogen-195-earn-34-using-options-2018-06-19", "https://www.nasdaq.com/articles/ptc-therapeutics-spinal-muscular-atrophy-study-successful-2018-06-19", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-jd-2018-06-18", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-774703-65-points-2018-06-18", "https://www.nasdaq.com/articles/top-analyst-reports-johnson-johnson-biogen-general-motors-2018-06-28", "https://www.nasdaq.com/articles/monday-sector-laggards-consumer-products-healthcare-2018-06-18", "https://www.nasdaq.com/articles/mondays-etf-unusual-volume-ixj-2018-06-18", "https://www.nasdaq.com/articles/notable-monday-option-activity-fb-biib-gww-2018-06-18", "https://www.nasdaq.com/articles/heres-why-ptc-therapeutics-soaring-while-biogen-and-ionis-struggle-2018-06-18", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-warren-buffett-6172018-2018-06-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-john-neff-6172018-2018-06-17", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-peter-lynch-6172018-2018-06-17", "https://www.nasdaq.com/articles/why-biogen-baytex-energy-and-catalyst-biosciences-slumped-today-2018-06-18", "https://www.nasdaq.com/articles/zacks-value-investor-highlights%3A-gilead-sciences-biogen-celgene-lannett-and-valeant-2018", "https://www.nasdaq.com/articles/roche-announces-positive-data-on-gazyva-and-ms-drug-ocrevus-2018-06-15", "https://www.nasdaq.com/articles/analysts-anticipate-oew-will-reach-37-2018-06-14", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-axon-soars-amgen-drugs-get-fda-ec-nod-2018-06-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-14-2018-2018-06-13", "https://www.nasdaq.com/articles/drug-stocks-next-hot-industry-or-value-traps-2018-06-13", "https://www.nasdaq.com/articles/gilead-sciences-top-socially-responsible-dividend-stock-32-yield-gild-2018-06-11", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-ibb-biib-gild-celg-2018-06-15", "https://www.nasdaq.com/articles/pfizer-boosts-venture-capital-efforts-neuroscience-in-focus-2018-06-07", "https://www.nasdaq.com/articles/ishares-nasdaq-biotechnology-etf-experiences-big-inflow-2018-06-06", "https://www.nasdaq.com/articles/health-care-sector-update-06062018-entaitciclrbalksbiib-2018-06-06", "https://www.nasdaq.com/articles/health-care-sector-update-06062018-itciclrbalksbiib-2018-06-06", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-june-2018-06-04", "https://www.nasdaq.com/articles/biogen-inc-stock-got-an-upgrade-but-should-you-listen-2018-06-04", "https://www.nasdaq.com/articles/biogen-inks-deal-with-tms-to-acquire-phase-ii-stroke-asset-2018-06-08", "https://www.nasdaq.com/articles/validea-john-neff-strategy-daily-upgrade-report-5302018-2018-05-30", "https://www.nasdaq.com/articles/3-top-biosimilars-will-lift-pfizer-inc-stock-even-more-2018-05-24", "https://www.nasdaq.com/articles/3-big-pharma-stocks-huge-future-growth-potential-2018-05-24", "https://www.nasdaq.com/articles/why-is-biogen-biib-up-6.7-since-its-last-earnings-report-2018-05-24", "https://www.nasdaq.com/articles/10-top-health-care-stocks-never-break-sweat-2018-05-24", "https://www.nasdaq.com/articles/ibb-biib-celg-vrtx-etf-outflow-alert-2018-05-21", "https://www.nasdaq.com/articles/better-buy-acadia-pharmaceuticals-vs-biogen-2018-05-18", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-celgene-2018-06-03", "https://www.nasdaq.com/articles/sangamo-therapeutics-stock-history-2018-05-17", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-16-2018-2018-05-15", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-inc-2018-05-15", "https://www.nasdaq.com/articles/novartis-multiple-sclerosis-drug-gets-fda-nod-for-adolescents-2018-05-14", "https://www.nasdaq.com/articles/moats-holdings-could-mean-14-gain-potential-2018-05-14", "https://www.nasdaq.com/articles/nasdaq-100-movers-symc-regn-2018-05-11", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-adbe-celg-biib-2018-05-11", "https://www.nasdaq.com/articles/sp-500-analyst-moves-biib-2018-05-17", "https://www.nasdaq.com/articles/3-stocks-turned-10000-1-million-2018-05-09", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-prepares-launch-2018-05-09", "https://www.nasdaq.com/articles/ibb-celg-biib-vrtx-etf-outflow-alert-2018-05-02", "https://www.nasdaq.com/articles/whats-in-the-cards-for-ionis-ions-this-earnings-season-2018-05-01", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-inc-2018-05-01", "https://www.nasdaq.com/articles/biogens-1-billion-bet-ionis-2018-04-30", "https://www.nasdaq.com/articles/the-good-and-the-bad-news-with-biogen-inc-earnings-results-2018-04-30", "https://www.nasdaq.com/articles/ibb-celg-biib-vrtx-etf-inflow-alert-2018-05-10", "https://www.nasdaq.com/articles/3-stocks-turned-10000-1-million-2018-05-09", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-prepares-launch-2018-05-09", "https://www.nasdaq.com/articles/ibb-celg-biib-vrtx-etf-outflow-alert-2018-05-02", "https://www.nasdaq.com/articles/whats-in-the-cards-for-ionis-ions-this-earnings-season-2018-05-01", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-prta-down-amgn-revises-view-biib-misses-on-sales-2018-04-25", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-4252018-2018-04-25", "https://www.nasdaq.com/articles/biogen-inc-buy-2018-04-28", "https://www.nasdaq.com/articles/biogen-biib-q1-earnings-beat-sales-miss-shares-down-2018-04-24", "https://www.nasdaq.com/articles/health-care-sector-update-04242018-lly-incy-biib-cnc-2018-04-24", "https://www.nasdaq.com/articles/biogen-biib-q1-earnings-beat-sales-miss-2018-04-24", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-545-follow-through-indicator-50-sensitive-2018-04-24", "https://www.nasdaq.com/articles/why-ionis-pharmaceuticals-crashed-today-2018-04-24", "https://www.nasdaq.com/articles/health-care-sector-update-04242018-enzholxbiibcncincy-2018-04-24", "https://www.nasdaq.com/articles/eli-lilly-and-co-produced-monstrous-q1-beat-it-enough-2018-04-24", "https://www.nasdaq.com/articles/biogen-posts-double-digit-profits-has-cash-burn-2018-04-25", "https://www.nasdaq.com/articles/drug-biotech-stock-q1-earnings-due-on-apr-24%3A-lly-biib-amgn-2018-04-23", "https://www.nasdaq.com/articles/roche-rhhby-presents-encouraging-data-on-ms-drug-ocrevus-2018-04-23", "https://www.nasdaq.com/articles/why-biogen-inc-giving-ionis-another-1-billion-2018-04-23", "https://www.nasdaq.com/articles/pre-market-earnings-report-april-24-2018-vz-ko-mmm-lmt-utx-cat-lly-nee-biib-trv-shw-fcx", "https://www.nasdaq.com/articles/novartis-nvs-reports-encouraging-data-on-ms-candidate-2018-04-20", "https://www.nasdaq.com/articles/whats-in-store-for-biogen-biib-this-earnings-season-2018-04-20", "https://www.nasdaq.com/articles/health-care-sector-update-04202018-ions-biib-rigl-cmta-vxrt-2018-04-20", "https://www.nasdaq.com/articles/health-care-sector-update-04242018-incy-biibcnc-2018-04-24", "https://www.nasdaq.com/articles/health-care-sector-update-04202018-cmiaionsbiibrigl-2018-04-20", "https://www.nasdaq.com/articles/big-biotech-etf-can-bounce-back-2018-04-18", "https://www.nasdaq.com/articles/it-time-give-alkermes-2018-04-16", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-john-neff-4152018-2018-04-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-warren-buffett-4152018-2018-04-15", "https://www.nasdaq.com/articles/ibb-gild-biib-vrtx-etf-outflow-alert-2018-04-12", "https://www.nasdaq.com/articles/add-parts-spyx-could-be-worth-74-2018-04-12", "https://www.nasdaq.com/articles/health-care-sector-update-04202018-vxrtcmiaionsbiibriglnabi-2018-04-20", "https://www.nasdaq.com/articles/why-one-drug-flop-tanked-incytes-stock-2018-04-12", "https://www.nasdaq.com/articles/mylan-fujifilm-kyowa-team-up-to-market-humira-biosimilar-2018-04-12", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-spectrum-up-incyte-down-avexis-to-merge-with-novartis-2018-04-11", "https://www.nasdaq.com/articles/top-research-reports-nextera-danaher-biogen-2018-04-11", "https://www.nasdaq.com/articles/novartis-acquisition-avexis-bad-news-biogen-2018-04-10", "https://www.nasdaq.com/articles/abbvies-ra-candidate-meets-primary-endpoints-in-phase-iii-2018-04-10", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-idcc-dal-biib-2018-04-10", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-nextera-danaher-biogen-facebook-and-apple-2018-04-12", "https://www.nasdaq.com/articles/why-avexis-inc-stock-soaring-today-2018-04-09", "https://www.nasdaq.com/articles/novartis-inks-%248.7-billion-gene-therapy-deal-to-buy-avexis-2018-04-09", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-472018-2018-04-07", "https://www.nasdaq.com/articles/biogen-cracks-the-case-with-abbvie-for-humira-biosimilar-2018-04-06", "https://www.nasdaq.com/articles/expect-chaos-continue-todays-jobs-report-2018-04-06", "https://www.nasdaq.com/articles/nasdaq-100-movers-mu-fb-2018-04-05", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-ibb-biib-vrtx-ilmn-2018-04-04", "https://www.nasdaq.com/articles/novartis-acquisition-avexis-takes-aim-biogen-2018-04-10", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-biogen-inc-2018-03-25", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-inc-buy-2018-03-24", "https://www.nasdaq.com/articles/better-buy-celgene-corporation-vs-biogen-inc-2018-03-22", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-oef-chtr-dhr-biib-2018-03-21", "https://www.nasdaq.com/articles/buy-bottom-biogen-inc-stock-100-return-2018-03-20", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-abbvie-novartis-teva-and-celgene-2018-03-19", "https://www.nasdaq.com/articles/despite-struggles-celgene-corporation-stock-still-buy-2018-03-19", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-inc-2018-03-30", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-warren-buffett-3182018-2018-03-18", "https://www.nasdaq.com/articles/why-multiple-sclerosis-is-a-promising-but-risky-space-2018-03-16", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-regn-cuts-praluent-price-orex-to-file-for-bankruptcy-2018-03-14", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-15-2018-2018-03-14", "https://www.nasdaq.com/articles/bull-day-regeneron-regn-2018-03-14", "https://www.nasdaq.com/articles/biogen-inc-buy-2018-03-14", "https://www.nasdaq.com/articles/why-biogen-stock-slumped-february-2018-03-13", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-john-neff-3182018-2018-03-18", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-bbh-celg-biib-vrtx-2018-03-13", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-751101-down-7731-points-2018-03-13", "https://www.nasdaq.com/articles/biogen-now-oversold-biib-2018-03-12", "https://www.nasdaq.com/articles/health-care-sector-update-03122018-srptbiibpfesvraalnysny-2018-03-12", "https://www.nasdaq.com/articles/pdl-biopharma-pdli-q4-earnings-beat-revenues-rise-y-y-2018-03-09", "https://www.nasdaq.com/articles/are-alzheimers-focused-stocks-set-for-a-financial-windfall-2018-03-06", "https://www.nasdaq.com/articles/more-commercial-revenue-its-way-ionis-pharmaceuticals-2018-03-01", "https://www.nasdaq.com/articles/biogen-to-buy-mid-stage-neuropsychiatry-asset-from-pfizer-2018-03-13", "https://www.nasdaq.com/articles/notable-monday-option-activity-lgih-biib-khc-2018-02-26", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-celgene-corporation-2018-02-23", "https://www.nasdaq.com/articles/whats-in-the-cards-for-ionis-ions-this-earnings-season-2018-02-22", "https://www.nasdaq.com/articles/ionis-out-licenses-second-candidate-to-astrazeneca-earns-%2430m-2018-02-21", "https://www.nasdaq.com/articles/agree-purchase-biogen-270-earn-91-annualized-using-options-2018-02-20", "https://www.nasdaq.com/articles/ibb-biib-celg-regn-etf-inflow-alert-2018-02-20", "https://www.nasdaq.com/articles/buy-biogen-stock-dip-2018-02-19", "https://www.nasdaq.com/articles/biogen-biib-down-17.2-since-earnings-report%3A-can-it-rebound-2018-02-26", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2018-02-17", "https://www.nasdaq.com/articles/acorda-acor-q4-earnings-miss-estimates-revenues-beat-2018-02-16", "https://www.nasdaq.com/articles/fda-sets-the-stage-for-earlier-stage-alzheimers-treatments-2018-02-16", "https://www.nasdaq.com/articles/biogen-now-oversold-2018-02-16", "https://www.nasdaq.com/articles/notable-friday-option-activity-cohu-biib-fdx-2018-02-16", "https://www.nasdaq.com/articles/validea-warren-buffett-strategy-daily-upgrade-report-2152018-2018-02-15", "https://www.nasdaq.com/articles/why-biogen-may-seek-merger-wake-alzheimers-worries-2018-02-15", "https://www.nasdaq.com/articles/valideas-top-five-healthcare-stocks-based-warren-buffett-2182018-2018-02-18", "https://www.nasdaq.com/articles/merck-mrk-halts-another-late-stage-study-on-alzheimers-2018-02-14", "https://www.nasdaq.com/articles/nasdaq-composite-index-closes-3155-points-week-rising-4th-straight-day-2018-02-14", "https://www.nasdaq.com/articles/why-biogen-groupon-and-omeros-slumped-today-2018-02-14", "https://www.nasdaq.com/articles/biib-makes-notable-cross-below-critical-moving-average-2018-02-14", "https://www.nasdaq.com/articles/heres-why-alkermes-spiked-today-2018-02-14", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-14-2018-2018-02-13", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2018-02-10", "https://www.nasdaq.com/articles/alkermes-alks-beats-q4-earnings-revenue-estimates-2018-02-15", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-novartis-bp-and-biogen-2018-02-09", "https://www.nasdaq.com/articles/notable-friday-option-activity-pwr-biib-itw-2018-02-09", "https://www.nasdaq.com/articles/biogen-halts-tysabri-development-in-stroke-as-study-fails-2018-02-08", "https://www.nasdaq.com/articles/analysts-expect-mgk-hit-128-2018-02-08", "https://www.nasdaq.com/articles/3-top-obesity-drug-stocks-consider-buying-now-2018-02-03", "https://www.nasdaq.com/articles/could-sanofis-ablynx-deal-spur-biopharma-buying-spree-2018-01-29", "https://www.nasdaq.com/articles/indexes-edge-lower-dr-pepper-surges-goldman-leads-dow-2018-01-29", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-2102018-2018-02-10", "https://www.nasdaq.com/articles/biogen-inc-caps-solid-2017-waits-aducanumab-2018-01-29", "https://www.nasdaq.com/articles/biogen-inc-beckoning-bulls-2018-01-26", "https://www.nasdaq.com/articles/why-insurers-havent-and-wont-push-back-rare-disease-drugs-2018-01-26", "https://www.nasdaq.com/articles/5-biotech-and-pharmaceutical-stocks-going-bonkers-2018-01-26", "https://www.nasdaq.com/articles/biogen-earns-relative-strength-rating-upgrade-hits-key-threshold-2018-01-26", "https://www.nasdaq.com/articles/biogen-sees-its-composite-rating-rise-98-2018-01-26", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-tmo-biib-antm-2018-01-25", "https://www.nasdaq.com/articles/sanofi-will-buy-ablynx-48-billion-heels-116-billion-bioverativ-deal-2018-01-29", "https://www.nasdaq.com/articles/health-care-sector-update-01252018-jnj-pfe-abt-mrk-amgn-var-xlnx-kpti-ocul-smmt-sn-2018-01", "https://www.nasdaq.com/articles/biogen-biib-q4-earnings-miss-sales-top-stock-up-2018-01-25", "https://www.nasdaq.com/articles/nasdaq-rebounds-intel-boeing-lift-dow-varian-nails-breakout-2018-01-25", "https://www.nasdaq.com/articles/biogen-revenue-tops-spinraza-ms-drugs-deliver-upside-2018-01-25", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-500-follow-through-indicator-51-sensitive-2018-01-25", "https://www.nasdaq.com/articles/health-care-sector-update-01252018-oculkptibiibsnnxlnx-2018-01-25", "https://www.nasdaq.com/articles/health-care-sector-update-01252018-kptibiibsnnxlnx-2018-01-25", "https://www.nasdaq.com/articles/biogen-biib-q4-earnings-miss-sales-top-2018-view-upbeat-2018-01-25", "https://www.nasdaq.com/articles/pre-market-earnings-report-january-25-2018-mmm-unp-cat-celg-biib-rtn-noc-px-shw-luv-fcau", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-lvs-hlf-biib-2018-01-24", "https://www.nasdaq.com/articles/intel-starbucks-biotechs-lead-earnings-rush-investing-action-plan-2018-01-24", "https://www.nasdaq.com/articles/3-pharma-and-biotech-stocks-to-watch-out-for-in-2018-2018-01-23", "https://www.nasdaq.com/articles/first-trust-mega-cap-alphadex-fund-insider-buying-index-registering-109-2018-01-23", "https://www.nasdaq.com/articles/biotech-ma-strong-start-2018-more-deals-follow-2018-01-23", "https://www.nasdaq.com/articles/insiders-were-right-biib-makes-new-52-week-high-2018-01-23", "https://www.nasdaq.com/articles/will-sanofis-big-hemophilia-deal-pay-2018-01-24", "https://www.nasdaq.com/articles/why-2017-was-year-remember-ionis-pharmaceuticals-inc-2018-01-22", "https://www.nasdaq.com/articles/celgene-will-buy-juno-therapeutics-9-billion-sanofi-acquires-bioverativ-2018-01-22", "https://www.nasdaq.com/articles/whats-in-the-cards-for-biogen-biib-this-earnings-season-2018-01-22", "https://www.nasdaq.com/articles/sanofi-to-acquire-haemophilia-focused-bioverativ-stock-dips-2018-01-22", "https://www.nasdaq.com/articles/why-bioverativ-inc-stock-soaring-today-2018-01-22", "https://www.nasdaq.com/articles/bioverativ-inc-stock-gets-64-premium-acquisition-sanofi-2018-01-22", "https://www.nasdaq.com/articles/will-biotechs-merger-spigot-turn-after-juno-bioverativ-2018-01-22", "https://www.nasdaq.com/articles/sanofis-bioverative-inc-buyout-just-start-2018-01-22", "https://www.nasdaq.com/articles/correction-futures-reverse-early-gains-focus-shifts-washington-2018-01-19", "https://www.nasdaq.com/articles/futures-reverse-early-gains-focus-shifts-washington-2018-01-19", "https://www.nasdaq.com/articles/stocks-rising-relative-strength-biogen-2018-01-18", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-psx-biib-jci-2018-01-17", "https://www.nasdaq.com/articles/3-pharma-and-biotech-stocks-watch-out-2018-2018-01-15", "https://www.nasdaq.com/articles/roche-ms-drug-ocrevus-gets-marketing-authorization-in-europe-2018-01-15", "https://www.nasdaq.com/articles/mid-day-update-wall-street-cautiously-optimistic-washington-scrambling-avert-shutdown-2018", "https://www.nasdaq.com/articles/will-2018-be-ionis-pharmaceuticals-incs-best-year-yet-2018-01-13", "https://www.nasdaq.com/articles/biogen-trying-close-key-technical-measure-2018-01-11", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-mck-abbv-biib-2018-01-09", "https://www.nasdaq.com/articles/nasdaq-100-movers-shpg-stx-2018-01-08", "https://www.nasdaq.com/articles/pfizer-to-stall-rd-for-alzheimers-parkinsons-cut-jobs-2018-01-08", "https://www.nasdaq.com/articles/monday-sector-laggards-healthcare-services-2018-01-08", "https://www.nasdaq.com/articles/biogen-unlikely-see-spinraza-rival-2018-avexis-delayed-2018-01-05", "https://www.nasdaq.com/articles/will-2018-be-biogen-incs-best-year-yet-2018-01-14", "https://www.nasdaq.com/articles/biotech-stock-roundup-gwph-submits-epidiolex-eu-sangamo-inks-deal-pfizer-2018-01-04", "https://www.nasdaq.com/articles/stocks-generating-improved-relative-strength-biogen-2018-01-03", "https://www.nasdaq.com/articles/generalists-biotech-sidelines-tax-reform-sweeps-us-2018-01-03", "https://www.nasdaq.com/articles/tuesday-sector-leaders-healthcare-services-2018-01-02", "https://www.nasdaq.com/articles/best-stocks-2017-biotechs-shined-despite-lack-profits-2017-12-29", "https://www.nasdaq.com/articles/another-reason-2018-might-not-be-banner-year-biotech-mergers-2017-12-27", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-xlv-gild-lly-biib-2017-12-27", "https://www.nasdaq.com/articles/iwf-nvda-low-biib-etf-outflow-alert-2018-01-05", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-pfizer-fedex-abbott-biogen-and-marathon-petroleum-2017", "https://www.nasdaq.com/articles/biogen-shares-drop-after-alzheimers-drug-misses-testing-2017-12-21", "https://www.nasdaq.com/articles/nasdaq-100-movers-payx-ntes-2017-12-21", "https://www.nasdaq.com/articles/top-8-market-moving-healthcare-stories-2017-2017-12-21", "https://www.nasdaq.com/articles/celgene-whacked-after-blood-drug-regimen-fails-phase-3-trial-2017-12-21", "https://www.nasdaq.com/articles/stocks-inch-higher-shutdown-threat-looms-2017-12-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-biib-celg-hit-pipeline-news-acquisition-deals-ignyta-sucampo-2017-12", "https://www.nasdaq.com/articles/notable-thursday-option-activity-kmx-biib-algn-2017-12-21", "https://www.nasdaq.com/articles/3-pharma-biotech-pipeline-areas-keep-eye-2018-2017-12-20", "https://www.nasdaq.com/articles/biogen-ionis-ink-deal-for-spinal-muscular-atrophy-therapies-2017-12-20", "https://www.nasdaq.com/articles/orbimed-advisors-llc-buys-clementia-pharmaceuticals-inc-aetna-inc-universal-health", "https://www.nasdaq.com/articles/biotech-stock-roundup-label-expansion-exelixiss-cabometyx-fda-nod-sparks-gene-therapy-2017", "https://www.nasdaq.com/articles/indexes-dip-tax-reform-gets-done-bullish-sentiment-rises-2017-12-20", "https://www.nasdaq.com/articles/stock-leads-oil-plays-apple-fine-how-far-will-bitcoin-etf-fall-2017-12-20", "https://www.nasdaq.com/articles/top-research-reports-for-pfizer-fedex-abbott-2017-12-21", "https://www.nasdaq.com/articles/biogen-ionis-sink-competitor-plans-rival-drug-spinraza-2017-12-14", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-december-14-2017-2017-12-13", "https://www.nasdaq.com/articles/5-biotech-buyout-candidates-2018-2017-12-13", "https://www.nasdaq.com/articles/biogen-sees-rs-rating-rise-72-2017-12-12", "https://www.nasdaq.com/articles/these-5-top-stocks-are-near-buys-bullish-pattern-action-plan-2017-12-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-amgen-pcsk9-inhibitor-revance-rt002-data-2017-12-06", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-biib-wfc-trox-2017-12-06", "https://www.nasdaq.com/articles/stocks-close-lower-oracle-falls-after-earnings-2017-12-14", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iyh-tmo-biib-aet-2017-12-04", "https://www.nasdaq.com/articles/sp-500-analyst-moves-biib-2017-11-30", "https://www.nasdaq.com/articles/heres-whats-unusual-about-regeneron-pharmaceuticals-latest-deal-2017-11-30", "https://www.nasdaq.com/articles/thursday-1130-insider-buying-report-biib-mdco-2017-11-30", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amazon-abbvie-biogen-mccormick-and-hyatt-2017-11-30", "https://www.nasdaq.com/articles/no-1-ranked-medical-stock-tests-support-new-base-2017-11-30", "https://www.nasdaq.com/articles/biotech-stock-roundup-regeneron-down-eylea-data-biogen-alkermes-ms-deal-2017-11-29", "https://www.nasdaq.com/articles/looking-top-stocks-strongest-performing-sectors-2017-12-05", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iyh-tmo-biib-aet-2017-12-04", "https://www.nasdaq.com/articles/sp-500-analyst-moves-biib-2017-11-30", "https://www.nasdaq.com/articles/sphera-funds-management-ltd-buys-cellcom-israel-allergan-plc-teva-pharmaceutical-0", "https://www.nasdaq.com/articles/biogens-multiple-sclerosis-franchise-getting-new-lease-life-2017-11-27", "https://www.nasdaq.com/articles/zacks-value-trader-highlights%3A-general-electric-macys-biogen-chipotle-and-exxon-mobil-2017", "https://www.nasdaq.com/articles/biogen-inc-buys-its-way-out-competition-2017-11-27", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-biib-tsn-ilmn-2017-11-27", "https://www.nasdaq.com/articles/biogen-acquires-worldwide-license-for-alkermes-ms-candidate-revised-2017-11-29", "https://www.nasdaq.com/articles/biotech-stock-roundup-rare-drug-gets-fda-nod-acorda-cytokinetics-hit-pipeline-setbacks", "https://www.nasdaq.com/articles/bet-biogen-inc-easy-profits-new-year-2017-11-21", "https://www.nasdaq.com/articles/ibd-rating-upgrades-biogen-shows-improved-price-strength-2017-11-20", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-2017-11-18", "https://www.nasdaq.com/articles/why-its-time-put-pfizer-inc-stock-your-watchlist-2017-11-17", "https://www.nasdaq.com/articles/americafirst-capital-management-llc-buys-sysco-corp-exelon-corp-thermo-fisher-scientific", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-16-2017-2017-11-15", "https://www.nasdaq.com/articles/should-you-buy-beaten-down-blue-chip-stocks-2017-11-22", "https://www.nasdaq.com/articles/can-marijuana-cure-alzheimers-disease-2017-11-13", "https://www.nasdaq.com/articles/better-buy-acadia-pharmaceuticals-vs-biogen-2017-11-11", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-earnings-results-fuel-volatility-2017-11-10", "https://www.nasdaq.com/articles/sphera-funds-management-ltd-buys-cellcom-israel-allergan-plc-teva-pharmaceutical", "https://www.nasdaq.com/articles/ionis-shares-dip-after-third-quarter-sales-earnings-miss-2017-11-07", "https://www.nasdaq.com/articles/biogen-shows-rising-relative-strength-still-shy-key-threshold-2017-11-06", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-11152017-2017-11-15", "https://www.nasdaq.com/articles/westend-advisors-llc-buys-bank-america-corporation-spdr-portfolio-short-term-corporate", "https://www.nasdaq.com/articles/biogen-sees-ibd-rs-rating-climb-73-2017-11-02", "https://www.nasdaq.com/articles/stoneridge-investment-partners-llc-buys-altria-group-inc-mondelez-international-inc-merck", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-ionis-ions-this-earnings-season-2017-11-01", "https://www.nasdaq.com/articles/acorda-acor-q3-earnings-lag-estimates-revenues-up-y-y-2017-11-01", "https://www.nasdaq.com/articles/biogen-sees-relative-strength-rating-climb-75-2017-10-31", "https://www.nasdaq.com/articles/pdl-biopharma-pdli-q3-earnings-beat-revenues-rise-y-y-2017-11-03", "https://www.nasdaq.com/articles/stocks-turn-red-tax-cut-report-these-2-iphone-chip-suppliers-break-out-2017-10-30", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-bbh-biib-q-shpg-2017-10-30", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-10272017-2017-10-27", "https://www.nasdaq.com/articles/key-predictions-for-q3-earnings-reports-of-abbv-mrk-2017-10-26", "https://www.nasdaq.com/articles/5-biotech-stocks-that-are-getting-battered-too-hard-for-comfort-2017-10-26", "https://www.nasdaq.com/articles/whats-biogens-big-risk-2017-10-25", "https://www.nasdaq.com/articles/biogen-inc-content-resilience-its-multiple-sclerosis-franchise-2017-10-25", "https://www.nasdaq.com/articles/ionis-down-big-analyst-miss-2017-10-31", "https://www.nasdaq.com/articles/biogen-biib-tops-q3-earnings-sales-spinraza-sales-up-2017-10-24", "https://www.nasdaq.com/articles/why-ionis-pharmaceuticals-inc-slipped-morning-2017-10-24", "https://www.nasdaq.com/articles/mid-day-market-update-dow-rises-175-points-identiv-shares-plunge-2017-10-24", "https://www.nasdaq.com/articles/3-big-stock-charts-for-tuesday%3A-biogen-inc-biib-lockheed-martin-corporation-lmt-and", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-has-2017-10-24", "https://www.nasdaq.com/articles/sp-500-movers-whr-glw-2017-10-24", "https://www.nasdaq.com/articles/lilly-lly-beats-on-q3-earnings-explores-sale-of-elanco-2017-10-24", "https://www.nasdaq.com/articles/industrial-strength-rebound-dow-2017-10-25", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-tumbles-biogens-miss-buy-or-sell-2017-10-24", "https://www.nasdaq.com/articles/biogen-biib-beats-on-q3-earnings-and-revenue-2017-10-24", "https://www.nasdaq.com/articles/biogen-dives-despite-topping-views-lilly-novartis-beat-2017-10-24", "https://www.nasdaq.com/articles/validea-warren-buffett-strategy-daily-upgrade-report-10242017-2017-10-24", "https://www.nasdaq.com/articles/3-gene-therapy-stocks-could-make-you-rich-2017-10-23", "https://www.nasdaq.com/articles/key-predictions-for-q3-earnings-reports-of-lly-biib-nvs-2017-10-23", "https://www.nasdaq.com/articles/ibds-no-1-group-under-pressure-these-6-key-earnings-loom-sp-500-futures-2017-10-23", "https://www.nasdaq.com/articles/morning-movers-more-cuts-geand-more-earnings-you-can-shake-stick-2017-10-24", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-biib-intc-fcx-2017-10-23", "https://www.nasdaq.com/articles/ishares-us-healthcare-etf-experiences-big-inflow-2017-10-20", "https://www.nasdaq.com/articles/zacks-market-edge-highlights%3A-gilead-biogen-teva-abbvie-and-aetna-2017-10-19", "https://www.nasdaq.com/articles/biogen-biib-q3-earnings%3A-will-it-deliver-a-beat-again-2017-10-18", "https://www.nasdaq.com/articles/biotech-stock-roundup-exelixis-soars-priority-review-fda-panel-supports-spark-drug-2017-10", "https://www.nasdaq.com/articles/stock-indexes-slightly-trump-threatens-drug-firms-2017-10-17", "https://www.nasdaq.com/articles/nasdaq-100-movers-stx-ulta-2017-10-17", "https://www.nasdaq.com/articles/pre-market-earnings-report-october-24-2017-mcd-mmm-utx-lly-lmt-cat-biib-gm-shw-nvs-glw", "https://www.nasdaq.com/articles/where-find-value-healthcare-stocks-2017-10-17", "https://www.nasdaq.com/articles/3-drug-stocks-hitting-52-week-highs-are-they-buys-2017-10-17", "https://www.nasdaq.com/articles/tuesday-sector-leaders-healthcare-utilities-2017-10-17", "https://www.nasdaq.com/articles/biib-crosses-above-average-analyst-target-2017-10-16", "https://www.nasdaq.com/articles/ibd-biotech-innovator-awards-2017-10-16", "https://www.nasdaq.com/articles/6-top-biotech-companies-innovation-earn-recognition-new-awards-2017-10-16", "https://www.nasdaq.com/articles/biogen-biomarkers-mark-way-alzheimers-parkinsons-treatments-2017-10-16", "https://www.nasdaq.com/articles/goldman-morgan-stanley-gain-earnings-spirit-airlines-flies-2017-10-17", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-fcx-bmy-biib-2017-10-16", "https://www.nasdaq.com/articles/why-these-biotech-players-look-poised-crush-earnings-views-2017-10-13", "https://www.nasdaq.com/articles/no-1-ranked-medical-stock-breaking-out-q3-earnings-due-2017-10-12", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-celgene-2017-10-10", "https://www.nasdaq.com/articles/emergent-biosolutions-acquires-sanofis-smallpox-vaccine-unit-2017-10-09", "https://www.nasdaq.com/articles/intercept-dives-along-ocaliva-prescriptions-fda-warning-2017-10-06", "https://www.nasdaq.com/articles/no-side-effects-to-this-bullish-trade-on-celgene-corporation-celg-stock-2017-10-06", "https://www.nasdaq.com/articles/trump-likely-sign-executive-order-drug-pricing-any-day-2017-10-16", "https://www.nasdaq.com/articles/acadias-antipsychotic-drug-gets-breakthrough-therapy-status-2017-10-05", "https://www.nasdaq.com/articles/catabasis-dmd-candidate-slows-disease-progression-stock-up-2017-10-05", "https://www.nasdaq.com/articles/ligand-lgnd-signs-deal-to-acquire-crystal-bioscience-2017-10-05", "https://www.nasdaq.com/articles/nasdaq-100-movers-celg-nclh-2017-10-05", "https://www.nasdaq.com/articles/117-ovlc-holdings-seeing-recent-insider-buys-2017-10-05", "https://www.nasdaq.com/articles/morning-movers-constellation-brands-jumps-biogen-bounces-celgene-slips-2017-10-05", "https://www.nasdaq.com/articles/5-stocks-to-buy-as-they-drive-the-market-melt-up-2017-10-05", "https://www.nasdaq.com/articles/notable-friday-option-activity-gdot-biib-crm-2017-10-06", "https://www.nasdaq.com/articles/celsions-immunotherapy-candidate-impresses-stock-surges-2017-10-04", "https://www.nasdaq.com/articles/emergent-completes-acquisition-of-anthrax-drug-raxibacumab-2017-10-04", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-vht-agn-tmo-biib-2017-10-04", "https://www.nasdaq.com/articles/nasdaq-100-movers-jd-myl-2017-10-04", "https://www.nasdaq.com/articles/allergans-botox-gets-fda-nod-for-forehead-line-treatment-2017-10-04", "https://www.nasdaq.com/articles/amgen-enters-into-an-immuno-oncology-partnership-with-cytomx-2017-10-04", "https://www.nasdaq.com/articles/zacks.com-featured-highlights-include-article-texas-instruments-applied-materials-pepsico", "https://www.nasdaq.com/articles/stocks-hold-gains-microsoft-amazoncom-aid-nasdaq-2017-10-05", "https://www.nasdaq.com/articles/after-intepirdine-flunked-alzheimers-disease-axovant-sciences-buy-2017-10-03", "https://www.nasdaq.com/articles/allergans-snda-for-anti-infective-avycaz-accepted-by-fda-2017-10-03", "https://www.nasdaq.com/articles/3-top-ranked-big-biotech-stocks-to-buy-now-2017-10-03", "https://www.nasdaq.com/articles/5-top-roe-stocks-buy-markets-snub-geopolitical-threats-2017-10-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-procter-gamble-petrochina-biogen-accenture-and-norfolk", "https://www.nasdaq.com/articles/why-ptc-therapeutics-inc-dropped-today-2017-10-03", "https://www.nasdaq.com/articles/endocyte-inks-deal-for-prostate-cancer-candidate-shares-up-2017-10-03", "https://www.nasdaq.com/articles/mallinckrodt-neuroprotexeon-team-up-for-inhalation-therapy-2017-10-03", "https://www.nasdaq.com/articles/novo-nordisks-fiasp-gets-fda-nod-for-diabetes-in-adults-2017-10-02", "https://www.nasdaq.com/articles/lilly-lly-makes-leadership-changes-to-executive-positions-2017-10-02", "https://www.nasdaq.com/articles/top-stock-reports-procter-gamble-petrochina-biogen-2017-10-02", "https://www.nasdaq.com/articles/top-stock-reports-for-procter-gamble-petrochina-biogen-2017-10-02", "https://www.nasdaq.com/articles/4-biotech-stocks-and-1-etf-to-buy-as-they-bolt-higher-2017-10-02", "https://www.nasdaq.com/articles/notable-friday-option-activity-biib-rjf-tsn-2017-09-29", "https://www.nasdaq.com/articles/biotechs-beating-market-are-they-buy-range-2017-09-28", "https://www.nasdaq.com/articles/avexis-flies-ptc-sinks-spinal-muscular-atrophy-data-2017-10-03", "https://www.nasdaq.com/articles/moat-oilu-big-etf-outflows-2017-09-26", "https://www.nasdaq.com/articles/is-biogen-inc.-biib-a-great-stock-for-value-investors-2017-09-25", "https://www.nasdaq.com/articles/sorry-qualcomm-inc.-qcom-stock-bears-it-has-bottomed-2017-09-19", "https://www.nasdaq.com/articles/play-the-support-test-in-vaneck-vectors-gold-miners-etf-gdx-2017-09-19", "https://www.nasdaq.com/articles/think-before-you-chase-nvidia-corporation-nvda-stocks-momentum-2017-09-19", "https://www.nasdaq.com/articles/profit-from-the-biogen-inc-biib-stock-dip-2017-09-19", "https://www.nasdaq.com/articles/billionaire-george-soros-fund-bought-these-3-pharma-stocks-should-you-2017-09-18", "https://www.nasdaq.com/articles/why-amgens-drug-win-sent-abbvie-stock-stratosphere-2017-09-28", "https://www.nasdaq.com/articles/4-biotech-stocks-for-the-long-term-2017-09-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-14-2017-2017-09-13", "https://www.nasdaq.com/articles/biib-january-2020-options-begin-trading-2017-09-11", "https://www.nasdaq.com/articles/why-biogen-stock-raced-higher-august-2017-09-11", "https://www.nasdaq.com/articles/biogen-reaches-analyst-target-price-2017-09-11", "https://www.nasdaq.com/articles/abbvie-submits-nda-for-endometriosis-candidate-to-the-fda-2017-09-07", "https://www.nasdaq.com/articles/novartis-nvs-ms-drug-gilenya-positive-in-long-term-study-2017-09-06", "https://www.nasdaq.com/articles/ibb-biib-regn-alxn-etf-inflow-alert-2017-09-15", "https://www.nasdaq.com/articles/4-biotech-stocks-for-the-long-term-2017-09-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-14-2017-2017-09-13", "https://www.nasdaq.com/articles/biib-january-2020-options-begin-trading-2017-09-11", "https://www.nasdaq.com/articles/vanguard-russell-1000-etf-insider-buying-index-registering-119-2017-08-28", "https://www.nasdaq.com/articles/monday-sector-leaders-healthcare-technology-communications-2017-08-28", "https://www.nasdaq.com/articles/consider-you-buy-biogen-2017-08-27", "https://www.nasdaq.com/articles/thursday-sector-leaders-healthcare-energy-2017-08-31", "https://www.nasdaq.com/articles/steven-cohen-plunges-opioid-replacement-maker-pacira-2017-08-24", "https://www.nasdaq.com/articles/biotech-stock-roundup-eu-label-expansion-alexion-biib-facing-drug-price-probe-2017-08-23", "https://www.nasdaq.com/articles/heres-simple-reason-why-multiple-sclerosis-drugs-cost-so-much-2017-08-23", "https://www.nasdaq.com/articles/orbimed-advisors-llc-buys-cigna-corp-clovis-oncology-inc-gilead-sciences-inc-sells-centene", "https://www.nasdaq.com/articles/biogen-6-other-multiple-sclerosis-drug-stocks-focus-heres-why-2017-08-21", "https://www.nasdaq.com/articles/we-did-math-oef-can-go-119-2017-08-18", "https://www.nasdaq.com/articles/orbimed-advisors-llc-buys-cigna-corp-clovis-oncology-inc-gilead-sciences-inc-sells-0", "https://www.nasdaq.com/articles/biogens-humira-biosimilar-imraldi-gets-approval-in-eu-2017-08-25", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-tqqq-goog-amgn-biib-2017-08-16", "https://www.nasdaq.com/articles/what-you-see-and-what-you-get-neurology-perception-2017-08-15", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-15-2017-2017-08-14", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-inc-growing-royalties-advancing-pipeline-and-getting-back-rights", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-activision-cigna-kraft-heinz-and-equinix-2017-08", "https://www.nasdaq.com/articles/noteworthy-etf-inflows-vht-tmo-biib-aet-2017-08-08", "https://www.nasdaq.com/articles/top-analyst-reports-biogen-activision-cigna-2017-08-08", "https://www.nasdaq.com/articles/notable-thursday-option-activity-de-nvda-biib-2017-08-17", "https://www.nasdaq.com/articles/pdl-biopharma-pdli-q2-earnings-beat-revenues-rise-y-y-2017-08-07", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-biogen-2017-08-04", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-ionis-ions-this-earnings-season-2017-08-01", "https://www.nasdaq.com/articles/7-explosive-healthcare-stocks-to-buy-now-2017-07-31", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-vht-lly-tmo-biib-2017-07-28", "https://www.nasdaq.com/articles/acorda-acor-q2-earnings-miss-estimates-revenues-in-line-2017-07-28", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-biogen-top-q2-estimates-update-incyte-ra-drug-2017-07-26", "https://www.nasdaq.com/articles/these-3-biotechs-just-crushed-analyst-expectations-2017-08-07", "https://www.nasdaq.com/articles/pdl-biopharma-pdli-q2-earnings-beat-revenues-rise-y-y-2017-08-07", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-biogen-2017-08-04", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-ionis-ions-this-earnings-season-2017-08-01", "https://www.nasdaq.com/articles/lilly-lly-q2-earnings-top-baricitinib-re-filing-delayed-2017-07-25", "https://www.nasdaq.com/articles/biogen-biib-tops-q2-earnings-and-revenue-2017-07-25", "https://www.nasdaq.com/articles/wal-mart-stores-inc-wmt-stock-is-perking-up-2017-07-25", "https://www.nasdaq.com/articles/market-close-report-historical-high-reached-nasdaq-composite-index-closes-642275-2017-07", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-583-follow-through-indicator-53-sensitive-2017-07-25", "https://www.nasdaq.com/articles/biogen-biib-tops-q2-earnings-sales-spinraza-sales-up-2017-07-25", "https://www.nasdaq.com/articles/big-pharma-q2-earnings-releases-on-jul-25%3A-lly-biib-amgn-2017-07-24", "https://www.nasdaq.com/articles/pre-market-earnings-report-july-25-2017-mmm-mcd-utx-lly-dd-cat-biib-gm-kmb-hca-pcar-trow", "https://www.nasdaq.com/articles/these-5-drugs-could-be-worth-45-billion-and-theyre-not-even-market-yet-2017-07-23", "https://www.nasdaq.com/articles/itot-tmo-cost-biib-etf-inflow-alert-2017-07-20", "https://www.nasdaq.com/articles/can-biogen-biib-keep-the-earnings-streak-alive-in-q2-2017-07-19", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-tuesday%3A-alphabet-inc-googl-biogen-inc-biib-and-michael-kors-holdings", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-583-follow-through-indicator-53-sensitive-2017-07-25", "https://www.nasdaq.com/articles/insiders-buy-holdings-bbh-etf-2017-07-18", "https://www.nasdaq.com/articles/avexis-inc-buy-high-2017-07-18", "https://www.nasdaq.com/articles/biogen-breaks-above-200-day-moving-average-bullish-biib-2017-07-17", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-vhc-agn-biib-2017-07-17", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-celgene-corporation-2017-07-16", "https://www.nasdaq.com/articles/top-stock-reports-boeing-abbvie-us-bancorp-2017-07-13", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-boosted-cf-data-fda-nod-gilead-puma-drugs-2017-07-19", "https://www.nasdaq.com/articles/math-shows-bbh-can-go-140-2017-07-12", "https://www.nasdaq.com/articles/amgen-inc.-amgn-stock-is-the-cure-for-ailing-portfolios-2017-07-10", "https://www.nasdaq.com/articles/bib-biib-regn-vrtx-etf-outflow-alert-2017-07-10", "https://www.nasdaq.com/articles/3-hot-biotech-stocks-ready-sectors-next-breakout-2017-07-06", "https://www.nasdaq.com/articles/biotech-stock-roundup-cara-plunges-study-data-regulatory-updates-more-2017-07-05", "https://www.nasdaq.com/articles/3-reasons-sizzling-hot-bioverativ-stock-can-go-even-higher-2017-07-05", "https://www.nasdaq.com/articles/3-best-performing-stocks-june-2017-07-03", "https://www.nasdaq.com/articles/how-biogen-inc-makes-most-its-money-2017-07-13", "https://www.nasdaq.com/articles/4-reasons-avexis-inc-rally-could-continue-2017-07-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-eu-nod-regeneron-ra-drug-portola-soars-fda-nod-2017-06-29", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-jkd-mo-biib-antm-2017-06-26", "https://www.nasdaq.com/articles/update-wall-street-weighed-down-oil-declines-health-stocks-lift-nasdaq-2017-06-21", "https://www.nasdaq.com/articles/5-biotech-stocks-that-are-roaring-back-to-life-2017-06-21", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-cmg-biib-aapl-2017-06-21", "https://www.nasdaq.com/articles/7-healthcare-stocks-to-buy-now-2017-06-21", "https://www.nasdaq.com/articles/3-charts-show-why-buy-gilead-sciences-stock-now-2017-07-02", "https://www.nasdaq.com/articles/bear-day-bioverativ-bivv-2017-06-16", "https://www.nasdaq.com/articles/nektar-nktr-stock-rallied-almost-50-this-year%3A-heres-why-2017-06-16", "https://www.nasdaq.com/articles/will-these-cutting-edge-cancer-killers-reignite-biotech-rally-2017-06-15", "https://www.nasdaq.com/articles/dont-be-scared-of-biogen-inc-biib-stock-2017-06-15", "https://www.nasdaq.com/articles/biogen-loses-top-executive-again-cfo-clancy-to-join-alexion-2017-06-14", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-alxn-2017-06-14", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-wednesday%3A-ford-motor-company-f-alexion-pharmaceuticals-inc.-alxn-and", "https://www.nasdaq.com/articles/monday-sector-leaders-healthcare-technology-communications-2017-06-19", "https://www.nasdaq.com/articles/noteworthy-wednesday-option-activity-aapl-biib-cmg-2017-06-14", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-14-2017-2017-06-13", "https://www.nasdaq.com/articles/insiders-buy-holdings-vone-etf-2017-06-12", "https://www.nasdaq.com/articles/2-reasons-why-biogens-shares-slumped-may-2017-06-09", "https://www.nasdaq.com/articles/3-stocks-could-be-life-changers-2017-06-06", "https://www.nasdaq.com/articles/why-ionis-pharmaceuticals-inc-swooned-6-may-2017-06-06", "https://www.nasdaq.com/articles/biogen-inc-biib-stock-can-help-you-earn-income-from-thin-air-2017-06-05", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-619489-down-2548-points-2017-06-14", "https://www.nasdaq.com/articles/biogen-ionis-spinraza-granted-marketing-authorization-in-eu-2017-06-02", "https://www.nasdaq.com/articles/notable-friday-option-activity-len-biib-rrc-2017-06-02", "https://www.nasdaq.com/articles/5-drug-stocks-focus-world-ms-day-2017-05-31", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-unitedhealth-group-union-pacific-biogen-united", "https://www.nasdaq.com/articles/celgenes-stock-may-be-incredibly-overvalued-right-now-heres-why-2017-05-31", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-inc-2017-05-31", "https://www.nasdaq.com/articles/are-nektars-nktr-key-drugs-set-to-drive-growth-in-2017-2017-05-30", "https://www.nasdaq.com/articles/biotech-etf-experiences-big-outflow-2017-06-02", "https://www.nasdaq.com/articles/merck-mrk-buys-rights-to-anti-tau-antibody-for-alzheimer-2017-05-26", "https://www.nasdaq.com/articles/stock-exchange-time-reconsider-health-care-2017-05-26", "https://www.nasdaq.com/articles/biogen-biib-down-9.5-since-earnings-report%3A-can-it-rebound-2017-05-26", "https://www.nasdaq.com/articles/biogens-fampyra-conditional-approval-converted-to-standard-2017-05-25", "https://www.nasdaq.com/articles/jeff-ubben-buys-1-sells-1-1st-quarter-2017-05-24", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-jnj-c-biib-2017-05-24", "https://www.nasdaq.com/articles/biotech-stock-roundup-puma-soars-advisory-panel-vote-priority-review-kite-drug-2017-05-30", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-vv-biib-pypl-dhr-2017-05-18", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-inks-deal-boost-pipeline-sangamo-soars-pfizer-deal-2017-05-17", "https://www.nasdaq.com/articles/want-get-biotech-check-out-these-3-stocks-2017-05-16", "https://www.nasdaq.com/articles/biogen-biib-buys-stroke-candidate-cirara-for-%24120m-2017-05-16", "https://www.nasdaq.com/articles/notable-monday-option-activity-rtn-biib-mon-2017-05-15", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-15-2017-2017-05-12", "https://www.nasdaq.com/articles/biogen-enters-oversold-territory-biib-2017-05-11", "https://www.nasdaq.com/articles/why-long-term-investors-should-prefer-celgene-over-biogen-2017-05-21", "https://www.nasdaq.com/articles/ishares-russell-1000-growth-etf-experiences-big-outflow-2017-05-10", "https://www.nasdaq.com/articles/iyhs-underlying-holdings-could-mean-10-gain-potential-2017-05-09", "https://www.nasdaq.com/articles/why-biogen-inc-shareholders-have-something-worry-about-2017-05-07", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-exxon-mobil-jpmorgan-union-pacific-biogen-and-becton", "https://www.nasdaq.com/articles/friday-sector-laggards-healthcare-financial-2017-05-05", "https://www.nasdaq.com/articles/notable-friday-option-activity-biib-nwl-nke-2017-05-05", "https://www.nasdaq.com/articles/whats-in-the-cards-for-ionis-ions-this-earnings-season-2017-05-04", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-incs-first-royalties-roll-2017-05-11", "https://www.nasdaq.com/articles/top-research-reports-may-4-2017-2017-05-04", "https://www.nasdaq.com/articles/morningstar-wide-moat-etf-insider-buying-index-registering-120-2017-05-03", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-bib-biib-regn-ilmn-2017-05-02", "https://www.nasdaq.com/articles/tuesday-52-insider-buying-report-biib-wwd-2017-05-02", "https://www.nasdaq.com/articles/acorda-acor-q1-loss-wider-than-expected-revenues-miss-2017-04-28", "https://www.nasdaq.com/articles/better-buy-ionis-pharmaceuticals-inc-vs-bluebird-bio-2017-04-27", "https://www.nasdaq.com/articles/pharma-stocks-q1-earnings-roster-for-apr-27%3A-celg-abbv-bmy-2017-04-26", "https://www.nasdaq.com/articles/whats-behind-ionis-pharmaceuticals-20-rally-april-2017-05-04", "https://www.nasdaq.com/articles/biogen-inc-earnings-new-drug-sparks-life-2017-04-26", "https://www.nasdaq.com/articles/biogen-inc-biib-stock-pops-strong-q1-earnings-2017-04-25", "https://www.nasdaq.com/articles/nasdaq-100-movers-esrx-biib-2017-04-25", "https://www.nasdaq.com/articles/lilly-lly-tops-q1-earnings-misses-sales-shares-down-2017-04-25", "https://www.nasdaq.com/articles/biogen-biib-q1-earnings-sales-top-spinraza-sales-strong-2017-04-25", "https://www.nasdaq.com/articles/biogen-biib-beats-on-q1-earnings-and-revenue-2017-04-25", "https://www.nasdaq.com/articles/health-care-sector-update-04252017-biib-esrx-jnj-pfe-abt-mrk-amgn-2017-04-25", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2017-04-26", "https://www.nasdaq.com/articles/spinrazas-fast-start-puts-ionis-path-profit-2017-04-25", "https://www.nasdaq.com/articles/biogen-and-alzheimers-theres-fundamental-problem-here-2017-04-25", "https://www.nasdaq.com/articles/mondays-vital-data%3A-apple-inc.-aapl-visa-inc-v-and-micron-technology-inc-mu-2017-04-24", "https://www.nasdaq.com/articles/3-key-factors-look-out-biogens-q1-results-2017-04-24", "https://www.nasdaq.com/articles/make-biogen-inc-biib-stock-pay-you-even-with-no-dividend-2017-04-24", "https://www.nasdaq.com/articles/drug-stocks-q1-earnings-releases-on-apr-25%3A-lly-biib-nvs-2017-04-24", "https://www.nasdaq.com/articles/pre-market-earnings-report-april-25-2017-ko-mmm-mcd-lly-lmt-dd-biib-cat-spgi-vlo-glw-bhi", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-583-follow-through-indicator-50-sensitive-2017-04-25", "https://www.nasdaq.com/articles/3-stocks-growth-investors-should-love-2017-04-23", "https://www.nasdaq.com/articles/marijuana-stocks-420-special-2017-04-20", "https://www.nasdaq.com/articles/whats-in-store-for-biogen-biib-this-earnings-season-2017-04-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-crl-hits-incyte-pipeline-setbacks-weigh-oncomed-2017-04-19", "https://www.nasdaq.com/articles/bristol-myers-and-nordic-ink-biomarker-collaboration-deal-2017-04-18", "https://www.nasdaq.com/articles/7-most-expensive-prescription-drugs-world-2017-04-18", "https://www.nasdaq.com/articles/commit-buy-biogen-140-earn-26-using-options-2017-04-18", "https://www.nasdaq.com/articles/noteworthy-monday-option-activity-aapl-isrg-biib-2017-04-24", "https://www.nasdaq.com/articles/abbvies-elagolix-meets-primary-endpoint-in-phase-ii-study-2017-04-10", "https://www.nasdaq.com/articles/roche-just-scored-one-biggest-pharma-wins-2017-2017-04-10", "https://www.nasdaq.com/articles/3-big-stock-charts-for-friday%3A-biogen-inc-biib-american-airlines-group-inc-aal-and-cisco", "https://www.nasdaq.com/articles/acorda-acor-to-reduce-workforce-focus-on-product-pipeline-2017-04-06", "https://www.nasdaq.com/articles/peek-under-hood-bbh-has-14-upside-2017-04-05", "https://www.nasdaq.com/articles/wednesday-sector-laggards-utilities-healthcare-2017-04-05", "https://www.nasdaq.com/articles/3-biotech-trades-for-the-faux-doomsday-scenario-2017-04-03", "https://www.nasdaq.com/articles/biogen-to-license-alzheimer-candidate-from-bristol-myers-2017-04-17", "https://www.nasdaq.com/articles/why-acorda-therapeutics-inc-and-forward-pharma-got-crushed-today-2017-03-31", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-drops-50-points-trc-companies-shares-spike-higher-2017-03", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-px-biib-expe-2017-03-31", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-vrtx-2017-03-29", "https://www.nasdaq.com/articles/roches-ocrevus-wins-fda-approval-for-2-forms-of-sclerosis-2017-03-29", "https://www.nasdaq.com/articles/biotech-etfs-defy-trump-tweets-rally-what-can-send-them-higher-2017-03-28", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-down-repatha-data-nektar-surges-pain-results-2017-03-22", "https://www.nasdaq.com/articles/acordas-acor-ms-drug-patents-invalidated-shares-plunge-2017-04-03", "https://www.nasdaq.com/articles/health-care-sector-update-03212017-biibptieaxsm-2017-03-21", "https://www.nasdaq.com/articles/billionaires-best-healthcare-stock-picks-2017-so-far-2017-03-21", "https://www.nasdaq.com/articles/avexis-inc-stock-spiking-again-today-heres-why-2017-03-17", "https://www.nasdaq.com/articles/stock-market-news-for-march-17-2017-2017-03-17", "https://www.nasdaq.com/articles/alkermes-starts-phase-iii-study-to-treat-multiple-sclerosis-2017-03-17", "https://www.nasdaq.com/articles/mid-day-market-update-us-stocks-turn-negative-gopro-shares-spike-higher-2017-03-16", "https://www.nasdaq.com/articles/biib-crosses-below-key-moving-average-level-2017-03-16", "https://www.nasdaq.com/articles/3-biotech-stocks-are-broker-favorites-2017-03-21", "https://www.nasdaq.com/articles/sp-500-movers-biib-orcl-2017-03-16", "https://www.nasdaq.com/articles/biogen-inc-biib%3A-profit-from-the-biib-stock-bears-2017-03-16", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-590076-71-points-2017-03-16", "https://www.nasdaq.com/articles/thursday-sector-laggards-healthcare-utilities-2017-03-16", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-mpc-biib-hum-2017-03-16", "https://www.nasdaq.com/articles/thursdays-etf-movers-itb-bbh-2017-03-16", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-ibb-biib-regn-incy-2017-03-16", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-14-2017-2017-03-13", "https://www.nasdaq.com/articles/biogen-spinoff-takes-flight-focus-hemophilia-drugs-2017-03-10", "https://www.nasdaq.com/articles/abbvie-stock-upgraded-what-you-need-know-2017-03-10", "https://www.nasdaq.com/articles/why-ionis-pharmaceuticals-rallied-12-february-2017-03-09", "https://www.nasdaq.com/articles/biotech-stock-roundup-trump-tweet-hits-biotech-stocks-concert-gains-vertex-deal-2017-03-08", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-iyh-gild-agn-biib-2017-03-07", "https://www.nasdaq.com/articles/repros-rprx-q4-earnings%3A-whats-in-store-for-the-stock-2017-03-07", "https://www.nasdaq.com/articles/acordas-four-ampyra-patents-upheld-by-ptab-shares-rise-2017-03-13", "https://www.nasdaq.com/articles/5-things-biogens-ceo-just-said-you-dont-want-miss-2017-03-07", "https://www.nasdaq.com/articles/inovio-ino%3A-whats-in-the-cards-this-earnings-season-2017-03-06", "https://www.nasdaq.com/articles/biodelivery-bdsi%3A-whats-in-store-this-earnings-season-2017-03-06", "https://www.nasdaq.com/articles/4-things-alkermes-wants-investors-know-2017-03-06", "https://www.nasdaq.com/articles/new-features-individual-portfolio-tracker-and-value-screens-tracker-2017-03-03", "https://www.nasdaq.com/articles/why-celgenes-shares-rallied-higher-february-2017-03-02", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-att-visa-biogen-tesla-and-pge-2017-03-01", "https://www.nasdaq.com/articles/right-time-invest-biotech-stocks-2017-03-07", "https://www.nasdaq.com/articles/get-biogen-inc-biib-stock-it-breaks-out-2017-02-28", "https://www.nasdaq.com/articles/perrigo-to-sell-tysabri-royalties-issues-tepid-2017-view-2017-02-28", "https://www.nasdaq.com/articles/qual-kmb-peg-biib-etf-inflow-alert-2017-02-27", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-inc-2017-02-27", "https://www.nasdaq.com/articles/heres-why-celgenes-latest-drug-so-exciting-2017-02-23", "https://www.nasdaq.com/articles/andreas-halvorsen-buys-maker-first-class-cancer-treatments-calithera-biosciences-2017-02", "https://www.nasdaq.com/articles/did-biogen-inc-shoot-itself-foot-2017-02-21", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-inc-turns-profit-other-drugmakers-money-2017-03-01", "https://www.nasdaq.com/articles/3-top-drug-stocks-can-be-purchased-cheap-winter-2017-02-20", "https://www.nasdaq.com/articles/could-celgene-have-another-billion-dollar-blockbuster-its-hands-2017-02-19", "https://www.nasdaq.com/articles/why-ionis-pharmaceuticals-ions-looks-worth-risk-2017-02-16", "https://www.nasdaq.com/articles/another-potential-alzheimers-disease-treatment-bites-dust-whats-next-2017-02-15", "https://www.nasdaq.com/articles/bib-biib-regn-ilmn-large-outflows-detected-etf-2017-02-13", "https://www.nasdaq.com/articles/primecap-management-buys-astrazeneca-plc-alkermes-plc-whirlpool-sells-union-pacific-2017", "https://www.nasdaq.com/articles/potential-20-billion-indication-2-must-have-biotechs-taking-alzheimers-disease-2017-02-11", "https://www.nasdaq.com/articles/ionis-ions-q4-earnings%3A-whats-in-the-cards-for-the-stock-2017-02-21", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-13-2017-2017-02-10", "https://www.nasdaq.com/articles/how-biogen-inc-biib-stock-could-gain-another-25-2017-02-08", "https://www.nasdaq.com/articles/whats-behind-bioverativs-spin-out-and-should-you-buy-2017-02-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-gilead-report-4q-results-ariad-seeks-eu-nod-brigatinib-2017-02", "https://www.nasdaq.com/articles/ironic-twist-generics-take-aim-teva-pharmaceutical-2017-02-07", "https://www.nasdaq.com/articles/3-healthcare-tickers-that-will-return-profits-in-3-months-2017-02-06", "https://www.nasdaq.com/articles/why-biogen-inc-biib-stock-is-a-solid-long-term-bet-2017-02-03", "https://www.nasdaq.com/articles/biogen-risky-stock-2017-02-10", "https://www.nasdaq.com/articles/qual-kmb-peg-biib-etf-outflow-alert-2017-02-02", "https://www.nasdaq.com/articles/5-drugmakers-battle-over-10-billion-hemophilia-market-2017-02-02", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-tsco-2017-02-02", "https://www.nasdaq.com/articles/implied-ryh-analyst-target-price-172-2017-02-02", "https://www.nasdaq.com/articles/what-could-make-biogen-crash-2017-02-02", "https://www.nasdaq.com/articles/biotech-stock-roundup-celgene-biogen-abbv-post-q4-results-catabasis-falls-dmd-data-2017-02", "https://www.nasdaq.com/articles/why-forward-pharma-stock-surged-107-january-2017-02-03", "https://www.nasdaq.com/articles/biogen-inc-makes-lackluster-revenue-growth-2017-01-27", "https://www.nasdaq.com/articles/how-to-trade-biogen-inc-biib-stock-after-its-q4-beat-2017-01-26", "https://www.nasdaq.com/articles/biogen-biib-q4-earnings-top-estimates-17-sales-view-soft-2017-01-26", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-johnson-johnson-biogen-celgene-and-bristol-myers-squibb", "https://www.nasdaq.com/articles/biogen-biib-beats-on-q4-earnings-misses-sales-2017-01-26", "https://www.nasdaq.com/articles/3-top-biotech-stocks-you-can-still-buy-dow-20000-2017-01-26", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-500-follow-through-indicator-45-sensitive-2017-01-26", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-att-biogen-qualcomm-facebook-and-royal-caribbean-2017", "https://www.nasdaq.com/articles/perrigos-prgo-generic-version-of-topicort-okayed-by-fda-2017-01-25", "https://www.nasdaq.com/articles/drug-stock-earnings-to-watch-on-jan-26%3A-biib-celg-bmy-2017-01-25", "https://www.nasdaq.com/articles/pre-market-earnings-report-january-26-2017-cmcsa-celg-bmy-dow-biib-cat-f-rtn-noc-px-aep", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-inc-2017-01-24", "https://www.nasdaq.com/articles/biogen-inc-biib-stock-enters-uncharted-waters-2017-01-24", "https://www.nasdaq.com/articles/5-drugs-are-way-cheaper-canada-2017-01-21", "https://www.nasdaq.com/articles/nektar-therapeutics-undervalued-biopharmaceuticals-company-plenty-pipeline-2017-01-20", "https://www.nasdaq.com/articles/notable-thursday-option-activity-pypl-biib-mjn-2017-01-26", "https://www.nasdaq.com/articles/alcobra-stock-down-on-poor-late-stage-data-on-adhd-drug-2017-01-18", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-microsoft-biogen-home-depot-bristol-myers-and-berkshire", "https://www.nasdaq.com/articles/why-forward-pharma-stock-gained-482-tuesday-2017-01-18", "https://www.nasdaq.com/articles/biogen-to-pay-%241.25b-to-forward-pharma-in-tecfidera-lawsuit-2017-01-18", "https://www.nasdaq.com/articles/midday-update-stocks-pressured-trumps-dollar-warning-earnings-and-inauguration-sell-0ff", "https://www.nasdaq.com/articles/mid-day-market-update-clayton-williams-energy-surges-acquisition-news-christopher-banks", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-nano-biib-swks-2017-01-19", "https://www.nasdaq.com/articles/biogen-biib-q4-earnings%3A-whats-in-store-for-the-stock-2017-01-19", "https://www.nasdaq.com/articles/why-netflix-inc.-nflx-stock-could-pop-after-q4-earnings-2017-01-17", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-tuesday%3A-chipotle-mexican-grill-inc.-cmg-noble-energy-inc.-nbl-and", "https://www.nasdaq.com/articles/biogen-inc-biib-will-win-a-battle-but-could-lose-the-war-2017-01-17", "https://www.nasdaq.com/articles/why-clayton-williams-energy-forward-pharma-and-luxottica-jumped-today-2017-01-17", "https://www.nasdaq.com/articles/merrimack-mack-goes-uphill%3A-is-a-turnaround-likely-2017-01-17", "https://www.nasdaq.com/articles/biogens-multiple-sclerosis-franchise-to-drive-growth-in-2017-2017-01-17", "https://www.nasdaq.com/articles/agree-buy-biogen-180-earn-53-using-options-2017-01-17", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-morgan-stanley-tops-q4-estimates-2017-01-17", "https://www.nasdaq.com/articles/biogens-stock-ready-heat-after-forgettable-2016-2017-01-13", "https://www.nasdaq.com/articles/market-close-report-historical-high-reached-nasdaq-composite-index-closes-557412-2017-01", "https://www.nasdaq.com/articles/top-research-reports-alibaba-costco-walgreens-2017-01-13", "https://www.nasdaq.com/articles/energous-corp-shines-brightly-as-the-next-fortune-building-company-watt-2017-01-12", "https://www.nasdaq.com/articles/deja-vu-drug-stocks-trump-slams-drug-pricing-again-2017-01-12", "https://www.nasdaq.com/articles/close-update-wall-street-braces-sell-fact-reaction-after-inauguration-2017-01-17", "https://www.nasdaq.com/articles/biotech-stock-roundup-ariad-be-acquired-52b-vertex-outlook-falls-short-2017-01-11", "https://www.nasdaq.com/articles/biogen-inc-biib-stock-should-move-higher-in-2017-2017-01-11", "https://www.nasdaq.com/articles/notable-wednesday-option-activity-biib-mrk-amgn-2017-01-11", "https://www.nasdaq.com/articles/stock-market-news-for-january-10-2017-2017-01-10", "https://www.nasdaq.com/articles/3-big-reasons-and-8-smaller-ones-buy-ionis-pharmaceuticals-stock-2017-01-10", "https://www.nasdaq.com/articles/top-stocks-buy-now-21st-century-cures-act-has-passed-2017-01-09", "https://www.nasdaq.com/articles/could-very-well-be-greatest-drug-advancement-decade-2017-01-09", "https://www.nasdaq.com/articles/1-biotech-stock-i-want-own-2017-2017-01-11", "https://www.nasdaq.com/articles/biotech-investing-3-bold-predictions-2017-2017-01-06", "https://www.nasdaq.com/articles/biogens-new-ceo-lots-questions-few-answers-2017-01-06", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iyh-celg-biib-aet-2017-01-05", "https://www.nasdaq.com/articles/ionis-ions-stock-up-on-positive-type-ii-diabetes-drug-data-2017-01-05", "https://www.nasdaq.com/articles/5-slides-every-ionis-pharmaceuticals-inc-investor-needs-see-2017-01-05", "https://www.nasdaq.com/articles/did-biogen-just-throw-towel-celgene-2017-01-04", "https://www.nasdaq.com/articles/biotech-stock-roundup-inotek-plunges-pipeline-setback-kite-files-ind-study-initiation-2017", "https://www.nasdaq.com/articles/biogen-licenses-amunixs-xten-technology-for-factor-ix-drug-2017-01-06", "https://www.nasdaq.com/articles/my-worst-predictions-biotech-2016-2017-01-03", "https://www.nasdaq.com/articles/abbvies-humira-and-imbruvica-drive-performance-in-2016-2016-12-30", "https://www.nasdaq.com/articles/ishares-edge-msci-usa-quality-factor-etf-experiences-big-outflow-2016-12-28", "https://www.nasdaq.com/articles/biotech-stock-roundup-fda-nod-biogenionis-drug-seattle-genetics-hit-clinical-hold-2016-12", "https://www.nasdaq.com/articles/why-twilio-northern-dynasty-minerals-and-ionis-pharmaceuticals-slumped-today-2016-12-28", "https://www.nasdaq.com/articles/will-spinraza-supercharge-biogens-top-line-next-year-2016-12-28", "https://www.nasdaq.com/articles/health-care-sector-update-12272016-sgen-ions-jnj-pfe-abt-mrk-amgn-2016-12-27", "https://www.nasdaq.com/articles/biogen-playing-fire-2017-01-04", "https://www.nasdaq.com/articles/health-care-sector-update-12272016-ionsbiibcapnengx-2016-12-27", "https://www.nasdaq.com/articles/3-biggest-risks-abbvie-2017-2016-12-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-conatus-soars-novartis-deal-early-fda-nod-clovis-drug-2016-12-21", "https://www.nasdaq.com/articles/2016s-worst-clinical-failures-2016-12-21", "https://www.nasdaq.com/articles/biogen-biib-board-okays-hemophilia-business-spin-off-2016-12-21", "https://www.nasdaq.com/articles/christmas-came-early-these-biotech-stocks-2016-12-21", "https://www.nasdaq.com/articles/ionis-biogen-spinraza-approved-for-spinal-muscular-atrophy-2016-12-27", "https://www.nasdaq.com/articles/3-biggest-risks-pfizer-2017-2016-12-27", "https://www.nasdaq.com/articles/3-reasons-biogen-inc-stock-set-soar-2017-2016-12-20", "https://www.nasdaq.com/articles/3-low-volatility-biotech-stocks-buy-2016-12-18", "https://www.nasdaq.com/articles/oef-wba-twx-biib-etf-outflow-alert-2016-12-16", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-barclays-netflix-nike-biogen-and-china-petroleum", "https://www.nasdaq.com/articles/biotech-stock-roundup-ophthotech-slumps-fovista-results-achaogen-skyrockets-data-2016-12", "https://www.nasdaq.com/articles/top-research-reports-barclays-netflix-and-nike-2016-12-13", "https://www.nasdaq.com/articles/3-stocks-to-watch-on-tuesday%3A-biogen-inc-biib-conatus-pharmaceuticals-inc-cnat-and-general", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-sale-2016-12-13", "https://www.nasdaq.com/articles/biogen-presents-positive-early-data-from-alzheimers-study-2016-12-12", "https://www.nasdaq.com/articles/lilly-astrazeneca-expand-alzheimer-disease-collaboration-2016-12-12", "https://www.nasdaq.com/articles/3-most-profit-friendly-biotech-stocks-2016-12-12", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2016-12-11", "https://www.nasdaq.com/articles/biogens-aducanumab-game-changing-alzheimers-drug-2016-12-10", "https://www.nasdaq.com/articles/does-new-alzheimers-data-make-biogen-stock-buy-now-2016-12-09", "https://www.nasdaq.com/articles/trade-valeant-pharmaceuticals-intl-inc-vrx-stock-for-free-profits-2016-12-13", "https://www.nasdaq.com/articles/nasdaq-100-movers-lrcx-biib-2016-12-09", "https://www.nasdaq.com/articles/should-you-buy-drug-stocks-their-post-election-drop-2016-12-09", "https://www.nasdaq.com/articles/sp-500-movers-grmn-biib-2016-12-09", "https://www.nasdaq.com/articles/health-care-sector-update-12092016-biib-2016-12-09", "https://www.nasdaq.com/articles/pre-market-most-active-dec-9-2016-swc-mgm-bac-tlk-lvs-mpel-wynn-vod-vale-sqqq-biib-tvix", "https://www.nasdaq.com/articles/biogen-inc-biib-stock-trade-showcases-the-art-of-the-steal-2016-12-08", "https://www.nasdaq.com/articles/stock-market-news-for-december-08-2016-2016-12-08", "https://www.nasdaq.com/articles/stock-market-news-for-december-09-2016-2016-12-09", "https://www.nasdaq.com/articles/nasdaq-100-movers-lrcx-biib-2016-12-09", "https://www.nasdaq.com/articles/should-you-buy-drug-stocks-their-post-election-drop-2016-12-09", "https://www.nasdaq.com/articles/how-can-value-screener-record-trends-explain-market-valuations-2016-12-02", "https://www.nasdaq.com/articles/stock-exchange-model-picks-teach-us-manage-risk-2016-12-02", "https://www.nasdaq.com/articles/gw-pharmaceuticals-gwph%3A-what-awaits-in-q4-earnings-2016-12-01", "https://www.nasdaq.com/articles/3-things-you-need-know-about-ionis-pharmaceuticals-pipeline-2016-12-01", "https://www.nasdaq.com/articles/3-best-biotech-stocks-2017-2016-12-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-actelion-soars-acquisition-talks-another-clinical-hold-juno-2016-11", "https://www.nasdaq.com/articles/charles-payne-on-biotech%3A-biogen-inc-biib-intercept-pharmaceuticals-inc-icpt-2016-11-29", "https://www.nasdaq.com/articles/will-lillys-solanezumab-setback-weigh-other-alzheimers-stocks-2016-11-25", "https://www.nasdaq.com/articles/lillys-alzheimer-drug-fails-phase-iii-study-stock-down-2016-11-24", "https://www.nasdaq.com/articles/eli-lilly-and-co-lly-drug-failure-doesnt-answer-the-bigger-question-2016-11-23", "https://www.nasdaq.com/articles/instant-analysis-eli-lilly-drops-pre-holiday-alzheimers-bomb-2016-11-23", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-ea-2016-11-23", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-amgen-2016-11-30", "https://www.nasdaq.com/articles/pre-market-most-active-nov-23-2016-lly-de-rdy-nvo-biib-eric-mt-sny-juno-qqq-xiv-tvix-2016", "https://www.nasdaq.com/articles/eli-lillys-alzheimers-drug-bust-2016-11-23", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-538068-down-567-points-2016-11-23", "https://www.nasdaq.com/articles/3-potentially-huge-catalysts-ionis-pharmaceuticals-inc-2017-2016-11-23", "https://www.nasdaq.com/articles/why-biogen-shareholders-lost-3-billion-today-2016-11-23", "https://www.nasdaq.com/articles/are-biogen-and-gilead-sciences-denial-2016-11-22", "https://www.nasdaq.com/articles/acorda-stops-post-stroke-development-program-on-ampyra-2016-11-22", "https://www.nasdaq.com/articles/pre-market-most-active-nov-23-2016-lly-nvo-tgt-mt-bac-de-juno-biib-eric-qqq-xiv-tvix-2016", "https://www.nasdaq.com/articles/3-biotechs-dont-pay-dividends-could-2016-11-22", "https://www.nasdaq.com/articles/13-billion-opportunity-5-companies-could-dominate-alzheimers-disease-market-2016-11-21", "https://www.nasdaq.com/articles/3-irrefutable-reasons-sell-johnson-johnson-stock-2016-11-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-honda-intel-csx-and-general-growth-properties", "https://www.nasdaq.com/articles/3-beaten-down-biotech-stocks-to-buy-for-huge-gains-2016-11-17", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-celgene-corporation-2016-11-15", "https://www.nasdaq.com/articles/how-invest-during-trump-presidency-2016-11-14", "https://www.nasdaq.com/articles/5-biotech-stocks-george-soros-buying-2016-11-22", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-inc-back-black-now-2016-11-11", "https://www.nasdaq.com/articles/xlv-jnj-gild-biib-etf-inflow-alert-2016-11-10", "https://www.nasdaq.com/articles/3-biotech-stocks-you-must-buy-for-donald-trumps-presidency-2016-11-10", "https://www.nasdaq.com/articles/perrigo-prgo-beats-on-q3-earnings-revenues-view-intact-2016-11-10", "https://www.nasdaq.com/articles/peek-into-drug-stocks-q3-earnings-on-nov-11%3A-xbit-reph-2016-11-10", "https://www.nasdaq.com/articles/how-donald-trump-presidency-could-affect-biotech-stocks-2016-11-09", "https://www.nasdaq.com/articles/why-biogen-inc-stock-lost-105-its-value-october-2016-11-09", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-14-2016-2016-11-11", "https://www.nasdaq.com/articles/biogens-growth-far-weaker-you-may-think-2016-11-08", "https://www.nasdaq.com/articles/company-news-for-november-08-2016-2016-11-08", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-biogen-2016-11-08", "https://www.nasdaq.com/articles/spinal-muscular-atrophy-focus-biogen-ions-shoot-data-2016-11-08", "https://www.nasdaq.com/articles/drug-stock-earnings-to-watch-on-nov-9%3A-myl-ions-more-2016-11-08", "https://www.nasdaq.com/articles/why-ionis-pharmaceuticals-inc-skyrocketed-higher-today-2016-11-07", "https://www.nasdaq.com/articles/midday-update-wall-streets-appetite-risk-returns-after-clinton-cleared-fbi-2016-11-07", "https://www.nasdaq.com/articles/why-ionis-pharma-rocketing-25-higher-today-2016-11-09", "https://www.nasdaq.com/articles/nasdaq-100-movers-lvnta-biib-2016-11-07", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-lendingclub-posts-narrower-expected-loss", "https://www.nasdaq.com/articles/3-mid-cap-stocks-buy-november-2016-11-07", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-bristol-myers-biogen-merck-celgene-and-ariad", "https://www.nasdaq.com/articles/close-update-stocks-soar-fbi-clears-potential-path-clinton-election-day-2016-11-07", "https://www.nasdaq.com/articles/biib-crosses-below-key-moving-average-level-2016-11-03", "https://www.nasdaq.com/articles/2-bullish-biotech-trades-to-take-your-mind-off-the-election-biib-celg-2016-11-02", "https://www.nasdaq.com/articles/mid-day-market-update-dow-gains-over-300-points-concordia-international-shares-drop", "https://www.nasdaq.com/articles/biogen-quietly-abandons-key-next-gen-multiple-sclerosis-drug-2016-10-29", "https://www.nasdaq.com/articles/make-valeant-pharmaceuticals-intl-inc-vrx-stock-pay-you-2016-10-28", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-qual-peg-cost-biib-2016-10-28", "https://www.nasdaq.com/articles/5-reasons-ionis-pharmaceuticals-top-stock-buy-now-2016-10-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-merck-eli-lilly-abbvie-and-immunogen-2016-10-28", "https://www.nasdaq.com/articles/acorda-acor-reports-wider-q3-loss-revenues-down-y-y-2016-10-28", "https://www.nasdaq.com/articles/heres-why-biogen-should-buy-ionis-pharmaceuticals-2016-10-28", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-november-2016-11-02", "https://www.nasdaq.com/articles/key-takeaways-biogens-q3-call-tecfidera-pipeline-biosimilars-2016-10-27", "https://www.nasdaq.com/articles/peek-into-drug-stocks-earnings-on-oct-28%3A-abbv-imgn-2016-10-27", "https://www.nasdaq.com/articles/biogen-inc-working-what-its-got-it-looks-diversify-2016-10-27", "https://www.nasdaq.com/articles/midday-update-stocks-trim-losses-supply-related-bounce-oil-2016-10-26", "https://www.nasdaq.com/articles/nasdaq-100-movers-aapl-akam-2016-10-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-clinical-holds-hit-inovio-aduro-vertex-q3-results-miss-estimates", "https://www.nasdaq.com/articles/biogen-biib-beats-on-q3-earnings-tecfidera-propels-sales-2016-10-26", "https://www.nasdaq.com/articles/bioverativ-could-be-why-investors-should-buy-biogen-2016-10-27", "https://www.nasdaq.com/articles/biogen-inc-biib-stock-rises-better-expected-quarter-2016-10-26", "https://www.nasdaq.com/articles/drug-stock-earnings-to-watch-on-oct-26%3A-biib-mdco-more-2016-10-25", "https://www.nasdaq.com/articles/pre-market-earnings-report-october-26-2016-ko-cmcsa-ba-mdlz-biib-spg-gd-noc-bsx-stt-wm-nsc", "https://www.nasdaq.com/articles/best-and-worst-biotech-etfs-2016-tell-tale-about-industry-2016-10-21", "https://www.nasdaq.com/articles/can-biogen-biib-keep-the-earnings-streak-alive-in-q3-2016-10-20", "https://www.nasdaq.com/articles/ishares-edge-msci-usa-quality-factor-etf-experiences-big-outflow-2016-10-19", "https://www.nasdaq.com/articles/biotech-stock-roundup-ariad-down-drug-pricing-tweet-regeneron-study-clinical-hold-2016-10", "https://www.nasdaq.com/articles/biogen-biib-beats-on-q3-earnings-and-sales-2016-10-26", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-inc-2016-10-18", "https://www.nasdaq.com/articles/commit-buy-biogen-180-earn-5-using-options-2016-10-18", "https://www.nasdaq.com/articles/alzheimers-remains-top-priority-big-pharma-2016-10-17", "https://www.nasdaq.com/articles/biomarin-issues-encouraging-update-on-hemophilia-a-drug-2016-10-14", "https://www.nasdaq.com/articles/avexis-major-threat-ionis-pharmaceuticals-2016-10-14", "https://www.nasdaq.com/articles/why-top-columbia-fund-loads-facebook-other-stock-leaders-2016-10-13", "https://www.nasdaq.com/articles/stock-market-news-for-october-12-2016-2016-10-12", "https://www.nasdaq.com/articles/3-stocks-that-will-be-bought-out-before-twitter-2016-10-19", "https://www.nasdaq.com/articles/3-biotechs-most-likely-be-acquired-2016-10-11", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2016-10-11", "https://www.nasdaq.com/articles/better-buy-biogen-vs-celgene-2016-10-10", "https://www.nasdaq.com/articles/6-healthcare-stocks-investors-cant-miss-in-q3-earnings-2016-10-07", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-nlnk-srpt-biib-2016-10-07", "https://www.nasdaq.com/articles/key-reason-ionis-pharmaceuticals-inc-gained-another-24-september-2016-10-07", "https://www.nasdaq.com/articles/biotech-stock-roundup-summit-soars-sarepta-deal-regeneron-presents-data-2016-10-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-alnylam-slumps-revusiran-update-tesaro-impresses-esmo-2016-10-12", "https://www.nasdaq.com/articles/instant-analysis-biogens-agreement-anavex-life-sciences-2016-09-28", "https://www.nasdaq.com/articles/will-celgene-depose-biogen-become-top-dog-multiple-sclerosis-2016-09-28", "https://www.nasdaq.com/articles/health-care-sector-update-09282016-athx-avxl-biib-galt-2016-09-28", "https://www.nasdaq.com/articles/anavex-life-sciences-corp.-avxl-scores-big-on-biogen-test-2016-09-28", "https://www.nasdaq.com/articles/why-anavex-life-sciences-corp-rocketed-higher-today-2016-09-28", "https://www.nasdaq.com/articles/health-care-sector-update-09282016-vsaravxlbiibgalt-2016-09-28", "https://www.nasdaq.com/articles/ionis-biogen-complete-nusinersen-nda-submission-in-u.s.-2016-09-27", "https://www.nasdaq.com/articles/better-buy-anavex-life-sciences-corp-vs-ionis-pharmaceuticals-inc-2016-10-05", "https://www.nasdaq.com/articles/implied-analyst-12-month-target-iwl-2016-09-26", "https://www.nasdaq.com/articles/stock-market-news-for-september-21-2016-2016-09-21", "https://www.nasdaq.com/articles/biotech-stock-roundup-tobira-soars-acquisition-deal-fda-says-yes-sarepta-dmd-drug-2016-09", "https://www.nasdaq.com/articles/trade-of-the-day%3A-ishares-nasdaq-biotechnology-index-etf-ibb-is-turning-things-around-2016", "https://www.nasdaq.com/articles/3-ways-ionis-pharmaceuticals-inc-beating-competition-2016-09-19", "https://www.nasdaq.com/articles/could-alzheimers-disease-drug-really-be-worth-20-billion-2016-09-19", "https://www.nasdaq.com/articles/marijuana-could-be-answer-curing-alzheimers-disease-study-shows-2016-09-18", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-moat-biib-tif-stt-2016-09-26", "https://www.nasdaq.com/articles/3-stocks-to-trade-now-for-new-years-profits-2016-09-15", "https://www.nasdaq.com/articles/spdr-sp-biotech-etf-xbi%3A-the-bears-got-nothin-on-biotech-stocks-2016-09-15", "https://www.nasdaq.com/articles/stock-market-news-for-september-15-2016-2016-09-15", "https://www.nasdaq.com/articles/biotech-stock-roundup-horizon-raptor-acquisition-deal-geron-down-pipeline-news-2016-09-14", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-14-2016-2016-09-13", "https://www.nasdaq.com/articles/perrigo-up-as-starboard-reveals-stake-changes-proposed-2016-09-13", "https://www.nasdaq.com/articles/why-applied-genetic-technologies-corp-tanking-today-2016-09-13", "https://www.nasdaq.com/articles/new-market-biggest-investment-idea-decade-2016-09-17", "https://www.nasdaq.com/articles/nasdaq-100-movers-swks-stx-2016-09-09", "https://www.nasdaq.com/articles/ixj-mdt-lly-biib-large-outflows-detected-etf-2016-09-08", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-gilead-sciences-2016-09-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-colucid-soars-migraine-data-dynavax-drug-fda-panel-meeting-cancelled", "https://www.nasdaq.com/articles/gw-pharmaceuticals-plc-adr-gwph-boards-the-buyout-rumor-mill-2016-09-07", "https://www.nasdaq.com/articles/spdr-gold-trust-etf-gld-is-ready-to-rally-2016-09-06", "https://www.nasdaq.com/articles/3-stocks-to-watch-tuesday%3A-monsanto-company-mon-biogen-inc-biib-and-navistar-international", "https://www.nasdaq.com/articles/how-tides-are-turning-alzheimers-research-2016-09-12", "https://www.nasdaq.com/articles/nasdaq-100-movers-avgo-biib-2016-09-02", "https://www.nasdaq.com/articles/biogen-biib-aducanumab-gets-fast-track-status-in-the-u.s.-2016-09-02", "https://www.nasdaq.com/articles/health-care-sector-update-09022016-biibatecgmedeltp-2016-09-02", "https://www.nasdaq.com/articles/tesla-motors-inc-tsla-needs-more-cash-for-gigafactory-model-3-2016-08-31", "https://www.nasdaq.com/articles/health-care-sector-update-08312016-biibveevatos-2016-08-31", "https://www.nasdaq.com/articles/analysts-anticipate-12-gains-ahead-ryh-2016-08-25", "https://www.nasdaq.com/articles/biotech-stock-roundup-medivation-pfizer-clovis-priority-review-2016-08-24", "https://www.nasdaq.com/articles/5-stocks-to-buy-for-september-2016-09-06", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-slips-study-halt-aurinia-plunges-lupus-data-2016-08-17", "https://www.nasdaq.com/articles/sarah-ketterer-takes-3-positions-2nd-quarter-2016-08-16", "https://www.nasdaq.com/articles/another-endorsement-biotech-etfs-2016-08-16", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-inc-begins-shift-focus-2016-08-16", "https://www.nasdaq.com/articles/allergan-buy-forsight-vision5-boost-glaucoma-pipeline-2016-08-15", "https://www.nasdaq.com/articles/top-3-research-reports-august-15-2016-2016-08-15", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-regeneron-biomarin-abbvie-amgen-and-biogen-2016-08-12", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-qld-txn-chtr-biib-2016-08-22", "https://www.nasdaq.com/articles/perrigo-prgo-misses-q2-earnings-estimates-cuts-16-view-2016-08-10", "https://www.nasdaq.com/articles/ionis-ions-q2-loss-narrower-than-expected-issues-outlook-2016-08-10", "https://www.nasdaq.com/articles/qual-peg-biib-nke-large-outflows-detected-etf-2016-08-09", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-intel-align-technology-qorvo-and-biogen-2016-08-09", "https://www.nasdaq.com/articles/intercept-icpt-reports-narrower-than-expected-q2-loss-2016-08-08", "https://www.nasdaq.com/articles/how-shows-greys-anatomy-influence-patient-perceptions-healthcare-2016-08-08", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-15-2016-2016-08-12", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-anglogold-ashanti-biogen-qualcomm-tallgrass-energy-gp-and", "https://www.nasdaq.com/articles/allergan-plc-will-downtrend-continue-agn-stock-2016-08-04", "https://www.nasdaq.com/articles/stop-dreaming-biogen-isnt-sale-2016-08-04", "https://www.nasdaq.com/articles/5-best-peg-stocks-for-a-lucrative-value-investing-2016-08-04", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-ions-q2-earnings%3A-stock-to-beat-2016-08-04", "https://www.nasdaq.com/articles/why-sangamo-biosciences-inc-fell-29-today-2016-08-04", "https://www.nasdaq.com/articles/exelixis-exel-posts-narrower-loss-in-q2-beats-on-revenues-2016-08-04", "https://www.nasdaq.com/articles/does-biogens-latest-win-make-its-shares-buy-2016-08-06", "https://www.nasdaq.com/articles/3-big-stock-charts-for-wednesday%3A-regeneron-pharmaceuticals-inc-regn-biogen-inc-biib-and", "https://www.nasdaq.com/articles/rumors-swirl-around-biogen-today-2016-08-02", "https://www.nasdaq.com/articles/why-biogen-inc-soared-18-july-2016-08-02", "https://www.nasdaq.com/articles/why-avon-products-inc.-avp-biogen-inc-biib-and-sodastream-international-ltd-soda-are-3-of", "https://www.nasdaq.com/articles/market-close-report-nasdaq-composite-index-closes-513773-down-4647-points-2016-08-02", "https://www.nasdaq.com/articles/biogen-inc-biib-tacks-7b-market-value-buyout-talk-2016-08-02", "https://www.nasdaq.com/articles/biogen-biib-stock-surges-8-takeover-rumors-2016-08-02", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrsk-cern-2016-08-03", "https://www.nasdaq.com/articles/midday-update-stocks-return-session-lows-oil-tumbles-towards-40barrel-2016-08-01", "https://www.nasdaq.com/articles/why-biogen-inc-biib-stock-is-soaring-today-2016-08-01", "https://www.nasdaq.com/articles/why-ionis-pharmaceuticals-inc-skyrocked-higher-today-2016-08-01", "https://www.nasdaq.com/articles/qqq-etf-posts-52-week-high-energy-stocks-sag-oil-drops-40-2016-08-01", "https://www.nasdaq.com/articles/nasdaq-100-movers-ctxs-biib-2016-08-01", "https://www.nasdaq.com/articles/sp-500-movers-rig-biib-2016-08-01", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-higher-tesla-acquire-solarcity-2016-08-01", "https://www.nasdaq.com/articles/2-biotech-funds-leading-nascent-bull-market-which-right-you-2016-08-02", "https://www.nasdaq.com/articles/midday-update-stocks-return-session-lows-oil-tumbles-towards-40barrel-2016-08-01", "https://www.nasdaq.com/articles/these-legendary-ceos-could-catch-lightning-bottle-again-2016-08-01", "https://www.nasdaq.com/articles/health-care-sector-update-08012016-eyegionskerxbiib-2016-08-01", "https://www.nasdaq.com/articles/mid-afternoon-market-update-trina-solar-gains-following-go-private-deal-insperity-shares", "https://www.nasdaq.com/articles/ionis-pharmaceuticals-ions-stock-surges-36-clinical-trial-success-2016-08-01", "https://www.nasdaq.com/articles/health-care-sector-update-08012016-itekionskerxbiib-2016-08-01", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-bib-amgn-celg-biib-2016-07-29", "https://www.nasdaq.com/articles/us-equity-futures-slightly-higher-mergers-provide-boost-2016-08-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-gilead-abbvie-amgen-and-celgene-2016-07-28", "https://www.nasdaq.com/articles/amgen-amgn-tops-q2-earnings-revenues-raises-view-2016-07-28", "https://www.nasdaq.com/articles/vertex-vrtx-posts-narrower-q2-loss-revenues-fall-short-2016-07-28", "https://www.nasdaq.com/articles/2-large-cap-drug-stocks-watch-earnings-abbv-mrk-2016-07-28", "https://www.nasdaq.com/articles/5-undervalued-growth-stocks-buy-today-2016-07-27", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-bristol-myers-pfizer-sanofi-amgen-and-biogen-2016-07-25", "https://www.nasdaq.com/articles/whats-store-these-5-drug-stocks-q2-earnings-2016-07-25", "https://www.nasdaq.com/articles/ucb-ucbjf-posts-1h16-results-reaffirms-2016-guidance-2016-07-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-gilead-abbvie-amgen-and-celgene-2016-07-28", "https://www.nasdaq.com/articles/amgen-amgn-tops-q2-earnings-revenues-raises-view-2016-07-28", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-bib-biib-regn-myl-2016-07-21", "https://www.nasdaq.com/articles/etrade-financial-corp%3A-etfc-stock-stepping-into-the-spotlight-2016-07-21", "https://www.nasdaq.com/articles/biogen-biib-stock-q2-earnings-beat-raised-outlook-2016-07-21", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-zafgen-celgene-amgen-abbvie-and-biogen-2016-07-21", "https://www.nasdaq.com/articles/week-could-decide-whether-biotech-etfs-rally-sizzles-or-fizzles-2016-07-25", "https://www.nasdaq.com/articles/thursdays-vital-data%3A-microsoft-corporation-msft-intel-corporation-intc-and-facebook-inc", "https://www.nasdaq.com/articles/biogen-biib-beats-on-q2-earnings-by-a-huge-margin-2016-07-21", "https://www.nasdaq.com/articles/biogen-inc-biib-stock%3A-q2-earnings-end-a-year-of-misery-2016-07-21", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-333-follow-through-indicator-38-sensitive-2016-07-21", "https://www.nasdaq.com/articles/biib-stock-what-know-about-biogen-inc-thursday-morning-2016-07-20", "https://www.nasdaq.com/articles/pre-market-earnings-report-july-21-2016-slb-unp-biib-gm-bk-trv-ppg-bbt-shw-jci-luv-nue", "https://www.nasdaq.com/articles/biotech-stock-roundup-celgene-immuno-oncology-deal-zafgen-drops-lead-drug-2016-07-20", "https://www.nasdaq.com/articles/futures-trade-lower-amid-data-earnings-deluge-2016-07-21", "https://www.nasdaq.com/articles/4-rock-solid-cheap-biotech-stocks-2016-07-16", "https://www.nasdaq.com/articles/agree-buy-biogen-135-earn-35-using-options-2016-07-15", "https://www.nasdaq.com/articles/nasdaq-100-movers-nclh-incy-2016-07-15", "https://www.nasdaq.com/articles/biogen-biib-q2-earnings-will-stock-disappoint-2016-07-15", "https://www.nasdaq.com/articles/does-biogens-lower-pe-ratio-make-it-better-buy-celgene-2016-07-15", "https://www.nasdaq.com/articles/how-much-do-stock-prices-matter-biotech-2016-07-14", "https://www.nasdaq.com/articles/biotech-stock-roundup-juno-and-out-clinical-hold-amgen-biosimilar-gets-panel-backing-2016", "https://www.nasdaq.com/articles/medical-stocks-to-post-earnings-this-week%3A-abt-biib-aliof-2016-07-19", "https://www.nasdaq.com/articles/how-marijuana-could-play-role-alzheimers-disease-treatment-2016-07-09", "https://www.nasdaq.com/articles/juno-juno-suffers-setback-pivotal-study-clinical-hold-2016-07-08", "https://www.nasdaq.com/articles/why-biogen-inc-stock-dropped-157-june-2016-07-08", "https://www.nasdaq.com/articles/stock-market-news-for-july-07-2016-2016-07-07", "https://www.nasdaq.com/articles/3-reasons-buy-biogen-2016-06-30", "https://www.nasdaq.com/articles/these-3-biotechs-are-down-more-36-year-and-theyre-bargains-2016-06-29", "https://www.nasdaq.com/articles/better-buy-nantkwest-inc-vs-ionis-pharmaceuticals-2016-06-28", "https://www.nasdaq.com/articles/which-pipeline-has-better-potential-celgene-or-biogen-2016-07-12", "https://www.nasdaq.com/articles/the-ishares-nasdaq-biotechnology-index-ibb%3A-biotech-stocks-are-pushing-for-recovery-2016", "https://www.nasdaq.com/articles/3-stocks-that-can-and-should-start-paying-dividends-2016-06-24", "https://www.nasdaq.com/articles/2-biotech-stocks-wont-pay-dividend-anytime-soon-and-1-should-2016-06-24", "https://www.nasdaq.com/articles/better-buy-biogen-inc-vs-celgene-corporation-2016-06-23", "https://www.nasdaq.com/articles/3-biotech-stocks-to-buy-now%3A-celg-regn-and-biib-2016-06-21", "https://www.nasdaq.com/articles/these-5-biotech-stocks-are-ridiculously-cheap-2016-06-21", "https://www.nasdaq.com/articles/why-biogen-inc-down-225-2016-2016-06-21", "https://www.nasdaq.com/articles/3-reasons-anavex-stock-could-rise-2016-06-27", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-ishares-nasdaq-biotechnology-biogen-alexion-pharma", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-14-2016-2016-06-13", "https://www.nasdaq.com/articles/biogen-buy-after-its-clinical-failure-2016-06-12", "https://www.nasdaq.com/articles/biotech-buzz-asco-winners-and-losers-and-biogens-discouraging-failure-2016-06-10", "https://www.nasdaq.com/articles/4-stocks-crushed-biotechnology-etf-ibb-week-2016-06-10", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-merrimack-pharmaceuticals-retrophin-idera", "https://www.nasdaq.com/articles/bbhs-holdings-imply-25-gain-potential-2016-06-09", "https://www.nasdaq.com/articles/stock-market-news-for-june-16-2016-2016-06-16", "https://www.nasdaq.com/articles/forget-biogen-biib-buy-these-5-biotech-stocks-instead-2016-06-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-slips-ms-results-asco-data-focus-2016-06-08", "https://www.nasdaq.com/articles/mid-day-market-update-ldr-rises-acquisition-news-dryships-shares-drop-2016-06-07", "https://www.nasdaq.com/articles/instant-analysis-biogens-anti-lingo-1-flunks-game-changing-study-ms-2016-06-07", "https://www.nasdaq.com/articles/ibb-ishares-nasdaq-biotechnology-index-etf-still-buy-2016-06-07", "https://www.nasdaq.com/articles/noteworthy-tuesday-option-activity-cytr-biib-z-2016-06-07", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-wdc-2016-06-07", "https://www.nasdaq.com/articles/better-buy-anavex-life-sciences-corp-vs-biogen-2016-06-09", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-higher-valeant-earnings-miss-views-2016-06-07", "https://www.nasdaq.com/articles/why-biogen-lendingclub-and-valeant-pharmaceuticals-slumped-today-2016-06-07", "https://www.nasdaq.com/articles/these-drug-stocks-just-disappointed-investors-are-they-buys-2016-06-07", "https://www.nasdaq.com/articles/why-biogen-inc-biib-lendingclub-corp-lc-and-valeant-pharmaceuticals-intl-inc-vrx-are-three", "https://www.nasdaq.com/articles/why-biogen-biib-stock-plunging-today-2016-06-07", "https://www.nasdaq.com/articles/tuesday-sector-laggards-healthcare-utilities-2016-06-07", "https://www.nasdaq.com/articles/mid-afternoon-market-update-navistar-climbs-following-earnings-beat-biogen-shares-tumble", "https://www.nasdaq.com/articles/sp-500-movers-biib-wdc-2016-06-07", "https://www.nasdaq.com/articles/tuesdays-etf-movers-xop-ibb-2016-06-07", "https://www.nasdaq.com/articles/why-biogen-incs-shares-couldnt-find-synergy-today-2016-06-07", "https://www.nasdaq.com/articles/new-17-billion-market-youve-probably-never-heard-and-3-stocks-poised-profit-2016-06-04", "https://www.nasdaq.com/articles/joel-greenblatt-bets-ebay-intel-biogen-2016-06-03", "https://www.nasdaq.com/articles/3-reasons-abbvies-and-biogens-latest-ms-drug-might-flop-2016-06-03", "https://www.nasdaq.com/articles/10-great-stocks-that-will-make-a-splash-this-summer-2016-06-03", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-sarepta-biogen-abbvie-intercept-and-ionis-2016-06-02", "https://www.nasdaq.com/articles/biogen-inc-biib-loses-8b-drug-failure-upside-remains-2016-06-07", "https://www.nasdaq.com/articles/las-vegas-sands-corp.%3A-ride-the-bull-without-the-risk-lvs-2016-06-01", "https://www.nasdaq.com/articles/biogen-inc-run-bulls-triple-digit-profits-biib-2016-06-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-sarepta-shoots-fda-delay-ionis-falls-pipeline-news-2016-06-01", "https://www.nasdaq.com/articles/nasdaq-100-movers-chtr-biib-2016-05-31", "https://www.nasdaq.com/articles/roches-subcutaneous-formulation-of-mabthera-gets-eu-nod-2016-05-31", "https://www.nasdaq.com/articles/10-biotech-stocks-with-symptoms-of-strong-growth-2016-05-31", "https://www.nasdaq.com/articles/biogen-abbvies-multiple-sclerosis-drug-gets-fda-nod-2016-05-30", "https://www.nasdaq.com/articles/kite-kite-and-biogens-drugs-included-in-prime-initiative-2016-06-02", "https://www.nasdaq.com/articles/las-vegas-sands-corp.%3A-ride-the-bull-without-the-risk-lvs-2016-06-01", "https://www.nasdaq.com/articles/biogen-inc-run-bulls-triple-digit-profits-biib-2016-06-01", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-ivw-mo-pcln-biib-2016-05-19", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-ahp-wday-biib-2016-05-19", "https://www.nasdaq.com/articles/biogen-inc-biib-spinout%3A-a-graceful-exit-for-the-hemophilia-biz-2016-05-16", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-biogen-2016-05-13", "https://www.nasdaq.com/articles/last-weeks-best-healthcare-etf-2016-05-28", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-13-2016-2016-05-12", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-iwb-lly-twx-biib-2016-05-10", "https://www.nasdaq.com/articles/stock-market-news-for-may-10-2016-2016-05-10", "https://www.nasdaq.com/articles/ionis-incurs-wider-than-expected-loss-in-q1-stock-down-2016-05-05", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-gilead-celgene-medivation-and-biogen-2016-05-05", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-vs-biogen-2016-05-04", "https://www.nasdaq.com/articles/forget-bluebird-bio-inc-these-3-stocks-are-better-buys-2016-05-03", "https://www.nasdaq.com/articles/perrigo-prgo-tops-q1-earnings-2016-earnings-view-intact-2016-05-12", "https://www.nasdaq.com/articles/biotech-etfs-sink-on-mixed-q1-results-2016-05-02", "https://www.nasdaq.com/articles/ibb-biib-celg-regn-etf-inflow-alert-2016-04-29", "https://www.nasdaq.com/articles/acorda-acor-q1-earnings-decline-yy-ampyra-focus-2016-04-29", "https://www.nasdaq.com/articles/3-drug-stocks-reporting-early-next-week%3A-pfe-myl-mnk-2016-04-29", "https://www.nasdaq.com/articles/alkermes-alks-reports-narrower-than-expected-q1-loss-2016-04-29", "https://www.nasdaq.com/articles/drug-stocks-q1-earnings-preview%3A-aegr-aeri-mack-prta-2016-04-29", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-sarepta-catalyst-pharmaceuticals-abbvie-and", "https://www.nasdaq.com/articles/whats-up-at-ionis-pharmaceuticals-ions-in-q1-earnings-2016-05-02", "https://www.nasdaq.com/articles/drug-stocks-earnings-previews%3A-kerx-bxlt-bmrn-agen-imgn-2016-04-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-tops-q1-earnings-sarepta-catalyst-plunge-regulatory-news-2016", "https://www.nasdaq.com/articles/biogen-inc%3A-market-takes-the-bull-by-the-horns-despite-sales-miss-biib-2016-04-22", "https://www.nasdaq.com/articles/biogen-inc-earnings-explode-higher-revenue-not-so-much-2016-04-22", "https://www.nasdaq.com/articles/dow-jones-holds-18000-despite-weak-tech-earnings-2016-04-22", "https://www.nasdaq.com/articles/6-mega-cap-tech-stocks-at-the-brink-of-imploding-2016-04-22", "https://www.nasdaq.com/articles/7-a-rated-stocks-with-rock-solid-foundations-2016-04-22", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-johnson-johnson-biogen-novartis-baxalta-incorporated", "https://www.nasdaq.com/articles/energy-select-sector-spdr-etf%3A-get-paid-to-gas-up-on-xle-2016-04-21", "https://www.nasdaq.com/articles/alibaba-group-holding-ltd%3A-baba-goes-boom-and-bulls-take-note-2016-04-21", "https://www.nasdaq.com/articles/biogen-biib-tops-q1-earnings-slight-revenue-miss-2016-04-21", "https://www.nasdaq.com/articles/biogen-inc-biib%3A-embrace-the-drug-trade-2016-04-21", "https://www.nasdaq.com/articles/health-care-sector-update-04212016-nvs-biib-2016-04-21", "https://www.nasdaq.com/articles/biogen-biib-beats-on-1q-earnings-by-a-wide-margin-2016-04-21", "https://www.nasdaq.com/articles/thursday-sector-leaders-healthcare-services-2016-04-21", "https://www.nasdaq.com/articles/key-morning-earnings-april-21-biib-gm-ua-vz-2016-04-21", "https://www.nasdaq.com/articles/pre-market-earnings-report-april-21-2016-vz-unp-dhr-biib-gm-bk-trv-ppg-luv-eric-shw-bbt", "https://www.nasdaq.com/articles/how-will-drug-stocks-biib-abt-nvs-perform-in-q1-earnings-2016-04-19", "https://www.nasdaq.com/articles/health-care-select-sector-spdr-fund-experiences-big-outflow-2016-04-18", "https://www.nasdaq.com/articles/biogen-inc-bet-biib-healthy-profits-2016-04-18", "https://www.nasdaq.com/articles/health-care-sector-update-04182016-mdvn-biib-amgn-mrk-abt-pfe-jnj-2016-04-18", "https://www.nasdaq.com/articles/will-ms-franchise-sales-boost-biogens-biib-1q-earnings-2016-04-18", "https://www.nasdaq.com/articles/will-perrigo-prgo-surprise-earnings-estimates-in-q1-2016-04-15", "https://www.nasdaq.com/articles/health-care-sector-update-04212016-biibcbaytrxc-2016-04-21", "https://www.nasdaq.com/articles/astrazeneca-eli-lilly-alzheimers-disease-drug-in-phase-iii-2016-04-11", "https://www.nasdaq.com/articles/commit-buy-biogen-150-earn-52-using-options-2016-04-08", "https://www.nasdaq.com/articles/ionis-tanks-fda-clinical-hold-on-ionis-ttrrx-phase-iii-study-2016-04-08", "https://www.nasdaq.com/articles/surprising-analyst-12-month-target-spxt-2016-04-07", "https://www.nasdaq.com/articles/biotech-stock-roundup-gileads-hiv-drug-approved-regeneron-positive-data-2016-04-06", "https://www.nasdaq.com/articles/ishares-us-healthcare-etf-experiences-big-outflow-2016-04-04", "https://www.nasdaq.com/articles/better-buy-gilead-sciences-inc-vs-biogen-inc-2016-04-04", "https://www.nasdaq.com/articles/clubcorp-holdings-inc-countering-bulls-2016-04-12", "https://www.nasdaq.com/articles/9-things-you-need-know-about-biosimilar-drugs-2016-03-28", "https://www.nasdaq.com/articles/gilead-biogens-patent-woes-amgen-scores-win-patent-litigation-2016-03-24", "https://www.nasdaq.com/articles/aveo-gives-av-203-ex-u.s.-rights-to-canbridge-life-sciences-2016-03-23", "https://www.nasdaq.com/articles/biogen-inc-vs-amgen-which-big-biotech-smarter-buy-today-2016-03-21", "https://www.nasdaq.com/articles/big-biotech-etf-faces-key-technical-test-2016-03-18", "https://www.nasdaq.com/articles/zacks-industry-outlook-highlights%3A-valeant-pfizer-amgen-and-biogen-2016-03-17", "https://www.nasdaq.com/articles/ishares-sp-500-growth-etf-experiences-big-outflow-2016-03-16", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-amgen-regeneron-ionis-and-biogen-2016-03-28", "https://www.nasdaq.com/articles/eli-lilly-down-alters-primary-endpoint-of-solanezumab-2016-03-16", "https://www.nasdaq.com/articles/john-buckingham-trades-etfs-4th-quarter-2016-03-16", "https://www.nasdaq.com/articles/better-short-biotech-etf-or-invest-inverse-counterpart-2016-03-15", "https://www.nasdaq.com/articles/how-ride-next-wave-potential-alzheimers-drugs-2016-03-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-march-14-2016-2016-03-11", "https://www.nasdaq.com/articles/biogen-inc-regenerate-profits-bear-trapped-biib-2016-03-11", "https://www.nasdaq.com/articles/better-buy-amgen-inc-vs-biogen-2016-03-10", "https://www.nasdaq.com/articles/stock-market-news-for-march-16-2016-2016-03-16", "https://www.nasdaq.com/articles/vug-abbv-ups-biib-large-outflows-detected-etf-2016-03-07", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-valeant-pharmaceuticals-international-gilead-sciences", "https://www.nasdaq.com/articles/3-stocks-are-ridiculously-cheap-right-now-2016-03-05", "https://www.nasdaq.com/articles/what-does-trumps-healthcare-plan-mean-investors-2016-03-04", "https://www.nasdaq.com/articles/ionis-incurs-wider-than-expected-loss-in-q4-shares-down-2016-02-26", "https://www.nasdaq.com/articles/alkermes-q4-loss-narrower-than-expected-updates-pipeline-2016-02-26", "https://www.nasdaq.com/articles/how-find-ethical-investments-pharmaceutical-industry-2016-02-24", "https://www.nasdaq.com/articles/better-big-biotech-stock-biogen-vs-celgene-2016-03-08", "https://www.nasdaq.com/articles/upro-biib-abt-dhr-large-outflows-detected-etf-2016-02-22", "https://www.nasdaq.com/articles/big-pharma-evil-2016-02-21", "https://www.nasdaq.com/articles/perrigo-lags-on-q4-earnings-and-revenues-updates-view-2016-02-18", "https://www.nasdaq.com/articles/3-biotechs-could-snap-back-and-soar-even-higher-2016-02-15", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iyh-jnj-biib-tmo-2016-02-12", "https://www.nasdaq.com/articles/acorda-q4-earnings-decline-yy-ampyra-pipeline-focus-2016-02-12", "https://www.nasdaq.com/articles/why-biogen-incs-stock-sank-january-2016-02-11", "https://www.nasdaq.com/articles/what-awaits-ionis-pharmaceuticals-ions-in-q4-earnings-2016-02-23", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-11-2016-2016-02-10", "https://www.nasdaq.com/articles/agony-high-returns-2016-02-09", "https://www.nasdaq.com/articles/biotech-etfs-slide-as-stocks-report-mixed-q4-results-2016-02-09", "https://www.nasdaq.com/articles/biogen-inc-takes-aim-johnson-johnson-2016-02-07", "https://www.nasdaq.com/articles/notable-friday-option-activity-biib-eigi-ally-2016-02-05", "https://www.nasdaq.com/articles/fbt-tech-qgen-biib-large-outflows-detected-etf-2016-02-04", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-gilead-abbvie-intrexon-and-newlink-2016-02-04", "https://www.nasdaq.com/articles/see-which-latest-13f-filers-holds-biogen-2016-02-11", "https://www.nasdaq.com/articles/start-new-year-right-3-best-biotech-stocks-2016-02-02", "https://www.nasdaq.com/articles/4-top-ranked-biotech-stocks-sale-2016-02-02", "https://www.nasdaq.com/articles/biogen-inc-slows-lets-keep-perspective-2016-02-02", "https://www.nasdaq.com/articles/financial-sector-update-02022016-pdlibiibacccacc-2016-02-02", "https://www.nasdaq.com/articles/biotech-etf-ibb-hits-new-52-week-low-2016-01-29", "https://www.nasdaq.com/articles/biogen-biib-looks-good%3A-stock-adds-5.2-in-session-2016-01-28", "https://www.nasdaq.com/articles/biogen-tops-q4-earnings-wide-margin-provides-view-2016-01-27", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-amgen-top-estimates-zika-virus-grabs-attention-2016-02-03", "https://www.nasdaq.com/articles/sp-500-movers-tss-cof-2016-01-27", "https://www.nasdaq.com/articles/biogen-biib-beats-4q-earnings-revenues-2016-01-27", "https://www.nasdaq.com/articles/us-stocks-eye-lower-open-ahead-fed-announcement-oil-weighs-commodities-stocks-2016-01-27", "https://www.nasdaq.com/articles/us-equities-futures-slip-amid-weaker-oil-prices-apple-disappointment-fed-decision-tap-2016", "https://www.nasdaq.com/articles/why-biogen-freeport-mcmoran-and-hawaiian-holdings-jumped-today-2016-01-27", "https://www.nasdaq.com/articles/3-healthcare-stocks-you-dont-have-babysit-2016-01-27", "https://www.nasdaq.com/articles/celgene-celg-to-report-q4-earnings%3A-what-to-expect-2016-01-26", "https://www.nasdaq.com/articles/nasdaq-100-movers-aapl-biib-2016-01-27", "https://www.nasdaq.com/articles/will-biogen-biib-beat-4q-earnings-ms-franchise-sales-2016-01-25", "https://www.nasdaq.com/articles/will-bristol-myers-bmy-beat-q4-earnings-expectations-2016-01-25", "https://www.nasdaq.com/articles/weekly-play-sell-calls-sector-ibb-2016-01-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-sarepta-plunges-briefing-documents-acorda-buy-biotie-2016-01-20", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-gilead-sciences-biogen-cytokinetics-and-bristol-myers", "https://www.nasdaq.com/articles/biogens-biib-biosimilar-of-amgens-enbrel-gets-eu-nod-2016-01-18", "https://www.nasdaq.com/articles/abbvies-management-just-made-some-pretty-bold-predictions-2016-01-16", "https://www.nasdaq.com/articles/pre-market-earnings-report-january-27-2016-ba-utx-biib-emc-gd-antm-itw-eric-stt-nsc-pgr", "https://www.nasdaq.com/articles/biogens-ceo-sums-everything-you-need-know-about-company-1-comment-2016-01-15", "https://www.nasdaq.com/articles/7-battered-biotech-stocks-bargains-or-busts-2016-01-14", "https://www.nasdaq.com/articles/was-celgene-corporations-bad-news-really-bad-2016-01-14", "https://www.nasdaq.com/articles/agree-buy-biogen-160-earn-61-using-options-2016-01-08", "https://www.nasdaq.com/articles/potential-7-billion-waste-celgene-corporation-2016-01-08", "https://www.nasdaq.com/articles/jean-hynes-finds-her-pot-gold-2016-01-07", "https://www.nasdaq.com/articles/biggest-healthcare-ma-news-2015-2015-12-27", "https://www.nasdaq.com/articles/4-biotech-stocks-looking-good-this-earnings-season-2016-01-15", "https://www.nasdaq.com/articles/biotech-industry-could-offer-early-profit-2016-2015-12-24", "https://www.nasdaq.com/articles/top-biotech-stocks-buy-2016-2015-12-21", "https://www.nasdaq.com/articles/alkermes-hits-52-week-high-on-pipeline-update-aristada-2015-12-17", "https://www.nasdaq.com/articles/health-care-sector-update-12162015-mrns-biib-alks-2015-12-16", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-hikes-first-quarter-dividend-ariad-lowers-iclusig-outlook-2015", "https://www.nasdaq.com/articles/isis-biogen-initiate-amyotrophic-lateral-sclerosis-study-2015-12-14", "https://www.nasdaq.com/articles/7-stocks-buy-december-2015-12-13", "https://www.nasdaq.com/articles/great-news-government-agency-just-received-big-raise-2015-12-26", "https://www.nasdaq.com/articles/ibb-amgn-regn-biib-large-outflows-detected-etf-2015-12-11", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-december-14-2015-2015-12-11", "https://www.nasdaq.com/articles/positive-clinical-data-sends-isis-pharmaceuticals-inc-soaring-november-2015-12-10", "https://www.nasdaq.com/articles/novartis-biosimilar-for-pfizers-enbrel-accepted-in-the-eu-2015-12-09", "https://www.nasdaq.com/articles/do-eli-lilly-and-biogen-have-alzheimers-all-wrong-anavex-life-sciences-thinks-so-2015-12", "https://www.nasdaq.com/articles/3-most-important-drugs-isis-pharmaceuticals-pipeline-2015-12-07", "https://www.nasdaq.com/articles/insight-eli-lillys-alzheimers-drugs-coming-soon-2015-12-04", "https://www.nasdaq.com/articles/average-american-spends-much-prescription-drugs-each-year-2015-12-12", "https://www.nasdaq.com/articles/pdl-biopharma-receives-%24133.7-million-in-cash-payments-2015-12-03", "https://www.nasdaq.com/articles/anavex-life-sciences-corp-stock-worth-buying-2015-12-02", "https://www.nasdaq.com/articles/biotech-stock-roundup-repros-tanks-crl-abbvie-multiple-myeloma-drug-approved-2015-12-02", "https://www.nasdaq.com/articles/worlds-largest-investing-firm-bought-these-2-biotech-stocks-should-you-2015-12-01", "https://www.nasdaq.com/articles/theres-00000000000028-chance-drug-doesnt-work-2015-11-30", "https://www.nasdaq.com/articles/26-billion-hedge-fund-just-bought-9-million-shares-stock-should-you-follow-2015-11-30", "https://www.nasdaq.com/articles/bristol-myers-cancer-drug-opdivo-gets-crl-from-the-fda-2015-11-30", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-ibb-regn-biib-alxn-2015-12-03", "https://www.nasdaq.com/articles/biotech-stock-roundup-kalobios-soars-shkreli-steps-fda-panel-not-convinced-about-biomarin", "https://www.nasdaq.com/articles/bristol-myers-opdivo-gets-fda-nod-for-another-indication-2015-11-25", "https://www.nasdaq.com/articles/biomarins-bmrn-kyndrisa-fails-to-impress-fda-panel-2015-11-25", "https://www.nasdaq.com/articles/gileads-gild-cocktail-hiv-drug-genvoya-approved-in-eu-2015-11-24", "https://www.nasdaq.com/articles/health-care-sector-update-11242015-syn-nvs-biib-2015-11-24", "https://www.nasdaq.com/articles/bristol-myers-opdivo-label-now-includes-renal-cell-cancer-2015-11-24", "https://www.nasdaq.com/articles/biogens-biib-biosimilar-of-pfizers-enbrel-gets-chmp-nod-2015-11-23", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biomarin-amgen-vertex-gilead-biogen-and-repros-2015-11", "https://www.nasdaq.com/articles/biotech-stock-roundup-clovis-plunges-label-expansion-gileads-harvoni-2015-11-18", "https://www.nasdaq.com/articles/why-sangamo-biosciences-shares-rose-26-october-2015-11-17", "https://www.nasdaq.com/articles/primecap-sells-stake-technology-company-2015-11-16", "https://www.nasdaq.com/articles/these-biotech-stocks-may-start-paying-dividends-2016-2015-11-16", "https://www.nasdaq.com/articles/pro-forma-profit-isis-pharmaceuticals-inc-2015-11-15", "https://www.nasdaq.com/articles/vug-ma-ups-biib-large-inflows-detected-etf-2015-11-11", "https://www.nasdaq.com/articles/nasdaq-100-movers-gmcr-biib-2015-11-11", "https://www.nasdaq.com/articles/amgens-repatha-too-bloody-pricey-uk-2015-11-19", "https://www.nasdaq.com/articles/biotech-stock-roundup-clovis-plunges-label-expansion-gileads-harvoni-2015-11-18", "https://www.nasdaq.com/articles/why-sangamo-biosciences-shares-rose-26-october-2015-11-17", "https://www.nasdaq.com/articles/59-billion-buyout-1-number-underpins-shires-huge-dyax-bet-2015-11-07", "https://www.nasdaq.com/articles/biotech-sees-better-than-expected-earnings%3A-etfs-in-focus-2015-11-06", "https://www.nasdaq.com/articles/gilead-and-2-biotech-picks-value-investors-will-love-2015-11-06", "https://www.nasdaq.com/articles/will-isis-pharmaceuticals-isis-surprise-in-q3-earnings-2015-11-05", "https://www.nasdaq.com/articles/biotech-stock-roundup-abbvies-humira-remains-strong-shire-buy-dyax-2015-11-04", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-november-12-2015-2015-11-11", "https://www.nasdaq.com/articles/12-companies-who-have-cut-jobs-2015-2015-10-30", "https://www.nasdaq.com/articles/after-hours-most-active-oct-30-2015-bac-hpq-mktx-cyn-nycb-foxa-qqq-hcbk-ge-pfe-msft-biib", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-tops-estimates-fda-approves-alexions-strensiq-2015-10-28", "https://www.nasdaq.com/articles/biogen-director-buys-310000-shares-2015-10-28", "https://www.nasdaq.com/articles/tuesday-1027-insider-buying-report-biib-dkl-2015-10-27", "https://www.nasdaq.com/articles/specialty-drug-classes-are-costing-consumers-arm-and-leg-2015-10-24", "https://www.nasdaq.com/articles/drug-going-be-big-threat-biogen-and-novartis-next-year-2015-11-04", "https://www.nasdaq.com/articles/battle-royale-amgen-inc-vs-biogen-inc-2015-10-23", "https://www.nasdaq.com/articles/3-earnings-reports-surprised-us-2015-10-23", "https://www.nasdaq.com/articles/perrigo-beats-on-q3-earnings-misses-revenues-cuts-jobs-2015-10-22", "https://www.nasdaq.com/articles/biogens-beat-raise-and-yawn-2015-10-22", "https://www.nasdaq.com/articles/biogen-cut-11-its-workforce-part-restructuring-plan-2015-10-21", "https://www.nasdaq.com/articles/bbh-celg-biib-bxlt-large-outflows-detected-etf-2015-10-21", "https://www.nasdaq.com/articles/commit-buy-biogen-180-earn-53-using-options-2015-10-21", "https://www.nasdaq.com/articles/acorda-up-on-q3-earnings-revenue-beat-ampyra-in-focus-2015-10-23", "https://www.nasdaq.com/articles/stock-market-news-for-october-21-2015-2015-10-21", "https://www.nasdaq.com/articles/biogen-biib-beats-on-3q-earnings-revenues-2015-10-21", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-455-follow-through-indicator-38-sensitive-2015-10-21", "https://www.nasdaq.com/articles/stock-market-news-for-october-20-2015-2015-10-20", "https://www.nasdaq.com/articles/did-roche-unleash-biogens-worst-nightmare-2015-10-20", "https://www.nasdaq.com/articles/isis-isis-begins-extension-study-shine-on-isis-smnrx-2015-10-20", "https://www.nasdaq.com/articles/pre-market-earnings-report-october-21-2015-ko-ba-biib-abt-emc-gm-tmo-kmb-itw-bhi-stj-nlsn", "https://www.nasdaq.com/articles/biogen-tops-q3-earnings-announces-job-cuts-ups-view-2015-10-21", "https://www.nasdaq.com/articles/3-blue-chip-biotech-stocks-worth-buying-long-haul-2015-10-17", "https://www.nasdaq.com/articles/can-these-repurposed-antibodies-reshape-multiple-sclerosis-market-2015-10-15", "https://www.nasdaq.com/articles/frank-sands-undervalued-holdings-growing-eps-2015-10-12", "https://www.nasdaq.com/articles/biogen-roche-novartis-present-data-on-ms-drugs-in-spain-2015-10-09", "https://www.nasdaq.com/articles/stock-market-news-for-october-08-2015-2015-10-08", "https://www.nasdaq.com/articles/sanofi-unveils-new-positive-data-on-lemtrada-and-aubagio-2015-10-08", "https://www.nasdaq.com/articles/stock-market-news-for-october-07-2015-2015-10-07", "https://www.nasdaq.com/articles/will-tecfidera-slowdown-hit-biogen-biib-earnings-q3-2015-10-19", "https://www.nasdaq.com/articles/3-blue-chip-biotech-stocks-worth-buying-long-haul-2015-10-17", "https://www.nasdaq.com/articles/3-biotech-bargains-buy-2015-10-05", "https://www.nasdaq.com/articles/vug-ma-unp-biib-large-inflows-detected-etf-2015-10-02", "https://www.nasdaq.com/articles/coming-clash-big-biotechs-biogen-vs-celgene-2015-10-01", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-regeneron-vertex-gilead-biogen-and-celgene-2015-10-01", "https://www.nasdaq.com/articles/best-selling-drugs-world-2020-2015-09-26", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-whose-valuations-should-make-you-skeptical-2015-10-07", "https://www.nasdaq.com/articles/health-care-sector-update-09252015-navb-biib-amgn-2015-09-25", "https://www.nasdaq.com/articles/biotech-stock-roundup-clintons-tweet-shakes-biotech-stocks-amgen-pipeline-boosting-deals", "https://www.nasdaq.com/articles/5-biotech-stocks-hit-hard-hillary-clintons-tweet-2015-09-22", "https://www.nasdaq.com/articles/undervalued-stocks-among-richard-snows-recent-buys-2015-09-17", "https://www.nasdaq.com/articles/beaten-down-biogen-stock-bargain-2015-09-17", "https://www.nasdaq.com/articles/which-biotech-blue-chip-stock-best-buy-2015-09-14", "https://www.nasdaq.com/articles/merck-kgaa-intends-to-file-for-approval-of-ms-drug-in-eu-2015-09-14", "https://www.nasdaq.com/articles/stock-market-news-for-september-25-2015-2015-09-25", "https://www.nasdaq.com/articles/4-ways-protect-yourself-biotech-meltdown-2015-09-13", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-september-14-2015-2015-09-11", "https://www.nasdaq.com/articles/biogens-surprising-weakness-2015-09-11", "https://www.nasdaq.com/articles/health-care-sector-update-09112015-akbabiibgildarwrnwbo-2015-09-11", "https://www.nasdaq.com/articles/2-questions-investors-need-ask-about-biogens-latest-deal-2015-09-10", "https://www.nasdaq.com/articles/nasdaq-100-movers-wynn-lila-2015-09-10", "https://www.nasdaq.com/articles/sp-500-movers-wynn-fcx-2015-09-10", "https://www.nasdaq.com/articles/better-buy-biogen-vs-gilead-sciences-2015-09-14", "https://www.nasdaq.com/articles/biotech-stock-roundup-biosimilar-competition-amgen-tetraphase-hit-disappointing-data-2015", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-iyh-abbv-mdt-biib-2015-09-04", "https://www.nasdaq.com/articles/roches-hemophilia-a-drug-gets-breakthrough-status-in-u.s.-2015-09-04", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-middle-turbulent-market-2015-09-03", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-news-ariad-takeover-target-2015-09-02", "https://www.nasdaq.com/articles/applied-genetic-meets-enrolment-milestone-in-xlrs-study-2015-08-31", "https://www.nasdaq.com/articles/we-believe-healthcares-next-biotech-buyout-target-2015-08-30", "https://www.nasdaq.com/articles/biogen-biib-autoimmune-disease-deal-worth-544m-2015-09-10", "https://www.nasdaq.com/articles/biogen-biib-crumbles%3A-stock-falls-by-5.9-2015-08-25", "https://www.nasdaq.com/articles/acorda-acor-gets-favorable-outcome-in-ampyra-ipr-issue-2015-08-25", "https://www.nasdaq.com/articles/bull-or-bear-biotechs-post-earnings-buys-and-sells-2015-08-23", "https://www.nasdaq.com/articles/using-etfs-run-your-own-hedge-fund-2015-08-20", "https://www.nasdaq.com/articles/biotech-stock-roundup-kite-addresses-patient-death-concerns-omeros-soars-data-2015-08-19", "https://www.nasdaq.com/articles/top-rated-stock-picks-and-most-read-stories-nasdaqcom-august-9-15-2015-08-18", "https://www.nasdaq.com/articles/ivw-nke-biib-kmi-large-outflows-detected-etf-2015-08-27", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-vug-orcl-v-biib-2015-08-12", "https://www.nasdaq.com/articles/nasdaq-100-movers-yhoo-biib-2015-08-12", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-august-13-2015-2015-08-12", "https://www.nasdaq.com/articles/nasdaq-100-movers-tsla-nvda-2015-08-07", "https://www.nasdaq.com/articles/emergent-biosolutions-tops-on-q2-earnings-plans-spin-off-analyst-blog-2015-08-07", "https://www.nasdaq.com/articles/3-crashing-healthcare-stocks-you-can-buy-2015-08-06", "https://www.nasdaq.com/articles/noteworthy-thursday-option-activity-tso-jpm-biib-2015-08-06", "https://www.nasdaq.com/articles/3-reasons-why-i-just-bought-biogen-inc-stock-2015-08-15", "https://www.nasdaq.com/articles/heres-why-biogen-lost-20-billion-market-value-july-2015-08-05", "https://www.nasdaq.com/articles/what-company-will-be-fastest-growing-big-cap-biotech-2015-08-05", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-vug-orcl-v-biib-2015-08-04", "https://www.nasdaq.com/articles/mixed-biotech-earnings-put-these-etfs-in-focus-etf-news-and-commentary-2015-08-04", "https://www.nasdaq.com/articles/will-isis-pharmaceuticals-isis-beat-q2-earnings-estimates-analyst-blog-2015-08-03", "https://www.nasdaq.com/articles/blockbuster-potential-biogen-incs-pipeline-2015-08-01", "https://www.nasdaq.com/articles/acorda-2q-earnings-revenues-top-ampyra-focus-analyst-blog-2015-07-31", "https://www.nasdaq.com/articles/perrigo-beats-on-q2-earnings-revenues-in-line-keeps-view-analyst-blog-2015-08-05", "https://www.nasdaq.com/articles/heres-why-biogen-lost-20-billion-market-value-july-2015-08-05", "https://www.nasdaq.com/articles/what-company-will-be-fastest-growing-big-cap-biotech-2015-08-05", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-ligand-pharmaceuticals-bluebird-bio-regeneron", "https://www.nasdaq.com/articles/3-big-biotech-buybacks-investors-should-love-2015-07-28", "https://www.nasdaq.com/articles/forget-biogen-buy-these-promising-biotech-stocks-instead-analyst-blog-2015-07-27", "https://www.nasdaq.com/articles/3-signs-healthcare-stock-bubble-might-have-just-popped-2015-07-27", "https://www.nasdaq.com/articles/sp-500-movers-myl-biib-2015-07-27", "https://www.nasdaq.com/articles/attention-new-biotech-investors-biogen-incs-recent-weakness-your-opportunity-2015-07-30", "https://www.nasdaq.com/articles/stock-market-news-for-july-27-2015-market-news-2015-07-27", "https://www.nasdaq.com/articles/look-ahead-biotech-and-energy-etfs-watch-week-2015-07-27", "https://www.nasdaq.com/articles/5-things-biogens-management-wants-you-know-2015-07-27", "https://www.nasdaq.com/articles/big-day-biotech-and-its-not-going-so-well-2015-07-27", "https://www.nasdaq.com/articles/biogen-enters-oversold-territory-biib-2015-07-24", "https://www.nasdaq.com/articles/biib-crosses-below-key-moving-average-level-2015-07-24", "https://www.nasdaq.com/articles/biogen-tops-q2-earnings-cuts-view-tecfidera-issues-analyst-blog-2015-07-24", "https://www.nasdaq.com/articles/nasdaq-100-movers-myl-biib-2015-07-27", "https://www.nasdaq.com/articles/sp-500-movers-biib-amzn-2015-07-24", "https://www.nasdaq.com/articles/3-alzheimers-drugs-investors-should-be-watching-2015-07-24", "https://www.nasdaq.com/articles/health-care-sector-update-07242015-cgix-reph-biib-2015-07-24", "https://www.nasdaq.com/articles/pre-market-most-active-jul-24-2015-exel-t-amzn-biib-itek-fb-stm-qqq-nok-un-alu-ci-2015-07", "https://www.nasdaq.com/articles/biogen-biib-beats-on-2q-earnings-misses-on-revenues-tale-of-the-tape-2015-07-24", "https://www.nasdaq.com/articles/earnings-reaction-history-biogen-idec-400-follow-through-indicator-21-sensitive-2015-07-24", "https://www.nasdaq.com/articles/biogens-terrible-horrible-no-good-very-bad-week-2015-07-24", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-amzn-2015-07-24", "https://www.nasdaq.com/articles/notable-friday-option-activity-biib-gt-xom-2015-07-24", "https://www.nasdaq.com/articles/september-4th-options-now-available-biogen-biib-2015-07-23", "https://www.nasdaq.com/articles/will-biogen-biib-surprise-in-2q-despite-tecfidera-issues-analyst-blog-2015-07-23", "https://www.nasdaq.com/articles/pre-market-earnings-report-july-24-2015-abbv-biib-spg-stt-vfc-jci-aal-mco-vtr-dte-xrx-col", "https://www.nasdaq.com/articles/eli-lilly-biogen-present-data-at-alzheimers-association-analyst-blog-2015-07-23", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-pcsk9-inhibitor-first-gain-approval-exelixis-positive-data", "https://www.nasdaq.com/articles/biotech-etfs-3-questions-ishares-investing-expert-2015-07-22", "https://www.nasdaq.com/articles/biogen-biib-stock-plummets-weak-guidance-stocks-news-2015-07-24", "https://www.nasdaq.com/articles/isis-pharmaceuticals-begins-huntingtons-disease-study-analyst-blog-2015-07-22", "https://www.nasdaq.com/articles/will-amerisourcebergen-abc-disappoint-earnings-in-q3-analyst-blog-2015-07-21", "https://www.nasdaq.com/articles/big-week-biogen-2015-07-21", "https://www.nasdaq.com/articles/celgene-buys-receptos-arena-pharmaceuticals-next-2015-07-21", "https://www.nasdaq.com/articles/notable-friday-option-activity-mat-sndk-biib-2015-07-17", "https://www.nasdaq.com/articles/sp-500-analyst-moves-biib-2015-07-16", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-eli-lilly-valeant-pharmaceuticals-international-biogen", "https://www.nasdaq.com/articles/why-earnings-season-should-matter-etf-investors-2015-07-22", "https://www.nasdaq.com/articles/stock-market-news-for-july-14-2015-market-news-2015-07-14", "https://www.nasdaq.com/articles/health-care-sector-update-07142015-biib-cah-cpxx-2015-07-14", "https://www.nasdaq.com/articles/4-health-care-stocks-to-watch-out-for-this-earnings-season-earnings-esp-2015-07-14", "https://www.nasdaq.com/articles/biogen-biib-slips-2.8-lead-rd-executive-set-to-leave-analyst-blog-2015-07-13", "https://www.nasdaq.com/articles/15-trillion-reasons-invest-these-companies-2015-07-12", "https://www.nasdaq.com/articles/sp-500-movers-biib-gci-2015-07-10", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-wba-2015-07-10", "https://www.nasdaq.com/articles/isis-pharmaceuticals-up-on-milestone-payment-from-biogen-analyst-blog-2015-07-15", "https://www.nasdaq.com/articles/noteworthy-friday-option-activity-googl-biib-ko-2015-07-10", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-vertex-biogen-applied-genetic-gilead-and-alexion-press", "https://www.nasdaq.com/articles/vanguard-growth-etf-experiences-big-outflow-2015-07-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-vertex-cf-drug-approved-biogen-strikes-deal-gene-therapy-analyst", "https://www.nasdaq.com/articles/are-biotechs-bubble-2015-07-07", "https://www.nasdaq.com/articles/biogen-sees-promise-gene-therapy-2015-07-07", "https://www.nasdaq.com/articles/forget-biogen-biib-buy-these-3-biotechnology-stocks-instead-stocks-news-2015-07-06", "https://www.nasdaq.com/articles/3-long-shots-biotech-companies-are-working-2015-07-10", "https://www.nasdaq.com/articles/why-applied-genetic-technologies-corporation-stock-jumped-today-2015-07-02", "https://www.nasdaq.com/articles/mid-day-market-update-us-stocks-down-xoom-shares-jump-acquisition-news-2015-07-02", "https://www.nasdaq.com/articles/midday-update-stocks-surrender-opening-gains-after-technical-resistances-holds-2015-07-02", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-higher-centene-acquire-health-net-63b-2015-07-02", "https://www.nasdaq.com/articles/futures-build-early-gains-june-payroll-report-2015-07-02", "https://www.nasdaq.com/articles/close-update-stocks-give-back-early-gains-greece-uncertainty-escalating-2015-07-02", "https://www.nasdaq.com/articles/health-care-sector-update-07022015-ntraagtcbiibiartspnev-2015-07-02", "https://www.nasdaq.com/articles/applied-genetic-up-on-biogen-deal-for-eye-disease-drugs-analyst-blog-2015-07-03", "https://www.nasdaq.com/articles/health-care-sector-update-07022015-hntcncctshagtcbiibiartspnev-2015-07-02", "https://www.nasdaq.com/articles/biotech-stock-roundup-juno-celgene-immunotherapy-deal-biomarinsarepta-dmd-drugs-progress", "https://www.nasdaq.com/articles/stock-market-news-for-july-01-2015-market-news-2015-07-01", "https://www.nasdaq.com/articles/bayer-files-hemophilia-a-drug-marketing-application-in-japan-analyst-blog-2015-07-01", "https://www.nasdaq.com/articles/vug-orcl-v-biib-large-outflows-detected-etf-2015-06-29", "https://www.nasdaq.com/articles/3-stocks-buy-if-biotech-crashes-2015-06-29", "https://www.nasdaq.com/articles/biogen-sobis-hemophilia-b-drug-alprolix-under-eu-review-analyst-blog-2015-06-29", "https://www.nasdaq.com/articles/mid-afternoon-market-update-international-speedway-slips-weak-results-applied-genetic", "https://www.nasdaq.com/articles/stock-market-news-for-june-23-2015-market-news-2015-06-23", "https://www.nasdaq.com/articles/isis-pharmaceuticals-up-on-spinal-muscular-atrophy-data-analyst-blog-2015-06-23", "https://www.nasdaq.com/articles/stock-market-news-for-june-19-2015-market-news-2015-06-19", "https://www.nasdaq.com/articles/3-big-healthcare-trends-wall-street-overlooking-2015-06-14", "https://www.nasdaq.com/articles/isis-pharmaceuticals-up-on-positive-data-on-isis-smnrx-analyst-blog-2015-06-12", "https://www.nasdaq.com/articles/gilead-sciences-inc-gild-ex-dividend-date-scheduled-june-12-2015-2015-06-11", "https://www.nasdaq.com/articles/stock-market-news-for-june-10-2015-market-news-2015-06-10", "https://www.nasdaq.com/articles/transition-therapeutics-tanks-on-alzheimers-disease-data-analyst-blog-2015-06-25", "https://www.nasdaq.com/articles/gilead-sciences-incs-moat-filling-sand-2015-06-06", "https://www.nasdaq.com/articles/why-isis-pharmaceuticals-inc-exploded-higher-19-may-2015-06-04", "https://www.nasdaq.com/articles/nasdaq-100-movers-vrtx-wynn-2015-06-02", "https://www.nasdaq.com/articles/investing-beginners-how-start-biotech-2015-05-30", "https://www.nasdaq.com/articles/oef-abbv-ba-biib-etf-outflow-alert-2015-05-28", "https://www.nasdaq.com/articles/pop-3-buy-if-biotech-stocks-burst-2015-05-26", "https://www.nasdaq.com/articles/healthcare-investment-opportunities-long-term-2015-05-23", "https://www.nasdaq.com/articles/stock-market-news-for-june-08-2015-market-news-2015-06-08", "https://www.nasdaq.com/articles/gilead-sciences-its-own-worst-enemy-2015-05-17", "https://www.nasdaq.com/articles/why-shares-sangamo-biosciences-fell-today-2015-05-14", "https://www.nasdaq.com/articles/biotech-stock-roundup-alexion-buy-synageva-fda-panel-backs-vertexs-orkambi-analyst-blog", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-may-12-2015-2015-05-11", "https://www.nasdaq.com/articles/heres-why-biotech-blue-chip-stock-biogen-inc-lost-11-april-2015-05-07", "https://www.nasdaq.com/articles/isis-pharmaceuticals-q1-loss-narrower-than-expected-analyst-blog-2015-05-06", "https://www.nasdaq.com/articles/mylan-q1-earnings-meet-expectations-2015-guidance-upheld-analyst-blog-2015-05-06", "https://www.nasdaq.com/articles/stock-market-news-for-may-21-2015-market-news-2015-05-21", "https://www.nasdaq.com/articles/why-street-keeps-doubting-gilead-sciences-inc-2015-05-05", "https://www.nasdaq.com/articles/frothy-china-or-no-world-mutual-funds-topped-april-2015-05-05", "https://www.nasdaq.com/articles/zoetis-beats-on-q1-earnings-revenue-guidance-lowered-analyst-blog-2015-05-05", "https://www.nasdaq.com/articles/incyte-posts-wider-than-expected-q1-loss-jakafi-grows-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/integra-lifesciences-tops-q1-earnings-revenues-view-up-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/pharmacyclics-beats-on-q1-earnings-misses-revenues-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/qlt-qlti-reports-wider-than-expected-loss-in-q1-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/10-most-profitable-businesses-boston-2015-05-06", "https://www.nasdaq.com/articles/biotechs-blue-chip-stocks-2015-05-04", "https://www.nasdaq.com/articles/kytheras-kyth-double-chin-drug-kybella-gets-fda-nod-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/will-isis-pharmaceuticals-isis-disappoint-in-q1-earnings-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/alkermes-q1-loss-narrower-than-expected-maintains-view-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/nektar-swings-to-q1-earnings-updates-2015-guidance-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/bayer-bayry-q1-net-income-down-y-y-2015-outlook-up-analyst-blog-2015-05-01", "https://www.nasdaq.com/articles/acorda-posts-1q-loss-ampyra-generic-challenges-focus-analyst-blog-2015-05-04", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-bristol-myers-squibb-biogen-actelion-and-horizon-pharma", "https://www.nasdaq.com/articles/valeant-pharmaceuticals-reports-in-line-earnings-ups-view-analyst-blog-2015-05-01", "https://www.nasdaq.com/articles/oncolytics-reolysin-gets-another-orphan-drug-status-in-eu-analyst-blog-2015-05-01", "https://www.nasdaq.com/articles/bristol-myers-supplemental-bla-for-opdivo-accepted-by-fda-analyst-blog-2015-05-01", "https://www.nasdaq.com/articles/amerisourcebergen-corp-beats-on-q2-earnings-ups-view-analyst-blog-2015-04-30", "https://www.nasdaq.com/articles/synageva-q1-loss-narrower-than-expected-pipeline-in-focus-analyst-blog-2015-04-30", "https://www.nasdaq.com/articles/surmodics-misses-on-q2-earnings-reaffirms-2015-guidance-analyst-blog-2015-05-01", "https://www.nasdaq.com/articles/vertex-posts-wider-1q-loss-affirms-kalydeco-outlook-analyst-blog-2015-04-30", "https://www.nasdaq.com/articles/celgene-beats-on-q1-earnings-misses-revenues-keeps-view-analyst-blog-2015-04-30", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-celladon-amgen-biogen-and-alnylam-pharmaceuticals-press", "https://www.nasdaq.com/articles/aeterna-zentaris-to-continue-phase-iii-study-of-cancer-drug-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/biomarin-upgraded-to-strong-buy-is-it-in-your-portfolio-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/celldex-1q-loss-narrower-expected-pipeline-focus-analyst-blog-2015-04-29", "https://www.nasdaq.com/articles/merck-mrk-beats-q1-earnings-revenues-ups-view-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-amgen-celladon-biogen-celgene-and-gilead-press-releases", "https://www.nasdaq.com/articles/hospira-set-to-be-acquired-by-pfizer-beats-on-q1-earnings-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/bristol-myers-q1-earnings-beat-driven-by-strong-sales-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/stock-market-news-for-april-28-2015-market-news-2015-04-28", "https://www.nasdaq.com/articles/pfizer-beats-q1-earnings-cuts-view-currency-woes-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/redhill-finishes-patient-enrollment-for-rhb-105-study-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/will-tevas-teva-earnings-streak-continue-in-q1-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/celgene-to-buy-quanticel-boost-pipeline-development-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/3-biotech-stocks-still-attractive-after-mondays-sell-off-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/10-most-profitable-businesses-biotech-2015-04-28", "https://www.nasdaq.com/articles/company-news-for-april-27-2015-corporate-summary-2015-04-27", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-nv5-holdings-tractor-supply-ulta-salon-cosmetics", "https://www.nasdaq.com/articles/gilead-and-bristol-myers-reveal-positive-data-on-hcv-drugs-analyst-blog-2015-04-27", "https://www.nasdaq.com/articles/fidelity-contrafund-beating-market-old-fashioned-way-2015-04-25", "https://www.nasdaq.com/articles/biogen-misses-1q-earnings-tecfidera-falls-short-analyst-blog-2015-04-24", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-amzn-2015-04-24", "https://www.nasdaq.com/articles/celladons-advanced-heart-failure-study-fails-shares-crash-analyst-blog-2015-04-28", "https://www.nasdaq.com/articles/merck-reports-encouraging-data-on-hcv-combo-candidate-analyst-blog-2015-04-24", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-releases-data-on-lead-drug-analyst-blog-2015-04-24", "https://www.nasdaq.com/articles/biogen-inc-earnings-tecfidera-turbulance-2015-04-24", "https://www.nasdaq.com/articles/close-update-record-highs-wall-street-tech-earnings-upstage-disappointing-durable-goods", "https://www.nasdaq.com/articles/abbvie-beats-earnings-humira-and-hcv-sales-ups-view-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/eli-lilly-beats-1q-earnings-wide-margin-affirms-view-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/alexion-misses-q1-earnings-estimates-keeps-2015-outlook-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/biogen-biib-misses-on-1q-earnings-revenues-tale-of-the-tape-2015-04-24", "https://www.nasdaq.com/articles/emergent-biosolutions-resumes-biothrax-manufacturing-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/gilead-gild-announces-encouraging-data-on-its-hcv-drugs-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/capricors-cap-1002-gets-orphan-drug-status-in-the-u.s.-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/baxter-international-inc-where-decline-win-2015-04-23", "https://www.nasdaq.com/articles/will-biogens-biib-earnings-streak-continue-1q-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/ultragenyx-announces-positive-data-from-triheptanoin-study-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/isis-pharmaceuticals-isis-ttr-effective-in-extension-study-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/acorda-reports-encouraging-data-on-ms-drug-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/emergent-biosolutions-resumes-biothrax-manufacturing-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/gilead-gild-announces-encouraging-data-on-its-hcv-drugs-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/capricors-cap-1002-gets-orphan-drug-status-in-the-u.s.-analyst-blog-2015-04-23", "https://www.nasdaq.com/articles/amgen-beats-q1-earnings-revenues-ups-earnings-view-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/perrigo-beats-on-q3-earnings-gives-view-rejects-mylan-bid-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/pfizers-cancer-drug-meets-first-primary-endpoint-in-phase-iii-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/pre-market-earnings-report-april-24-2015-biib-spg-lyb-aal-stt-vtr-tyc-dte-xrx-cog-ims-lea", "https://www.nasdaq.com/articles/will-agenus-agen-disappoint-in-q1-earning-season-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/alnylam-reports-positive-patisiran-results-shares-up-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/biotech-stock-roundup-amgen-starts-earnings-season-strong-note-setbacks-ampio-athersys", "https://www.nasdaq.com/articles/will-edwards-lifesciences-ew-top-q1-earnings-estimates-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/can-healthways-hway-pull-a-surprise-this-earnings-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/fate-therapeutics-fate-jumps%3A-stock-moves-12.4-higher-tale-of-the-tape-2015-04-21", "https://www.nasdaq.com/articles/forget-gilead-gild-buy-these-impressive-biotech-stocks-instead-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/immunomedics-immu-provides-update-on-lead-adc-candidate-analyst-blog-2015-04-22", "https://www.nasdaq.com/articles/pharmacyclics-announces-positive-results-on-imbruvica-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/c.-r.-bard-bcr-q1-earnings%3A-lutonix-dcb-holds-the-key-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/will-alexions-alxn-soliris-drive-q1-earnings-beat-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/actavis-botox-upper-limb-spasticity-label-expanded-by-fda-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/is-abbvie-abbv-set-to-top-1q-earnings-on-humira-hcv-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/will-eli-lilly-lly-beat-earnings-in-1q-despite-generics-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/will-novartis-nvs-earnings-disappoint-this-quarter-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/bristol-myers-announces-positive-data-from-opdivo-study-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/will-mead-johnsons-mjn-q1-earnings-surprise-estimates-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/resmed-rmd-poised-to-outshine-q3-earnings-estimates-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/clovis-oncology-clvs-falls%3A-stock-goes-down-5.3-tale-of-the-tape-2015-04-20", "https://www.nasdaq.com/articles/athersys-slumps-as-multistem-fails-in-mid-stage-study-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/bristol-myers-study-on-opdivo-halted-on-early-success-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/will-amgen-amgn-keep-earnings-streak-alive-1q-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/will-conmed-cnmd-disappoint-earnings-estimates-in-q1-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/will-baxters-bax-earnings-disappoint-estimates-in-q1-analyst-blog-2015-04-21", "https://www.nasdaq.com/articles/3-biotech-stocks-could-be-developing-billion-dollar-drugs-2015-04-19", "https://www.nasdaq.com/articles/biotech-investors-shouldnt-miss-these-stocks-this-earnings-earnings-esp-2015-04-17", "https://www.nasdaq.com/articles/will-intuitive-surgical-isrg-surprise-earnings-in-q1-analyst-blog-2015-04-17", "https://www.nasdaq.com/articles/can-illumina-ilmn-keep-the-earnings-streak-alive-in-q1-analyst-blog-2015-04-17", "https://www.nasdaq.com/articles/amgen-gets-fda-nod-for-chronic-heart-failure-drug-corlanor-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/vivus-responds-to-tevas-filing-for-qsymia-generics-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/abbvies-hcv-treatment-granted-priority-review-in-japan-analyst-blog-2015-04-16", "https://www.nasdaq.com/articles/will-abbott-labs-abt-disappoint-on-earnings-this-quarter-analyst-blog-2015-04-20", "https://www.nasdaq.com/articles/bayer-to-expand-copanlisib-program-by-three-new-studies-analyst-blog-2015-04-15", "https://www.nasdaq.com/articles/biotech-stock-roundup-favorable-briefing-documents-mdcos-kengreal-alexion-soliris-label", "https://www.nasdaq.com/articles/jj-beats-q1-earnings-cuts-view-currency-woes-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/alnylam-reports-publication-of-new-data-on-hemophilia-drug-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/aeterna-zentaris-to-advance-hormone-drug-to-phase-iii-study-analyst-blog-2015-04-14", "https://www.nasdaq.com/articles/will-pharmaceutical-sales-drive-jj-jnj-earnings-again-analyst-blog-2015-04-13", "https://www.nasdaq.com/articles/biogen-sodastream-taser-international-napco-security-technologies-and-supercom-highlighted", "https://www.nasdaq.com/articles/biogen-reports-new-data-from-acute-optic-neuritis-study-analyst-blog-2015-04-15", "https://www.nasdaq.com/articles/3-best-stocks-invest-biotechnology-2015-04-11", "https://www.nasdaq.com/articles/10-largest-companies-market-cap-biotech-2015-04-11", "https://www.nasdaq.com/articles/stock-market-news-for-april-09-2015-market-news-2015-04-09", "https://www.nasdaq.com/articles/apple-top-mutual-fund-managers-concerns-2015-04-07", "https://www.nasdaq.com/articles/why-smart-money-loves-biotech-stock-2015-04-05", "https://www.nasdaq.com/articles/truly-staggering-cost-alzheimers-disease-2015-04-04", "https://www.nasdaq.com/articles/has-biotech-bubble-already-popped-2015-04-04", "https://www.nasdaq.com/articles/bull-day-biogen-biib-bull-day-2015-04-13", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-iwf-act-biib-celg-2015-04-02", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-horizon-pharma-hyperion-therapeutics-conatus-amgen-and", "https://www.nasdaq.com/articles/stock-market-news-for-april-01-2015-market-news-2015-04-01", "https://www.nasdaq.com/articles/why-receptos-inc-shares-soared-higher-today-2015-04-01", "https://www.nasdaq.com/articles/biotech-stock-roundup-horizon-buy-hyperion-conatus-liver-disease-data-analyst-blog-2015-04", "https://www.nasdaq.com/articles/biogens-biosimilar-version-of-remicade-under-eu-review-analyst-blog-2015-03-31", "https://www.nasdaq.com/articles/stock-market-news-for-march-30-2015-market-news-2015-03-30", "https://www.nasdaq.com/articles/safest-biotech-bet-market-2015-04-04", "https://www.nasdaq.com/articles/based-study-alzheimers-disease-cure-could-be-around-corner-2015-03-29", "https://www.nasdaq.com/articles/could-these-experimental-drugs-eclipse-harvonis-historic-launch-2015-03-28", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-prothena-vertex-gilead-and-amgen-press-releases", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-soars-alzheimers-data-gilead-hcv-drugs-label-update-analyst", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-hsbc-holdings-goldman-sachs-acorda-therapeutics-biogen", "https://www.nasdaq.com/articles/tiny-biotech-offers-new-hope-parkinsons-disease-patients-2015-03-25", "https://www.nasdaq.com/articles/bubble-bursting-3-top-stock-biotech-stocks-buy-2015-03-25", "https://www.nasdaq.com/articles/biogen-abbvies-ms-drug-zinbryta-under-review-in-the-eu-analyst-blog-2015-03-30", "https://www.nasdaq.com/articles/biogen-gains-on-positive-alzheimers-drug-interim-results-analyst-blog-2015-03-23", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-if-sector-crashes-2015-03-23", "https://www.nasdaq.com/articles/financial-sector-update-03232015-gnwbiibocnbrxbx-2015-03-23", "https://www.nasdaq.com/articles/1-biotech-stock-you-can-buy-and-hold-next-20-years-2015-03-21", "https://www.nasdaq.com/articles/midday-update-first-day-spring-brings-green-wall-street-nasdaq-hits-15-yr-high-2015-03-20", "https://www.nasdaq.com/articles/biogen-idec-incs-stock-bursts-higher-alzheimers-news-heres-why-2015-03-20", "https://www.nasdaq.com/articles/2-stocks-to-beat-the-dollars-volatile-run-analyst-blog-2015-03-24", "https://www.nasdaq.com/articles/nasdaq-100-movers-dish-biib-2015-03-20", "https://www.nasdaq.com/articles/sp-500-movers-mac-biib-2015-03-20", "https://www.nasdaq.com/articles/us-stock-futures-follow-european-markets-higher-hopes-greece-deal-2015-03-20", "https://www.nasdaq.com/articles/pre-market-most-active-mar-20-2015-mac-biib-ctrp-nok-qqq-bac-fb-aapl-prta-nke-kbh-hseb", "https://www.nasdaq.com/articles/us-stock-futures-point-higher-after-weak-thursday-session-germany-sees-hope-greece-deal", "https://www.nasdaq.com/articles/closing-update-session-long-surge-lifts-market-gauges-big-weekly-advance-nasdaq-composite", "https://www.nasdaq.com/articles/health-care-sector-update-03202015-biibprtathrx-2015-03-20", "https://www.nasdaq.com/articles/notable-etf-inflow-detected-xlv-amgn-biib-celg-2015-03-20", "https://www.nasdaq.com/articles/new-biotech-etfs-highlight-evolving-growth-opportunities-2015-03-17", "https://www.nasdaq.com/articles/zacks-investment-ideas-feature-highlights%3A-biogen-amgen-spdr-sp-biotech-etf-bioshares", "https://www.nasdaq.com/articles/should-gilead-sciences-incs-slowing-growth-concern-investors-2015-03-15", "https://www.nasdaq.com/articles/3-biotech-etfs-crushing-market-2015-etf-news-and-commentary-2015-03-13", "https://www.nasdaq.com/articles/sp-500-analyst-moves-biib-2015-03-13", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-xlv-mdt-biib-celg-2015-03-10", "https://www.nasdaq.com/articles/merck-kgaa-to-pay-%243m-to-opexa-for-tcelna-study-analyst-blog-2015-03-10", "https://www.nasdaq.com/articles/can-biotech-stock-go-good-great-2015-03-19", "https://www.nasdaq.com/articles/could-study-help-lead-cure-select-multiple-sclerosis-patients-2015-03-08", "https://www.nasdaq.com/articles/2-tiny-biotechs-could-have-blockbuster-opportunity-2015-03-07", "https://www.nasdaq.com/articles/health-care-sector-update-03062015-cala-isis-hznp-2015-03-06", "https://www.nasdaq.com/articles/top-funds-buying-rackspace-allergan-biogen-idec-apple-2015-03-03", "https://www.nasdaq.com/articles/isis-pharmaceuticals-up-on-q4-earnings-and-revenues-beat-analyst-blog-2015-03-02", "https://www.nasdaq.com/articles/biogen-sobi-report-postive-phase-iii-data-on-alprolix-analyst-blog-2015-03-02", "https://www.nasdaq.com/articles/3-big-cap-biotechs-could-trounce-gilead-sciences-year-2015-03-01", "https://www.nasdaq.com/articles/isis-pharmaceuticals-earns-milestone-payment-from-biogen-analyst-blog-2015-03-09", "https://www.nasdaq.com/articles/ishares-sp-500-growth-etf-experiences-big-outflow-2015-02-27", "https://www.nasdaq.com/articles/5-things-biogen-idec-incs-management-wants-you-know-2015-02-25", "https://www.nasdaq.com/articles/3-biotech-stocks-id-love-stash-away-my-portfolio-forever-2015-02-22", "https://www.nasdaq.com/articles/stock-market-news-for-february-18-2015-market-news-2015-02-18", "https://www.nasdaq.com/articles/could-solution-treating-alzheimers-disease-really-be-simple-2015-02-15", "https://www.nasdaq.com/articles/3-stocks-were-huge-winners-last-week-2015-02-14", "https://www.nasdaq.com/articles/3-biotech-stocks-i-love-2015-02-14", "https://www.nasdaq.com/articles/why-dont-these-winning-stocks-pay-dividends-2015-03-01", "https://www.nasdaq.com/articles/ironwood-pharmaceuticals-cuts-loss-on-higher-revenues-analyst-blog-2015-02-13", "https://www.nasdaq.com/articles/oncolytics-reolysin-gets-orphan-status-for-ovarian-cancer-analyst-blog-2015-02-12", "https://www.nasdaq.com/articles/forget-gilead-sciences-here-are-3-better-biotech-stocks-2015-02-12", "https://www.nasdaq.com/articles/sucampo-par-pharmaceuticals-enter-license-agreement-analyst-blog-2015-02-12", "https://www.nasdaq.com/articles/why-sangamo-biosciences-inc-shares-rocketed-higher-today-2015-02-11", "https://www.nasdaq.com/articles/charles-river-crl-beats-on-q4-earnings-and-revenues-analyst-blog-2015-02-11", "https://www.nasdaq.com/articles/isis-pharma-to-get-%245m-from-biogen-analyst-blog-2015-02-11", "https://www.nasdaq.com/articles/acorda-beats-q4-earnings-estimates-ampyra-sales-grow-analyst-blog-2015-02-13", "https://www.nasdaq.com/articles/orexigen-gives-positive-updates-on-its-weight-loss-drug-analyst-blog-2015-02-10", "https://www.nasdaq.com/articles/alkermes-reports-positive-data-on-multiple-sclerosis-drug-analyst-blog-2015-02-10", "https://www.nasdaq.com/articles/oncolytics-seeks-orphan-drug-status-for-reolysin-in-the-u.s.-analyst-blog-2015-02-10", "https://www.nasdaq.com/articles/amgen-inc-amgn-ex-dividend-date-scheduled-february-10-2015-2015-02-09", "https://www.nasdaq.com/articles/will-sangamo-sgmo-disappoint-this-earnings-season-analyst-blog-2015-02-09", "https://www.nasdaq.com/articles/3-medical-advancements-you-may-be-missing-out-2015-02-08", "https://www.nasdaq.com/articles/3-biotech-stocks-weve-fallen-2015-02-07", "https://www.nasdaq.com/articles/how-profit-elon-musks-space-internet-2015-02-10", "https://www.nasdaq.com/articles/orexigen-gives-positive-updates-on-its-weight-loss-drug-analyst-blog-2015-02-10", "https://www.nasdaq.com/articles/sanofi-misses-on-q4-earnings-maintains-diabetes-guidance-analyst-blog-2015-02-06", "https://www.nasdaq.com/articles/gilead-amgen-q4-earnings-weak-outlook-affect-biotech-etfs-etf-news-and-commentary-2015-02", "https://www.nasdaq.com/articles/perrigo-beats-on-earnings-fy15-guidance-in-line-analyst-blog-2015-02-05", "https://www.nasdaq.com/articles/allergan-beats-earnings-yet-again-on-strong-revenues-analyst-blog-2015-02-05", "https://www.nasdaq.com/articles/bluebird-bios-thalassemia-drug-gets-breakthrough-status-analyst-blog-2015-02-05", "https://www.nasdaq.com/articles/merck-mrk-beats-q4-earnings-guidance-falls-short-analyst-blog-2015-02-04", "https://www.nasdaq.com/articles/these-common-medications-may-put-you-greater-risk-developing-dementia-2015-02-07", "https://www.nasdaq.com/articles/3-blockbuster-drugs-may-be-obsolete-5-years-2015-02-07", "https://www.nasdaq.com/articles/sanofi-misses-on-q4-earnings-maintains-diabetes-guidance-analyst-blog-2015-02-06", "https://www.nasdaq.com/articles/gilead-amgen-q4-earnings-weak-outlook-affect-biotech-etfs-etf-news-and-commentary-2015-02", "https://www.nasdaq.com/articles/top-performing-funds-favor-leisure-medical-reits-2015-02-03", "https://www.nasdaq.com/articles/biogen-idec-biib-shows-strength%3A-stock-moves-up-10.2-tale-of-the-tape-2015-02-02", "https://www.nasdaq.com/articles/could-be-game-changing-news-battle-against-multiple-sclerosis-2015-02-01", "https://www.nasdaq.com/articles/3-biotech-giants-shouldnt-pay-dividend-2015-01-31", "https://www.nasdaq.com/articles/5-things-abbvie-incs-management-wants-you-know-2015-02-04", "https://www.nasdaq.com/articles/biogen-tops-q4-earnings-provides-strong-outlook-for-2015-analyst-blog-2015-01-30", "https://www.nasdaq.com/articles/nasdaq-100-movers-pcar-amzn-2015-01-30", "https://www.nasdaq.com/articles/sp-500-movers-pcar-biib-2015-01-30", "https://www.nasdaq.com/articles/why-biogen-idecs-shares-skyrocketed-higher-2015-01-30", "https://www.nasdaq.com/articles/vertex-posts-wider-4q-loss-affirms-kalydeco-outlook-analyst-blog-2015-01-29", "https://www.nasdaq.com/articles/biogen-idec-inc-earnings-worth-wait-2015-01-29", "https://www.nasdaq.com/articles/after-hours-earnings-report-january-29-2015-amzn-v-biib-cb-brcm-bxp-pfg-bcr-hbi-emn-mchp-n", "https://www.nasdaq.com/articles/iusg-vz-biib-hon-etf-outflow-alert-2015-01-30", "https://www.nasdaq.com/articles/pre-market-earnings-report-january-28-2015-ba-biib-emc-gd-px-aep-tel-ip-trow-hes-abc-stj", "https://www.nasdaq.com/articles/commit-purchase-biogen-idec-240-earn-67-using-options-2015-01-26", "https://www.nasdaq.com/articles/how-will-ma-etfs-perform-2015-many-deals-lined-2015-01-26", "https://www.nasdaq.com/articles/biotech-stock-roundup-eu-approvals-abbvie-celgene-drugs-cytrx-partial-clinical-hold-lifted", "https://www.nasdaq.com/articles/state-union-address-investing-idea-precision-medicine-2015-01-21", "https://www.nasdaq.com/articles/abbvie-incs-insights-jp-morgan-healthcare-conference-2015-01-15", "https://www.nasdaq.com/articles/isis-pharmaceuticals-earns-milestone-payment-from-biogen-analyst-blog-2015-01-15", "https://www.nasdaq.com/articles/will-biogen-biib-surpass-q4-earnings-expectations-analyst-blog-2015-01-27", "https://www.nasdaq.com/articles/biogen-to-acquire-convergence-expand-pain-pipeline-analyst-blog-2015-01-13", "https://www.nasdaq.com/articles/seattle-genetics-bristol-myers-to-study-adcetris-opdivo-analyst-blog-2015-01-13", "https://www.nasdaq.com/articles/which-big-biotech-will-soar-2015-2015-01-12", "https://www.nasdaq.com/articles/better-healthcare-buy-big-or-little-biotechs-2015-01-11", "https://www.nasdaq.com/articles/iyh-biib-mdt-act-etf-inflow-alert-2015-01-09", "https://www.nasdaq.com/articles/isis-pharmaceuticals-improves-2014-outlook-shares-up-analyst-blog-2015-01-09", "https://www.nasdaq.com/articles/diving-deeper-biogens-lingo-results-2015-01-09", "https://www.nasdaq.com/articles/health-care-sector-update-01142015-azn-isis-vicl-2015-01-14", "https://www.nasdaq.com/articles/nasdaq-100-movers-biib-tsco-2015-01-08", "https://www.nasdaq.com/articles/3-biotech-stocks-could-trounce-gilead-sciences-inc-2015-2015-01-07", "https://www.nasdaq.com/articles/why-isis-pharmaceuticals-inc-stock-surged-19-december-2015-01-07", "https://www.nasdaq.com/articles/nasdaq-100-movers-nxpi-biib-2015-01-06", "https://www.nasdaq.com/articles/why-biogen-idec-inc-stock-catapulted-10-higher-december-2015-01-06", "https://www.nasdaq.com/articles/isis-pharmaceuticals-up-on-collaboration-with-jj-analyst-blog-2015-01-06", "https://www.nasdaq.com/articles/vug-celg-biib-act-large-inflows-detected-etf-2014-12-31", "https://www.nasdaq.com/articles/biogen-reveals-positive-data-from-acute-optic-neuritis-study-analyst-blog-2015-01-09", "https://www.nasdaq.com/articles/devon-energy-achieves-107-analyst-rank-surpassing-biogen-idec-2014-12-26", "https://www.nasdaq.com/articles/stock-market-news-for-december-26-2014-market-news-2014-12-26", "https://www.nasdaq.com/articles/after-gilead-sciences-is-it-time-to-sell-biotech-stocks-analyst-blog-2014-12-26", "https://www.nasdaq.com/articles/vanda-gains-fanapt-rights-from-novartis-for-the-u.s.-region-analyst-blog-2014-12-24", "https://www.nasdaq.com/articles/xlv-biib-act-agn-large-inflows-detected-etf-2014-12-22", "https://www.nasdaq.com/articles/3-drugmakers-facing-pivotal-2015-2014-12-22", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-kalydeco-label-expanded-in-the-u.s.-analyst-blog-2014-12-30", "https://www.nasdaq.com/articles/prothena-corp.-prta-looks-good%3A-stock-moves-up-5.7-tale-of-the-tape-2014-12-22", "https://www.nasdaq.com/articles/orexigens-obesity-drug-mysimba-gets-chmp-nod-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/genomic-health-ghdx-shines-on-prospective-cancer-tests-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/roche-to-acquire-austrian-biotechnology-company-dutalys-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/celgene-gets-positive-chmp-recommendation-for-revlimid-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/novo-nordisks-tresiba-favored-by-chmp-for-expanded-use-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/eli-lilly-adocia-strike-deal-to-develop-ultra-rapid-insulin-analyst-blog-2014-12-22", "https://www.nasdaq.com/articles/puma-biotechnology-pbyi-jumps%3A-stock-moves-6.1-up-tale-of-the-tape-2014-12-22", "https://www.nasdaq.com/articles/prothena-corp.-prta-looks-good%3A-stock-moves-up-5.7-tale-of-the-tape-2014-12-22", "https://www.nasdaq.com/articles/3-pharma-giants-growing-significantly-faster-pfizer-inc-2014-12-19", "https://www.nasdaq.com/articles/agenus-jumps-on-positive-data-from-shingles-candidate-analyst-blog-2014-12-19", "https://www.nasdaq.com/articles/integra-lifesciences-up-on-launch-of-bilayer-skin-product-analyst-blog-2014-12-19", "https://www.nasdaq.com/articles/bruker-unveils-bioafm-system-for-high-resolution-imaging-analyst-blog-2014-12-18", "https://www.nasdaq.com/articles/ovascience-slumps%3A-ovas-tanks-12.3-in-session-tale-of-the-tape-2014-12-16", "https://www.nasdaq.com/articles/which-biotech-will-become-next-gilead-sciences-inc-2014-12-16", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-could-surprise-investors-2015-2014-12-21", "https://www.nasdaq.com/articles/trevena-trvn-in-focus%3A-stock-rallies-7.5-tale-of-the-tape-2014-12-16", "https://www.nasdaq.com/articles/alkermes-starts-phase-i-study-on-schizophrenia-candidate-analyst-blog-2014-12-16", "https://www.nasdaq.com/articles/acordas-ampyra-in-phase-iii-for-post-stroke-walking-deficit-analyst-blog-2014-12-16", "https://www.nasdaq.com/articles/is-illumina-ilmn-worth-adding-to-your-portfolio-analyst-blog-2014-12-16", "https://www.nasdaq.com/articles/opko-up-on-announcing-global-partnership-with-pfizer-analyst-blog-2014-12-16", "https://www.nasdaq.com/articles/genomic-healths-breast-cancer-test-yields-positive-results-analyst-blog-2014-12-16", "https://www.nasdaq.com/articles/strength-seen-in-gtx-inc-gtxi%3A-stock-rises-10.6-tale-of-the-tape-2014-12-15", "https://www.nasdaq.com/articles/biodelivery-sciences-bdsi-in-focus%3A-stock-tanks-11-tale-of-the-tape-2014-12-16", "https://www.nasdaq.com/articles/alexions-soliris-receives-orphan-drug-status-in-japan-analyst-blog-2014-12-15", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-starts-defibrotide-rolling-nda-filing-analyst-blog-2014-12-15", "https://www.nasdaq.com/articles/sangamo-biosciences-sgmo-jumps%3A-stock-rises-7.2-tale-of-the-tape-2014-12-12", "https://www.nasdaq.com/articles/alder-biopharmaceuticals-inc.-aldr-in-focus%3A-stock-soars-31.9-tale-of-the-tape-2014-12-12", "https://www.nasdaq.com/articles/celladon-corporation-cldn-falls%3A-stock-goes-down-8.6-tale-of-the-tape-2014-12-12", "https://www.nasdaq.com/articles/3-reasons-biogen-idec-inc-could-soar-2015-2014-12-12", "https://www.nasdaq.com/articles/tevas-teva-2015-guidance-hit-by-generics-analyst-blog-2014-12-12", "https://www.nasdaq.com/articles/alder-biopharmaceuticals-slumps%3A-aldr-falls-5.5-in-session-tale-of-the-tape-2014-12-15", "https://www.nasdaq.com/articles/alexions-soliris-receives-orphan-drug-status-in-japan-analyst-blog-2014-12-15", "https://www.nasdaq.com/articles/pdl-biopharmas-q4-revenues-to-rise-y-y-on-higher-royalties-analyst-blog-2014-12-11", "https://www.nasdaq.com/articles/genomic-healths-liquid-biopsy-tests-positive-in-twin-studies-analyst-blog-2014-12-11", "https://www.nasdaq.com/articles/abbvie-reveals-phase-ii-data-on-blood-cancer-drug-at-ash-revised-analyst-blog-2014-12-10", "https://www.nasdaq.com/articles/3-biotech-stocks-buy-december-2014-12-10", "https://www.nasdaq.com/articles/avalanche-biotechnologies-aavl-jumps%3A-stock-adds-6.1-in-session-tale-of-the-tape-2014-12", "https://www.nasdaq.com/articles/incyte-incy-gains-on-positive-baricitinib-study-results-analyst-blog-2014-12-10", "https://www.nasdaq.com/articles/ophthotech-corporation-opht-jumps%3A-stock-gains-5-tale-of-the-tape-2014-12-11", "https://www.nasdaq.com/articles/myriad-genetics-unveils-positive-cancer-study-results-analyst-blog-2014-12-10", "https://www.nasdaq.com/articles/rexahn-pharmaceuticals-inc.-rnn-rises%3A-stock-up-8.6-tale-of-the-tape-2014-12-09", "https://www.nasdaq.com/articles/acceleron-pharma-inc.-xlrn-in-focus%3A-stock-soars-13.6-tale-of-the-tape-2014-12-09", "https://www.nasdaq.com/articles/bluebird-bio-blue-in-focus%3A-stock-surges-9.4-tale-of-the-tape-2014-12-09", "https://www.nasdaq.com/articles/isis-jumps-on-positive-results-for-venous-thrombosis-drug-analyst-blog-2014-12-09", "https://www.nasdaq.com/articles/dynavax-astrazeneca-alter-agreement-for-asthma-product-analyst-blog-2014-12-09", "https://www.nasdaq.com/articles/alnylam-reports-positive-initial-phase-i-data-on-aln-at3-analyst-blog-2014-12-09", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-slips-after-dosing-issue-on-jzp-386-analyst-blog-2014-12-10", "https://www.nasdaq.com/articles/myriad-genetics-unveils-positive-cancer-study-results-analyst-blog-2014-12-10", "https://www.nasdaq.com/articles/compugen-cgen-worth-watching%3A-stock-moves-8.8-higher-tale-of-the-tape-2014-12-08", "https://www.nasdaq.com/articles/kindred-biosciences-inc.-kin-in-focus%3A-stock-soars-10.6-tale-of-the-tape-2014-12-08", "https://www.nasdaq.com/articles/amgen-unveils-positive-results-from-blood-cancer-studies-analyst-blog-2014-12-08", "https://www.nasdaq.com/articles/pharmacyclics-pcyc-launches-u.s.-based-cll-registry-analyst-blog-2014-12-08", "https://www.nasdaq.com/articles/agios-agio-reports-encouraging-data-on-leukemia-drug-analyst-blog-2014-12-08", "https://www.nasdaq.com/articles/pharmacyclics-presents-imbruvica-data-at-the-ash-meeting-analyst-blog-2014-12-09", "https://www.nasdaq.com/articles/abbvie-reveals-phase-ii-data-on-blood-cancer-drug-at-ash-analyst-blog-2014-12-08", "https://www.nasdaq.com/articles/3-large-cap-biotech-stocks-could-pay-dividends-wont-2014-12-07", "https://www.nasdaq.com/articles/exciting-news-game-changing-alzheimers-drug-could-be-its-way-2014-12-06", "https://www.nasdaq.com/articles/bayer-files-hemophilia-a-drug-marketing-application-in-eu-analyst-blog-2014-12-05", "https://www.nasdaq.com/articles/array-biopharma-inc.-arry-in-focus%3A-stock-soars-14.3-tale-of-the-tape-2014-12-05", "https://www.nasdaq.com/articles/walgreens-wag-up-on-4.9-y-y-rise-in-november-sales-analyst-blog-2014-12-05", "https://www.nasdaq.com/articles/celldexs-glembatumumab-vedotin-in-phase-ii-for-melanoma-analyst-blog-2014-12-05", "https://www.nasdaq.com/articles/seattle-genetics-takedas-adcetris-shows-long-term-effect-analyst-blog-2014-12-08", "https://www.nasdaq.com/articles/why-isis-pharmaceuticals-inc-stock-leaped-12-november-2014-12-04", "https://www.nasdaq.com/articles/sequenom-inc.-sqnm-in-focus%3A-stock-surges-23.6-tale-of-the-tape-2014-12-04", "https://www.nasdaq.com/articles/amgens-blincyto-gets-fda-nod-carries-boxed-warning-analyst-blog-2014-12-04", "https://www.nasdaq.com/articles/adma-biologics-ri-002-positive-in-phase-iii-study-analyst-blog-2014-12-04", "https://www.nasdaq.com/articles/synageva-completes-bla-submission-for-sebelipase-alfa-analyst-blog-2014-12-04", "https://www.nasdaq.com/articles/array-biopharma-regains-binimetinib-rights-from-novartis-analyst-blog-2014-12-04", "https://www.nasdaq.com/articles/biotech-stock-roundup-avanir-be-acquired-japanese-firm-biogen-scores-alzheimers-study", "https://www.nasdaq.com/articles/incytes-jakafi-gets-fda-approval-for-polycythemia-vera-analyst-blog-2014-12-05", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-jazz-starts-late-stage-study-on-xyrem-analyst-blog-2014-12-03", "https://www.nasdaq.com/articles/biogen-idec-biib-shows-strength%3A-stock-moves-6.4-up-tale-of-the-tape-2014-12-03", "https://www.nasdaq.com/articles/puma-biotechnology-down-on-delay-in-neratinib-nda-filing-analyst-blog-2014-12-03", "https://www.nasdaq.com/articles/actelion-submits-marketing-application-for-uptravi-in-eu-analyst-blog-2014-12-03", "https://www.nasdaq.com/articles/biogen-up-on-encouraging-interim-data-on-alzheimers-drug-analyst-blog-2014-12-03", "https://www.nasdaq.com/articles/myriad-genetics-prolaris%3A-a-pocket-friendly-cancer-test-analyst-blog-2014-12-03", "https://www.nasdaq.com/articles/midday-update-stocks-positive-construction-spending-auto-sales-2014-12-02", "https://www.nasdaq.com/articles/stock-market-news-for-december-03-2014-market-news-2014-12-03", "https://www.nasdaq.com/articles/nasdaq-100-movers-nxpi-biib-2014-12-02", "https://www.nasdaq.com/articles/stocks-resume-advance-buoyed-construction-spending-2014-12-02", "https://www.nasdaq.com/articles/noteworthy-etf-outflows-mtum-mu-act-biib-2014-12-02", "https://www.nasdaq.com/articles/intra-cellular-therapies-itci-jumps%3A-stock-rises-6.8-tale-of-the-tape-2014-12-02", "https://www.nasdaq.com/articles/medicinova-mnov-looks-good%3A-stock-soars-19.3-tale-of-the-tape-2014-12-02", "https://www.nasdaq.com/articles/pharmacyclics-jj-seek-imbruvica-label-expansion-in-eu-analyst-blog-2014-12-02", "https://www.nasdaq.com/articles/regeneron-bayers-eylea-to-be-reviewed-on-a-priority-basis-analyst-blog-2014-12-02", "https://www.nasdaq.com/articles/sp-500-movers-nem-biib-2014-12-02", "https://www.nasdaq.com/articles/astrazeneca-eli-lilly-start-mid-stage-alzheimers-study-analyst-blog-2014-12-02", "https://www.nasdaq.com/articles/momentas-necuparanib-gets-fast-track-status-in-the-u.s.-analyst-blog-2014-12-02", "https://www.nasdaq.com/articles/health-care-sector-update-12022014-biib-imnp-qdel-pfe-gsk-2014-12-02", "https://www.nasdaq.com/articles/dynavax-regains-tlr-7-9-inhibitor-dv1179-rights-from-glaxo-analyst-blog-2014-12-01", "https://www.nasdaq.com/articles/vertex-pharmaceuticals-52-week-high-driven-by-kalydeco-analyst-blog-2014-12-01", "https://www.nasdaq.com/articles/oncothyreon-inc.-onty-in-focus%3A-stock-surges-10.1-tale-of-the-tape-2014-11-28", "https://www.nasdaq.com/articles/alexions-soliris-gets-final-positive-nice-recommendation-analyst-blog-2014-11-28", "https://www.nasdaq.com/articles/closing-update-dow-closes-record-high-positive-data-rebound-energy-sector-2014-12-02", "https://www.nasdaq.com/articles/strength-seen-in-kythera-kyth%3A-stock-moves-5.5-higher-tale-of-the-tape-2014-11-26", "https://www.nasdaq.com/articles/alexions-alxn-soliris-gets-orphan-drug-status-in-japan-analyst-blog-2014-11-26", "https://www.nasdaq.com/articles/isis-pharmaceuticals-earns-milestone-on-study-initiation-analyst-blog-2014-11-26", "https://www.nasdaq.com/articles/intra-cellular-commences-phase-iii-schizophrenia-study-analyst-blog-2014-11-26", "https://www.nasdaq.com/articles/coronado-biosciences-cndo-jumps%3A-stock-rises-8.5-tale-of-the-tape-2014-11-25", "https://www.nasdaq.com/articles/prosensa-soars-on-%24680m-buyout-offer-from-biomarin-analyst-blog-2014-11-25", "https://www.nasdaq.com/articles/amgen-ends-gastric-cancer-drug-studies-safety-review-analyst-blog-2014-11-25", "https://www.nasdaq.com/articles/avanirs-migraine-drug-gets-complete-response-letter-analyst-blog-2014-11-27", "https://www.nasdaq.com/articles/ocera-therapeutics-ocrx-worth-watching%3A-stock-up-9.4-tale-of-the-tape-2014-11-24", "https://www.nasdaq.com/articles/enzo-biochem-enz-in-focus%3A-stock-moves-6.9-higher-tale-of-the-tape-2014-11-24", "https://www.nasdaq.com/articles/abbvies-hcv-cocktail-treatment-closer-eu-approval-analyst-blog-2014-11-24", "https://www.nasdaq.com/articles/immunomedics-veltuzumab-receives-orphan-drug-status-analyst-blog-2014-11-24", "https://www.nasdaq.com/articles/xoma-corp-worth-watching%3A-stock-moves-10.3-higher-tale-of-the-tape-2014-11-21", "https://www.nasdaq.com/articles/epirus-biopharmaceuticals-eprs-jumps%3A-stock-up-15.9-tale-of-the-tape-2014-11-21", "https://www.nasdaq.com/articles/compugen-cgen-worth-watching%3A-stock-adds-6-in-session-tale-of-the-tape-2014-11-21", "https://www.nasdaq.com/articles/spy-ba-cop-biib-etf-outflow-alert-2014-11-24", "https://www.nasdaq.com/articles/novavax-gains-on-fast-track-designation-for-rsv-f-vaccine-analyst-blog-2014-11-21", "https://www.nasdaq.com/articles/epizyme-gains-on-positive-phase-i-data-on-epz-6438-analyst-blog-2014-11-21", "https://www.nasdaq.com/articles/is-illumina-ilmn-worth-adding-to-your-portfolio-analyst-blog-2014-11-21", "https://www.nasdaq.com/articles/amgen-and-abbvie-strengthen-manufacturing-facilities-in-asia-analyst-blog-2014-11-21", "https://www.nasdaq.com/articles/agios-agio-shares-up-on-positive-ag-120-study-data-analyst-blog-2014-11-20", "https://www.nasdaq.com/articles/mallinckrodt-q4-earnings-boosted-by-acquisitions-sales-beat-analyst-blog-2014-11-19", "https://www.nasdaq.com/articles/argos-therapeutics-args-jumps%3A-stock-gains-7.4-tale-of-the-tape-2014-11-19", "https://www.nasdaq.com/articles/high-yield-dividend-stock-screams-danger-2014-11-21", "https://www.nasdaq.com/articles/kite-pharma-gains-on-positive-opinion-for-kte-c19-analyst-blog-2014-11-18", "https://www.nasdaq.com/articles/actavis-strikes-66-billion-deal-botox-maker-allergan-analyst-blog-2014-11-18", "https://www.nasdaq.com/articles/kite-pharmas-q3-loss-narrows-y-y-focus-on-pipeline-analyst-blog-2014-11-17", "https://www.nasdaq.com/articles/alnylam-reports-positive-initial-phase-ii-data-on-revusiran-analyst-blog-2014-11-17", "https://www.nasdaq.com/articles/is-mallinckrodt-mnk-poised-to-beat-q4-earnings-estimates-analyst-blog-2014-11-17", "https://www.nasdaq.com/articles/sanofis-lemtrada-gets-u.s.-approval-carries-boxed-warning-analyst-blog-2014-11-17", "https://www.nasdaq.com/articles/puma-biotechnology-falls-on-disappointing-neratinib-data-analyst-blog-2014-11-17"], "Content": []}